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In this thesis, we developed methods for micropeptide discovery and applied these 
methods to several biological systems to find evidence of novel translated 
micropeptides. Micropeptides are small proteins translated from open reading frames 
shorter than 100 codons, and have historically been understudied in genome 
annotations. This framework allows discovery of these peptides, by an approach called 
proteogenomics, which combines mass spectrometry-based proteomics with deep 
sequencing-based transcriptomics in order to study the genome. We developed a 
bioinformatics framework for micropeptide discovery experiments, and also developed 
and validated an LC-MS/MS platform for micropeptide discovery. Finally, to show these 
methods are broadly applicable, we used these methods to analyze the liver proteome, 
the HIV-1 virion proteome, and the mouse cerebellum proteome, finding evidence of 
novel micropeptides in each case. 
Micropeptides are thought to be low-abundance, and therefore difficult to detect by 
biochemical methods. A lack of sensitivity in proteomics is often due to suppression 
effects of high abundance molecules which co-elute with low abundance molecules. We 
developed a two dimensional chromatography platform, in which a strong cation 
exchange column is coupled in series with two hydrophobicity columns all coupled to a 
tandem mass spectrometer, allowing online fractionation of peptides. Applying this 
system to micropeptidomics, we have shown that sensitivity for micropeptides greatly 
increases as well. This system is applied in to discover novel micropeptides in human 
liver. 
The framework was applied to several biological systems with varying degrees of 
genome complexity: the HepG2 liver cell line, to study the human liver proteome, purified 
HIV-1 virions, to study the packaged virion proteome, and the mouse brain. The three 
experiments represent a large range of genomic complexity: HIV-1 has a very small 
genome, the human genome is much larger, and the mammalian CNS genome is 
believed to be highly complex due to alternative splicing.  
The human liver HepG2 cell line was subjected to proteogenomics analysis. A 
transcriptome assembly was translated in silico and used to search for peptide products 
from all possible open reading frames shorter than 100 codons. Two novel peptides 
were found with high confidence. Next, HIV-1 virions were subjected to proteogenomics. 
The HIV-1 genome is very small, so the whole genome was translated. In order to 
capture strain-specific differences, three biological replicates were genomically 
sequenced, and the resulting HIV-1 genome assemblies translated in silico. One novel 
peptide was observed in each replicate with high confidence. 
Finally, the mouse brain was subjected to proteogenomics in order to find novel secreted 
peptides. The soluble fraction of mouse brain was used to generate proteomics data. As 
the mammalian CNS proteome is believed to be very complex due to alternative splicing 
we utilized ribosome profiling data, which allows reading frame and translation start sites 
to be determined. A translatome was assembled from the frame determination and used 
to generate the database for proteomics analysis. Several micropeptides were again 
found, and in particular one highly expressed peptide was found to be enriched in 
behavior regulating regions of the brain. 
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Thus, applying the framework to several different biological systems shows that it is 
robust against various genomes so that micropeptides can be discovered in various 
experimental contexts. The results also suggest the ubiquity of micropeptide expression 
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The sequencing and publication of complete genomic sequences of many 
organisms has aided the medical sciences greatly, allowing advances in both the 
genetics and biology of human disease and greater understanding of the biology of 
human pathogens. In particular, the human genome sequence has advanced human 
disease genetics by allowing genome-wide association studies (GWAS), and knowledge 
of gene sequences and their chromosomal loci has produced deeper understanding of 
the biology of all organisms whose genomes have been sequenced, including human 
pathogens such as HIV. Crucial to all of these efforts is genome annotation, which uses 
genomic, genetic, epigenetic, and other information to find loci in the genome which 
code functional genes. While genome annotation has been performed alongside efforts 
to sequence genomes, the continuing pace of novel gene discovery, aided by advancing 
technology in molecular biology and biochemistry, shows that annotation is often 
incomplete. 
During the early stages of genome annotation, when genomes such as the 
human genome were first sequenced, a lower limit was placed upon the length of an 
open reading frame (ORF) that could be considered a possible gene(Bissette, Nemeroff, 
& MacKay, 1986; Dujon et al., 1994). These limits were set by modeling a biochemically 
equivalent random genome, and determining the ORF length distribution over that 
random genome, thus showing the length distribution of ‘random’ ORFs. In the case of 
the human genome, in order to exclude such random ORFs, the minimum ORF length 
was set to be 100 codons by reasoning about the size distribution of random ORFs. 
However, while a high proportion of ORFs below these limits may be spurious, there are 
also a substantial number which are real genes, and these are missed by such a filtering 
step(Basrai, Hieter, & Boeke, 1997). Furthermore, while gene discovery can be 
accomplished by means other than genome annotation, it appears that these original 
3 
 
genome annotation decisions continue to be reflected in our current understanding of 
genomes, since there is a disproportionately low number of genes annotated for the 
human genome below the 100 codon cutoff(Frith et al., 2006). 
Recently, evidence has emerged that many of these short (<100 codons) open 
reading frames may indeed be protein-coding genes, whose gene products have been 
named ‘micropeptides.’ Evidence for functionality of these short peptides has come from 
several sources, including bioinformatics, through novel conservation analyses(Crowe, 
Wang, & Rothnagel, 2006), and biochemical approaches, such as expressed sequence 
tag experiments(Frith et al., 2006), deep sequencing based-experiments such RNA 
sequencing(Kageyama, Kondo, & Hashimoto, 2011) and ribosome profiling(Ingolia, 
Lareau, & Weissman, 2011). These micropeptides have been found in studies of many 
model organisms, suggesting that micropeptide genes indeed exist throughout all 
genomes. Nevertheless, it has been controversial how many micropeptide genes there 
are, and general estimates have varied by orders of magnitude. In particular, since all 
techniques have biases and false positives, there has been continued debate on the 
extent to which evidence for micropeptides is artifact of the techniques used for 
discovery(Guttman, Russell, Ingolia, Weissman, & Lander, 2013; Ingolia et al., 2014). 
Furthermore, the mechanisms by which micropeptides perform their functions in the cell 
is often difficult to define exactly; in particular, it is still not clear whether micropeptides 
as a class of protein share a general cellular role, or whether they have diverse functions 
in the same way large well-annotated proteins do. 
In prokaryotes, annotation of short open reading frame (sORF)-encoded 
micropeptides has been of increasing interest. In the bacterium Mycoplasma 
pneumoniae, micropeptides translated from non-coding RNA (ncRNA) were discovered 
by mass spectrometry, defining the total complement of micropeptides in that organism’s 
genome at 67, approximately 5% of all coding genes(Lluch-Senar et al., 2015). A 
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transposon-based essentiality screen found that 53% of these micropeptides were 
essential for the bacterium’s growth, indicating that many micropeptides are not only 
functional but essential for bacterial growth. Since M. pneumoniae has a relatively small 
genome of 816 kb which is likely to be well annotated, such an essentiality study also 
suggests that many micropeptides are proteins essential for a minimal organism and 
thus essential for life(Lluch-Senar et al., 2015). Similarly, in the bacterial strains 
Synechocystis 6803 and Synechocystis 6714, and bioinformatics screen using BLAST 
searches found 293 transcriptional units putatively encoding micropeptides, of which 5 
could be functionally characterized, showing structural features such as transmembrane 
helices and regulated expression during environmental perturbation and bacterial stress 
responses(Baumgartner, Kopf, Klahn, Steglich, & Hess, 2016; Hemm et al., 2010). 
Finally, in the widely used model bacterium Escherichia coli, 44 micropeptides have 
been found, many of which also perform basic functions in the cell(Hemm, Paul, 
Schneider, Storz, & Rudd, 2008). 
Micropeptide discovery has also continued apace in eukaryotic model systems. A 
study in Saccharomyces cerevisiae by ribosome profiling found many cases of 
translation of micropeptides, which appear to serve some purpose during the meiotic 
process(Brar et al., 2012). During meiosis, translation of some 9,989 unannotated ORFs 
was found, with a mean lengths of the novel ORFs of 46.8 codons, much shorter than 
the average of known genes of 484.9, and substantially under the 80 to 100 codon cutoff 
which was used to annotate the yeast genome. These novel genes appeared to have 
their translation increased in a regulated fashion during meiosis, indicating once again 
that they are functional, although the functions of these many putative novel genes have 
not been defined yet(Brar et al., 2012). A bioinformatics screen of the yeast genome 
searching for micropeptides similarly yielded 184 yeast sORFs conserved across many 
species, suggesting that they may be functional(Kastenmayer et al., 2006). These novel 
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genes were then validated as to function by development of deletion strains for 140 of 
them, of which 9 gave clearly observable phenotypes. The latter study provides a model 
of how novel micropeptide genes can be validated as to function; furthermore, the large 
increase in the number of micropeptides observed between the two studies 
demonstrates the role of advancing technology in the rapid advance of micropeptide 
annotation. 
Studies in higher-order animals have also found several significant novel 
micropeptides. Perhaps most relevantly for human health, a screen in Danio rerio 
discovered a novel micropeptide translated from a transcript annotated as a long non-
coding transcript (lncRNA), christening the micropeptide Toddler(Pauli et al., 2014). This 
micropeptide was discovered by a series of screens, in which developing zebrafish were 
subjected to RNA sequencing to discover novel lncRNAs(Chew et al., 2013), and the 
same material was used for a ribosome profiling study(Pauli et al., 2012). The latter 
ribosome profiling study showed that 399 of the putative lncRNAs were indeed 
translated, of which one produced a micropeptide which was confirmed by mass 
spectrometry. GFP-tagging of the novel micropeptide to find tissue distribution and 
production of a knockout animal showed that the micropeptide appeared to function as 
an extracellular secreted ligand for the Apelin receptor, essential for cell migration during 
embryonic development(Pauli et al., 2014). Importantly, the same micropeptide was 
found to be essential for regulation of the human cardiovascular system, again 
functioning as a ligand for the Apelin receptor(Yang et al., 2017). As GPCRs are very 
frequently targeted by drugs, the discovery of this novel ligand could eventually produce 
a novel cardiovascular therapy, as has been recently proposed. This series of studies 
thus shows that discoveries of micropeptides in animals can not only be relevant for 
human biology, they can also almost immediately lead to novel therapies. 
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In another animal model system, Drosophila melanogaster, progress in 
annotation of micropeptides has been even more rapid. Several screens of this system 
have produced a number of novel micropeptides which regulate the cardiovascular 
system(Magny et al., 2013), developmental regulation through proteasomal 
function(Zanet et al., 2015), and control of RNA polymerase(Hanyu-Nakamura, Sonobe-
Nojima, Tanigawa, Lasko, & Nakamura, 2008). In the cardiovascular system, the 
micropeptides Sarcolamban A and B were initially found in a search for functional 
sORFs among the set of putative ncRNAs, a screen which found two possible 
micropeptides of 28 and 29 amino acids long on a single transcript(Magny et al., 2013). 
In vivo translation and GFP tagging confirmed translation localized to the sarcoplasmic 
reticulum, and a null mutant showed a cardiac arrhythmia phenotype with dysregulated 
calcium transients, suggesting a novel micropeptide involved in regulation of the 
Sarcoplasmic-endoplasmic reticulum calcium (SERCA) pump. Strikingly, the 
micropeptides were found to be highly evolutionarily conserved throughout evolution, 
including in humans(Magny et al., 2013). In Drosophila development, the mlpt/tal/pri 
gene, discovered independently by several groups, contains four sORFs which appear 
to code for peptides(Zanet, Chanut-Delalande, Plaza, & Payre, 2016). Null mutants of 
this gene show dramatically dysregulated development, apparently due to disruption of a 
transcription factor(Zanet et al., 2015). In this case, the micropeptides appear in some 
fashion to regulate the ubiquitination and proteasomal degradation of the transcription 
factor. Finally, in the regulation of transcription, the micropeptide pgc was postulated to 
be a coding transcript by investigation of the Kozak sequence surrounding a translation 
start site(Hanyu-Nakamura et al., 2008). Synthesis and injection of the micropeptide into 
the embryo showed that it directly regulated phosphorylation of the CTD of Pol II, and 
immunoprecipitation showed that this was mediated by an interaction with P-TEFb. 
These three examples, unlike the above Toddler example above, show cases of 
7 
 
intracellular micropeptides regulating protein-protein interactions, in the case of 
Sarcolamban hydrophobic micropeptides regulating a membrane bound ion channel, 
and in the latter two cases soluble micropeptides regulating cytosolic interaction. 
Further, a recent genome-wide study by ribosome profiling has increased the number of 
candidate micropeptides in that genome to ~285, although most of these are of unknown 
function(Aspden et al., 2014; Zanet et al., 2016). 
In mouse and human, finally, there has also been progress in identifying 
biologically relevant micropeptides, including the case of the Toddler peptide described 
above. Next, and also significantly, is the Myoregulin micropeptide, which followed on 
from the discovery of Sarcolamban in Drosophila already described(Anderson et al., 
2015). Like Sarcolamban, the Myoregulin micropeptide regulates activity of the SERCA 
pump and thereby calcium transients, and similarly, it was found by bioinformatically 
screening newly discovered non-coding RNA transcripts for sORFs which could encode 
putative micropeptides. In this case, the screening was done by evolutionary 
conservation, and found a 46 amino acid peptide in a skeletal muscle-specific transcript. 
The peptide was found by labeling experiments to interact with the SERCA pump and 
have some homology to Sarcolamban, as well as to the human peptides 
Phospholamban and Sarcolipin(Anderson et al., 2015). Remarkably, the 
Phospholamban and Sarcolipin micropeptides have been known for some time as 
regulators of SERCA activity, but their tissue expression is limited to slow skeletal 
muscle and cardiac muscle, leaving a long-standing mystery as to how SERCA is 
regulated in other tissues; the Myoregulin peptide begins to solve this mystery. Further, 
extending work on the Myoregulin micropeptide, three more micropeptide members of 
the same family were found by screening the peptide binding motif of the family, 
discovering the micropeptides Dworf(B. R. Nelson et al., 2016), Endoregulin and 
Another-regulin(Anderson et al., 2016). These peptides all regulate SERCA, and their 
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tissue distribution is substantially different, including tissues beyond muscle(Anderson et 
al., 2016), indicating that micropeptide-SERCA interactions are a widespread and 
perhaps fundamental system for regulating calcium transients in mouse and human. 
Beyond bioinformatics screens of ORFs in ncRNAs, the human and mouse 
systems have also been substantially probed for micropeptides by ribosome profiling. A 
recent study in mouse embryonic stem cells found that many sORFs are indeed 
translated in these cells, and the majority of lincRNAs have translation levels 
comparable to annotated protein-coding genes, suggesting that many lincRNAs in fact 
encode micropeptides(Ingolia et al., 2011). The same study also observed widespread 
translation in upstream ORFs (uORFs) of known coding genes, which translation was 
downregulated during embryoid body formation. However, these latter observations 
cannot necessarily be taken to indicate functional micropeptides, since ribosome 
presence on a transcript means at most that a peptide is produced, but not that it is 
functional. For example, ribosome presence on upstream ORFs has canonically been 
interpreted as a regulatory process by which the ribosome’s access to the main coding 
ORF is blocked, thus impeding translation of the main ORF(Hinnebusch, 2014). These 
uORF peptides, however, have been recently found to presented on MHC molecules, 
indicating at least a potential function in human immunity in some cases(Starck et al., 
2016). Similarly, in human HEK293 cells, a recent ribosome profiling study found 
evidence of widespread translation in both uORFs and ncRNA-sORFs, and found 
evolutionary conservation of these translated ORFs(S. Lee et al., 2012). Once again, 
however, this cannot be taken to be definitive evidence of functional micropeptides. 
In the human genome, annotation of micropeptides as to function has been 
somewhat limited, possibly by the complexity of the system; however, two functional 
micropeptides have been found, both in the human mitochondrial genome. The Humanin 
peptide, encoded by a short ORF from the mitochondrial DNA, was discovered some 
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years ago by a purely functional cDNA library screen for genes inhibiting 
apoptosis(Hashimoto et al., 2001). The cDNA was then confirmed to produce a peptide 
by discovery of its interaction with a cell-death regulator by a yeast 2-hybrid screen(Guo 
et al., 2003). More recently, the MOTS-c peptide, which regulates metabolism in some 
fashion, has been discovered in an sORF on the 12s rRNA gene in the mitochondrial 
genome by a bioinformatics screen of sORFs in mtDNA, showing a conserved 51 nt 
ORF with a strong Kozak context(C. Lee et al., 2015). Treatment of HEK293 cells with a 
synthetic peptide substantially regulated gene expression of enzymes involved in cellular 
metabolism, and treatment of mice fed a high fat diet prevented obesity, suggesting that 
the peptide is an extracellular signaling molecule.  
Finally, substantial probing of viral genomes for micropeptides has also yielded 
some interesting results. Due to the small size of many their genomes, historically, viral 
genomes were not usually annotated with the explicit lower limits on the lengths of open 
reading frames, although the vaccinia virus, which has a large genome, had a lower limit 
of 65 codons for its original annotation(Goebel et al., 1990). Even without explicit minima 
during annotation, many viral micropeptides were simply overlooked because of 
systematic assumptions of how large genes should be, as genomes were annotated in 
an ad hoc fashion(Ratner et al., 1985). Micropeptides in viral genomes have been 
discovered in a similarly ad hoc manner, with several micropeptides found in influenza 
virus, human immunodeficiency virus, papillomavirus, poxviruses and 
paramyxoviruses(DiMaio, 2014). These micropeptides are often dominated by a single 
alpha-helical transmembrane domain, which allows them to be inserted into lipid 
bilayers, in which context they can interact with and regulate host cell proteins (i.e., HIV-
1 Vpu), form ion-selective pores (i.e., influenza M2), allow binding and entry into host 
cells (i.e., poxvirus (O3L), or perform other functions crucial for the viral life 
cycle(DiMaio, 2014). These micropeptides are short genes which have been discovered 
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in genomes with many reading frames of such a size, and indeed, a recent genome-wide 
screen of human cytomegalovirus by ribosome profiling and mass spectrometry found 
~484 novel ORFs shorter than 80 codons, including 245 shorter than 20 codons which 
were actively translated by the ribosome(Stern-Ginossar et al., 2012). These latter 
micropeptides must be validated by functional studies, but the high number identified 
here shows that there may be a substantial number of micropeptides produced by 
viruses. 
It has been widely shown by a variety of methods, therefore, that despite 
underrepresentation in genome annotations, sORFs encode functional micropeptides in 
nearly all genomes studied, thus suggesting that there may be many micropeptides 
produced both from the human genome and from human pathogens that may be of 
relevance to human health. However, how many micropeptides there may be in 
genomes is still controversial. Many types of genome-wide approaches have given a 
wide range for how many coding micropeptides there are in the human genome, from 
tens of thousands to a few dozen(Andrews & Rothnagel, 2014). These problems reflect 
issues identifying sORFs which caused them to be overlooked in all genomes. In 
particular, it is difficult to detect evolutionary conservation of these ORFs, because their 
small size disrupts the statistical assumptions of homology detection algorithms such as 
BLAST or PhyloCSF(Couso, 2015). Thus, genome wide searches for conservation of 
sORFs incorrectly showed them to be unconserved. Secondly, very short peptides were 
thought to not have stable secondary structure, and thus, if biological function is 
assumed to be entirely dependent on the structure of the protein, short peptides could 
be assumed not to have a function(Ingolia et al., 2014; Wright & Dyson, 2015). This lack 
of secondary structure can also cause difficulties for genome-wide description of sORF-
encoded micropeptides, for example by a biochemical method such as mass 
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spectrometry, since peptides without stable conformations may be rapidly degraded 
when cell are lysed for extraction(Hackett et al., 1986). 
If these are reasons for micropeptide numbers to be underestimated historically, 
questions of artifact in newer methods may cause the number of functional 
micropeptides to be overestimated. In particular, each genome-wide method for 
micropeptide discovery can be prone to false positives for various reasons. Central 
methods which have been used to discover micropeptides genome-wide are ribosome 
profiling, mass spectrometry, RNA sequencing, and direct searches for conservation. In 
ribosome profiling, polysomes are extracted from cells, then treated with RNase to 
destroy RNA which is unprotected by ribosomes(Ingolia, Ghaemmaghami, Newman, & 
Weissman, 2009). The ribosome footprints are then sequenced, and these are used to 
map the positions of the ribosomes. These studies were some of the first to find 
translation of sORFs in the genome, and indeed found many ORFs translated from 
alternative start codons, which, if correct, would exponentially increase even the 
estimates of the number of potential sORFs in the genome(Ingolia et al., 2011). 
However, failure of RNase to digest a given section of the genome may be due factors 
besides ribosome content; in particular, RNA secondary structure may also block 
digestion, and RNA may also be underdigested due to sub-optimal reaction conditions. 
RNA-binding proteins may also block digestion. Furthermore, the mere presence of 
ribosomes in a given ORF does not necessarily demonstrate translation of that ORF. 
Certain features of ribosome profiling datasets, such as codon periodicity, can be used 
to determine ‘genuine’ translation, this continues to be controversial and as yet there is 
no definitive metric by which ORFs can be determined to be translated(Calviello et al., 
2016; Guttman et al., 2013; Ingolia et al., 2014).  
In RNA sequencing, the length of the transcript is sequenced, and the high 
sensitivity of this method has allowed many novel transcripts to be discovered. In 
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particular, RNA sequencing has recently discovered a large set of novel RNAs called 
long non-coding RNAs(Hart & Goff, 2016; Sun et al., 2013; Ulitsky & Bartel, 2013). 
These RNAs were originally believed to be non-coding because they contain no long 
ORF, but subsequent conservation analyses of short ORFs have revealed several of 
these lncRNAs to indeed be micropeptide-encoding(Anderson et al., 2015; Pauli et al., 
2014). Thus, lncRNAs, which continue to be discovered by improved deep sequencing 
methods, may therefore be a large source of novel micropeptides. However, for the 
reasons mentioned above, most mainstream conservation analyses cannot be well 
applied to short ORFs, and thus, screening for conserved sORFs in lncRNAs to search 
for micropeptides likely underestimates the total number of sORFs, and indeed may 
account for why some lncRNAs were originally misclassified as non-coding. A recent 
attempt to address this problem, in which a novel conservation detection method was 
developed using an SVM classifier, some 2000 novel ORFs were found in the 
genome(Mackowiak et al., 2015). However, only a small percentage of these could be 
identified by mass spectrometry or ribosomal profiling data, raising the possibility that 
this paper overestimates the number of conserved sORFs. Thus, the number of 
micropeptides produced by newly discovered lncRNAs continues to be an open 
question. For these kinds of reasons, RNA sequencing experiments have not been able 
to provide a clear picture of how many micropeptides there may be in genomes. 
Mass spectrometry for discovery of micropeptides also seems to run afoul of the 
underestimation problem. Firstly, as mentioned above, mass spectrometry attempts to 
directly detect micropeptides, and if it is correct that micropeptides are rapidly degraded 
by proteolytic enzymes after cell lysis, mass spectrometry thus may have problems with 
the speed of degradation of micropeptides after cell lysis. Secondly, lncRNAs are now 
known to be very low abundance in any given tissue(Cabili et al., 2015). Thus, detecting 
micropeptides translated from lncRNAs by mass spectrometry may have problems with 
13 
 
sufficient sensitivity. Indeed, across the literature one finds a mismatch between deep-
sequencing based results and mass spectrometry, with deep-sequencing based results 
generally producing much higher numbers of micropeptides detected than mass 
spectrometry. There are two possible explanations for the latter phenomenon; first, mass 
spectrometry may underestimate, or deep sequencing may overestimate, the number of 
micropeptides in the genome, or both; second, ribosomes may bind to many ORFs 
promiscuously, but these peptides are either not translated or quickly degraded and non-
functional. The former model implies that there are an undetermined number of 
micropeptides in the genome to discover, but the latter implies that there is no clear 
evidence that there is any substantial number of micropeptides in the genome. 
Considering these issues, we propose that micropeptide discovery can be well-
approached by the new technique of proteogenomics bioinformatics(Nesvizhskii, 2014), 
in which deep-sequencing data is used to generated candidate sequences to analyze 
mass spectrometry proteomics data. Mass spectrometry data must be searched against 
a database of candidate proteins in order to match experimental spectra to peptide 
sequences, and these databases have historically been lists of all annotated proteins 
from a genome(Eng, McCormack, & Yates, 1994); in proteogenomics, the database is 
produced by in vitro translation of a set of candidate sequences, from genomic or 
transcriptomic data. This allows mass spectrometry to orthogonally confirm ribosome 
profiling data indicating translation of micropeptides, and thus addresses the problem of 
the specific artifacts of each technical method to search for micropeptides genome-wide. 
Furthermore, we propose that since micropeptides are very low abundance, the 
sensitivity of mass spectrometry must be improved in order to discover them. We 
therefore here present a set of methods to discover micropeptides by mass 
spectrometry-based proteogenomics methods. In Chapter 2, we develop a novel method 
for online fractionation to improve sensitivity. This method can also be applied to 
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metabolomic profiling of cells and tissues, an application which we describe. In Chapter 
3, these mass spectrometry methods are used to find micropeptides in HepG2 cells and 
HIV-1 purified virions, by combining mass spectrometry data with RNA sequencing data. 
Finally in Chapter 4, the proteogenomics approach is used to combine mass 




























Chapter 2: Integrated Microfluidic Chip and Online SCX Separation Allows 





In order to study micropeptides, mass spectrometry methods must be developed in order 
to capture them for analysis. We have here developed a two-dimensional LC-MS/MS 
system, which allows high-sensitivity detection of micropeptides in tissues. This was 
accomplished by liquid-liquid extraction of peptides and metabolites from tissue samples 
and online SCX separation to allow characterization of each population individually. The 
platform was validated both by a mixed set of purified standards for synthetic peptide 
sequences and by an analysis of splenic tissue from SIV-infected macaques, showing 
both good reproducibility in chromatography, with RSD of hold time less than 0.4%, and 
clear separation of charge states, with ~95% of molecular features in SCX separated 
runs at expected charge states. The system can indeed be used to detect micropeptides 
as short as a few amino acids. Secondarily, we find that we can apply this system to 
perform metabolomics and micropeptidomics. These two molecular populations, 
metabolites and peptides, can be extracted from tissues in a similar fashion, and we 
therefore have here developed an integrated platform for their extraction and 
characterization. Finally, we used this platform to analyze the physiological response to 
infection in the spleen, showing that the spleen contains an abundance of hemoglobin-
derived peptides, which do not appear to change in response to infection, and that there 
appears to be a large and variable metabolic response to infection. We therefore present 





In recent years, the study of endogenous small molecule metabolites and 
endogenous peptides have both been greatly advanced by the application of high-
throughput methods. These fields, now called “metabolomics” and “peptidomics” involve 
the study of a broad swath of the metabolite and peptide molecular content of cells or 
tissues.(Milne, Mathews, Myers, Ivanova, & Brown, 2013; Oliver, Winson, Kell, & 
Baganz, 1998; Patti, Yanes, & Siuzdak, 2012; Schulz-Knappe, Schrader, & Zucht, 2005; 
Tautenhahn et al., 2012) The results from these kinds of analyses can support “systems” 
analyses of cells or tissues under perturbed or pathological conditions, in which the 
integration of data on several molecular species allows a holistic picture of a biological 
response.  Systems analyses therefore require methods by which several molecular 
species can be surveyed simultaneously. Furthermore, so-called micropeptides, which 
are produced by short open reading frames in genomes, can be discovered by mass 
spectrometry; however, since they are very low abundance, a high-sensitivity method for 
mass spectrometry must be used. Online fractionation can allow higher sensitivity for 
these low abundance analytes. 
The metabolome consists of all small molecule intermediates of metabolism in a 
cell, and thus includes amino acids, nucleotides, fatty acids, lipids, and each of their 
various metabolites. It can thus be considered the molecular component of a cell which 
is not under the direct control of the genome.(Milne et al., 2013) The peptidome, 
similarly, is the complement of peptide species produced by a cell. Peptides and 
metabolites together perform significant biological functions, and thus their levels can be 
used for direct phenotyping of a biological system. For example, in the nervous system, 
peptides and small molecule metabolites of amino acids both function as 
neurotransmitters. Finally, study of the small molecule complement of tissues allows the 
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characterization of exogenous molecules, such as drugs and environmental exposures; 
the so-called “exposome.”(Wild, 2012) Therefore, since a profile of these species, 
micropeptides and metabolites, provides a useful molecular picture of a cell or tissue, we 
sought to develop a simple and robust means of simultaneously extracting and then 
analyzing them, by means of a single sample preparation and then an online LC-MS 
separation. 
Here, we report the development of an HPLC-MS platform for simultaneous 
metabolomics and micropeptidomics. This was accomplished by integration of an online 
SCX separation into a nanoRPLC-MS/MS system. The platform was validated by a 
mixed set of small molecule and peptide standards, which showed separation into SCX 
fractions with good reproducibility. Applying our method to a tissue sample, we found 
that endogenous peptides seem to preferentially ionize in nanoESI, suppressing small 
molecule metabolite detection; these two molecular populations could be separated by 
our online SCX method, allowing both populations to be characterized. Finally, we used 
our platform to analyze the metabolome and peptidome of tissue samples in two 
biological conditions. Our platform thus provides an integrated workflow for fast and 
robust metabolite and peptide profiling in nanoLC systems already adapted for 
proteomics experiments, all in a combined MS analysis. 
Methods 
Reagents and Materials 
Ascorbic acid, ammonium hydroxide, dithiothreitol, sodium chloride and HPLC-grade 
acetic acid, formic acid, methanol, and acetonitrile were acquired from Sigma-Aldrich 
(St. Louis, MO). Amicon 50,000 MWCO filters were obtained from Millipore (Bedford, 
MA). SDS sample buffer was obtained from Life Technologies (Carlsbad, California). 
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Atenolol, serotonin creatinine sulfate monohydrate, and 9-anthracene carboxylic acid 
were used at 100 µM, 100 µM, and 10 µM, respectively, and were obtained from Sigma-
Aldrich (St. Louis, MO). Peptide standards were used at 150 pM and obtained from 
Biognosys AG (Zurich, Switzerland). 
Nanoflow HPLC-MS/MS System Profiling Method 
For the online SCX method, we integrated one SCX column (150 μm i.d. 2 cm length, 
Polysulfoethyl A, 5 μm 300 Å, PolyLC) into the Agilent HPLC-MS system, which is 
comprised of a 1200 Infinity HPLC system coupled to an Agilent 6520 QTOF via an 
HPLC Chip Cube interface. The HPLC Chip contains an enrichment column to capture 
compounds and then a C18 analytical column, with rotor microvalve switching to bring 
the enrichment column in line with the analytical column for separation and 
injection.(Buckenmaier, Vollmer, Trojer, & Emotte, 2008) Thus, the whole sample 
metabolite extract was loaded onto the SCX column at 1.8 μL/min and the flowthrough 
compounds captured by the enrichment column, prior to further separation by the C18 
HPLC analytical column and MS detection. The SCX-captured compounds were eluted 
off the SCX column by injecting 6 μL of 500 mM NaCl in 2% ACN/0.1% FA using the 
autosampler. The salt elution was captured by a C18 enrichment column integrated in 
the Agilent ultra-high capacity small molecule HPLC-Chip, (500 nL, 80 Å C18 trap with a 
75 μm i.d., 150 mm length, 80 Å C18 analytical column). 
For both fraction injections (flowthrough and salt elution), desalting was done on the 
enrichment column in the HPLC Chip by washing with 6 μL 3% ACN/0.1% FA. The rotor 
valve was then switched and HPLC gradient started at nanoflow, eluting the analyte from 
the enrichment column and separating it on the C18 analytical column. Elution of both 
fractions from the analytical column was performed using a gradient starting at 98% A, 
2% B (A: 99.9% water, 0.1% FA; B: 89.9% ACN, 10% water and 0.1% FA) at 300 
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nL/min. The mobile phase gradient for both fractions was 2-98% B for 13 min, 
maintained at 98% B for 6 min, followed by re-equilibration of column with 2% B for 5 
min.  
Nanoflow HPLC-MS/MS System Shotgun Method 
An online SCX column fractionation method was used as described for the profiling 
method. Data dependent acquisition mode was used for MS acquisition by an Agilent 
6520 QTOF. Precursor MS spectra were acquired within the m/z range 315 to 1700 and 
the top 4 peaks were selected for MS/MS analysis. Product scans were acquired within 
the m/z range 50 to 1700 at a scan rate of 1.5/second. A medium isolation width (∼4 
amu) was used, and a collision energy of slope 3.9 V/100 Da with a 2.9 V offset was 
applied for fragmentation for peptide acquisition, while a fixed collision energy of 10 and 
20 V was applied for metabolite acquisition. A dynamic exclusion list was applied, with 
precursor exclusion of 0.50 min after two MS/MS spectrum was acquired. 
Bioinformatics Analysis 
Molecular Feature Extraction was performed using the Agilent MassHunter Qualitative 
Analysis program, version B.04.00. Centroided peaks were filtered at 5,000 counts and 
the chromatographic small molecules extraction algorithm was used. Allowed adducts 
were H+ and Na+. Charge state determination was unrestricted to avoid improper 
charge state assignment. For isotope grouping, peak spacing tolerance was 0.0025 m/z 
plus 7 ppm, and an isotope model of common organic molecules was used. For peptide 
identifications, Mascot (version 2.2) was used with variable modifications of oxidation of 
methionine and carbamylation of cysteine. Database was constructed in-house with 
sequences from SwissProt with a Mammals taxonomy limitation and HIV and SIV 
sequences (66,813 sequences). The search results were filtered and annotated in 
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MASPECTRAS 2.0;(Ubaida Mohien et al., 2010) filtering was done with a minimum of 
two peptides per protein. For metabolite identifications, the METLIN database was 
searched using the MassHunter Qualitative Analysis program (Agilent Technologies, 
version B.04.00) with precursor and product m/z expansion of 10 ppm ± 2 mDa and 20 
ppm ± 2 mDa, respectively, relative height of 0.5%, no collision energy limitation, and 
minimum reverse score of 80. For quantitative profiling, Mass Profiler (Agilent 
Technologies, version B.03.00) with default settings of minimum relative frequency of 
70% in at least one group and minimum differential score of 85% was then used to align 
runs, and all features, along with annotations for number of runs aligned, were exported 
to spreadsheets for further analysis. 
Results and Discussion 
We sought to develop a method for profiling both metabolite and micropeptide 
species simultaneously. We noted, firstly, that peptide species and small molecules can 
be made to co-partition in a Bligh-Dyer extraction.(Sana & Fischer, 2007) Secondly, 
peptide species become more highly charged in acidic conditions (i.e., pH < 3) than 
smaller metabolites. We hypothesized, therefore, that peptides and metabolites could be 
extracted together in a modified Bligh-Dyer reaction and then separated by an online 
SCX column. Therefore, we integrated a short SCX column into the HPLC Chip Cube 
system, in line with the autosampler. In this platform, the biosample extract can be 
injected and loaded onto the SCX column, while the SCX flowthrough is captured by the 
enrichment column on the HPLC Chip. We have developed a similar method for online 
multidimensional proteomics.(Tao et al., 2014) The captured flowthrough is then eluted 
from the enrichment column to the analytical column and analyzed by MS. As the 
loading buffer is acidic, the SCX flowthrough should contain small molecule metabolites, 
as these collect less charge in acidic conditions. The captured peptides are then eluted 
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by an injection of high salt buffer and loaded onto the enrichment column for desalting, 
then in turn eluted and analyzed by MS and MS/MS (Figure 1). 
We first tested our platform for separation and reproducibility with a mix of 
purified standards. In order to apply the platform to a range of possible analytes, we 
used one bioactive endogenous small molecule, serotonin, one exogenous 
pharmacological compound, atenolol, and one polycyclic aromatic hydrocarbon, 
anthracene carboxylic acid, as an environmental compound. These were combined with 
three synthetic peptides (Table 1). The small molecule and peptide species were well 
separated by the SCX column, and chromatography was highly reproducible, with RSD 
of reproducibility at hold time of no greater than 0.4% (Figure 1, Table 1). 
We next applied our LC-MS platform to the analysis of tissue sample extracts 
containing both peptides and metabolites. Mammalian spleen tissue is a mix of both 
liquid and solid biological matrix, since the spleen contains an open blood circulation 
which is filtered through sinusoids composed of structural and immune cells.(Mebius & 
Kraal, 2005) As such it provides a useful test sample for a profiling method such as ours.   
Four spleen homogenates from rhesus macaques were suspended in methanol and 
chloroform to precipitate proteins, and the aqueous (upper) phase collected to remove 
lipids. The resulting peptide and metabolite extracts MS runs were run in triplicate. The 
MS results show a significant change in the charge state distribution of the SCX 
flowthrough fractions vs. the high salt elution, with the vast majority (~95%) of molecular 
features in the flowthrough at +1 or +2, while the high salt elution produced a large range 
of charge states in a distribution centered around +4, with ~76% at charge states >2 
(Figure 2b). By contrast, when the same samples were run without SCX fractionation, 
we observed only the broad charge state distribution (Figure 2a). We thus show that the 
SCX system reproducibly separates analytes by charge state. 
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The charge state distributions thus suggested that, when samples were run 
without SCX separation, peptide species preferentially ionized and suppressed detection 
of small molecule metabolites. Indeed, when MS/MS was performed on both peptides 
and metabolites in a “shotgun proteomics-like” manner, in which masses were acquired 
and fragmented with a rolling exclusion window, peptide suppression was reflected in a 
high percentage of features identified as peptides by a Mascot search, with a 
correspondingly low level of identifications of metabolites by a METLIN search (Figure 
2c). In this experiment our SCX platform produced an improvement of 2- to 5-fold in 
metabolite identification (Figure 2d). We also found that the peptide population was 
shifted into the high-salt elution fractions (Figure 2e), showing that the high charge state 
features were accounted for by peptide. Peptide identifications were derived from 
degradation products of hemoglobin (Table S1), which was not unexpected from 
aqueous phase extractions from spleen, in which red blood cells are reprocessed and 
hemoglobin catabolized. 
The overall metabolite identification results from the HPLC-MS metabolomics 
and HPLC-MS/MS “shotgun” metabolomics experiments are shown in Table S2 
(identified by both accurate mass and MS/MS spectra), Table S3 (identified by MS/MS 
spectra), and Table S4 (identified by accurate mass alone). Metabolites identified by 
both MS and MS/MS spectra were primarily single amino acids, and identifications only 
by MS/MS spectra also contain many single amino acids. Finally, by accurate mass 
(AM) alone we find a large number of candidate small molecules. As these identifications 
are only by AM, they should not considered absolute identifications, and it would be 
necessary to confirm by running purified standards. Nevertheless, we show here that we 
can profile small molecules and peptides by our nanoflow-SCX system, especially, in 
this case, bioactive amino acids. Our SCX-nanoRPLC-MS system, therefore, allows 
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metabolomics and peptidomics profiling experiments for qualitative metabolite 
identification. 
Finally, in order to test whether our system could be used to discover 
pathological differences in the metabolome and peptidome in tissues in a disease state, 
we applied the system to find metabolomic and peptidomic changes in SIV-infected 
spleen tissues compared with healthy controls. This macaque model of SIV is well 
characterized and contains clear peripheral inflammation during the acute phase of 
infection.(Clements, Mankowski, Gama, & Zink, 2008; Dinoso et al., 2009; Mankowski, 
Clements, & Zink, 2002) Here, metabolites and peptides were extracted as above, with 6 
spleens derived from SIV-infected macaques and 6 derived from uninfected control 
macaques. In order to maximize metabolite yield, extractions were performed at three 
different pH levels and the extracts combined. Metabolite and peptide species were 
analyzed by the platform as described above. LC-MS runs were aligned and features 
that aligned in greater than 80% percent of runs were quantified. Although we find no 
significant differences in particular metabolite features, possibly reflecting a large 
variability in the response to infection in particular biochemical pathways, we find 
differences in clustering by PCA in features derived from the SCX flowthrough fractions 
(Figure 3). In particular, while control uninfected animal tissues clustered closely 
together, the metabolomes of the infected tissue were spread widely, suggesting a 
response to infection which was variable at the level of particular metabolites. No 
significant differences were observed in peptide levels (Table S5). We speculate that 
while there may be no changes in the hemoglobin content of the spleen during acute 
infection, the infected spleens are undergoing tissue-level and cellular population 
changes which cause these metabolomic differences. However, we cannot rule out that 
there may be significant changes in particular metabolites or peptides which are not 
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being detected by our platform, and it is possible more sensitive metabolomic methods 
may detect differences in particular metabolites. Finally, we must note that biopsies were 
taken without any knowledge of the local anatomy of the frozen spleen tissue, which 
may mean that some biopsies from infected samples may have included splenic zones 
such as germinal centers, while some did not, and this may account for some of the 
variability we see in the metabolic response. Nevertheless, the data shows that the SCX-
nanoRPLC-MS method can provide reproducible chromatography and allows 
metabolomic and peptidomic profiling which detects biological differences across 
treatment conditions. 
Conclusion 
In this work, we present a method for profiling of metabolite and peptide extracts 
from whole tissue samples. We find that nanoflow metabolomic profiling of tissue may be 
substantially suppressed by peptide ionization and this suppression may be avoided by 
a simple and robust system whereby peptides and metabolites are separated by online 
SCX fractionation. Thus, our system allows extraction of a large range of metabolites 
and peptides from tissue samples and their simultaneous characterization in a single 
sample injection. While offline SCX separation has previously been used to purify 
metabolites before analysis, we know of no other integrated online separation system 
such as ours, which allows immediate analysis of both species. Furthermore, we show 
that the SCX-nanoRPLC-MS method produces chromatography which is sufficiently 
reproducible for quantitative profiling. Most importantly, this method is easy to 
implement, as it requires only the addition of an SCX column, and it utilizes the same 
chromatography buffers as most proteomics experiments. We believe this will make 
metabolomics more accessible to labs already using nanoHPLC for protein identification. 
Finally, although we have not attempted this here, we speculate that if protein samples 
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were to be digested and then precipitated in our modified Bligh-Dyer, this method could 
be used for simultaneous metabolomics and proteomics in the same analysis run. We 
therefore believe that this method may be useful for the development of integrated 






Figure 1. Schema and EIC of online SCX separated metabolite and peptide 
standard mixtures. Three metabolite standards, Atenolol (100 µM), Serotonin (100 µM) 
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and 9-anthracenecarboxylic acid (10 µM), and purified peptides TPVISGGPYYER, 
GDLDAASYYAPVR and DAVTPADFSEWSK (150 pM). Mix of three small molecule 
standards and three peptide standards were run in replicate injections, with HPLC 
separation only and with SCX separation online with HPLC separation. A, small 
molecule (top) and peptide (bottom) signals for replicate runs separated by HPLC alone. 
Metabolite and peptide mix is first desalted on an enrichment column and then eluted by 
an acetonitrile gradient into the MS. B, small molecule (top) and peptide (bottom) signal 
for SCX flowthrough of replicate runs separated online by both SCX and HPLC. Peptides 
are captured on an SCX column, and the metabolites are desalted on an enrichment 
column, then eluted and analyzed by MS. The peptides are then eluted from the SCX 
column by a 500 mM NaCl injection, then desalted on the enrichment column, and then 
eluted and analyzed by MS. Each replicate sample run is coded by color, y-axes are ion 





Figure 2.  SCX separation alleviates peptide contamination of nanoflow 
metabolomic profiling experiments and allows characterization of both species. 
(A) Charge state distribution as a percentage of total features for an unseparated 
sample. 4 spleen homogenates were analyzed in triplicate by MS and molecular features 
extracted, percentages were averaged over all 12 runs. Charge states greater than +1 
suggest peptide species. (B) Charge state distribution as a percentage of total features 
for SCX separated sample. 12 spleen homogenates were analyzed by MS with an SCX 
column placed inline with the autosampler, and high salt washes run after each sample 
run. Molecular features were extracted and percentages were averaged over all 12 runs. 
(C-E) Number of peptides identified by Mascot and number of metabolites identified by 
METLIN search, as percentage of total features extracted, from (C) unseparated sample, 
(D) SCX flowthrough runs, and (E) high salt elutions. Error bars are 95% CI, p-values 




Figure 3. Principal Components Analysis for control and infected metabolite 
samples analyzed by online SCX system. PCA shows differences between control 
and infected samples. Control animals are clustered together (Red, n=6) and show a 
clear separation from infected (Blue, n=6), which are widely spread, showing strong but 
variable response to infection. The PCA components are represented as X, Y and Z, 
where X axis is PCA component 1 (accounts for 48.73%), Y axis PCA component 2 





Table 1. Retention time reproducibility and abundance reproducibility of peptide 
and metabolite standards with and without online SCX fractionation. Top, without 














Height RT Score 
Lysine -1.2 147.1129 2 90347 0.785 98.86 
Histidine -1.29 156.077 1 31454 0.812 93.18 
Glutamic Acid 3.72 148.0599 1 34331 0.839 93.96 
Proline 1.93 116.0704 1 20162 0.844 98.66 
Valine 3.23 118.0859 1 35557 0.854 93.9 
Glutamic Acid 2.18 148.0601 1 22997 0.859 93.66 
Glutamic Acid -0.78 148.0605 1 28662 0.877 95.2 
Phenylalanine 2.42 166.0859 1 18551 0.889 94.31 
Phenylalanine 0.87 166.0861 1 26964 1.111 96.36 
Isoleucine 3.21 132.1015 1 817179 1.18 96.35 
Serotonin -1.37 177.1025 1 123370 1.188 95.61 
Phenylalanine -1.89 166.0866 1 537654 1.341 99.29 
ALANYL-dl-
LEUCINE 
-1.9 203.1394 1 33200 2.675 92.35 
Ile Val -3.1 231.171 1 28451 3.628 94.64 
Tryptophan -3 205.0978 1 71304 4.324 94.57 
ALANYL-dl-
PHENYLALANINE 
-3.7 237.1242 1 37393 4.418 95.07 
Met Ile -2.65 263.1431 1 107960 5.584 91.53 
Val Phe -3.95 265.1557 1 238602 5.691 91.47 
Phe Phe -4.9 313.1562 1 24608 5.872 91.6 
Phe Phe -3.04 313.1556 1 9563 6.157 93.53 
Leu Leu -4.69 245.1871 1 66097 6.783 91.51 
URAPIDIL 3.02 388.2331 1 15552 8.936 93.15 
ALPRENOLOL 4.24 250.1791 1 19272 10.678 89.76 
ALPRENOLOL 0.87 250.1799 1 21869 10.688 94.16 
ALPRENOLOL 4.48 250.179 1 21294 10.691 89.24 
ALPRENOLOL -0.9 250.1804 1 37392 10.697 94.15 
ALPRENOLOL 0.78 250.18 1 27664 10.726 94.21 
1-Octadecanamine -4.76 270.3168 1 33166 13.843 90.13 
 
Table S2. Putative metabolite identifications by accurate mass and MS/MS with 
METLIN search. Nanoflow-SCX runs were extracted by Agilent MFE and searched for 










Height RT Score 
Asymmetric 
dimethylarginine 
-5.45 203.1514 1 159161 0.818 44.98 
Isoleucine 17.18 132.0997 1 51595 0.973 42.97 
Isoleucine 7.97 132.1009 1 64163 1 45.16 
Leucine 9.08 132.1007 1 40917 1.008 44.49 
Isoleucine 20.54 132.0992 1 49822 1.01 41.78 
Ile Thr -7.72 233.1514 1 27306 1.059 42.74 
Serotonin -9.26 177.1039 1 28174 1.071 50 




















-18.23 238.1018 1 53776 1.205 44.1 
Phe Ile -11.78 279.1736 1 64760 1.209 47.05 
Phe Ile -10.21 279.1732 1 67324 1.213 48 




-14.31 238.1009 1 15926 1.221 44.1 
Phe Ile -7.2 279.1723 1 60471 1.225 46.6 
Phe Ile -8.61 279.1727 1 85743 1.232 48.44 




-11.99 238.1003 1 76179 1.306 49.37 
Phe Phe 9.04 313.1518 1 26984 1.331 46.56 
Phe Ile -8.69 279.1727 1 11677 5.474 44.93 
Phe Tyr -5.5 329.1514 1 58218 5.615 48.81 
Phe Phe -5.33 313.1563 1 52690 5.961 49.97 
Tyr Phe -6.1 329.1516 1 66741 6.097 46.84 
Val Trp -9.11 304.1683 1 71197 6.12 48.11 





















-13.08 238.1006 1 27841 6.425 49.37 
Phe Ile -8.92 279.1728 1 50416 6.468 47.37 
Phe Leu -6.96 279.1723 1 16295 6.481 44.86 
Phe Ile -9.38 279.1729 1 53411 6.516 48.28 
Phe Ile -8.03 279.1726 1 119162 6.517 48.43 
Phe Ile -6.57 279.1722 1 3532588 6.589 48.94 





7.07 266.1732 1 13735 9.635 41.12 
Decanoyl-L-carnitine 3191.78 316.2499 1 21616 10.506 48.29 
Decanoyl-L-carnitine 3190.26 316.2504 1 71348 10.545 49.74 
ALPRENOLOL 6.03 250.1787 1 24692 10.721 44.37 
1-Monopalmitin -5.66 331.2862 1 1863084 17.625 41.56 
 
Table S3. Putative metabolite identifications by MS/MS with METLIN search. 




















































1 9432 1.06 96.7 


































1 17215 1.09 95.1
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1 7554 1.14 46.8
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Gly Leu -3.35 189.12
4 
1 82908 1.17 47.9
1 









































































1 66411 4.37 49.4
5 






Leu Pro -3.51 229.15
55 
1 36112 4.46 47.0
9 
Ala Thr Phe -3.22 338.17
21 
1 5844 4.53 92.4
8 

























Leu Val -1.8 231.17 1 30938 5.19 49.2
38 
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1 43806 5.28 48.0
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MYCOPHENOLIC ACID -1.68 321.13
38 
1 21637 6.6 98.0
1 





MYCOPHENOLIC ACID 0.12 321.13
32 
1 22179 6.63 49.9
9 























































MYCOPHENOLIC ACID -3.24 321.13
43 
1 22981 6.71 92.7
9 










































Met Cys Thr -0.14 354.11
52 
1 9960 6.96 99.9
8 
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MYCOPHENOLIC ACID 0.14 321.13
32 
1 15226 7.16 99.9
9 



















































































































Avermectin B2b 3.67 877.49 2 14493 7.83 40.2
41 
 




































































































1 6839 8.15 92.9
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1 18149 8.34 93.1
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1 16976 8.35 93.8
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Biliverdin IX -1.34 583.25
59 
1 57760 8.37 48.9 




























































Biliverdin IX 0.14 583.25
5 
























































































Biliverdin IX 3.14 583.25
33 
1 37520 8.52 44.3 






































































































3-Hydroxydodecanedioic acid -4.66 247.15
51 
1 22242 8.7 44.5
7 



















































































































































































































































































































































ISOSAFROLE -0.19 163.07 1 13907 9.91 49.9
47 
 































































































































































































































































































N,O-Didesmethylvenlafaxine 1.15 250.17 1 15240 10.6 99.2
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Phenylmethyl methyl ketone 0.67 135.08
04 
1 51522 11 49.9
5 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































        
1 5.173 0.072 2299.421 0.0082 10712300 1.76 11 
2 4.966 0.089 1950.26 0.0033 3383959 0.95 11 
3 9.525 0.01 5105.319 0.0111 1985346 1.2 7 
4 5.074 0.089 2044.262 0.0071 1814915 1.66 10 
5 5.369 0.053 4616.801 0.0093 1403083 1.25 9 
6 6.725 0.049 2990.891 0.0061 1063425 1.02 8 
7 7.187 0.038 2718.765 0.0109 783807.2 1.62 8 
8 6.323 0.064 2027.31 0.0034 759346.6 1.52 9 
9 7.07 0.052 4000.529 0.0088 645555.9 1.78 7 
10 6.466 0.077 2311.426 0.0049 508573.8 1.09 9 
11 5.064 0.083 1713.164 0.0025 431022.8 1.54 9 
12 4.894 0.106 1216.723 0.0042 302935.8 0.95 11 
13 4.194 0.083 1223.802 0.0026 202507.2 1.3 8 
14 6.675 0.047 3380.156 0.0091 181467.8 1.02 8 
15 4.864 0.069 1328.849 0.0026 167090.9 2.19 7 
16 8.03 0.007 388.2251 0.001 135835.5 0.85 9 
17 7.437 0.02 334.1449 0.0006 91489.84 1.05 8 
18 9.496 0.006 516.2809 0.0011 83118.66 0.86 8 
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19 9.495 0.006 534.2933 0.0009 81963.34 0.92 8 
20 7.794 0.008 292.131 0.0008 75743.84 0.79 9 
21 7.332 0.009 298.1868 0.0006 68577.66 0.95 7 
22 9.439 0.009 490.2644 0.0014 56360.92 0.88 8 




   Abundance Abundance  
Feature ID Retention 
Time 
Mass Value Relative Standard 
Deviation 
Number of replicates 
detected 
      
1 5.143 2299.4211 19743080 1.22 5 
2 4.925 1950.26 3872292 0.92 5 
3 9.525 5105.3222 256379.7 2.45 1 
4 5.044 2044.2621 3147434 1.23 6 
5 5.344 4616.804 771782.2 1.52 3 
6 6.707 2990.8882 674499.7 1.66 2 
7 7.178 2718.766 403623.8 2.29 2 
8 6.322 2027.312 307694.8 1.14 3 
9 6.997 4000.5272 63567.5 2.45 1 
10 6.42 2311.4268 236574.2 1.35 3 
11 5 1713.1632 485356.3 1.67 3 
12 4.859 1216.7226 380874.3 1 6 
13 4.198 1223.8012 152642.7 1.88 2 
14 6.655 3380.1521 142568.8 1.56 2 
15 4.869 1328.8475 22501.33 2.45 1 
16 8.029 388.2248 84382 1.56 3 
17 7.444 334.1451 61107 1.61 2 
18 9.492 516.2816 41529.33 1.69 2 
19 9.492 534.2935 26942.67 1.64 2 
20 7.797 292.131 58045.17 1.36 3 
21 7.339 298.1874 28566.67 2.45 1 
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22 9.429 490.2657 22861.67 1.57 2 




   Abundance Abundance  
 ID Retention 
Time 






      
1 5.199 2299.4207 1681507 1.29 6 
2 4.999 1950.2598 2895625 1.06 6 
3 9.525 5105.3184 3714313 0.59 6 
4 5.12 2044.2617 482395.7 1.75 4 
5 5.381 4616.7999 2034384 1.04 6 
6 6.731 2990.8912 1452350 0.68 6 
7 7.189 2718.7644 1163991 1.31 6 
8 6.324 2027.3094 1210998 1.25 6 
9 7.082 4000.5294 1227544 1.18 6 
10 6.489 2311.425 780573.5 0.81 6 
11 5.097 1713.1648 376689.3 1.48 6 
12 4.937 1216.7227 224997.3 0.67 5 
13 4.193 1223.8021 252371.7 1.01 6 
14 6.681 3380.1575 220366.8 0.67 6 
15 4.863 1328.8494 311680.5 1.58 6 
16 8.031 388.2253 187289 0.41 6 
17 7.434 334.1448 121872.7 0.76 6 
18 9.498 516.2807 124708 0.37 6 
19 9.496 534.2932 136984 0.43 6 
20 7.793 292.1311 93442.5 0.31 6 
21 7.33 298.1867 108588.7 0.21 6 
22 9.442 490.2639 89860.16 0.42 6 
Table S5c. Quantitation by features in peptide detection SCX runs. Uninfected samples. 
 
 
 Difference Difference    
ID Retention 
Time 





1 0.055 -0.0004 3.55 up 90.201 
2 0.074 -0.0002 0.42 up 37.7258 
3 0 -0.0038 -3.86 down 99.5874 
4 0.076 -0.0004 2.71 up 86.9826 
5 0.037 -0.0041 -1.4 down 77.0709 
6 0.024 0.003 -1.11 down 76.8964 
7 0.011 -0.0016 -1.53 down 67.8575 
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8 0.001 -0.0026 -1.98 down 81.4423 
9 0.085 0.0022 -4.27 down 92.2189 
10 0.069 -0.0018 -1.72 down 91.0606 
11 0.096 0.0016 0.37 up 20.8016 
12 0.078 0.0001 0.76 up 62.5016 
13 -0.005 0.0009 -0.73 down 46.1446 
14 0.026 0.0055 -0.63 down 50.8959 
15 -0.006 0.0019 -3.79 down 81.6749 
16 0.002 0.0005 -1.15 down 87.0767 
17 -0.011 -0.0002 -1 down 70.448 
18 0.006 -0.0009 -1.59 down 96.4052 
19 0.004 -0.0002 -2.35 down 99.5737 
20 -0.004 0.0001 -0.69 down 67.3768 
21 -0.009 -0.0008 -1.93 down 97.6409 
22 0.013 -0.0017 -1.97 down 99.009 
Table S5d. Quantitation by features in peptide detection SCX runs. Control vs infected 
comparison. 
Table S5. Peptide features extracted for high salt runs. Nanoflow-SCX high salt 
elution runs were profiled for endogenous peptide features, and retention time and peak 
areas were quantified by MassHunter. 
Supplemental Methods. 
Animal Infection Protocol 
Six juvenile pigtailed macaques (Macaca nemestrina) were infected with SIV by 
intravenous inoculation with both an immunosuppressive swarm (SIV/DeltaB670) at a 
dose of 10,000 times 50% animal infectious dose and a neurovirulent clone (SIV/17E-Fr) 
at a dose of 50 times 50% animal infectious dose, as described previously.(Clements et 
al., 2008) Sacrifice and necropsy were at 7 days post-infection. Negative controls were 
six juvenile pigtailed macaques, mock inoculated with PBS and then sacrificed. Spleen 
tissue samples were collected from all 12 macaques and fresh frozen. Animal protocols 
were approved by the Johns Hopkins University Institutional Animal Care and Use 
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Committee in accordance with Animal Welfare Act regulations and the USPHS Policy on 
Humane Care and Use of Laboratory Animals. 
Animal Studies Ethics Statement 
“Animal studies were approved by the Johns Hopkins Animal Care and Use Committee 
(IACUC protocol #PR12M310); animals were humanely treated in accordance with 
federal guidelines and institutional policies. Pigtailed macaques (Macaca nemestrina) 
used in this study were obtained from nonhuman primate breeding facilities within the 
United States, and were housed in Johns Hopkins University facilities that are fully 
accredited by the association for the Assessment and Accreditation of Laboratory Animal 
Care, International (AALAC). All housing met or exceeded guidelines of the National 
Institutes of Health “Guide for the Care and Use of Laboratory Animals” and the United 
States Department of Agriculture Animal Welfare Act. Macaques were fed a balanced, 
commercial macaque chow (Purina Mills, Gray Summit, MO, USA) once a day 
supplemented with a variety of food enrichment.” 
Tissue Sample Collection and Preparation 
Miltex 3 mm biopsy punches of fresh-frozen spleens were resuspended in 500 µL 0.1% 
ascorbic acid in a 1 mL Kontes Duall Tissue Grinder, and homogenized by hand for 10 
minutes. Metabolites were extracted by a modified(Sana & Fischer, 2007)  Bligh-Dyer 
protocol: 150 µL homogenate was added to 600 µL methanol at -20°C. 450 µL room-
temperature chloroform was then added, and the solution vortexed and returned to an 
ice bath. The solution was then vortexed every 5 minutes for 30 minutes, returning to the 
ice bath each time. At the penultimate step, 150 µL ice cold MilliQ water was added, and 
samples were maintained at -20°C for 2 hours to create phase separation. The upper 
(aqueous) phase was then collected. 
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Next, in order to maximize metabolite yield, the above extraction procedure was 
repeated with 2% ammonium hydroxide at pH 9, and with 1% formic acid at pH 2. 
Specifically, the organic phase from the first extraction was dried and then resuspended 
in water. The methanol and chloroform steps were repeated as above, and then the pH 
9 buffer was added to create the phase. The aqueous phase following this step was 
collected, and the procedure was repeated with a buffer at pH 2. All three extractions 
were filtered with a 50,000 MWCO to remove large particulates, and flowthroughs were 
combined, dried, and resuspended in 2% ACN/0.1% FA for HPLC-MS analysis. 
Protein Normalization for Quantitative Profiling 
For quantitative metabolite profiling, protein amounts in each homogenate were 
estimated by a modified Lowry method after a deoxycholate precipitation (2D Quant Kit, 
GE Healthcare). Protein estimations were confirmed by 1D gel electrophoresis and 
SYPRO Ruby (Life Technologies) staining. For gels, 2 µg sample was combined with 2.5 
µL SDS sample buffer, and 1 µL 100mM DTT, and the final solution diluted up to 10 µL 
with MilliQ water. Running buffer was prepared by diluting MES SDS running buffer (Life 
Technologies) 1:20 in MilliQ water with 20% methanol. Samples were denatured for 10 



















In the previous chapter, we have developed a high-sensitivity peptidomics method to 
detect low-abundance novel micropeptides in various genomes. We now apply this 
method to biological samples in order to discover micropeptides being translated. First, 
in this chapter, we apply the method to the HepG2 cell line, which is a widely used 
line(Mersch-Sundermann, Knasmuller, Wu, Darroudi, & Kassie, 2004). Such studies will 
inform both cases in which this cell line is used as a model for hepatocellular 
carcinoma(Samarakoon, Thabrew, Galhena, & Tennekoon, 2012) as well as cases in 
which HepG2 is used in other model systems, such as in malaria 
infection(Chattopadhyay et al., 2011). In order to discover novel genes by proteomics, it 
is necessary to include candidates of novel genes in the database used to search the 
mass spectrometry data. In this study, we have developed a strategy for generation of 
databases which include both known genes and novel micropeptides, in order to 
facilitate novel micropeptide discovery by RNA sequencing by searching an in silico 
translation of the transcriptome. Thus, the combination of our novel LC-MS/MS method 
and the novel bioinformatics method developed here allows the discovery of 
micropeptides encoded by the human genome. In a second experiment, we searched in 
a human pathogen genome, the HIV-1 genome, for novel micropeptides, using a similar 
strategy of high-sensitivity mass spectrometry for acquisition of spectra from 







HepG2 dataset. The HepG2 cell line proteomics dataset was downloaded from the 
ProteomeXchange Consortium(Deutsch et al., 2017) by the dataset identifier 
PXD000682. In that study(Deutsch et al., 2017), HepG2 cells were treated or untreated 
with HGF (50 ng/ml, for 24 hours), then subcellular enrichment was performed upon 
cellular lysis to enrich for membrane or cytosolic proteins. Soluble proteins were 
extracted by 4 cycle freeze thaw in the presence of protease inhibitors. The cell 
remainder was pelleted, and membrane proteins were extracted by lysis in SDST buffer. 
Finally, both sets of lysates were fractionated by the 2D strong cation exchange system 
described in Chapter 2 of this thesis, fractionating each sample run into 0, 15, 30, 45, 60, 
120, 160, and 300 mM NaCl fractions which were analyzed online. All fractions were re-
combined for peak-picking to produce a single Mascot Generic Format (MGF) file, in a 
Multidimensional Protein Identification Technology (MuDPIT) strategy(Kislinger, 
Gramolini, MacLennan, & Emili, 2005). The datasets from that publication which were re-
analyzed for this publication are detailed in Table 1. Briefly, datasets from three 
biological replicates of the HGF experiment were re-analyzed. For the first replicate, 2 
replicate injections of the membrane extraction and 3 replicate injections of the cytosolic 
extraction for the HGF treated cells were used, and 2 replicate injections of the 
membrane extraction and 4 replicate injections of the cytosolic extraction of the HGF-
untreated cells were used. For the second replicate, 2 replicate injections of the 
membrane extraction and 4 replicate injections of the cytosolic extraction of the HGF 
treated cells were used, and 2 replicate injections of the membrane extraction and 4 
replicate injections of the cytosolic extraction of the untreated cells were used. For the 
third replicate, 1 injection of the membrane fraction, and 2 replicate injections of the 
cytosolic extractions of the HGF-treated cells were used, and 1 replicate injection of the 
membrane extraction and 2 replicate injections of the cytosolic extraction of the 
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untreated cells were used. Not all replicate datasets of the original publication were 
used, in order to minimize the computational resources necessary. 
HepG2 Analysis transcriptome assembly and database generation. Assembled 
transcriptome for HepG2 cells was obtained from the ENCODE project data(Djebali et 
al., 2012). A database of all possible transcribed open reading frames was generated 
using the EMBOSS tools through Galaxy version 5.0.0: the getorf(Blankenberg et al., 
2007; Rice, Longden, & Bleasby, 2000) tool was used with standard codon table with 
alternative start codons (NUG) recoding Met for alternative start, a minimum open 
reading frame size of 15 nucleotides, corresponding to 5 amino acids(Koskinen, Emery, 
Creasy, & Cottrell, 2011), and a max of 300 nucleotides, corresponding to 100 amino 
acids, encompassing the ORF size range from 5-100 codons. Open reading frames 
were considered as translated regions from start to stop codons, rather than from stop to 
stop codons, and the translated sequences were output rather than the nucleic acids. All 
start codons were forced to code for methionine including alternative start 
codons(Peabody, 1989). Circular sequences were not allowed, ORFs were not searched 
in the reverse complement sequences (as this is transcript, not genomic, data), no 
flanking nucleotides were output, and output format was NCBI FASTA. The database 
thus generated was concatenated with Swissprot(The UniProt, 2017) delimited for 
taxonomy to human, and the final database contains 1,313,498 protein sequences. 
HIV-1 experiment. 
HIV-1 isolation and purification. Three lab isolates of HIV-1 were used for this study: first, 
virus produced from the NCI’s HIV-1(MN)/H9 CL.4 cell line, which is a cell line containing 
a single active provirus cloned by limiting dilution(Ott, Nigida, Henderson, & Arthur, 
1995); second, virus produced from the NCI’s HIV-1(MN)CL.4/CEMx174(T1) cell 
line(Salter, Howell, & Cresswell, 1985), which is a B cell/T cell hybridoma cell line, 
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infected with the cloned virus above; third, virus produced from the NCI’s HIV-1 
ADA/SUPT1-CCR5 CL.30 cell line(Del Prete et al., 2009), which is infected by a swarm 
of viruses produced by infecting human primary peripheral blood mononuclear cells with 
the HIV-1 ADA strain. These three viruses were used as three biological replicates in 
which to search for novel virus-encoded micropeptides. Viral purification was done by 
continuous flow ultracentrifugation in a sucrose density gradient, followed by direct 
pelleting to remove sucrose. All preparations were then treated with aldrithiol-2 to render 
virions intact but uninfectious(Rossio et al., 1998) before further biochemical processing. 
Deep sequencing of HIV-1 genomes. Random hexamers were used to prime first-strand 
cDNA synthesis of viral RNA in a genome-wide, unbiased fashion(Hughes et al., 2012). 
Libraries were then prepared from vRNA by a Nextera tagmentation kit and sequenced 
by MiSeq by standard protocols. 
Protein extraction from purified HIV-1 virions. Virions were secondarily destroyed and 
inactivated by the addition of 3 volumes of methanol, and the protein allowed to 
precipitate and pelleted. The pellet was dried and lysed in a standard Urea-based 
proteomics lysis buffer (8M Urea, 2M Thiourea, 2% CHAPS, 2% ASB-14, 1% Triton X-
100, 1% Triton X-114, 10 mM DTT, 150 mM NaCl, 50 mM Tris) for an approximate 
concentration of 1 mg/ml. Reduction and alkylation was performed, then all detergents 
were removed by methanol/chloroform precipitation. The remaining pellet was then 
resuspended in a standard Urea-based proteomics buffer without detergent (8M Urea, 
2M Thiourea, 25 mM DTT, 100 mM NaCl). Trypsin digestion was then performed by 
diluting protein solution to 2M by addition of ammonium bicarbonate to a final 
concentration of 50 mM, and trypsin was then added at 1:80 trypsin:protein ratio. 
Digestion was performed at 37⁰C for 24 hours with agitation. Samples were 
resuspended in 3% buffer B for HPLC desalting (90% acetonitrile, 9.9% water, 0.1% 
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formic acid), and desalted using a C18 column on an Agilent 1200 HPLC system with an 
11 minute HPLC protocol: 4 min, 3% B, 4 min 99% B, 3 min 3% B with a flow rate of 500 
uL/minute, with UV detection at 214nm for peak collection. Sample was collected and 
desalted twice. 
Mass spectrometry proteomics analysis. Mass spectrometry of HIV-1 derived purified 
tryptic peptides was performed by an ABSciex 5600 TripleTOF mass spectrometer 
running in data-dependent acquisition (DDA) mode using an online Eksigent NanoLC 
400 HPLC system. Peptides were resuspended in buffer B (0.1% (v/v) formic acid, 90% 
(v/v) acetonitrile) and run on a 105 minute HPLC gradient of 10-98% buffer A (0.1% (v/v) 
formic acid, 2% (v/v) acetonitrile) at a flow rate of 750nL/min. MS/MS spectra were 
collected in the range of 100-1500m/z. All three samples were run in triplicate, and 
replicates were analyzed together. 
HIV-1 genome assembly and database generation. Assembly of genomes was 
performed with Trinity de novo assembler(Grabherr et al., 2011) (Trinity Galaxy version 
0.0.1). The group pairs distance was set for 500 nucleotides, the path reinforcement 
distance was set at 75 nucleotides, the minimum kmer coverage for contig construction 
was set to 1, the max transcript reads per graph was set to 2,000,000, and the minimum 
contig length was set to 200 nucleotides. Since the transcripts (RNA genomes) thus 
assembled were only considered to produce candidates for the proteomics search, the 
assembler settings were not optimized. Databases were produced from all three HIV-1 
strains described above, in a manner identical to that for the HepG2 study, and as 
above, each database was concatenated to the human Swissprot database, since HIV 
virions are well known to contain human host proteins, and viral purifications can also 
contain host cell exosomes of the same density as virions, which may also contain both 
human and viral proteins. For the HIV-1(MN)/H9 CL.4 virus, this analysis produced 
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34,834 candidate novel protein sequences, which after concatenation expanded to 
55,485 sequences. For the HIV-1(MN)CL.4/CEMx174(T1) virus, this analysis produced 
41,366 candidate novel protein sequences, which after concatenation expanded to 
62,017 sequences. For the HIV-1 ADA/SUPT1-CCR5 CL.30 virus, this analysis 
produced 48,641 candidate novel protein sequences, which after concatenation 
expanded to 69,292 sequences. 
Bioinformatics analysis for both experiments. 
The datasets detailed above were searched with Mascot version 2.5.1.2 (Matrix Science, 
London, UK)(Perkins, Pappin, Creasy, & Cottrell, 1999), and the protein identification 
results from these Mascot searches were further analyzed in Scaffold 4.4.5(Proteome 
Software, Portland, OR, USA) in a subset database search approach(Tharakan, 
Edwards, & Graham, 2010) with X!Tandem CYCLONE(Fenyo & Beavis, 2003), version 
2010.12.01.1. Both Mascot and X!Tandem searches were run with a parent ion mass 
tolerance and fragment ion mass tolerance of 50 ppm and 0.60 Da, respectively. Two 
missed cleavages were allowed. Variable modifications were set in Mascot as 
deamidation of asparagine and glutamine, oxidation of methionine, carbamylation of 
lysine and carbamidomethylation of cysteine. In the X!Tandem subset database search, 
the variable modifications list was allowed to expand to take advantage of the smaller 
search space (cite), allowing conversion of glutamate or glutamine to pyroglutamate at 
the N-terminus, ammonia-loss of the N-terminus, deamidation of asparagine and 
glutamine, oxidation of methionine, carbamylation of lysine and carbamidomethylation of 
cysteine. Both peptide and protein identifications were accepted if they could be 
established at greater than 95% probability by the PeptideProphet algorithm(Keller, 
Nesvizhskii, Kolker, & Aebersold, 2002) with Scaffold delta-mass correction and by the 




Results and Discussion 
In order to discover novel micropeptides in the human genome, we took a 
proteogenomics approach to the HepG2 cell line. We used RNA sequencing data from 
the ENCODE project to assemble a database of all possible short open reading frames 
which are transcribed in that cell line. This database was then concatenated with a 
database of known, well-annotated human proteins, Swissprot. This large database thus 
contains known human proteins as well as potential proteins which could be transcribed 
from short open reading frames. Concatenation is necessary in order to prevent many 
spurious proteomic matches by known human proteins to the short open reading frame 
(sORF) database, which, since they will overlap with many sORFs in the transcriptome, 
such as alternate start site sORFs, are not unambiguously identified from proteomics 
data(Vanderperre et al., 2013). For this reason, the database is first concatenated with a 
generic known protein database, and so any alternate frame sORF will be mapped 
twice, both to the sORF database entry and to the known protein database entry. For 
these hits, we consider them not to be unambiguously identified as micropeptides, since 
any alternate start internal sORF will be matched if its corresponding canonical protein is 
matched. Furthermore, since the SwissProt database is well-annotated, but does not 
contain all known human proteins, we cannot assume that all possible ambiguous 
coding frames mapping to a known human gene can be eliminated by this process(The 
UniProt, 2017). Therefore, we use a second step of filtering to eliminate alternate coding 
open reading frames which are not represented in the SwissProt database, by using 
BLAST searches(Altschul, Gish, Miller, Myers, & Lipman, 1990) against all protein 
sequences represented in NCBI nr, which is a comprehensive and highly redundant 
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protein database. The protein BLAST matches were then evaluated for whether the 
transcripts they mapped to could be considered to be novel or not. 
The complete list of proteins identified in the HepG2 proteomics analysis is 
shown in Table 2. Allowing a threshold of 95% confidence (see Methods), produces a 
dataset of 2864 proteins, with .3% peptide FDR and 1% protein FDR. These proteins 
can be clustered by shared peptides, assuming that proteins that share peptides cannot 
be unambiguously identified, and that proteins that share peptides are similar enough in 
sequence to be similar in function or isoforms of each other(Ubaida Mohien et al., 2010). 
Clustering the proteins in this manner reduces the protein list to 2629 clusters of similar, 
undifferentiable proteins. Thus, the analysis identifies a large component of the 
proteome successfully, a proof of principle that the analysis can be used to discover 
novel peptides as well. A second validation is that proteins which would be expected to 
be enriched in their respective fractions are indeed enriched. Table 3 shows proteomic 
identifications separated into HepG2 HGF treated and untreated, and into membrane 
and cytosolic fractions. Estimates can be derived in a general manner by spectral 
counts(Choi, Fermin, & Nesvizhskii, 2008). The table shows that several proteins which 
are expected to be enriched in cytosolic fractions were indeed enriched. For example, 
the chaperone proteins heat shock protein 90a and 90b are both enriched in the soluble 
fraction, which is to be expected since they are primarily cytosolic(Wandinger, Richter, & 
Buchner, 2008). Similarly, UQCRC2(Hosokawa, Suzuki, Toda, Nishikimi, & Ozawa, 
1989), which is a component of Complex III of the respiratory chain, is found only in 
fractions processed for membrane enrichment, as is ATP Synthase 5B(Neckelmann et 
al., 1989). However, many of the membrane-enriched proteins are soluble proteins 
found in membrane-enclosed fractions, such as lamins(Gruenbaum, Wilson, Harel, 
Goldberg, & Cohen, 2000) and histones(Marino-Ramirez, Kann, Shoemaker, & 
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Landsman, 2005) in the nucleus, suggesting that the membrane fraction may better be 
considered a non-cytosolic fraction. Finally, the analysis is also validated by the 
probability distributions generated by the PeptideProphet(Ma, Vitek, & Nesvizhskii, 2012) 
algorithm. As the algorithm is described, two distributions are generated from the protein 
scores of all proteins, both of which follow a Gaussian distribution. If the Gaussian model 
fits well to the distributions of scores, the lower distribution can be considered a 
distribution of ‘incorrect’ matches, while the higher distribution can be considered correct 
matches. If the dataset is too sparse, the distributions cannot be modeled and the 
probabilities are not accurate. Figure 1 shows the distributions modeled by the 
PeptideProphet algorithm for this analysis, for charge state +2, showing that the 
probabilities thus calculated can be considered accurate.  
After filtering by probability as described, the list of 2629 clustered proteins 
contains 27 proteins which map to sORFs from the HepG2 ENCODE transcriptome 
without any shared peptides with known proteins. Of these, only 2 survived the BLAST 
homology filtering step described above, with the remainder found to be homologous 
with known proteins. These latter two can be considered to be novel micropeptides 
discovered by our proteogenomics approach. The first peptide, shown in Figure 2, is 
represented by a single spectrum, which has fairly good coverage but several 
unidentified peaks. The peptide is produced from the gene SLC35A3(Ishida, Yoshioka, 
Chiba, Takeuchi, & Kawakita, 1999), which is a UDP-GlcNAc transporter in the Golgi 
apparatus. The transcript is 5708 nt long, with a ~1100 nucleotide CDS and a long 
(~4500 nucleotide) 3’UTR. The 12-codon ORF is in the 3’UTR of the transcript at 
positions 5410-5448, and has an alternative start leucine codon which is recoded as 
NUG to Methionine, for a final translation of MSVCCFICNYKII. The peptide is detected 
only in the membrane fractions. The second peptide, shown in Figure 3, is represented 
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by 4 spectra, which are shown in 4b. The spectra appear to have a clear B and Y series, 
but do also contain prominent unidentified peaks. The peptide hit is contained in gene 
WASHC4(Ropers et al., 2011), which has a transcript 5812 nucleotides long, with a 
~3500 nucleotide CDS and a long (~2300 nucleotide) 3’UTR. The 3’UTR contains a 34-
codon ORF at positions 4154-4255 with an in-frame stop. The translation initiation site is 
a leucine codon recoded to methionine, in a second case of alternative initiation. The 
peptide, like WASHC4 itself, is detected only in soluble proteome fractions. The 
translation product sequence is MMILLSLLISCDSQELLMSLMRHFITSLHCFENI, of 
which a tryptic portion is detected, ILLSLLISCDSQELLMSLMR. In both these cases, 
long 3’UTRs produce cryptic micropeptides in transcripts which have that structure. This 
is similar to a case described in another SLC transporter-class protein, in which 
SLC35A4 was found to produce a cryptic micropeptide from a long 5’UTR(Andreev et 
al., 2015). Thus, this proteogenomics analysis can be shown to be robust for describing 
the proteome in a normal fashion, and also finds translation of at least one (from the 
WASHC4 transcript) and possibly two novel micropeptide genes. 
In a second approach to discovering novel micropeptides in genome, we targeted 
an important human pathogen, HIV-1. We produced proteomic and genomic data from 
three HIV-1 lab isolates: first, a virus grown from HIV-1(MN)/H9 CL.4, a cloned cell line 
infected with a single HIV-1 clone; second, a virus grown from HIV-
1(MN)CL.4/CEMx174(T1), an uncloned cell line infected with many different HIV-1 clone, 
and producing them all; and third, HIV-1 ADA/SUPT1-CCR5 CL.30, which is an 
uncloned cell line infected by a swarm of HIV-1 viruses produced from human primary 
PBMC (J. Bess, Personal Communication, and see Methods). The viral isolates could 
thus be considered to have increasing levels of genomic heterogeneity. The three viral 
isolates were analyzed by proteomics; in this case, a higher-sensitivity mass 
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spectrometer was used (see Methods) obviating the need to use 2D fractionation for 
high sensitivity. In parallel, viral RNA was extracted from each isolate and their genomes 
sequenced. These sequences were assembled de novo into sets of putative HIV-1 
genome sequences, and a database was generated from them using methods similar to 
that used for the HepG2 experiment above. Finally, these proteomics datasets was 
searched against the databases thus generated in a proteogenomics approach to novel 
micropeptide discovery.  
De novo assembly generated several thousand genomic sequences for each 
isolate (see Methods). We emphasize that these sequences should not be taken to 
demonstrate that each viral isolate has many thousands of completely divergent 
genomic sequences. Indeed, de novo assembly is difficult and all known de novo 
assemblers are adapted for cellular transcriptomes, rather than the viral ssRNA 
genomes. However, we nevertheless argue that we can use the genomic sequences 
thus assembled as candidate sequences of the HIV genomes present in the actual 
samples. Importantly, the sequences thus generated are used as candidates for the 
proteomic analysis, and thus if the proteomics and the genomic sequences match we 
may say that we have a putatively translated novel sequence. Finally, we show in Figure 
4 that our pipeline identifies a novel isoform of the Env protein, which is known to by 
hypermutated to evade the immune response. Thus, our pipeline does indeed match 
proteins which are expected to highly mutated, and expected to exist in the sample, thus 
validating the proteogenomics approach. Finally, a single novel micropeptide was also 
found, as shown in Figure 5. 
As in the HepG2 experiment above, the proteogenomics pipeline captures a 
substantial number of proteins, showing that the proteogenomics pipeline successfully 
recapitulates the standard proteome along with the novel sORF proteome: at the filtering 
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thresholds described in Methods, for the HIV-1(MN)/H9 CL.4 virus, 1606 proteins were 
found, reduced to 1319 after clustering, of which 1 mapped to a novel sORF; for the HIV-
1(MN)CL.4/CEMx174(T1), 1775 proteins were found, reduced to 1457 after clustering, of 
which 4 mapped to novel sORFs; for the HIV-1 ADA/SUPT1-CCR5 CL.30, 1420 proteins 
were found, reduced to 1105 after clustering, of which 7 mapped to novel sORFs. All but 
one of these were eliminated by the BLAST search filtering. The complete results are 
shown in Table 4. 
Thus, in this chapter we have shown that, by our 2D LC-MS/MS platform, along 
with a bioinformatic approach to generating databases which include micropeptides 
generated by short open reading frames, by directly translating in silico all open reading 
frames shorter 100 codons and longer than 5 codons in assembled transcriptomes. We 
utilize this system to find evidence of translation of two novel micropeptides expressed in 














Figure 2a. Micropeptide hit in gene SLC35A3. Fragmentation table shows good coverage of both B and Y ions. Mass spectrum 
shows one set of unidentified peaks which are likely due to incomplete fragmentation of doubly charged precursor. 
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Figure 2b. Micropeptide sequence maps to the 
gene Solute carrier family 35 member A3 
(ENST00000370153.6), whose function is a 
UDP-GlcNAc transporter in the Golgi apparatus. 
The transcript is 5708 nt long, with a ~1100 
nucleotide CDS and a long (~4500 nucleotide) 
3’UTR. The 12-codon ORF is in the 3’UTR at 
positions 5410-5448 with an in-frame stop, and 
alternative start leucine codon which is recoded 
as NUG to Methionine, for a final translation of 
MSVCCFICNYKII. The peptide is detected only 
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gnl|unk|ENST00000557933_37 96.10% 5 
HKDC1_HUMAN 100.00% 6 
TBL3_HUMAN 96.10% 6 
MGAT2_HUMAN 96.10% 1 
ALG11_HUMAN 100.00% 4 
IF5A1_HUMAN 100.00% 8 
HS71A_HUMAN,HS71B_HUMAN 100.00% 41 
GNAI3_HUMAN 100.00% 21 
S39AE_HUMAN 100.00% 44 
SPS2L_HUMAN 100.00% 5 
LICH_HUMAN 96.10% 3 
SAR1B_HUMAN 60.60% 3 
HNRPC_HUMAN 100.00% 33 
CTDS1_HUMAN 94.80% 4 
SRSF2_HUMAN 100.00% 4 
gnl|unk|ENST00000487233_4 97.40% 1 
CCHL_HUMAN 100.00% 9 
NOP56_HUMAN 100.00% 49 
RAB1B_HUMAN 100.00% 57 
99 
 
MGST2_HUMAN,gnl|unk|ENST00000506797_5,gnl|unk|ENST00000515067_3 56.50% 1 
VATE1_HUMAN 100.00% 15 
AHSA1_HUMAN 96.10% 5 
ATM_HUMAN 96.10% 6 
CY24A_HUMAN 100.00% 2 
DDRGK_HUMAN 100.00% 13 
ECHP_HUMAN 96.10% 3 
VAPA_HUMAN 100.00% 53 
PRS8_HUMAN 96.10% 1 
VTA1_HUMAN 68.00% 1 
DIDO1_HUMAN 96.10% 6 
TRAM1_HUMAN 99.10% 1 
NDUV1_HUMAN 100.00% 59 
SEPT9_HUMAN 100.00% 7 
IDHC_HUMAN 99.90% 3 
EF1A1_HUMAN 100.00% 695 
CXAR_HUMAN 100.00% 15 
NT5D2_HUMAN 100.00% 1 
VATL_HUMAN 96.10% 9 
NONO_HUMAN 100.00% 43 
DX39A_HUMAN 52.70% 14 
TIM14_HUMAN 100.00% 1 
ACTB_HUMAN 100.00% 2091 
PROX1_HUMAN 96.90% 1 
SAC1_HUMAN 100.00% 11 
FAF2_HUMAN 100.00% 37 
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CND3_HUMAN 100.00% 11 
TCPD_HUMAN 100.00% 4 
QCR1_HUMAN 100.00% 140 
LITAF_HUMAN 96.10% 4 
SLU7_HUMAN 96.10% 4 
WDR75_HUMAN 100.00% 8 
RS2_HUMAN 100.00% 44 
SRPRB_HUMAN 100.00% 33 
RINT1_HUMAN 96.10% 1 
TM41B_HUMAN 96.10% 10 
SNAA_HUMAN 100.00% 45 
STF1_HUMAN 96.10% 1 
CR3L2_HUMAN 96.10% 1 
ALG2_HUMAN 100.00% 23 
K2013_HUMAN 100.00% 5 
LETM1_HUMAN 100.00% 28 
ELOV1_HUMAN 96.10% 8 
TMX3_HUMAN 100.00% 4 
NU5M_HUMAN 100.00% 10 
DHCR7_HUMAN 100.00% 15 
ESF1_HUMAN 96.10% 4 
NDUF3_HUMAN 96.10% 8 
BEND3_HUMAN 96.10% 3 
SFXN1_HUMAN 100.00% 35 
RL31_HUMAN 100.00% 18 
ARFG1_HUMAN 100.00% 4 
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P121C_HUMAN 100.00% 4 
BAZ2A_HUMAN 99.90% 1 
AUP1_HUMAN 100.00% 6 
HEAT1_HUMAN 100.00% 7 
VATF_HUMAN 96.10% 6 
HCD2_HUMAN 100.00% 11 
RNPS1_HUMAN 100.00% 11 
CDC20_HUMAN 99.80% 2 
EXOS3_HUMAN 96.10% 4 
SC11C_HUMAN,gnl|unk|ENST00000299714_4 96.10% 1 
TGM2_HUMAN 100.00% 6 
NC2B_HUMAN 96.10% 4 
NUP53_HUMAN 8.50% 0 
NDUAA_HUMAN 100.00% 19 
ERG28_HUMAN 100.00% 3 
PHB2_HUMAN 100.00% 143 
TRRAP_HUMAN 100.00% 4 
SCAM1_HUMAN 96.10% 6 
3MG_HUMAN 96.10% 5 
TMED9_HUMAN 100.00% 55 
NKD1_HUMAN 100.00% 2 
MTFP1_HUMAN 95.20% 1 
GL8D1_HUMAN 78.10% 3 
SF3A1_HUMAN 96.10% 2 
PNKD_HUMAN 100.00% 19 
TCOF_HUMAN 99.80% 1 
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HMGA1_HUMAN 100.00% 35 
SRSF3_HUMAN 99.90% 14 
SMD1_HUMAN 100.00% 18 
H2AV_HUMAN,H2AZ_HUMAN 100.00% 84 
TP53B_HUMAN 96.10% 1 
RL13A_HUMAN 100.00% 16 
RAP2B_HUMAN 96.10% 6 
RFA1_HUMAN 100.00% 8 
NU188_HUMAN 100.00% 7 
TEBP_HUMAN 99.80% 9 
UBP7_HUMAN 100.00% 9 
IPO9_HUMAN 96.10% 1 
MTCH1_HUMAN 96.10% 2 
VAMP3_HUMAN,gnl|unk|ENST00000054666_6 100.00% 11 
CBX3_HUMAN 99.90% 3 
IFM3_HUMAN 26.60% 0 
SPCS1_HUMAN 100.00% 24 
SYFA_HUMAN 88.70% 3 
VRK3_HUMAN 94.70% 1 
SC61B_HUMAN,gnl|unk|ENST00000223641_2 100.00% 10 
OS9_HUMAN 100.00% 11 
PLCA_HUMAN 96.10% 4 
RPF2_HUMAN 96.10% 1 
HNRPU_HUMAN 100.00% 157 
RS4Y1_HUMAN 100.00% 26 
SATT_HUMAN 96.10% 2 
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TM209_HUMAN 96.10% 6 
ANO6_HUMAN 96.10% 6 
ITIH2_HUMAN 100.00% 9 
ANXA6_HUMAN 100.00% 12 
P5CR2_HUMAN 5.50% 0 
FARP1_HUMAN 100.00% 2 
VAS1_HUMAN 99.90% 4 
YIF1B_HUMAN 96.10% 6 
PTN1_HUMAN 100.00% 22 
gnl|unk|ENST00000352511_93 72.80% 1 
TM9S2_HUMAN 100.00% 15 
TMCO1_HUMAN 100.00% 7 
RBM39_HUMAN 100.00% 3 
RL3_HUMAN 100.00% 59 
GCN1_HUMAN 100.00% 10 
DNJC9_HUMAN 100.00% 8 
NUP98_HUMAN 100.00% 5 
CTNB1_HUMAN 100.00% 65 
MCU_HUMAN 100.00% 5 
HCFC1_HUMAN 100.00% 11 
ITB1_HUMAN 100.00% 86 
SMC3_HUMAN 100.00% 9 
XPO5_HUMAN 65.70% 1 
GLYR1_HUMAN 100.00% 3 
ABD12_HUMAN 96.10% 1 
ENOA_HUMAN 100.00% 38 
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CO3_HUMAN 100.00% 39 
AURKB_HUMAN 99.80% 2 
EZRI_HUMAN 6.20% 1 
LTOR2_HUMAN 96.10% 6 
SSBP_HUMAN 100.00% 19 
WFS1_HUMAN 100.00% 16 
CN166_HUMAN 96.10% 2 
RL36_HUMAN 100.00% 11 
SYK_HUMAN 96.10% 3 
FA83H_HUMAN 64.60% 1 
ILF3_HUMAN 100.00% 39 
ZGPAT_HUMAN 98.90% 1 
SND1_HUMAN 100.00% 32 
F210B_HUMAN 100.00% 10 
DHC24_HUMAN 100.00% 53 
gnl|unk|ENST00000493646_6 96.10% 4 
RL23A_HUMAN 100.00% 9 
RRP1B_HUMAN 100.00% 4 
H32_HUMAN 99.90% 40 
B4GA1_HUMAN 100.00% 4 
PP1G_HUMAN 89.60% 52 
NDUAB_HUMAN 100.00% 22 
SCAM2_HUMAN 100.00% 14 
TPM4_HUMAN 100.00% 10 
SNR40_HUMAN 100.00% 5 
NUP37_HUMAN 96.10% 2 
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GAR1_HUMAN 96.10% 2 
gnl|unk|ENST00000502784_11 74.40% 1 
RL7A_HUMAN 100.00% 45 
DPM1_HUMAN 100.00% 19 
SAS10_HUMAN 96.10% 3 
LTOR1_HUMAN 99.80% 4 
PSIP1_HUMAN 99.00% 5 
68MP_HUMAN,gnl|unk|ENST00000286953_5,gnl|unk|ENST00000557040_6 99.90% 3 
PON3_HUMAN 96.10% 1 
STX5_HUMAN 100.00% 6 
SEC62_HUMAN,gnl|unk|ENST00000460513_4,gnl|unk|ENST00000487736_9 96.10% 1 
RAB5B_HUMAN 99.90% 16 
RFA2_HUMAN 96.10% 5 
PRDX5_HUMAN 96.10% 11 
SC22B_HUMAN 100.00% 27 
H2A2B_HUMAN 97.40% 210 
MRP1_HUMAN 100.00% 8 
FER_HUMAN 96.10% 1 
VATA_HUMAN 100.00% 2 
TBB4B_HUMAN 100.00% 279 
UD2B7_HUMAN 100.00% 5 
SPCS2_HUMAN 100.00% 33 
PIGS_HUMAN 100.00% 18 
RBBP5_HUMAN 96.10% 1 
RTN4_HUMAN 100.00% 45 




RLA0_HUMAN 100.00% 33 
CCD47_HUMAN 100.00% 37 
ARF1_HUMAN,ARF3_HUMAN 100.00% 8 
ACTN1_HUMAN 96.30% 13 
NEP1_HUMAN 58.90% 1 
BAG2_HUMAN 100.00% 25 
RAD50_HUMAN 98.50% 1 
TMED4_HUMAN 100.00% 19 
FACE1_HUMAN 100.00% 16 
RBM15_HUMAN 100.00% 6 
NIPA1_HUMAN 96.10% 1 
TOIP2_HUMAN 100.00% 2 
CSTF3_HUMAN 10.40% 0 
PALM_HUMAN 96.10% 4 
UBXN6_HUMAN 96.10% 1 
F169A_HUMAN 100.00% 6 
TCP4_HUMAN 100.00% 19 
UTRO_HUMAN 99.80% 1 
RUXF_HUMAN 57.80% 1 
DEST_HUMAN 96.10% 4 
APOA1_HUMAN 100.00% 22 
EMC3_HUMAN 96.10% 3 
THEM6_HUMAN 100.00% 35 
DHRS7_HUMAN 100.00% 18 
CSN3_HUMAN 55.40% 1 
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PRS6B_HUMAN 32.50% 0 
DEGS1_HUMAN 96.10% 5 
IPO4_HUMAN 82.70% 3 
TM45B_HUMAN 96.10% 1 
CHDH_HUMAN 100.00% 3 
COASY_HUMAN 100.00% 4 
SAMC_HUMAN 96.10% 4 
SSRA_HUMAN 100.00% 114 
EFTS_HUMAN 96.10% 5 
ACTBL_HUMAN 100.00% 67 
LBR_HUMAN 100.00% 14 
K2C8_HUMAN 100.00% 428 
CHD1_HUMAN 96.10% 2 
BRI3B_HUMAN 100.00% 6 
TRI25_HUMAN 100.00% 5 
H33_HUMAN 99.90% 42 
TI23B_HUMAN,TIM23_HUMAN 100.00% 3 
RAB18_HUMAN 100.00% 12 
UB2G2_HUMAN 96.10% 5 
GTR1_HUMAN 100.00% 87 
WDR55_HUMAN 96.10% 3 
UGGG1_HUMAN 98.20% 0 
CWC22_HUMAN 96.10% 2 
RSMB_HUMAN,RSMN_HUMAN 13.90% 0 
NUP93_HUMAN 100.00% 34 
gnl|unk|ENST00000377524_2 97.50% 1 
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DHB11_HUMAN 100.00% 11 
UGDH_HUMAN 100.00% 2 
DDX24_HUMAN 99.30% 6 
MESD_HUMAN 96.10% 4 
RM45_HUMAN 100.00% 9 
VATB2_HUMAN 100.00% 10 
BAF_HUMAN,gnl|unk|ENST00000312175_10,gnl|unk|ENST00000445560_7 100.00% 43 
UDB10_HUMAN 99.20% 2 
SEC63_HUMAN 100.00% 27 
PSA3_HUMAN 96.10% 1 
RPB9_HUMAN 96.10% 5 
UD2A3_HUMAN 100.00% 13 
VPS45_HUMAN 96.10% 3 
VWA8_HUMAN 96.10% 1 
DIC_HUMAN 100.00% 62 
NSF_HUMAN 100.00% 21 
THOC2_HUMAN 93.90% 1 
DEFM_HUMAN 100.00% 4 
ABCF2_HUMAN 96.10% 6 
OPA1_HUMAN 100.00% 27 
PP1B_HUMAN 100.00% 54 
FADS1_HUMAN 100.00% 4 
TOM34_HUMAN 100.00% 2 
T126A_HUMAN 100.00% 11 
TIM16_HUMAN 96.10% 4 
ZNT7_HUMAN 99.90% 3 
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TM55B_HUMAN 96.10% 1 
RSF1_HUMAN 96.10% 1 
PKP2_HUMAN 100.00% 24 
CNBP_HUMAN 100.00% 5 
MSH3_HUMAN 96.10% 1 
NUP85_HUMAN 100.00% 28 
TKT_HUMAN 100.00% 8 
ACADV_HUMAN 100.00% 25 
RUXG_HUMAN,gnl|unk|ENST00000272348_6 96.10% 7 
GALT1_HUMAN 98.60% 1 
EMC4_HUMAN 100.00% 10 
AT1B3_HUMAN 100.00% 13 
HM13_HUMAN 100.00% 22 
ERG7_HUMAN 100.00% 52 
NPM3_HUMAN 100.00% 9 
RL18A_HUMAN 100.00% 7 
LRC8D_HUMAN 73.90% 0 
MYO1B_HUMAN 100.00% 30 
ASGR2_HUMAN 100.00% 31 
RU1C_HUMAN 96.10% 7 




CISD1_HUMAN,gnl|unk|ENST00000489785_8 100.00% 3 
THOC4_HUMAN 100.00% 153 
IMDH2_HUMAN 100.00% 2 
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REEP6_HUMAN 100.00% 4 
LSM5_HUMAN,gnl|unk|ENST00000450169_6 96.10% 5 
PPIH_HUMAN 96.10% 4 
HINT3_HUMAN 96.10% 1 
CAZA2_HUMAN 100.00% 11 
MOT1_HUMAN 100.00% 15 
NOC3L_HUMAN 100.00% 3 
1433E_HUMAN 99.60% 1 
RL23_HUMAN 100.00% 10 
DDX5_HUMAN 100.00% 50 
NDUA7_HUMAN 100.00% 6 
HDAC1_HUMAN 100.00% 7 
NP1L4_HUMAN 13.60% 0 
PLIN2_HUMAN 100.00% 63 
HNRPQ_HUMAN 70.80% 1 
AT2C1_HUMAN 96.10% 2 
ZNT1_HUMAN 100.00% 11 
CEAM1_HUMAN 100.00% 29 
RAB21_HUMAN 100.00% 12 
ENPL_HUMAN 100.00% 72 
MFF_HUMAN 100.00% 6 
RS18_HUMAN 100.00% 2 
TXD15_HUMAN 96.10% 2 
SYIC_HUMAN 100.00% 24 
UBXN1_HUMAN 96.10% 1 
CP51A_HUMAN 100.00% 30 
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TFAM_HUMAN 100.00% 36 
CALU_HUMAN 100.00% 11 
CSK2B_HUMAN 72.00% 1 
COMT_HUMAN 100.00% 88 
DNJC5_HUMAN 100.00% 10 
DHRS2_HUMAN 100.00% 112 
RTCB_HUMAN 100.00% 6 
CDC27_HUMAN 99.90% 2 
CO4A_HUMAN,CO4B_HUMAN 100.00% 10 
UHRF1_HUMAN 100.00% 26 
SPTC1_HUMAN 100.00% 21 
PRP6_HUMAN 100.00% 13 
CD63_HUMAN 100.00% 4 
PRAF3_HUMAN 100.00% 10 
ST1A3_HUMAN,ST1A4_HUMAN 96.10% 4 
ATD3A_HUMAN 100.00% 52 
DX39B_HUMAN 99.60% 14 
GTF2I_HUMAN 100.00% 18 
MRE11_HUMAN 77.70% 1 
KIF22_HUMAN 96.10% 1 
COBL_HUMAN 96.10% 1 
SFXN2_HUMAN 96.10% 7 
HNRPK_HUMAN 100.00% 4 
QCR8_HUMAN,gnl|unk|ENST00000378667_5 96.10% 5 
AT5F1_HUMAN 100.00% 41 
PVR_HUMAN 100.00% 9 
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CTBL1_HUMAN 99.90% 5 
COX11_HUMAN 100.00% 4 
CETN2_HUMAN 43.00% 0 
SSRP1_HUMAN 100.00% 66 
APOH_HUMAN 100.00% 6 
SYRC_HUMAN 100.00% 12 
SMRD2_HUMAN 99.90% 3 
NDUB6_HUMAN 100.00% 18 
IF2G_HUMAN 100.00% 16 
RL15_HUMAN 100.00% 11 
RCC1_HUMAN 100.00% 104 
SRS10_HUMAN 96.10% 2 




CNIH4_HUMAN,gnl|unk|ENST00000468318_8 96.10% 12 
ROMO1_HUMAN,gnl|unk|ENST00000374078_3,gnl|unk|ENST00000397416_1 96.10% 7 
SP3_HUMAN 96.10% 1 
ICT1_HUMAN,gnl|unk|ENST00000580800_9 6.90% 0 
TF3C5_HUMAN 96.10% 6 
PWP2_HUMAN 96.10% 2 
GABT_HUMAN 92.40% 2 
IF2P_HUMAN 96.10% 8 
TF3C4_HUMAN 96.10% 5 
TBA1C_HUMAN 100.00% 144 
FMNL2_HUMAN 99.70% 1 
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PDIA3_HUMAN 100.00% 163 
ADT2_HUMAN 100.00% 103 
SGT1_HUMAN 15.00% 0 
DYLT1_HUMAN,gnl|unk|ENST00000367085_4 100.00% 10 
ERLN1_HUMAN 100.00% 18 
ZW10_HUMAN 100.00% 10 
MIC26_HUMAN 96.10% 6 
RT35_HUMAN 95.60% 1 
TM189_HUMAN 100.00% 7 
ESAM_HUMAN 96.10% 4 
COX1_HUMAN 99.40% 36 
ROA0_HUMAN 100.00% 13 
PGK1_HUMAN 83.80% 0 




SF3A3_HUMAN 97.90% 0 
P4HA1_HUMAN 96.10% 2 
NDUA8_HUMAN 100.00% 25 
HDAC2_HUMAN 28.10% 4 
PLIN3_HUMAN 100.00% 3 
K22E_HUMAN 99.40% 3 
SOAT1_HUMAN 100.00% 5 
STEA3_HUMAN 100.00% 1 
AL1A1_HUMAN 100.00% 7 
K1C19_HUMAN 100.00% 400 
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NSUN5_HUMAN 96.10% 1 
E41L5_HUMAN 6.40% 0 
RS19_HUMAN 100.00% 9 
DNJB1_HUMAN 99.90% 4 
SMCA1_HUMAN 100.00% 7 
TIM50_HUMAN 100.00% 22 
NDUS6_HUMAN 100.00% 9 
ARAP1_HUMAN 96.10% 6 
APMAP_HUMAN 100.00% 93 
SNF5_HUMAN 98.20% 4 
PRP19_HUMAN 100.00% 47 
ITPR2_HUMAN 100.00% 16 
THIK_HUMAN 96.10% 3 
SMC1A_HUMAN 100.00% 6 
ATD3B_HUMAN 100.00% 34 
SAHH_HUMAN 99.30% 6 
RBBP4_HUMAN 100.00% 11 
S61A1_HUMAN 100.00% 41 
IL6RB_HUMAN 100.00% 2 
HMOX2_HUMAN 100.00% 20 
RPOM_HUMAN 96.10% 5 
GOLP3_HUMAN 96.10% 2 
JAK1_HUMAN 96.10% 4 
TAF5_HUMAN 99.10% 1 
VIGLN_HUMAN 96.10% 1 
TMEDA_HUMAN 100.00% 61 
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IF5_HUMAN 96.10% 3 
PHB_HUMAN 100.00% 118 
TOP1_HUMAN 100.00% 40 
ACSL5_HUMAN 100.00% 90 
ALBU_HUMAN 100.00% 24 
NDUA2_HUMAN 100.00% 1 
ZN326_HUMAN 99.10% 1 
HNRPL_HUMAN 100.00% 26 
2AAA_HUMAN 100.00% 4 
TKFC_HUMAN 5.60% 0 
DDB1_HUMAN 100.00% 4 
DDX50_HUMAN 41.00% 2 
RN149_HUMAN 96.10% 6 
CAF1A_HUMAN 100.00% 2 
PUR2_HUMAN 21.20% 0 
AT2B4_HUMAN 99.90% 10 
COX15_HUMAN 96.10% 4 
UBQL2_HUMAN 96.10% 1 
H12_HUMAN 100.00% 120 
gnl|unk|ENST00000424846_20,gnl|unk|ENST00000492121_18 100.00% 12 
RRBP1_HUMAN 100.00% 64 
ATP5H_HUMAN 100.00% 117 
RAD21_HUMAN 100.00% 8 
DNJA3_HUMAN 100.00% 5 
KIF4A_HUMAN 96.10% 4 
LMAN1_HUMAN 100.00% 114 
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RALB_HUMAN 93.10% 0 
OCAD1_HUMAN 100.00% 4 
FA83D_HUMAN 96.10% 2 
TOP2B_HUMAN 100.00% 35 
MLF2_HUMAN 96.10% 2 
NBAS_HUMAN 99.40% 0 
PGAM1_HUMAN 99.90% 4 
SUN1_HUMAN 100.00% 8 
AMPN_HUMAN 100.00% 122 
S26A6_HUMAN 96.10% 1 
ADT3_HUMAN 100.00% 128 
GDIB_HUMAN 100.00% 6 
ERLN2_HUMAN 100.00% 22 
FLNB_HUMAN 100.00% 12 
CDC5L_HUMAN 100.00% 14 
MPC2_HUMAN 99.90% 1 
ERBB2_HUMAN 77.10% 0 
B2CL1_HUMAN 96.10% 1 
PO210_HUMAN 100.00% 56 
MIC27_HUMAN 100.00% 2 
HNRPF_HUMAN 100.00% 16 
DPP4_HUMAN 100.00% 77 
SKP1_HUMAN 96.10% 1 
CP2W1_HUMAN 100.00% 8 
ATAD1_HUMAN 100.00% 2 
VATG1_HUMAN 100.00% 10 
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PEG3_HUMAN 99.80% 5 
ELOV5_HUMAN 96.10% 6 
COPB2_HUMAN 96.10% 1 
NFIP1_HUMAN,gnl|unk|ENST00000509436_2 96.10% 2 
NUP43_HUMAN 100.00% 7 
NSDHL_HUMAN 100.00% 12 
NDUB1_HUMAN,gnl|unk|ENST00000553514_8,gnl|unk|ENST00000555441_6 99.00% 3 
OSBL2_HUMAN 96.10% 1 
DAG1_HUMAN 99.80% 7 
IF2B_HUMAN 99.90% 4 
RL10_HUMAN 100.00% 54 




ROA1_HUMAN 100.00% 41 
ATP5L_HUMAN 100.00% 12 
TBB2B_HUMAN 99.90% 239 
ML12A_HUMAN,ML12B_HUMAN 100.00% 105 
CALX_HUMAN 100.00% 414 
NPM_HUMAN 100.00% 90 
VDAC1_HUMAN 100.00% 484 
RAN_HUMAN 100.00% 29 
BASI_HUMAN 100.00% 110 
SYMC_HUMAN 100.00% 39 
PININ_HUMAN 100.00% 8 
NDUS7_HUMAN 96.10% 10 
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TPP1_HUMAN 100.00% 4 
HSP72_HUMAN 27.70% 44 
ZFPL1_HUMAN 96.10% 6 
LAT1_HUMAN 100.00% 21 
RT30_HUMAN 12.50% 0 
ABCD1_HUMAN 99.90% 1 
MPCP_HUMAN 100.00% 62 
SF3B2_HUMAN 99.90% 1 
RL5_HUMAN 100.00% 6 
SUZ12_HUMAN 96.10% 1 
TCPG_HUMAN 100.00% 14 
GSLG1_HUMAN 100.00% 129 
RM16_HUMAN 35.90% 0 
MET7A_HUMAN 100.00% 12 
HMGB2_HUMAN 99.20% 5 
TFR1_HUMAN 100.00% 104 
SPTN1_HUMAN 100.00% 470 
LAMP2_HUMAN 100.00% 12 
MIC19_HUMAN 100.00% 17 
RS5_HUMAN 100.00% 74 
DYL2_HUMAN 6.30% 11 
SAHH2_HUMAN 85.20% 2 
RPN2_HUMAN 100.00% 532 
HNRH1_HUMAN 100.00% 39 
COPE_HUMAN 96.10% 5 
ALG5_HUMAN 99.90% 8 
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STT3A_HUMAN 100.00% 29 
ACY1_HUMAN 96.10% 1 
IMPA3_HUMAN 35.70% 0 
K1C14_HUMAN 99.80% 13 
MD1L1_HUMAN 100.00% 4 
RS14_HUMAN,gnl|unk|ENST00000519690_58 100.00% 29 
DMD_HUMAN 100.00% 2 
RASH_HUMAN 99.30% 10 
TOM22_HUMAN 100.00% 70 
GRWD1_HUMAN 96.10% 3 
NH2L1_HUMAN 100.00% 26 
GPI8_HUMAN 100.00% 10 
NDUS1_HUMAN 100.00% 101 
AT131_HUMAN 100.00% 15 
PDLI1_HUMAN 100.00% 12 
EXOS6_HUMAN 96.10% 1 
DNJA4_HUMAN 96.10% 1 
GPC5C_HUMAN 96.10% 1 
UFL1_HUMAN 100.00% 25 
TOP2A_HUMAN 100.00% 125 
LAMC1_HUMAN 100.00% 6 
SUN2_HUMAN 100.00% 44 
UTP20_HUMAN 96.10% 2 
T2FA_HUMAN 96.10% 4 
SCAM4_HUMAN 100.00% 11 




KCY_HUMAN 77.10% 1 
HG2A_HUMAN 100.00% 10 
BCS1_HUMAN 99.90% 3 
RT05_HUMAN 19.20% 0 
MDC1_HUMAN 100.00% 2 
PR40A_HUMAN 100.00% 10 
COIA1_HUMAN 96.10% 5 
gnl|unk|ENST00000354895_3 96.10% 4 
AKAP1_HUMAN 100.00% 12 
ATAD2_HUMAN 100.00% 14 
SEPT2_HUMAN 18.30% 0 
RAB7A_HUMAN 100.00% 34 
GLYM_HUMAN 99.80% 1 
SQRD_HUMAN 100.00% 41 
UXS1_HUMAN 100.00% 4 
BAZ1B_HUMAN 100.00% 23 
PAIRB_HUMAN 100.00% 20 
TMTC3_HUMAN 96.10% 2 
SFPQ_HUMAN 100.00% 122 
RMD3_HUMAN 99.90% 1 
CPT2_HUMAN 100.00% 8 
K1C23_HUMAN 96.10% 3 
TOM7_HUMAN,gnl|unk|ENST00000358435_4 99.90% 4 
NCEH1_HUMAN 100.00% 5 
TMOD3_HUMAN 100.00% 7 
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CLCC1_HUMAN 100.00% 6 
AN32B_HUMAN 7.40% 4 
ICAM1_HUMAN 100.00% 9 
PRDX2_HUMAN 99.80% 5 
YIPF5_HUMAN 96.10% 3 
PYC_HUMAN 96.10% 1 
HEMH_HUMAN 96.10% 2 
SMHD1_HUMAN 100.00% 10 
NUP50_HUMAN 96.10% 1 
RS4X_HUMAN 100.00% 38 
DC1I2_HUMAN 100.00% 12 
CAZA1_HUMAN 100.00% 10 
S12A7_HUMAN 99.10% 1 
PLXB2_HUMAN 99.90% 5 
SC5A6_HUMAN 100.00% 3 
SMRC1_HUMAN 100.00% 9 
KAD4_HUMAN 99.90% 14 
TM115_HUMAN 90.70% 1 
SCPDL_HUMAN 100.00% 10 
MIA3_HUMAN 100.00% 17 
HSPB1_HUMAN 100.00% 25 
SF3B3_HUMAN 100.00% 2 
RL6_HUMAN 100.00% 37 
CTND1_HUMAN 100.00% 114 
EMD_HUMAN 100.00% 22 
SNX5_HUMAN 96.10% 4 
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U5S1_HUMAN 100.00% 30 
GBB2_HUMAN 100.00% 29 
NGDN_HUMAN 96.10% 4 
SMC6_HUMAN 96.10% 4 
RAB6C_HUMAN 96.10% 1 
MP2K3_HUMAN 96.10% 4 
TPIS_HUMAN 100.00% 3 
RING1_HUMAN,RING2_HUMAN 96.10% 6 
FXR1_HUMAN 96.10% 3 
ALDOC_HUMAN 99.20% 9 
ESYT1_HUMAN 100.00% 64 
GBG5_HUMAN 100.00% 26 
NDUB5_HUMAN 100.00% 29 
IF4G2_HUMAN 99.40% 1 
K1C15_HUMAN 45.90% 11 
IR3IP_HUMAN,gnl|unk|ENST00000256433_3,gnl|unk|ENST00000588705_3 98.60% 6 
CDS2_HUMAN 100.00% 22 
AOFB_HUMAN 100.00% 20 
GPX1_HUMAN 37.80% 0 
CXB1_HUMAN 99.20% 6 
ARC1B_HUMAN 96.10% 4 
NDUS2_HUMAN 100.00% 34 
SPNS1_HUMAN 100.00% 18 
TM41A_HUMAN 100.00% 4 
NOP10_HUMAN,gnl|unk|ENST00000328848_6 96.10% 1 
KHDR1_HUMAN 100.00% 24 
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MOT4_HUMAN 100.00% 15 
UBIA1_HUMAN 96.10% 5 
NNTM_HUMAN 100.00% 11 
ADNP_HUMAN 92.50% 2 
CND1_HUMAN 99.80% 1 
TCPB_HUMAN 100.00% 4 
TIM13_HUMAN,gnl|unk|ENST00000215570_5 99.90% 3 
LAMA5_HUMAN 100.00% 6 
G45IP_HUMAN 96.10% 5 
WDR18_HUMAN 96.10% 2 
ZYX_HUMAN 100.00% 7 
LC7L2_HUMAN 98.10% 5 
IMB1_HUMAN 100.00% 19 
SCRIB_HUMAN 100.00% 6 
NECT2_HUMAN 100.00% 7 
ITAV_HUMAN 100.00% 8 
EPT1_HUMAN 100.00% 6 
RADI_HUMAN 98.80% 2 
SRSF7_HUMAN 99.90% 11 
DAD1_HUMAN 100.00% 16 
TMX1_HUMAN 100.00% 12 
IF4A1_HUMAN 100.00% 26 
DHE3_HUMAN 100.00% 11 
RMND1_HUMAN 100.00% 4 
ACSL3_HUMAN 100.00% 146 
PGRC2_HUMAN 100.00% 14 
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AR6P1_HUMAN 98.20% 2 
VATD_HUMAN 96.10% 1 
RSSA_HUMAN 100.00% 7 
ACINU_HUMAN 99.90% 2 
TOM70_HUMAN 100.00% 71 
STAT3_HUMAN 100.00% 3 
CND2_HUMAN 96.10% 6 
SYJ2B_HUMAN,gnl|unk|ENST00000618385_4 96.10% 6 
AGRIN_HUMAN 100.00% 3 
YBOX1_HUMAN 100.00% 14 
RBP56_HUMAN 99.20% 9 
DDX27_HUMAN 100.00% 5 
CYB5B_HUMAN 100.00% 500 
ATPG_HUMAN 100.00% 55 
TBL2_HUMAN 100.00% 15 
ARF6_HUMAN 96.10% 2 
ACTN4_HUMAN 100.00% 25 
WDR12_HUMAN 96.10% 3 
CLH1_HUMAN 100.00% 141 
MK03_HUMAN 96.10% 2 
TMED7_HUMAN 100.00% 34 
DSRAD_HUMAN 100.00% 10 
COX2_HUMAN 100.00% 58 
EMC2_HUMAN 100.00% 25 
FCGRN_HUMAN 99.90% 6 
EPN4_HUMAN 96.00% 1 
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GOGB1_HUMAN 100.00% 3 
NU133_HUMAN 100.00% 22 
SRSF1_HUMAN 100.00% 6 
SNW1_HUMAN 96.10% 4 
H2AX_HUMAN 100.00% 216 
ABI1_HUMAN 96.10% 6 
ADRM1_HUMAN 14.50% 0 
B4GT1_HUMAN 96.10% 1 
ACPM_HUMAN 100.00% 25 
ASPH_HUMAN 100.00% 12 
P2RX4_HUMAN 96.10% 1 
RS26_HUMAN 99.90% 2 
ITB5_HUMAN 100.00% 4 
SRC_HUMAN 100.00% 6 
DGLB_HUMAN 100.00% 1 
RM39_HUMAN 42.50% 0 
LYSC_HUMAN 96.10% 6 
ETFB_HUMAN 96.10% 4 
HACD3_HUMAN 100.00% 58 
RM44_HUMAN 100.00% 11 
GANAB_HUMAN 100.00% 7 
MLEC_HUMAN 100.00% 38 
gnl|unk|ENST00000509601_5 100.00% 5 
SSRD_HUMAN 100.00% 59 
PUF60_HUMAN 96.10% 2 
INT3_HUMAN 99.80% 1 
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DDX21_HUMAN 100.00% 76 
SYVN1_HUMAN 99.90% 1 
VRK1_HUMAN 100.00% 9 
TRIPC_HUMAN 100.00% 8 
CHD4_HUMAN 100.00% 61 
SEH1_HUMAN 100.00% 9 
SGPL1_HUMAN 100.00% 20 
ANXA4_HUMAN 100.00% 8 
RAB23_HUMAN 100.00% 2 
H1X_HUMAN 100.00% 30 
ERO1A_HUMAN 16.20% 0 
S12A2_HUMAN 96.10% 1 
TCPZ_HUMAN 96.10% 6 
CERS2_HUMAN 100.00% 11 
MAP4_HUMAN 100.00% 10 
SELS_HUMAN 96.10% 1 
CLCN7_HUMAN 99.40% 3 
MCM3_HUMAN 91.20% 1 
TM2D2_HUMAN 96.10% 6 
RUVB1_HUMAN 100.00% 13 
ACATN_HUMAN 96.10% 6 
RALY_HUMAN 100.00% 6 
MAVS_HUMAN 100.00% 2 
CALR_HUMAN 100.00% 50 
AGK_HUMAN 100.00% 21 
M2OM_HUMAN 100.00% 19 
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PMM2_HUMAN 96.10% 8 
PESC_HUMAN 7.70% 0 
SRPRA_HUMAN 100.00% 23 
LC7L3_HUMAN 96.10% 4 
KAP2_HUMAN 100.00% 12 
MDHM_HUMAN 96.10% 7 
RB11B_HUMAN 100.00% 7 
PDIP3_HUMAN 100.00% 5 
TFCP2_HUMAN 77.00% 0 
ALG1_HUMAN 100.00% 23 
gnl|unk|ENST00000514511_3 96.10% 3 
PRDX4_HUMAN 100.00% 11 
HNRPR_HUMAN 100.00% 11 
HYEP_HUMAN 100.00% 188 
MARC1_HUMAN 99.80% 6 
HS2ST_HUMAN 99.20% 1 
K1C10_HUMAN 100.00% 16 
DERL1_HUMAN 97.80% 0 
S27A2_HUMAN 100.00% 7 
AP2A2_HUMAN 42.80% 5 
NIP7_HUMAN 99.20% 6 
ASAH1_HUMAN 100.00% 12 
TBB5_HUMAN 100.00% 318 
PBIP1_HUMAN 100.00% 6 
NDUB8_HUMAN 83.30% 1 
U520_HUMAN 100.00% 36 
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DREB_HUMAN 100.00% 6 
SRRM1_HUMAN 100.00% 1 
DIM1_HUMAN 98.90% 1 




CHP1_HUMAN 100.00% 4 
MTX2_HUMAN 100.00% 10 
EMAL4_HUMAN 96.10% 2 
MPPA_HUMAN 96.10% 5 
CLIC1_HUMAN 100.00% 7 
BYST_HUMAN 96.10% 6 
PEBP1_HUMAN 96.10% 8 
METK2_HUMAN 96.10% 2 
ERP29_HUMAN 100.00% 8 
CTNA1_HUMAN 100.00% 16 
DJC10_HUMAN 100.00% 2 
H2AY_HUMAN 100.00% 97 
STAU1_HUMAN 100.00% 18 
CP27A_HUMAN 100.00% 11 
FIBG_HUMAN 100.00% 104 
ARK72_HUMAN 9.90% 0 
3BHS7_HUMAN 100.00% 7 
IMA4_HUMAN 96.10% 2 
AOFA_HUMAN 100.00% 20 
MATR3_HUMAN 100.00% 13 
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ERG1_HUMAN 100.00% 32 
TAP2_HUMAN 96.10% 1 
VTNC_HUMAN 96.10% 2 
NIPBL_HUMAN 96.10% 1 
AP2B1_HUMAN 100.00% 13 
FSCN1_HUMAN 96.10% 2 
ERLEC_HUMAN 100.00% 29 
ATPO_HUMAN 100.00% 54 
GNA11_HUMAN 100.00% 10 
MARE2_HUMAN 96.10% 5 
ATPB_HUMAN 100.00% 1252 
RL26_HUMAN 100.00% 6 
gnl|unk|ENST00000576925_5 99.00% 11 
SYDC_HUMAN 100.00% 11 
SCFD2_HUMAN 96.10% 6 
LAD1_HUMAN 100.00% 13 
MBOA5_HUMAN 100.00% 3 
GRN_HUMAN 100.00% 7 
NDRG1_HUMAN 98.30% 6 
ANXA5_HUMAN 100.00% 9 
LMO7_HUMAN 100.00% 13 
NSMA3_HUMAN 100.00% 31 
TMED2_HUMAN 100.00% 18 
KPYM_HUMAN 100.00% 61 
DNMT1_HUMAN 100.00% 7 
FLOT1_HUMAN 100.00% 20 
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SNP23_HUMAN 100.00% 25 
SELT_HUMAN,gnl|unk|ENST00000466234_3 96.10% 3 
UBXN4_HUMAN 100.00% 9 
PRR11_HUMAN 100.00% 5 
EMC1_HUMAN 100.00% 68 
FIBA_HUMAN 100.00% 35 
MK67I_HUMAN 100.00% 7 
MFAP1_HUMAN 99.60% 1 
FND3A_HUMAN 100.00% 10 
MYH10_HUMAN 100.00% 293 
EHD1_HUMAN 96.10% 5 
RPB2_HUMAN 100.00% 6 
ITM2C_HUMAN 96.10% 6 
OSTB_HUMAN 68.00% 1 
ECE1_HUMAN 100.00% 5 
LASP1_HUMAN 100.00% 17 
M4K4_HUMAN 100.00% 7 
C560_HUMAN 100.00% 9 
EF1G_HUMAN 100.00% 9 
HERP1_HUMAN 100.00% 10 
GPAA1_HUMAN 99.30% 2 
RL3L_HUMAN 99.90% 19 
STML2_HUMAN 100.00% 86 
H2A1B_HUMAN,H2A1C_HUMAN,H2A3_HUMAN 100.00% 216 
ACTS_HUMAN 99.30% 187 
RBMX_HUMAN 100.00% 30 
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APC1_HUMAN 96.10% 3 
NCLN_HUMAN 100.00% 39 
JAG1_HUMAN 96.10% 1 
YES_HUMAN 100.00% 14 
MA1B1_HUMAN 100.00% 8 
COX5B_HUMAN 100.00% 21 
ETFA_HUMAN 100.00% 8 
RL35_HUMAN 100.00% 28 
NDUB9_HUMAN 100.00% 39 
LPP_HUMAN 96.10% 1 
RL18_HUMAN 100.00% 27 
ILF2_HUMAN 100.00% 13 
PLPP6_HUMAN 96.10% 2 
NDUS4_HUMAN 100.00% 10 
H31_HUMAN 99.90% 95 
FDFT_HUMAN 100.00% 136 
CH60_HUMAN 100.00% 247 
SYNE3_HUMAN 100.00% 3 
H14_HUMAN 100.00% 110 
IGSF1_HUMAN 100.00% 12 
UCRIL_HUMAN 99.90% 17 
ABCE1_HUMAN 100.00% 3 
SRBD1_HUMAN 100.00% 5 
RT29_HUMAN 96.10% 3 
UB2L3_HUMAN 96.10% 1 
PNO1_HUMAN 96.10% 10 
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RER1_HUMAN 100.00% 9 
UCRI_HUMAN 100.00% 50 
TPM3_HUMAN 100.00% 12 
ST1A1_HUMAN 96.10% 2 
ACSF2_HUMAN 96.10% 1 
HS90B_HUMAN 100.00% 95 




NPTN_HUMAN 99.80% 11 
IKIP_HUMAN 100.00% 6 
ITA2_HUMAN 100.00% 13 
XPC_HUMAN 99.80% 6 
IF2B1_HUMAN 100.00% 10 
FUBP3_HUMAN 100.00% 5 
JAGN1_HUMAN 100.00% 4 
MPZL1_HUMAN 96.10% 1 
ADT1_HUMAN 100.00% 115 
TIF1B_HUMAN 100.00% 37 
MBOA7_HUMAN 96.10% 6 
BST2_HUMAN,gnl|unk|ENST00000533098_5 96.10% 7 
UBAC2_HUMAN 35.50% 0 
NDUB3_HUMAN 99.90% 2 
APT_HUMAN 91.60% 1 
RD23B_HUMAN 96.10% 3 
TBB4A_HUMAN 99.90% 159 
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RRS1_HUMAN 100.00% 17 
gnl|unk|ENST00000394186_3,gnl|unk|ENST00000485011_2,gnl|unk|ENST00000488775_2 57.00% 24 
RAB10_HUMAN 100.00% 37 
FBRL_HUMAN 100.00% 57 
XRCC6_HUMAN 100.00% 16 
RTN3_HUMAN 25.80% 0 
FABP5_HUMAN 17.80% 0 
RL27_HUMAN 100.00% 40 
AIMP2_HUMAN 96.10% 1 
S19A1_HUMAN 99.40% 6 
TSN6_HUMAN 99.90% 5 
VDAC3_HUMAN 100.00% 115 
VMP1_HUMAN 100.00% 15 
NOG1_HUMAN 100.00% 3 
RHDF2_HUMAN 96.10% 1 
PCYOX_HUMAN 100.00% 94 
RBM14_HUMAN 96.10% 3 
C1QBP_HUMAN 96.10% 6 
TOIP1_HUMAN 100.00% 21 
SURF1_HUMAN 96.10% 2 
SMCA4_HUMAN 100.00% 5 
RUXE_HUMAN,gnl|unk|ENST00000414487_4 100.00% 11 
LDHA_HUMAN 100.00% 6 
FIBB_HUMAN 100.00% 49 
AT1B1_HUMAN 100.00% 24 
AP1M1_HUMAN 95.50% 1 
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FND3B_HUMAN 100.00% 16 
INT1_HUMAN 96.10% 1 
UBB_HUMAN,UBC_HUMAN 100.00% 85 
SAR1A_HUMAN 94.40% 3 
HIG1A_HUMAN,gnl|unk|ENST00000418900_4,gnl|unk|ENST00000625589_4 98.10% 9 
PINX1_HUMAN 96.10% 1 
SUCB1_HUMAN 96.10% 2 
RBBP7_HUMAN 100.00% 8 
JAM1_HUMAN 100.00% 17 
LCLT1_HUMAN 99.90% 8 
OSTC_HUMAN 96.10% 10 
EF2_HUMAN 100.00% 110 
RPAC1_HUMAN 89.30% 1 
DHB4_HUMAN 100.00% 37 
NDUC2_HUMAN,gnl|unk|ENST00000525085_5 99.00% 3 
RHOG_HUMAN 90.50% 0 
RL21_HUMAN 100.00% 26 
SMU1_HUMAN 99.80% 2 
Table 2. All proteins identified in HepG2 by this analysis. Database searching was performed on the datasets described in Table 1. 
In column 1, protein identifications are shown along with their cluster partners. In column 2, identification probabilities are shown. In 
column 3, spectral counts are shown for each protein idenfication. Probabilities here were calculated by the PeptideProphet algorithm 















ACTB_HUMAN 2091 2018 765 745 
ACTG_HUMAN 2088 2023 757 742 
ACTBL_HUMAN 67 72 53 48 
POTEE_HUMAN 1293 1121 363 343 
ACTBM_HUMAN 110 113 114 112 
ACTS_HUMAN 187 200 188 185 
ACTC_HUMAN 187 200 188 185 
CH60_HUMAN 247 237 1486 1647 
HS90B_HUMAN 95 73 808 717 
HS90A_HUMAN 37 32 748 695 
HS905_HUMAN 0 0 139 113 
H90B2_HUMAN 0 0 133 121 
HS904_HUMAN 0 0 0 46 
H90B4_HUMAN 0 0 44 0 
ATPB_HUMAN 1252 1161 87 88 
gnl|unk|ENST00000548474_4 0 34 0 0 
FAS_HUMAN 101 114 987 896 
H2B1C_HUMAN 952 961 68 40 
H2B1D_HUMAN 952 961 68 40 
H2B1H_HUMAN 952 961 68 40 
H2B1K_HUMAN 952 961 68 40 
H2B1L_HUMAN 952 961 68 40 
H2B1N_HUMAN 952 961 68 40 
H2B2F_HUMAN 952 961 68 40 
H2B3B_HUMAN 933 939 68 37 
H2B1A_HUMAN 0 0 0 0 
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EF1A1_HUMAN 695 424 388 342 
EF1A2_HUMAN 0 0 0 0 
TBB5_HUMAN 318 338 539 537 
TBB3_HUMAN 180 218 336 327 
TBB2B_HUMAN 239 269 396 401 
TBB4B_HUMAN 279 300 488 483 
TBB4A_HUMAN 159 160 304 312 
TBB1_HUMAN 0 0 0 0 
H4_HUMAN 622 583 3 7 
SPTB2_HUMAN 621 545 74 52 
SPTN2_HUMAN 0 0 0 0 
SPTN4_HUMAN 0 0 0 0 
SPTB1_HUMAN 0 0 0 0 
ATPA_HUMAN 690 713 28 29 
MYH9_HUMAN 526 489 0 0 
MYH10_HUMAN 293 273 2 0 
MYH14_HUMAN 31 33 0 0 
MYH11_HUMAN 0 0 0 0 
G3P_HUMAN 22 17 651 597 
G3PT_HUMAN 0 0 0 0 
PDIA1_HUMAN 76 68 546 531 
GRP78_HUMAN 166 134 475 470 
K2C8_HUMAN 428 428 64 65 
K2C1_HUMAN 17 20 11 0 
K22E_HUMAN 3 2 0 0 
K2C80_HUMAN 0 0 0 0 
gnl|unk|ENST00000547031_7 26 0 0 0 
K2C5_HUMAN 0 0 0 0 
K2C7_HUMAN 0 0 0 0 
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PDIA3_HUMAN 163 156 443 410 
ENPL_HUMAN 72 54 589 528 
ENPLL_HUMAN 0 0 0 0 
ACTN4_HUMAN 25 23 413 397 
ACTN1_HUMAN 13 13 286 240 
ACTN2_HUMAN 0 0 0 0 
ACTN3_HUMAN 0 0 0 0 
SPTN1_HUMAN 470 410 25 25 
EF2_HUMAN 110 98 405 381 
RPN2_HUMAN 532 482 5 6 
CYB5B_HUMAN 500 471 6 5 
CALR_HUMAN 50 37 415 399 
CALX_HUMAN 414 412 7 6 
VDAC1_HUMAN 484 472 1 0 
CLH1_HUMAN 141 115 271 262 
ENOA_HUMAN 38 35 396 350 
ENOG_HUMAN 0 0 60 74 
TBA1B_HUMAN 171 149 231 227 
TBA1C_HUMAN 144 138 195 203 
TBA8_HUMAN 0 0 0 0 
K1C18_HUMAN 354 325 27 32 
AL1A1_HUMAN 7 6 166 145 
AL1B1_HUMAN 2 1 138 142 
ALDH2_HUMAN 1 1 91 98 
AL1A2_HUMAN 0 0 0 0 
AL1A3_HUMAN 0 0 0 0 
HSP7C_HUMAN 101 106 315 290 
HSP72_HUMAN 44 46 99 96 
NPM_HUMAN 90 83 346 338 
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NUCL_HUMAN 68 43 339 311 
LPPRC_HUMAN 1 2 294 317 
HNRPU_HUMAN 157 154 179 170 
ECHA_HUMAN 139 156 147 166 
RPN1_HUMAN 323 278 1 0 
TERA_HUMAN 56 55 271 256 
PEX1_HUMAN 0 0 0 0 
K1C19_HUMAN 400 336 30 30 
K1C16_HUMAN 9 8 0 0 
gnl|unk|ENST00000405746_3 0 1 0 0 
K1C15_HUMAN 11 11 0 1 
K1C14_HUMAN 13 0 0 0 
K1C17_HUMAN 0 9 0 0 
KPYM_HUMAN 61 66 280 253 
HNRPK_HUMAN 4 10 273 291 
LMNA_HUMAN 273 238 0 0 
DHRS2_HUMAN 112 97 177 193 
SERPH_HUMAN 144 172 81 79 
ROA1_HUMAN 41 57 365 295 
XRCC5_HUMAN 51 32 240 230 
PDIA6_HUMAN 30 39 270 255 
PRKDC_HUMAN 185 216 38 31 
DESP_HUMAN 258 230 0 0 
DHE3_HUMAN 11 7 231 246 
CKAP4_HUMAN 247 227 0 0 
XRCC6_HUMAN 16 16 224 237 
RS7_HUMAN 176 111 128 121 
ALDOA_HUMAN 13 5 228 249 
HNRPM_HUMAN 114 100 88 89 
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RL4_HUMAN 92 77 89 94 
H2A1D_HUMAN 221 256 14 20 
H2A1H_HUMAN 221 256 14 20 
H2A1J_HUMAN 221 256 14 20 
H2A1_HUMAN 221 256 14 20 
H2AJ_HUMAN 221 256 14 20 
H2A1B_HUMAN 216 251 0 0 
H2A1C_HUMAN 216 251 0 0 
H2A3_HUMAN 216 251 0 0 
H2A2B_HUMAN 210 250 0 0 
H2AX_HUMAN 216 256 0 0 
LDHA_HUMAN 6 6 223 195 
LDHC_HUMAN 0 1 0 0 
LDH6A_HUMAN 0 0 0 0 
gnl|unk|ENST00000394996_1
2 
0 0 0 0 
ALBU_HUMAN 24 20 189 191 
gnl|unk|ENST00000504043_6 0 0 0 0 
RACK1_HUMAN 121 127 120 88 
gnl|unk|ENST00000504726_4 0 0 7 8 
NCPR_HUMAN 225 230 0 4 
H31_HUMAN 95 97 11 0 
H32_HUMAN 40 31 1 0 
H33_HUMAN 42 27 0 0 
H31T_HUMAN 23 21 0 0 
H3C_HUMAN 0 0 0 0 
EFTU_HUMAN 75 85 106 124 
ADT2_HUMAN 103 114 0 0 
ADT3_HUMAN 128 92 0 0 
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ADT1_HUMAN 115 79 0 0 
PCBP1_HUMAN 27 27 141 123 
PCBP2_HUMAN 0 4 67 68 
PCBP4_HUMAN 0 0 0 0 
PCBP3_HUMAN 0 0 0 0 
gnl|unk|ENST00000550910_3 0 0 0 0 
OST48_HUMAN 149 79 0 0 
SFPQ_HUMAN 122 85 80 75 
UGDH_HUMAN 2 0 226 225 
gnl|unk|ENST00000503779_5 0 0 0 0 
HYEP_HUMAN 188 174 2 3 
DYHC1_HUMAN 162 162 14 11 
P5CS_HUMAN 103 108 62 52 
CH10_HUMAN 9 8 166 155 
GRP75_HUMAN 47 42 148 172 
MIC60_HUMAN 149 122 0 0 
ROA2_HUMAN 34 27 296 202 
RS4X_HUMAN 38 40 81 84 
RS4Y1_HUMAN 26 21 50 48 
U520_HUMAN 36 50 154 129 
ROA3_HUMAN 42 35 131 123 
gnl|unk|ENST00000424736_5 0 0 65 60 
EST1_HUMAN 15 10 165 174 
HYOU1_HUMAN 40 27 184 151 
RAB10_HUMAN 37 53 4 7 
RAB14_HUMAN 38 35 7 8 
RAB1B_HUMAN 57 50 8 15 
RAB1A_HUMAN 49 55 8 15 
RAB8A_HUMAN 21 27 0 0 
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RAB35_HUMAN 15 23 0 7 
RAB4A_HUMAN 11 15 0 0 
RAB3A_HUMAN 0 0 0 0 
TRFE_HUMAN 80 76 83 93 
LMNB1_HUMAN 180 159 0 0 
DDX5_HUMAN 50 43 70 68 
DDX17_HUMAN 19 29 50 42 
DDX49_HUMAN 0 0 0 0 
gnl|unk|ENST00000601772_1 0 0 0 0 
NB5R3_HUMAN 192 144 0 0 
FLNB_HUMAN 12 22 149 193 
RCC1_HUMAN 104 94 0 0 
PDIA4_HUMAN 13 19 150 181 
TPIS_HUMAN 3 0 192 180 
FIBG_HUMAN 104 106 62 56 
RRBP1_HUMAN 64 61 87 106 
PTBP1_HUMAN 16 12 166 153 
NDKB_HUMAN 6 0 159 136 
NDKA_HUMAN 2 2 46 46 
NDK8_HUMAN 0 0 0 0 
COF1_HUMAN 7 4 137 142 
COF2_HUMAN 6 3 44 47 
ILF3_HUMAN 39 22 112 114 
STRBP_HUMAN 0 0 0 14 
PRDX6_HUMAN 0 0 151 165 
FLNA_HUMAN 84 118 78 72 
THOC4_HUMAN 153 149 13 11 
GANAB_HUMAN 7 6 152 136 
PRDX1_HUMAN 14 13 130 132 
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H12_HUMAN 120 128 1 0 
H14_HUMAN 110 102 1 0 
H11_HUMAN 0 0 0 0 
H13_HUMAN 0 0 0 0 
H1T_HUMAN 0 0 0 0 
PHB2_HUMAN 143 118 0 0 
PPIB_HUMAN 43 33 79 62 
AMPN_HUMAN 122 89 44 37 
PLEC_HUMAN 130 122 8 11 
RL3_HUMAN 59 52 57 51 
RL3L_HUMAN 19 12 9 8 
RS3A_HUMAN 85 82 59 49 
gnl|unk|ENST00000461022_1
4 
0 0 0 0 
QCR1_HUMAN 140 143 20 17 
FETA_HUMAN 18 16 130 112 
UBB_HUMAN 85 82 44 38 
UBC_HUMAN 85 82 44 38 
4F2_HUMAN 141 129 4 1 
LRC59_HUMAN 138 145 0 0 
CATD_HUMAN 10 12 139 149 
TOP2A_HUMAN 125 115 0 0 
TOP2B_HUMAN 35 51 0 0 
ACLY_HUMAN 1 0 134 142 
PHB_HUMAN 118 134 0 0 
PARP1_HUMAN 101 92 9 10 
AT2A2_HUMAN 113 119 0 0 
AT2A3_HUMAN 0 0 0 0 
AT2A1_HUMAN 0 0 0 0 
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HNRPC_HUMAN 33 40 87 85 
HNRC1_HUMAN 0 0 0 0 
HNRC2_HUMAN 0 0 0 0 
HNRC3_HUMAN 0 0 0 0 
HNRC4_HUMAN 0 0 0 0 
HS71A_HUMAN 41 40 108 120 
HS71B_HUMAN 41 40 108 120 
HS71L_HUMAN 22 22 69 62 
RL1D1_HUMAN 57 63 65 76 
gnl|unk|ENST00000572090_5 0 0 0 0 
RL12_HUMAN 68 71 76 72 
RL7_HUMAN 52 53 80 74 
LMAN1_HUMAN 114 132 0 0 
THIC_HUMAN 9 6 144 147 
ATP5H_HUMAN 117 127 0 0 
PPIA_HUMAN 10 12 116 91 
TCPG_HUMAN 14 9 119 114 
TPM4_HUMAN 10 9 34 53 
TPM3_HUMAN 12 11 27 40 
gnl|unk|ENST00000509601_5 5 4 30 38 
TPM1_HUMAN 6 4 13 15 
MDHM_HUMAN 7 4 134 145 
FINC_HUMAN 150 120 0 0 
VDAC2_HUMAN 118 121 0 0 
TCPE_HUMAN 4 2 120 135 
TCPB_HUMAN 4 1 130 118 
NIPS1_HUMAN 94 76 53 43 
PEBP1_HUMAN 8 3 129 108 
GSLG1_HUMAN 129 113 0 0 
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RSSA_HUMAN 7 3 115 108 
HNRPL_HUMAN 26 25 96 90 
MATR3_HUMAN 13 24 104 106 
ML12A_HUMAN 105 108 0 0 
ML12B_HUMAN 105 108 0 0 
gnl|unk|ENST00000577510_4 0 0 0 0 
IDHC_HUMAN 3 9 132 125 
DHX9_HUMAN 19 17 81 88 
RL10A_HUMAN 51 50 34 32 
QCR2_HUMAN 101 89 7 5 
gnl|unk|ENST00000567597_5 0 0 0 0 
ACSL3_HUMAN 146 117 3 7 
FDFT_HUMAN 136 131 0 0 
gnl|unk|ENST00000446331_6 0 0 0 0 
RL7A_HUMAN 45 56 55 46 
GDIB_HUMAN 6 5 116 124 
PUR9_HUMAN 5 3 127 118 
RLA2_HUMAN 67 64 92 80 
SODC_HUMAN 0 0 142 146 
PGK1_HUMAN 0 0 119 105 
PGK2_HUMAN 0 0 0 0 
PP1B_HUMAN 54 43 64 53 
PP1G_HUMAN 52 39 69 57 
PP1A_HUMAN 52 39 64 54 
ACSL4_HUMAN 97 91 24 42 
DDX21_HUMAN 76 65 48 49 
LMNB2_HUMAN 112 112 0 0 
SURF4_HUMAN 134 105 0 0 
TCPD_HUMAN 4 7 126 136 
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PEG10_HUMAN 23 24 73 75 
PCKGM_HUMAN 8 15 79 101 
PLIN3_HUMAN 3 5 118 116 
CISY_HUMAN 0 0 108 104 
RL6_HUMAN 37 35 62 66 
TXND5_HUMAN 22 16 104 97 
CALM_HUMAN 52 46 33 50 
gnl|unk|ENST00000553422_3 0 0 17 20 
gnl|unk|ENST00000486500_1
1 
0 0 0 0 
CTND1_HUMAN 114 81 0 0 
GLYM_HUMAN 1 0 111 106 
HNRH1_HUMAN 39 29 101 97 
HNRH2_HUMAN 0 0 61 60 
RS3_HUMAN 41 46 44 36 
RS2_HUMAN 44 54 62 56 
NDUS1_HUMAN 101 105 5 3 
TIF1B_HUMAN 37 29 92 77 
RS5_HUMAN 74 80 49 47 
C1QBP_HUMAN 6 4 115 88 
ANXA6_HUMAN 12 6 79 76 
SAHH_HUMAN 6 5 100 111 
TKT_HUMAN 8 12 96 80 
TCPZ_HUMAN 6 4 87 93 
TCPW_HUMAN 0 0 0 0 
PDLI1_HUMAN 12 6 89 85 
UBA1_HUMAN 3 0 107 115 
KTN1_HUMAN 71 89 0 0 
RS13_HUMAN 32 27 42 45 
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MTCH2_HUMAN 104 93 0 0 
PGAM1_HUMAN 4 3 99 86 
DX39B_HUMAN 14 13 87 88 
DX39A_HUMAN 14 13 65 58 
SF3B1_HUMAN 10 16 83 90 
BASI_HUMAN 110 95 0 0 
gnl|unk|ENST00000576925_5 11 10 0 0 
TFR1_HUMAN 104 84 0 1 
MYL6_HUMAN 93 77 14 13 
MYL6B_HUMAN 0 0 0 0 
RS9_HUMAN 25 19 25 22 
ECHB_HUMAN 34 43 45 51 
PCYOX_HUMAN 94 62 0 0 
TCPH_HUMAN 9 5 81 92 
ETFA_HUMAN 8 5 98 101 
SND1_HUMAN 32 24 59 57 
CY1_HUMAN 112 86 0 0 
RAN_HUMAN 29 22 70 62 
APMAP_HUMAN 93 86 0 0 
ANXA4_HUMAN 8 6 79 75 
DPP4_HUMAN 77 66 0 0 
MOGS_HUMAN 93 72 0 0 
RS12_HUMAN 33 31 60 63 
LA_HUMAN 0 0 100 92 
gnl|unk|ENST00000494051_1
0 
0 0 0 0 
ANXA5_HUMAN 9 4 69 75 
RL8_HUMAN 75 54 34 35 
AATM_HUMAN 0 0 102 105 
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RL10_HUMAN 54 61 38 31 
FBRL_HUMAN 57 55 24 31 
IMB1_HUMAN 19 21 64 81 
NOP56_HUMAN 49 68 15 29 
KAD4_HUMAN 14 11 72 56 
TCPQ_HUMAN 0 0 71 86 
CMC2_HUMAN 64 70 0 0 
CMC1_HUMAN 9 13 0 0 
PLIN2_HUMAN 63 43 37 28 
TKFC_HUMAN 0 0 104 98 
gnl|unk|ENST00000530329_5 0 0 0 0 
RL27_HUMAN 40 39 35 28 
VILI_HUMAN 21 17 58 75 
SSRA_HUMAN 114 47 0 0 
PROF1_HUMAN 7 8 80 86 
IF5A1_HUMAN 8 4 92 82 
IF5A2_HUMAN 0 0 0 0 
ABCD3_HUMAN 90 79 0 0 
SYAC_HUMAN 0 0 71 72 
YBOX1_HUMAN 14 17 82 74 
YBOX3_HUMAN 0 0 23 21 
IF4A1_HUMAN 26 24 81 89 
IF4A2_HUMAN 19 19 44 52 
PABP1_HUMAN 0 0 81 80 
PABP4_HUMAN 0 0 42 45 
PAP1M_HUMAN 0 0 0 0 
GCSP_HUMAN 0 0 89 93 
TCPA_HUMAN 7 6 84 79 
VDAC3_HUMAN 115 106 3 0 
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COPA_HUMAN 5 9 75 83 
COX2_HUMAN 58 77 0 0 
MPRI_HUMAN 95 73 0 0 
IF2B1_HUMAN 10 13 77 80 
COMT_HUMAN 88 72 28 21 
TMEDA_HUMAN 61 72 0 0 
UGGG1_HUMAN 0 1 82 80 
UGGG2_HUMAN 0 0 0 0 
RLA0_HUMAN 33 42 43 44 
RLA0L_HUMAN 23 26 22 25 
PSME2_HUMAN 0 0 97 92 
AT1A1_HUMAN 86 78 0 0 
AT1A4_HUMAN 12 0 0 0 
AT1A2_HUMAN 0 0 0 0 
ATP4A_HUMAN 0 0 0 0 
H2AY_HUMAN 97 138 0 0 
QCR6_HUMAN 88 84 0 0 
gnl|unk|ENST00000311672_9 88 84 0 0 
APOB_HUMAN 49 49 7 7 
U5S1_HUMAN 30 21 49 38 
CALU_HUMAN 11 8 56 40 
PRP19_HUMAN 47 33 38 37 
SSRP1_HUMAN 66 67 7 7 
1433E_HUMAN 1 2 85 92 
ARF4_HUMAN 20 24 27 41 
ARF1_HUMAN 8 12 35 47 
ARF3_HUMAN 8 12 35 47 
ARF5_HUMAN 0 6 0 0 
GTR1_HUMAN 87 68 0 0 
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VIGLN_HUMAN 1 0 83 88 
G6PI_HUMAN 0 0 79 75 
gnl|unk|ENST00000586425_1
4 
0 0 0 0 
ACSL5_HUMAN 90 61 0 0 
PRDX4_HUMAN 11 10 72 61 
FIBB_HUMAN 49 52 19 15 
HNRPF_HUMAN 16 20 84 90 
PRP8_HUMAN 24 23 41 46 
EF1G_HUMAN 9 12 41 40 
AL4A1_HUMAN 26 23 48 42 
TOM40_HUMAN 68 76 0 0 
STML2_HUMAN 86 64 11 29 
RL17_HUMAN 35 17 36 28 
TLN1_HUMAN 0 0 78 87 
TLN2_HUMAN 0 0 0 0 
ATPG_HUMAN 55 65 0 0 
CO3_HUMAN 39 35 38 34 
ATD3A_HUMAN 52 50 0 0 
ATD3B_HUMAN 34 28 0 0 
ADRO_HUMAN 0 0 64 69 
HMCS1_HUMAN 0 0 66 79 
NP1L1_HUMAN 0 0 100 93 
CHD4_HUMAN 61 44 8 7 
CHD3_HUMAN 0 0 0 0 
CHD5_HUMAN 0 0 0 0 
RL30_HUMAN 28 34 44 40 
EMAL4_HUMAN 2 2 65 55 
MPCP_HUMAN 62 43 0 0 
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RS8_HUMAN 37 38 30 34 
TOP1_HUMAN 40 56 0 0 
TOP1M_HUMAN 4 7 0 0 
RS17_HUMAN 29 18 46 44 
ASGR1_HUMAN 43 36 0 0 
DDX3X_HUMAN 38 32 30 28 
DDX3Y_HUMAN 30 20 27 27 
DDX4_HUMAN 0 0 0 0 
DDX1_HUMAN 13 4 57 61 
ECHM_HUMAN 0 1 76 73 
ITB1_HUMAN 86 59 0 0 
RS10_HUMAN 46 53 20 21 
VAPA_HUMAN 53 50 0 1 
1A02_HUMAN 31 26 0 0 
1A23_HUMAN 26 19 0 0 
1A24_HUMAN 26 19 0 0 
1A80_HUMAN 7 7 0 0 
1B37_HUMAN 0 0 0 0 
CTNB1_HUMAN 65 53 25 26 
IDHP_HUMAN 0 0 84 80 
RTN4_HUMAN 45 55 18 16 
ITPR3_HUMAN 50 21 0 0 
ITPR2_HUMAN 16 19 0 0 
ITPR1_HUMAN 0 0 0 0 
COPB_HUMAN 12 5 74 54 
DHB4_HUMAN 37 31 19 28 
PRDX3_HUMAN 32 32 35 25 
ACOT2_HUMAN 0 0 70 77 
ACOT1_HUMAN 0 0 61 68 
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AL3A2_HUMAN 79 75 0 0 
AL3B1_HUMAN 0 0 0 0 
KHDR1_HUMAN 24 13 56 46 
NDUA9_HUMAN 60 50 0 0 
THIL_HUMAN 21 23 55 48 
ERP29_HUMAN 8 2 66 61 
CLIC1_HUMAN 7 6 66 69 
ESYT1_HUMAN 64 64 0 3 
PA2G4_HUMAN 14 8 60 56 
RS19_HUMAN 9 14 16 19 
SET_HUMAN 0 0 56 72 
UBP7_HUMAN 9 5 58 49 
P5CR1_HUMAN 20 36 39 45 
RL18_HUMAN 27 30 28 33 
gnl|unk|ENST00000552705_1
9 
0 0 0 0 
RS11_HUMAN 21 20 33 25 
DIC_HUMAN 62 60 0 0 
HACD3_HUMAN 58 73 0 0 
ILF2_HUMAN 13 4 60 60 
SYEP_HUMAN 21 20 39 40 
TOM70_HUMAN 71 56 0 0 
GABT_HUMAN 2 0 68 73 
EMC1_HUMAN 68 53 0 0 
ERG7_HUMAN 52 65 0 0 
HNRPR_HUMAN 11 13 69 57 
NDUV1_HUMAN 59 54 0 0 
DHC24_HUMAN 53 36 0 0 
RLA1_HUMAN 45 42 42 38 
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NOMO2_HUMAN 66 51 0 0 
NOMO3_HUMAN 66 51 0 0 
gnl|unk|ENST00000569051_1
4 
0 0 0 0 
gnl|unk|ENST00000570346_4 0 0 0 0 
DHB12_HUMAN 63 52 0 0 
LAP2B_HUMAN 51 55 0 0 
LAP2A_HUMAN 20 45 0 1 
PRDX5_HUMAN 11 6 49 54 
ADHX_HUMAN 0 0 75 69 
APOE_HUMAN 49 46 4 17 
SCFD1_HUMAN 27 25 42 43 
gnl|unk|ENST00000554776_5 0 0 0 0 
WDR1_HUMAN 4 0 47 40 
DDB1_HUMAN 4 13 57 62 
GBB1_HUMAN 47 44 0 0 
GBB2_HUMAN 29 29 0 0 
ATPO_HUMAN 54 63 0 0 
NU205_HUMAN 65 43 0 0 
TM214_HUMAN 48 52 0 0 
SP16H_HUMAN 38 33 8 11 
ACOX1_HUMAN 19 14 36 47 
PRDX2_HUMAN 5 6 48 53 
U2AF2_HUMAN 21 10 33 43 
NONO_HUMAN 43 36 7 11 
SAP_HUMAN 6 4 52 49 
UCRI_HUMAN 50 58 0 0 
UCRIL_HUMAN 17 16 0 0 
GLSK_HUMAN 14 10 37 36 
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NU155_HUMAN 70 51 0 0 
CX6B1_HUMAN 69 64 0 0 
RL5_HUMAN 6 8 37 41 
XPO2_HUMAN 7 7 34 40 
RL15_HUMAN 11 6 30 30 
gnl|unk|ENST00000465786_1
5 
0 0 0 0 
LONM_HUMAN 0 0 53 52 
UB2L3_HUMAN 1 0 64 56 
RL35_HUMAN 28 32 14 14 
AT5F1_HUMAN 41 50 0 0 
TPR_HUMAN 19 29 5 4 
CATA_HUMAN 0 2 46 55 
RS14_HUMAN 29 32 24 26 
gnl|unk|ENST00000519690_5
8 
29 32 24 26 
SDHA_HUMAN 57 30 8 7 
NOP58_HUMAN 39 34 18 5 
gnl|unk|ENST00000478941_7 0 0 0 1 
PCNA_HUMAN 5 9 44 45 
SERA_HUMAN 0 2 42 44 
THIM_HUMAN 0 0 54 54 
H2AV_HUMAN 84 96 1 1 
H2AZ_HUMAN 84 96 1 1 
SYQ_HUMAN 17 13 27 25 
TOM22_HUMAN 70 67 0 0 
AK1C3_HUMAN 0 0 47 40 
AK1C2_HUMAN 0 0 8 7 
AK1C1_HUMAN 0 0 0 0 
154 
 
FIBA_HUMAN 35 35 18 18 
TADBP_HUMAN 0 0 63 65 
PO210_HUMAN 56 61 0 0 
ERG1_HUMAN 32 37 0 0 
PLAK_HUMAN 82 68 12 8 
HCD2_HUMAN 11 9 46 58 
1433Z_HUMAN 0 2 57 64 
DHB2_HUMAN 57 53 0 0 
RBP2_HUMAN 33 36 24 10 
RGPD1_HUMAN 0 0 0 0 
RGPD2_HUMAN 0 0 0 0 
RGPD8_HUMAN 0 0 0 0 
RGPD4_HUMAN 0 0 0 0 
RS20_HUMAN 13 13 28 24 
SF3B3_HUMAN 2 2 44 44 
TRAP1_HUMAN 0 0 78 85 
CNPY2_HUMAN 0 0 59 53 
DSG2_HUMAN 35 44 7 9 
QOR_HUMAN 0 0 62 57 
SYMC_HUMAN 39 24 13 21 
CDC42_HUMAN 16 19 6 19 
RAC1_HUMAN 11 11 4 6 
RAC2_HUMAN 6 6 0 0 
RHOG_HUMAN 0 3 0 0 
RHOQ_HUMAN 0 0 0 0 
HSP74_HUMAN 0 0 50 51 
SAM50_HUMAN 50 48 0 0 
SERC_HUMAN 0 0 42 40 
ETFB_HUMAN 4 3 34 52 
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SYIC_HUMAN 24 17 23 23 
TECR_HUMAN 34 30 0 0 
AL7A1_HUMAN 0 0 44 57 
MDHC_HUMAN 0 0 49 46 
PSA7_HUMAN 0 0 60 49 
PUR6_HUMAN 12 7 50 33 
ACPM_HUMAN 25 27 20 22 
GLU2B_HUMAN 5 0 51 42 
BAF_HUMAN 43 15 0 0 
gnl|unk|ENST00000312175_1
0 
43 15 0 0 
gnl|unk|ENST00000445560_7 43 15 0 0 
IMDH2_HUMAN 2 2 51 36 
RAB5C_HUMAN 46 39 0 2 
RAB5B_HUMAN 16 6 0 0 
SSRD_HUMAN 59 49 0 0 
XRN2_HUMAN 0 0 40 24 
CAPZB_HUMAN 32 29 28 17 
PGRC1_HUMAN 61 37 7 4 
RL22_HUMAN 17 13 44 32 
RL38_HUMAN 14 15 6 7 
gnl|unk|ENST00000311111_5 14 15 6 7 
gnl|unk|ENST00000439590_6 14 15 6 7 
gnl|unk|ENST00000533498_7 14 15 6 7 
GTR3_HUMAN 46 42 0 0 
PSMD3_HUMAN 4 0 48 36 
RS16_HUMAN 13 15 16 16 
SC23A_HUMAN 32 19 15 18 
SC23B_HUMAN 7 6 0 0 
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ACDSB_HUMAN 0 0 36 43 
PSMD2_HUMAN 4 5 47 42 
PTK7_HUMAN 46 39 3 0 
AHNK_HUMAN 0 0 55 38 
PSD11_HUMAN 0 0 31 24 
RBBP4_HUMAN 11 14 31 29 
MYO1B_HUMAN 30 30 1 3 
MYO1A_HUMAN 0 0 0 0 
6PGD_HUMAN 0 0 48 57 
CNDP2_HUMAN 0 0 35 47 
NDUS3_HUMAN 46 52 0 0 
SYRC_HUMAN 12 22 15 21 
PSB3_HUMAN 0 0 51 50 
LGUL_HUMAN 0 0 50 50 
PSA2_HUMAN 0 0 52 59 
RAB7A_HUMAN 34 35 5 7 
EIF3A_HUMAN 0 0 38 48 
FUMH_HUMAN 0 0 47 56 
KAD2_HUMAN 0 0 44 36 
OAT_HUMAN 0 0 40 60 
PYC_HUMAN 1 0 52 51 
SE1L1_HUMAN 55 25 0 0 
AMPL_HUMAN 0 3 40 45 
CCD47_HUMAN 37 40 0 0 
HSPB1_HUMAN 25 18 30 22 
NASP_HUMAN 0 0 42 49 
CO4A_HUMAN 10 8 33 40 
CO4B_HUMAN 10 8 33 40 
DKC1_HUMAN 12 6 25 24 
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DNJA1_HUMAN 15 16 27 25 
G3BP1_HUMAN 0 2 20 19 
HNRPQ_HUMAN 1 4 51 51 
RL23_HUMAN 10 22 28 22 
RL9_HUMAN 25 28 17 18 
STT3A_HUMAN 29 29 0 0 
HS105_HUMAN 2 0 50 51 
RS25_HUMAN 25 28 13 15 
gnl|unk|ENST00000524864_1
8 
25 28 13 15 
IF6_HUMAN 7 9 47 41 
gnl|unk|ENST00000444717_7 0 0 0 0 
PSMD7_HUMAN 0 0 44 42 
RL21_HUMAN 26 24 14 14 
TCP4_HUMAN 19 17 27 30 
FABPL_HUMAN 0 0 48 57 
RS15A_HUMAN 12 10 26 21 
gnl|unk|ENST00000569083_3 12 10 26 21 
gnl|unk|ENST00000574723_4 0 0 0 0 
SFXN1_HUMAN 35 30 0 0 
SFXN3_HUMAN 0 0 0 0 
gnl|unk|ENST00000508290_7 0 0 0 0 
S61A1_HUMAN 41 29 0 0 
MAP4_HUMAN 10 8 26 30 
TEBP_HUMAN 9 11 32 24 
2AAA_HUMAN 4 7 26 34 
ANM5_HUMAN 0 0 31 28 
IPYR_HUMAN 0 0 41 35 
PSB1_HUMAN 0 0 41 40 
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COX41_HUMAN 34 34 0 0 
KAD3_HUMAN 0 0 42 30 
EIF3C_HUMAN 0 0 48 44 
HNRPD_HUMAN 0 4 58 46 
PARK7_HUMAN 0 0 31 31 
SEC13_HUMAN 13 12 24 26 
STIP1_HUMAN 0 0 29 49 
COX5A_HUMAN 22 16 22 17 
DPYL2_HUMAN 0 0 36 54 
DPYL1_HUMAN 0 0 0 0 
NUP62_HUMAN 45 35 2 4 
PSMD1_HUMAN 0 0 38 40 
FPPS_HUMAN 0 0 34 48 
G6PD_HUMAN 0 0 28 26 
NDUS5_HUMAN 33 28 0 0 
NQO1_HUMAN 0 2 29 29 
RS6_HUMAN 15 16 13 14 
RTCB_HUMAN 6 7 15 14 
GSHR_HUMAN 0 0 38 44 
IMA1_HUMAN 6 10 36 30 
NDUAD_HUMAN 22 18 0 0 
PSME1_HUMAN 0 0 42 37 
SYSC_HUMAN 0 0 45 46 
DHX15_HUMAN 12 14 20 15 
ERP44_HUMAN 12 9 29 19 
RL13A_HUMAN 16 21 6 10 
RL13_HUMAN 12 11 16 12 
A2MG_HUMAN 0 0 31 38 
C1TC_HUMAN 0 1 34 36 
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SF3B2_HUMAN 1 1 23 35 
SNAA_HUMAN 45 45 0 0 
TMED9_HUMAN 55 44 3 0 
ASGR2_HUMAN 31 22 0 0 
CP51A_HUMAN 30 29 0 0 
ERO1A_HUMAN 0 0 37 28 
RANG_HUMAN 0 0 51 42 
SQRD_HUMAN 41 34 0 0 
SLIRP_HUMAN 0 0 27 30 
gnl|unk|ENST00000556831_5 0 0 27 30 
gnl|unk|ENST00000557623_5 0 0 27 30 
gnl|unk|ENST00000613856_5 0 0 27 30 
gnl|unk|ENST00000553981_4 0 0 0 15 
ECH1_HUMAN 0 0 22 43 
NDUS2_HUMAN 34 19 0 1 
DDX18_HUMAN 8 11 39 28 
FSCN1_HUMAN 2 4 31 32 
LYAG_HUMAN 0 0 32 34 
PSA1_HUMAN 0 0 32 32 
RM12_HUMAN 20 19 21 20 
S39AE_HUMAN 44 37 0 0 
TM9S4_HUMAN 35 41 0 0 
ANGT_HUMAN 0 0 45 41 
CAP1_HUMAN 0 0 39 39 
CBX3_HUMAN 3 3 34 33 
GDIR1_HUMAN 0 0 36 38 
RALY_HUMAN 6 10 17 22 
RS24_HUMAN 7 6 31 25 
SUN2_HUMAN 44 22 0 0 
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TPD54_HUMAN 15 10 30 31 
CYB5_HUMAN 30 29 0 1 
gnl|unk|ENST00000494131_5 30 29 0 1 
F162A_HUMAN 40 35 0 0 
NCLN_HUMAN 39 32 0 0 
RL27A_HUMAN 3 8 24 26 
SYK_HUMAN 3 1 26 30 
TSN_HUMAN 0 0 46 40 
GFPT1_HUMAN 30 19 1 1 
GFPT2_HUMAN 0 0 0 0 
ACON_HUMAN 0 0 24 38 
GCN1_HUMAN 10 14 24 19 
SYDC_HUMAN 11 11 9 14 
ARL8B_HUMAN 38 21 0 2 
KS6A3_HUMAN 15 13 18 13 
CUTA_HUMAN 0 0 48 44 
SAFB1_HUMAN 17 18 22 20 
SAFB2_HUMAN 11 11 22 17 
TMED7_HUMAN 34 31 0 0 
IF2G_HUMAN 16 15 15 18 
PAIRB_HUMAN 20 11 23 17 
PPGB_HUMAN 0 0 36 32 
PRS8_HUMAN 1 0 29 33 
GNAI2_HUMAN 32 19 0 0 
GNAI3_HUMAN 21 11 0 0 
GNAL_HUMAN 2 2 0 0 
GNAT3_HUMAN 0 0 0 0 
GNAI1_HUMAN 0 0 0 0 
EIF3L_HUMAN 0 0 20 20 
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FUBP2_HUMAN 0 0 35 45 
VAT1_HUMAN 33 36 1 7 
1433B_HUMAN 3 2 53 54 
gnl|unk|ENST00000633979_1
3 
0 0 0 0 
ANM1_HUMAN 0 0 39 33 
H15_HUMAN 33 33 0 0 
IF4A3_HUMAN 27 31 36 35 
RBMX_HUMAN 30 28 9 10 
RL23A_HUMAN 9 16 8 6 
RL7L_HUMAN 5 7 20 14 
ECI2_HUMAN 23 18 21 17 
HMOX1_HUMAN 30 24 0 1 
LETM1_HUMAN 28 29 0 0 
RUVB1_HUMAN 13 14 21 30 
SEC63_HUMAN 27 20 0 0 
FAF2_HUMAN 37 30 0 0 
NDUB9_HUMAN 39 35 0 0 
NUP93_HUMAN 34 35 1 0 
PON2_HUMAN 26 22 0 0 
SMD2_HUMAN 11 16 18 21 
NDUAC_HUMAN 18 18 0 0 
NH2L1_HUMAN 26 19 4 9 
RPR1B_HUMAN 14 13 24 20 
RPR1A_HUMAN 0 0 0 0 
UFL1_HUMAN 25 24 0 0 
CD59_HUMAN 25 27 0 0 
ACOD_HUMAN 42 20 0 0 
AIFM1_HUMAN 0 2 34 34 
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BAG2_HUMAN 25 19 17 10 
CAZA1_HUMAN 10 10 23 22 
MLEC_HUMAN 38 25 0 0 
NDUBA_HUMAN 34 26 0 0 
SC31A_HUMAN 0 0 19 16 
PTMA_HUMAN 5 4 40 28 
gnl|unk|ENST00000481928_5 5 4 40 28 
ALDOC_HUMAN 9 2 56 64 
ALDR_HUMAN 0 0 25 28 
LASP1_HUMAN 17 15 12 14 
RETST_HUMAN 33 25 0 0 
RINI_HUMAN 0 0 36 43 
RL24_HUMAN 5 9 14 17 
TFAM_HUMAN 36 40 0 0 
SMD3_HUMAN 19 8 19 11 
COPG1_HUMAN 0 1 43 39 
FKB10_HUMAN 0 0 17 22 
NHRF1_HUMAN 6 5 32 31 
RL32_HUMAN 19 19 11 6 
MCFD2_HUMAN 0 0 18 23 
ATPK_HUMAN 34 27 0 0 
gnl|unk|ENST00000359832_3 34 27 0 0 
gnl|unk|ENST00000394186_3 24 21 0 0 
gnl|unk|ENST00000485011_2 24 21 0 0 
gnl|unk|ENST00000488775_2 24 21 0 0 
CPVL_HUMAN 0 0 37 27 
IPO5_HUMAN 9 4 19 23 
PTH2_HUMAN 36 37 0 0 
SPCS2_HUMAN 33 33 0 0 
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SPEB_HUMAN 0 0 34 37 
1433T_HUMAN 0 0 48 42 
HMGA1_HUMAN 35 42 0 0 
PRS4_HUMAN 0 0 33 18 
SYFA_HUMAN 3 4 21 15 
TM9S3_HUMAN 26 24 0 0 
TXTP_HUMAN 16 19 0 0 
RL14_HUMAN 25 15 12 10 
gnl|unk|ENST00000461368_5 0 0 0 0 
AFG32_HUMAN 24 25 0 0 
ANK2_HUMAN 0 0 0 0 
AATC_HUMAN 0 0 37 37 
ATP5J_HUMAN 29 33 0 0 
BAZ1B_HUMAN 23 29 0 0 
SIAS_HUMAN 0 0 24 22 
ACBP_HUMAN 0 0 31 33 
CPPED_HUMAN 0 0 27 23 
CYBP_HUMAN 0 0 41 24 
ES1_HUMAN 0 0 38 35 
SMD1_HUMAN 18 18 17 14 
SYIM_HUMAN 0 0 26 21 
CYC_HUMAN 0 0 31 23 
EZRI_HUMAN 1 0 22 16 
RADI_HUMAN 2 0 8 8 
MOES_HUMAN 0 0 0 0 
AIMP1_HUMAN 5 5 20 12 
FUS_HUMAN 39 35 15 11 
BOLA2_HUMAN 0 0 24 22 
RL31_HUMAN 18 13 7 7 
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gnl|unk|ENST00000441435_6 0 0 0 0 
A1AT_HUMAN 3 0 8 11 
ACY1_HUMAN 1 0 19 18 
ERLEC_HUMAN 29 24 0 0 
MBB1A_HUMAN 5 11 24 16 
MPPA_HUMAN 5 2 33 19 
PREB_HUMAN 37 25 0 0 
RL11_HUMAN 23 19 8 14 
SYVC_HUMAN 0 0 22 48 
U2AF1_HUMAN 16 18 8 8 
U2AF5_HUMAN 16 18 8 8 
gnl|unk|ENST00000492222_7 13 19 22 15 
gnl|unk|ENST00000591758_7 13 19 22 15 
RSMB_HUMAN 0 4 6 9 
RSMN_HUMAN 0 4 6 9 
gnl|unk|ENST00000461548_1
0 
0 0 3 6 
COPB2_HUMAN 1 1 30 25 
EIF3B_HUMAN 0 0 26 25 
KCRB_HUMAN 0 0 34 25 
PUF60_HUMAN 2 3 35 26 
RS18_HUMAN 2 4 4 13 
TMM97_HUMAN 21 23 0 0 
RP1BL_HUMAN 29 16 0 0 
RAP1A_HUMAN 19 11 0 0 
RASH_HUMAN 10 6 0 0 
NDUA8_HUMAN 25 25 0 0 
NUMA1_HUMAN 6 12 26 18 
QCR7_HUMAN 24 23 0 0 
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STIM1_HUMAN 21 18 0 0 
THEM6_HUMAN 35 29 0 0 
RS29_HUMAN 15 8 6 13 
gnl|unk|ENST00000245458_3 15 8 6 13 
gnl|unk|ENST00000401543_3 15 8 6 13 
gnl|unk|ENST00000611563_5 15 8 6 13 
COPE_HUMAN 5 5 26 18 
EPIPL_HUMAN 6 0 33 40 
F10A1_HUMAN 0 0 25 25 
PFKAL_HUMAN 0 0 27 27 
ERF3A_HUMAN 0 0 24 24 
ERF3B_HUMAN 0 0 8 9 
FLOT1_HUMAN 20 18 0 0 
M2OM_HUMAN 19 23 0 0 
NACAM_HUMAN 0 0 24 23 
NU133_HUMAN 22 24 0 0 
PTN1_HUMAN 22 18 0 0 
SRPRB_HUMAN 33 20 0 0 
BTF3_HUMAN 0 0 34 26 
PGAM5_HUMAN 18 20 0 0 
RBBP7_HUMAN 8 6 20 13 
VAPB_HUMAN 22 22 0 0 
VATA_HUMAN 2 3 22 25 
ODPA_HUMAN 0 0 37 33 
ODPAT_HUMAN 0 0 0 0 
PA1B2_HUMAN 0 0 30 30 
PSB5_HUMAN 0 0 27 29 
SODM_HUMAN 0 0 29 30 
SUCB2_HUMAN 0 0 26 22 
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UGPA_HUMAN 0 0 31 23 
RS26_HUMAN 2 5 24 25 
COX1_HUMAN 36 31 0 0 
CATB_HUMAN 0 0 20 16 
gnl|unk|ENST00000526481_2 0 0 0 0 
ACSS3_HUMAN 0 0 24 25 
RS21_HUMAN 8 6 22 28 
gnl|unk|ENST00000343986_2 8 6 22 28 
gnl|unk|ENST00000450116_2 8 6 22 28 
gnl|unk|ENST00000492356_2 8 6 22 28 
RT29_HUMAN 3 1 15 11 
SC22B_HUMAN 27 30 0 0 
SPEE_HUMAN 0 0 32 29 
TOM6_HUMAN 29 30 0 0 
gnl|unk|ENST00000335515_3
6 
29 30 0 0 
gnl|unk|ENST00000398881_6 29 30 0 0 
gnl|unk|ENST00000398884_6 29 30 0 0 
gnl|unk|ENST00000456057_4
1 
29 30 0 0 
gnl|unk|ENST00000487182_3
9 
29 30 0 0 
TRA2B_HUMAN 19 11 12 6 
BRX1_HUMAN 11 6 17 8 
AOFA_HUMAN 20 19 0 0 
BAP31_HUMAN 21 23 0 0 
GPX1_HUMAN 0 0 19 25 
NDUAA_HUMAN 19 15 7 9 
RM39_HUMAN 0 0 1 8 
LAMP1_HUMAN 23 19 5 6 
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NDUB5_HUMAN 29 27 0 0 
HINT1_HUMAN 0 0 17 19 
gnl|unk|ENST00000508495_9 0 0 0 0 
ASPH_HUMAN 12 11 0 0 
CN37_HUMAN 17 14 7 7 
HP1B3_HUMAN 9 23 1 0 
MARE1_HUMAN 6 5 21 19 
MIC19_HUMAN 17 21 0 0 
NSF_HUMAN 21 19 0 0 
NU1M_HUMAN 25 28 0 0 
RAGP1_HUMAN 0 0 29 23 
UBP5_HUMAN 0 0 21 26 
DECR_HUMAN 17 10 16 13 
NOP2_HUMAN 8 8 20 15 
OTUB1_HUMAN 0 0 28 24 
PSA_HUMAN 0 0 26 29 
TMM33_HUMAN 26 15 0 0 
COX6C_HUMAN 18 23 0 0 
gnl|unk|ENST00000297564_4 18 23 0 0 
gnl|unk|ENST00000517682_4 18 23 0 0 
gnl|unk|ENST00000522940_7 18 23 0 0 
gnl|unk|ENST00000524245_5 18 23 0 0 
COPZ1_HUMAN 5 9 15 11 
HNRL2_HUMAN 0 0 21 26 
MA1A1_HUMAN 21 17 1 0 
MTDC_HUMAN 2 1 20 19 
NUP85_HUMAN 28 30 0 0 
PH4H_HUMAN 0 2 23 20 
PLOD1_HUMAN 0 0 18 23 
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PRS7_HUMAN 0 0 21 22 
SMCA5_HUMAN 20 25 0 0 
SRSF3_HUMAN 14 15 25 24 
ABHEB_HUMAN 0 0 27 25 
ACADV_HUMAN 25 22 7 6 
AT131_HUMAN 15 15 0 0 
COX5B_HUMAN 21 27 0 0 
GTF2I_HUMAN 18 17 7 10 
SDHB_HUMAN 14 12 0 0 
SSBP_HUMAN 19 23 6 4 
ST1A3_HUMAN 4 5 26 40 
ST1A4_HUMAN 4 5 26 40 
STOM_HUMAN 23 26 0 0 
XPO1_HUMAN 0 0 33 25 
TMED2_HUMAN 18 16 0 0 
CDC5L_HUMAN 14 17 14 8 
CSK21_HUMAN 6 1 33 21 
EIF3G_HUMAN 1 0 31 28 
FADS2_HUMAN 13 12 0 0 
HSDL2_HUMAN 0 0 27 24 
IPO7_HUMAN 1 0 35 26 
MPP10_HUMAN 7 1 16 7 
OPA1_HUMAN 27 19 0 0 
RL26_HUMAN 6 6 4 4 
ROA0_HUMAN 13 13 14 13 
CN166_HUMAN 2 1 22 26 
GLPK_HUMAN 30 20 0 0 
ILVBL_HUMAN 19 19 0 0 
NSMA3_HUMAN 31 25 0 0 
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PKP2_HUMAN 24 30 0 0 
SF01_HUMAN 1 0 16 17 
SPCS1_HUMAN 24 26 0 0 
AOFB_HUMAN 20 16 0 0 
CYTB_HUMAN 3 1 18 19 
EF1B_HUMAN 2 2 23 31 
ETHE1_HUMAN 0 0 21 21 
GRHPR_HUMAN 0 0 17 19 
MTX1_HUMAN 16 13 0 0 
NPC2_HUMAN 0 0 24 39 
PESC_HUMAN 0 1 19 15 
PRS6B_HUMAN 0 0 19 19 
RBM39_HUMAN 3 5 20 26 
SF3A3_HUMAN 0 0 12 11 
ST1A1_HUMAN 2 4 24 40 
SC61G_HUMAN 29 26 0 0 
gnl|unk|ENST00000352861_4 29 26 0 0 
gnl|unk|ENST00000395535_4 29 26 0 0 
gnl|unk|ENST00000415949_8 29 26 0 0 
gnl|unk|ENST00000450622_4 29 26 0 0 
AT2B1_HUMAN 21 18 0 0 
AT2B4_HUMAN 10 11 0 0 
AT1B1_HUMAN 24 23 0 0 
CCAR2_HUMAN 0 0 29 23 
ECI1_HUMAN 0 0 22 26 
ELAV1_HUMAN 0 0 24 25 
H1X_HUMAN 30 31 0 0 
ITIH2_HUMAN 9 6 11 10 
MGST1_HUMAN 30 26 0 0 
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RUXE_HUMAN 11 13 13 8 
gnl|unk|ENST00000414487_4 11 13 13 8 
GBG5_HUMAN 26 29 0 0 
AK1A1_HUMAN 1 0 26 27 
CEAM1_HUMAN 29 24 0 0 
HMOX2_HUMAN 20 12 0 0 
MCCB_HUMAN 0 0 23 19 
PABP2_HUMAN 1 2 33 23 
SRPRA_HUMAN 23 21 0 0 
SRSF1_HUMAN 6 11 15 14 
VATG1_HUMAN 10 11 9 10 
ERMP1_HUMAN 13 12 0 0 
GUAA_HUMAN 0 0 18 30 
IQGA1_HUMAN 0 0 27 28 
PYGB_HUMAN 0 0 24 25 
RU17_HUMAN 6 6 15 15 
MMSA_HUMAN 8 11 0 5 
EMD_HUMAN 22 23 0 0 
FIS1_HUMAN 27 25 0 0 
HM13_HUMAN 22 16 0 0 
IPO4_HUMAN 3 3 22 22 
LMAN2_HUMAN 17 13 0 0 
RM13_HUMAN 12 8 11 8 
DHRS7_HUMAN 18 17 0 0 
HPPD_HUMAN 0 0 28 24 
IMA4_HUMAN 2 2 23 21 
PSMD6_HUMAN 0 1 16 13 
STT3B_HUMAN 21 23 0 0 
STX18_HUMAN 33 16 0 0 
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SMRC1_HUMAN 9 4 2 0 
SMRC2_HUMAN 3 5 0 0 
ACSL1_HUMAN 16 11 0 0 
BIEA_HUMAN 0 0 14 13 
GT251_HUMAN 1 2 13 16 
PRS10_HUMAN 0 1 27 28 
PSA6_HUMAN 0 0 24 32 
SOX_HUMAN 0 0 10 20 
SYG_HUMAN 0 0 22 17 
UBE2N_HUMAN 0 0 22 23 
VINC_HUMAN 0 0 18 25 
LBR_HUMAN 14 13 0 0 
MESD_HUMAN 4 0 22 21 
AHSA1_HUMAN 5 6 18 21 
ALG1_HUMAN 23 15 0 0 
ALG2_HUMAN 23 13 0 0 
BUB3_HUMAN 0 0 19 14 
CDC37_HUMAN 0 0 24 21 
NU160_HUMAN 17 9 0 2 
SF3A1_HUMAN 2 0 20 18 
DNJC8_HUMAN 0 0 25 23 
UHRF1_HUMAN 26 17 0 0 
UHRF2_HUMAN 0 0 0 0 
3HIDH_HUMAN 0 0 23 26 
AGK_HUMAN 21 10 0 0 
FKBP4_HUMAN 0 0 30 18 
H2AW_HUMAN 56 75 0 0 
KCY_HUMAN 1 0 19 17 
LKHA4_HUMAN 0 0 17 18 
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OLA1_HUMAN 0 0 11 17 
PCY2_HUMAN 0 0 18 26 
PDXD1_HUMAN 4 1 12 19 
RL36_HUMAN 11 5 1 4 
RRS1_HUMAN 17 14 6 4 
SAE1_HUMAN 0 0 15 23 
STAU1_HUMAN 18 9 0 3 
RS27_HUMAN 8 11 3 5 
gnl|unk|ENST00000368567_2 8 11 3 5 
gnl|unk|ENST00000457554_4 8 11 3 5 
gnl|unk|ENST00000495392_4 8 11 3 5 
RS27L_HUMAN 0 0 0 0 
IF4B_HUMAN 0 0 11 12 
gnl|unk|ENST00000549592_1
1 
0 0 0 0 
ATAD2_HUMAN 14 11 0 0 
NDUB6_HUMAN 18 20 0 0 
NUP98_HUMAN 5 13 0 0 
RL19_HUMAN 15 17 2 3 
SMHD1_HUMAN 10 6 0 0 
SRP72_HUMAN 14 14 10 8 
TM9S2_HUMAN 15 15 0 0 
WFS1_HUMAN 16 14 0 0 
ACINU_HUMAN 2 5 4 5 
ADH4_HUMAN 0 0 24 22 
CISD2_HUMAN 16 13 0 0 
DPP3_HUMAN 0 0 21 23 
ESTD_HUMAN 0 0 16 17 
FLOT2_HUMAN 18 23 0 0 
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FTCD_HUMAN 0 0 24 23 
GLOD4_HUMAN 0 0 23 19 
LYRIC_HUMAN 16 18 0 0 
NSUN2_HUMAN 0 0 28 18 
ODP2_HUMAN 0 0 21 22 
PNPO_HUMAN 0 0 14 26 
PSA5_HUMAN 0 0 23 17 
RHOA_HUMAN 16 16 2 3 
SNP23_HUMAN 25 22 0 0 
SNTB1_HUMAN 16 15 1 1 
MGN2_HUMAN 5 2 10 6 
MGN_HUMAN 0 0 10 6 
APOA1_HUMAN 22 22 0 0 
APT_HUMAN 1 0 17 20 
BAG6_HUMAN 0 0 21 24 
CATC_HUMAN 0 0 11 10 
CAZA2_HUMAN 11 10 12 7 
CDS2_HUMAN 22 15 0 0 
DCTN2_HUMAN 0 0 23 19 
DPM1_HUMAN 19 14 0 0 
EIF3F_HUMAN 0 0 23 27 
GRSF1_HUMAN 0 0 15 23 
HMGA2_HUMAN 25 19 0 0 
NU153_HUMAN 15 10 1 0 
NU214_HUMAN 11 16 0 1 
OFUT1_HUMAN 0 0 20 21 
RL18A_HUMAN 7 9 8 11 
SON_HUMAN 15 18 0 0 





12 6 7 9 
gnl|unk|ENST00000492121_1
8 
12 6 7 9 
OS9_HUMAN 11 7 0 0 
gnl|unk|ENST00000550848_8 1 2 0 0 
gnl|unk|ENST00000551285_7 1 2 0 0 
CSK22_HUMAN 0 0 15 14 
F213A_HUMAN 16 23 0 0 
MIF_HUMAN 1 0 12 13 
P4HA1_HUMAN 2 0 19 18 
PEG3_HUMAN 5 4 17 14 
PGES2_HUMAN 20 11 5 5 
PSD13_HUMAN 0 0 23 14 
PUR2_HUMAN 0 3 15 12 
RT23_HUMAN 0 0 16 16 
UBF1_HUMAN 15 6 0 0 
NOG1_HUMAN 3 7 10 7 
VATB2_HUMAN 10 10 6 8 
VATB1_HUMAN 0 0 0 0 
LYPA2_HUMAN 0 0 22 21 
gnl|unk|ENST00000374502_1
0 
0 0 0 0 
COR1C_HUMAN 7 10 11 13 
DEK_HUMAN 12 9 0 0 
ERLN2_HUMAN 22 30 0 0 
FARP1_HUMAN 2 4 12 15 
KAP0_HUMAN 4 3 15 20 
LG3BP_HUMAN 0 0 17 23 
SGTA_HUMAN 0 0 20 24 
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SPTC1_HUMAN 21 19 0 0 
USMG5_HUMAN 17 17 0 0 
gnl|unk|ENST00000309579_4 17 17 0 0 
gnl|unk|ENST00000337003_1
0 
17 17 0 0 
gnl|unk|ENST00000369815_1
1 
17 17 0 0 
gnl|unk|ENST00000369825_1
4 
17 17 0 0 
gnl|unk|ENST00000425964_4 17 17 0 0 
RL28_HUMAN 11 7 5 2 
gnl|unk|ENST00000428193_4 11 7 5 2 
gnl|unk|ENST00000431533_4 11 7 5 2 
gnl|unk|ENST00000558131_4 11 7 5 2 
gnl|unk|ENST00000560881_4 11 7 5 2 
AP2B1_HUMAN 13 17 0 4 
AP1B1_HUMAN 0 0 1 3 
NMT1_HUMAN 8 5 9 8 
NMT2_HUMAN 0 0 0 0 
ARPC2_HUMAN 1 0 18 16 
C1TM_HUMAN 3 2 14 12 
EBP2_HUMAN 5 5 10 6 
EST2_HUMAN 0 0 13 19 
KI67_HUMAN 14 15 0 0 
ODO1_HUMAN 0 0 13 17 
RM03_HUMAN 0 1 16 15 
SEPT9_HUMAN 7 10 9 5 
SRSF7_HUMAN 11 13 11 15 
TALDO_HUMAN 0 0 10 15 
TMX1_HUMAN 12 4 0 0 
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DAD1_HUMAN 16 13 0 0 
SMU1_HUMAN 2 5 6 7 
CAPR1_HUMAN 0 0 10 13 
A16A1_HUMAN 0 0 22 25 
ACS2L_HUMAN 0 0 19 22 
NDUA5_HUMAN 14 11 6 6 
PRP6_HUMAN 13 17 0 2 
SART3_HUMAN 0 0 19 17 
TFB1M_HUMAN 0 0 13 10 
HCFC1_HUMAN 11 12 11 10 
AP2A1_HUMAN 5 7 7 14 
AP2A2_HUMAN 5 6 1 1 
KAP2_HUMAN 12 7 12 10 
KAP3_HUMAN 0 0 0 0 
SSRG_HUMAN 22 15 0 0 
R39L5_HUMAN 5 6 0 0 
RL39_HUMAN 5 6 0 0 
gnl|unk|ENST00000361575_1 5 6 0 0 
gnl|unk|ENST00000424573_3 5 6 0 0 
gnl|unk|ENST00000446011_4 5 6 0 0 
gnl|unk|ENST00000468844_3
4 
5 6 0 0 
RALA_HUMAN 3 7 0 0 
RALB_HUMAN 0 2 0 0 
gnl|unk|ENST00000470417_6 0 0 0 0 
AT1B3_HUMAN 13 15 0 0 
FUBP1_HUMAN 0 0 9 15 
ISOC2_HUMAN 0 0 20 15 
LAMB1_HUMAN 7 8 5 6 
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MOT4_HUMAN 15 13 0 0 
NOLC1_HUMAN 0 0 21 8 
ODPB_HUMAN 0 0 12 15 
RM04_HUMAN 0 0 16 19 
TMM43_HUMAN 16 11 0 0 
SYYC_HUMAN 0 0 18 27 
gnl|unk|ENST00000490826_1
0 
0 0 0 0 
CXAR_HUMAN 15 15 0 0 
FACE1_HUMAN 16 8 0 0 
H10_HUMAN 17 15 0 0 
MANF_HUMAN 0 0 13 10 
MIA3_HUMAN 17 17 0 0 
NAT10_HUMAN 19 10 3 2 
PSA4_HUMAN 0 0 21 12 
PSME3_HUMAN 0 0 14 22 
RDH11_HUMAN 16 13 0 0 
TOIP1_HUMAN 21 11 0 0 
UD2A3_HUMAN 13 18 0 0 
CCAR1_HUMAN 0 0 11 10 
GSTO1_HUMAN 0 0 16 15 
NPM3_HUMAN 9 12 12 12 
gnl|unk|ENST00000420712_6 13 11 5 8 
ARC1B_HUMAN 4 6 16 12 
CERS2_HUMAN 11 11 0 0 
CSK2B_HUMAN 1 0 20 16 
GLRX1_HUMAN 0 0 16 20 
HEM6_HUMAN 0 0 19 17 
IF2A_HUMAN 0 4 12 8 
178 
 
MAVS_HUMAN 2 7 10 12 
NOP9_HUMAN 0 0 20 20 
NUCB1_HUMAN 8 2 13 11 
NUDC_HUMAN 0 0 17 17 
OXA1L_HUMAN 9 4 0 0 
PTRD1_HUMAN 0 0 20 17 
RM44_HUMAN 11 10 6 7 
SGPL1_HUMAN 20 12 0 0 
SYLC_HUMAN 0 0 12 21 
TBL2_HUMAN 15 20 0 0 
TBL3_HUMAN 6 3 11 14 
TIM50_HUMAN 22 16 0 0 
TM9S1_HUMAN 11 21 0 0 
SC11A_HUMAN 11 14 0 0 
THIO_HUMAN 0 0 7 7 
TPP1_HUMAN 4 5 9 5 
NDUAB_HUMAN 22 19 0 0 
RBM3_HUMAN 4 1 11 16 
SNR40_HUMAN 5 2 7 5 
DHRS1_HUMAN 14 15 0 0 
gnl|unk|ENST00000559483_7 7 0 0 0 
RAB32_HUMAN 17 14 0 0 
RAB7L_HUMAN 0 0 0 0 
ADH6_HUMAN 0 0 18 14 
AIFM2_HUMAN 23 10 0 0 
ARK72_HUMAN 0 0 13 12 
DAZP1_HUMAN 0 0 13 8 
DDX42_HUMAN 0 1 15 13 
DOHH_HUMAN 0 0 21 18 
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EPCAM_HUMAN 27 16 0 0 
JAM1_HUMAN 17 16 0 0 
LAT1_HUMAN 21 19 0 0 
M4K4_HUMAN 7 9 6 6 
MCM2_HUMAN 0 0 17 17 
PA1B3_HUMAN 0 0 11 15 
PR40A_HUMAN 10 7 2 0 
PSB4_HUMAN 0 0 18 16 
PUR4_HUMAN 0 0 19 9 
RB11B_HUMAN 7 4 0 2 
ROAA_HUMAN 0 0 21 22 
STAT3_HUMAN 3 5 13 8 
SYWC_HUMAN 0 0 28 12 
TR150_HUMAN 0 0 16 13 
ZO2_HUMAN 12 6 8 4 
AN32A_HUMAN 4 0 25 25 
IF4G1_HUMAN 0 0 17 17 
IF4G3_HUMAN 0 0 0 0 
AAAT_HUMAN 15 13 0 0 
ACSF2_HUMAN 1 0 20 15 
CPNE1_HUMAN 0 0 8 13 
ELYS_HUMAN 10 17 0 0 
EMC2_HUMAN 25 14 0 0 
GRN_HUMAN 7 3 10 7 
HCDH_HUMAN 0 0 13 21 
NSDHL_HUMAN 12 17 0 0 
PUR8_HUMAN 0 0 8 18 
ACSA_HUMAN 0 0 9 8 
ARP3_HUMAN 2 2 12 11 
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CK5P3_HUMAN 19 9 0 0 
DCXR_HUMAN 0 0 15 16 
DHCR7_HUMAN 15 13 0 0 
FND3B_HUMAN 16 14 0 0 
GLRX3_HUMAN 0 0 13 19 
HUWE1_HUMAN 0 0 18 12 
MARCS_HUMAN 16 8 7 9 
NDUB4_HUMAN 8 9 0 0 
NNTM_HUMAN 11 14 0 0 
PSDE_HUMAN 0 0 12 12 
RD23B_HUMAN 3 3 19 12 
RPB2_HUMAN 6 9 0 0 
SCAM2_HUMAN 14 9 0 0 
THTM_HUMAN 0 0 14 18 
DJB11_HUMAN 16 10 5 6 
DNJB1_HUMAN 4 3 1 3 
RRP5_HUMAN 0 2 8 5 
ECHP_HUMAN 3 0 7 14 
HNRDL_HUMAN 0 0 33 24 
MYO1C_HUMAN 16 12 0 2 
NP1L4_HUMAN 0 1 29 27 
PIGS_HUMAN 18 12 0 0 
PNKD_HUMAN 19 17 0 0 
RENT1_HUMAN 0 0 11 13 
RNT2_HUMAN 0 0 11 11 
SYYM_HUMAN 1 7 10 7 
SPNS1_HUMAN 18 13 0 0 
HMGB1_HUMAN 5 3 4 8 
SRRM1_HUMAN 1 2 12 12 
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MCA3_HUMAN 12 12 4 4 
ABCF1_HUMAN 6 9 6 6 
CATH_HUMAN 0 0 18 18 
COPD_HUMAN 0 0 15 18 
DHB11_HUMAN 11 10 0 0 
DNPEP_HUMAN 0 0 15 10 
EIF3H_HUMAN 0 0 9 11 
GNL3_HUMAN 7 9 1 0 
LMO7_HUMAN 13 11 3 4 
MCM6_HUMAN 0 0 13 8 
MSMO1_HUMAN 19 19 0 0 
NEP1_HUMAN 1 2 9 12 
NU188_HUMAN 7 13 0 0 
P5CR2_HUMAN 0 4 24 16 
PGM1_HUMAN 0 0 17 20 
PSA3_HUMAN 1 0 15 14 
RAB2A_HUMAN 16 13 0 0 
RS23_HUMAN 13 11 0 4 
SEPT2_HUMAN 0 0 10 8 
SRRM2_HUMAN 0 0 13 12 
SGMR1_HUMAN 14 15 0 0 
CTBL1_HUMAN 5 5 3 5 
NEDD8_HUMAN 0 0 15 17 
gnl|unk|ENST00000250495_5 0 0 15 17 
gnl|unk|ENST00000527046_1
1 
0 0 15 17 
gnl|unk|ENST00000531430_6 0 0 15 17 
gnl|unk|ENST00000560427_1
4 
0 0 15 17 
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1433F_HUMAN 0 0 30 27 
1433G_HUMAN 0 0 31 28 
1433S_HUMAN 0 0 31 28 
ALAT2_HUMAN 0 0 12 18 
ATP5L_HUMAN 12 11 0 0 
MRP_HUMAN 18 6 5 4 
NUP58_HUMAN 12 13 0 0 
PNPH_HUMAN 0 0 15 14 
RAVR1_HUMAN 0 0 12 10 
SCAM4_HUMAN 11 12 0 0 
CCD86_HUMAN 16 15 0 0 
ELMD2_HUMAN 10 8 0 0 
SRP14_HUMAN 4 3 12 13 
gnl|unk|ENST00000517881_4 0 0 16 10 
AGM1_HUMAN 0 0 16 11 
CAND1_HUMAN 0 0 15 11 
CHDH_HUMAN 3 5 0 0 
EF1D_HUMAN 0 2 16 18 
MK67I_HUMAN 7 8 9 4 
PYM1_HUMAN 0 0 16 18 
SMC1A_HUMAN 6 10 0 0 
SPRE_HUMAN 0 0 13 20 
TTL12_HUMAN 0 0 14 20 
AAAS_HUMAN 9 10 0 0 
PSB6_HUMAN 0 0 13 14 
GRPE1_HUMAN 0 0 9 9 
HSDL1_HUMAN 10 11 0 0 
AP1M1_HUMAN 1 1 5 4 
RFA3_HUMAN 5 6 6 5 
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68MP_HUMAN 3 5 0 0 
gnl|unk|ENST00000286953_5 3 5 0 0 
gnl|unk|ENST00000557040_6 3 5 0 0 
COX20_HUMAN 15 9 0 0 
DDX47_HUMAN 11 12 6 2 
EDC4_HUMAN 2 0 11 11 
FABP5_HUMAN 0 0 6 15 
FAKD2_HUMAN 0 0 16 11 
GALT2_HUMAN 7 15 0 0 
GLGB_HUMAN 0 0 16 16 
HDGF_HUMAN 0 0 17 12 
PGRC2_HUMAN 14 11 0 0 
PRS6A_HUMAN 0 0 14 11 
TRXR1_HUMAN 0 0 14 14 
SRSF2_HUMAN 4 2 15 8 
THOC2_HUMAN 1 2 7 5 
NDUF3_HUMAN 8 7 0 0 
DHPR_HUMAN 0 0 10 17 
DNJC5_HUMAN 10 3 0 0 
IGSF1_HUMAN 12 17 0 0 
LSM2_HUMAN 0 0 14 17 
gnl|unk|ENST00000375661_7 0 0 14 17 
MTX2_HUMAN 10 11 0 0 
SNW1_HUMAN 4 4 14 13 
SPB1_HUMAN 2 4 16 12 
USO1_HUMAN 0 0 18 15 
EIF3M_HUMAN 0 2 18 11 
DC1I2_HUMAN 12 13 0 0 
RM50_HUMAN 0 0 18 11 
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VTA1_HUMAN 1 1 0 2 
G3BP2_HUMAN 4 4 11 6 
LAD1_HUMAN 13 13 3 3 
LAMA5_HUMAN 6 9 1 0 
NDUS6_HUMAN 9 16 0 0 
RT27_HUMAN 0 0 12 14 
ST2A1_HUMAN 0 0 5 10 
TRIPC_HUMAN 8 10 0 0 
MINP1_HUMAN 0 0 18 14 
SRS11_HUMAN 0 1 19 10 
NPTN_HUMAN 11 5 0 0 
SNUT2_HUMAN 9 8 5 3 
ACL6A_HUMAN 11 13 3 2 
ARL1_HUMAN 10 14 0 0 
BOP1_HUMAN 1 3 12 16 
DD19A_HUMAN 0 0 9 12 
DSRAD_HUMAN 10 4 4 6 
E41L2_HUMAN 1 0 10 9 
ENPP1_HUMAN 10 13 0 0 
IF5_HUMAN 3 1 11 6 
YMEL1_HUMAN 17 13 0 0 
ATX2L_HUMAN 0 0 11 11 
TRI25_HUMAN 5 2 2 4 
S29A1_HUMAN 14 10 0 0 
CX7A2_HUMAN 9 10 0 0 
NOL6_HUMAN 6 1 11 12 
MOT1_HUMAN 15 8 0 0 
LSM5_HUMAN 5 2 10 10 
gnl|unk|ENST00000450169_6 5 2 10 10 
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KINH_HUMAN 0 1 8 6 
KIF5A_HUMAN 0 0 0 0 
AP3D1_HUMAN 2 2 8 5 
BGAL_HUMAN 0 0 8 10 
CHERP_HUMAN 3 0 11 12 
PIGT_HUMAN 14 14 0 0 
RM46_HUMAN 0 1 11 10 
TIM44_HUMAN 2 4 9 13 
TM205_HUMAN 17 15 0 0 
CHSP1_HUMAN 0 0 14 10 
MIMIT_HUMAN 13 16 0 0 
LSM8_HUMAN 0 0 13 11 
MIC25_HUMAN 14 7 0 0 
UB2D2_HUMAN 0 0 15 13 
UB2D3_HUMAN 0 0 15 13 
LC7L2_HUMAN 5 2 0 0 
LUC7L_HUMAN 0 0 0 0 
LTOR2_HUMAN 6 9 8 5 
PDS5B_HUMAN 8 5 0 0 
PDS5A_HUMAN 1 1 1 0 
AMRP_HUMAN 0 0 7 8 
CLIC4_HUMAN 0 0 12 14 
CSTF3_HUMAN 0 0 16 13 
DGAT1_HUMAN 19 11 0 0 
DLDH_HUMAN 0 0 11 15 
DNJC9_HUMAN 8 11 0 0 
HEAT1_HUMAN 7 7 2 2 
MA2A1_HUMAN 9 8 0 0 
MVD1_HUMAN 0 0 14 12 
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NCEH1_HUMAN 5 11 0 0 
NDUS8_HUMAN 14 11 0 0 
PPM1G_HUMAN 0 0 6 5 
RFA1_HUMAN 8 7 6 6 
VPS35_HUMAN 0 0 8 11 
WDR75_HUMAN 8 1 8 5 
ZNT1_HUMAN 11 5 0 0 
NADC_HUMAN 0 0 9 13 
AN32B_HUMAN 4 3 20 19 
MYDGF_HUMAN 0 0 12 12 
ARP2_HUMAN 2 4 6 5 
SAMH1_HUMAN 0 0 13 8 
FEN1_HUMAN 0 0 12 12 
NDUA4_HUMAN 15 13 0 0 
gnl|unk|ENST00000339600_9 15 13 0 0 
NUCB2_HUMAN 7 3 6 7 
DNJC3_HUMAN 0 0 14 11 
ASNA_HUMAN 11 2 1 2 
C560_HUMAN 9 13 0 0 
DEST_HUMAN 4 3 11 10 
SIAT1_HUMAN 10 12 0 0 
HNF4A_HUMAN 7 6 1 4 
6PGL_HUMAN 0 0 14 11 
CSN1_HUMAN 0 0 9 10 
FUBP3_HUMAN 5 5 7 10 
GSTK1_HUMAN 1 2 10 9 
IDE_HUMAN 0 0 7 4 
ITAV_HUMAN 8 3 0 0 
ITPA_HUMAN 0 0 16 15 
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MCM3_HUMAN 1 4 10 5 
MET7A_HUMAN 12 13 0 0 
PP2AA_HUMAN 0 0 13 13 
RT22_HUMAN 0 0 13 13 
STAT1_HUMAN 10 7 0 1 
SYNC_HUMAN 0 0 7 14 
WDR12_HUMAN 3 3 8 6 
IF2P_HUMAN 8 2 9 7 
BMS1_HUMAN 0 0 11 5 
PICAL_HUMAN 2 1 10 14 
FBX2_HUMAN 0 0 7 6 
YES_HUMAN 14 14 0 0 
HCK_HUMAN 0 0 0 0 
CCD58_HUMAN 0 0 10 11 
gnl|unk|ENST00000590792_3 0 0 0 3 
ASNS_HUMAN 0 0 7 19 
CTNA1_HUMAN 16 14 0 0 
EIF3E_HUMAN 0 0 12 8 
EMC7_HUMAN 10 8 0 0 
IKIP_HUMAN 6 4 0 0 
PBIP1_HUMAN 6 8 0 0 
RPB1_HUMAN 10 8 3 3 
TXNL1_HUMAN 0 0 14 12 
PSD12_HUMAN 0 0 11 7 
BCLF1_HUMAN 1 0 8 9 
PGM2_HUMAN 0 0 16 11 
CNN2_HUMAN 0 0 15 12 
PRAF3_HUMAN 10 9 0 0 
EIF3I_HUMAN 0 0 13 12 
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SOAT1_HUMAN 5 2 0 0 
ODO2_HUMAN 0 0 12 16 
CNBP_HUMAN 5 4 7 7 
SKP1_HUMAN 1 3 15 11 
CAB45_HUMAN 1 0 3 6 
LCLT1_HUMAN 8 8 0 0 
TOM20_HUMAN 10 10 0 0 
gnl|unk|ENST00000467767_4 10 10 0 0 
METK2_HUMAN 2 5 4 5 
METK1_HUMAN 0 0 4 7 
SYJ2B_HUMAN 6 6 0 0 
gnl|unk|ENST00000618385_4 6 6 0 0 
CD166_HUMAN 12 11 0 0 
FND3A_HUMAN 10 13 0 0 
LYPA1_HUMAN 0 0 12 12 
MAGT1_HUMAN 14 14 0 0 
MIRO2_HUMAN 8 9 0 0 
RS15_HUMAN 5 4 2 3 
RT18B_HUMAN 0 0 5 10 
SGT1_HUMAN 0 0 8 11 
PDIP2_HUMAN 0 0 12 11 
TXD12_HUMAN 0 0 9 11 
NOL10_HUMAN 2 2 9 7 
VPS29_HUMAN 0 0 9 14 
SAR1A_HUMAN 3 9 1 0 
SAR1B_HUMAN 3 4 0 2 
ARI3A_HUMAN 0 0 7 12 
ARI3C_HUMAN 0 0 0 0 
GNS_HUMAN 0 0 11 10 
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GPI8_HUMAN 10 8 0 0 
HN1_HUMAN 0 0 11 12 
IQGA2_HUMAN 5 6 3 4 
NAMPT_HUMAN 0 0 15 10 
RAB21_HUMAN 12 13 1 1 
SCRB2_HUMAN 12 3 0 0 
RUVB2_HUMAN 5 5 2 6 
TMED4_HUMAN 19 21 0 0 
DJC11_HUMAN 12 10 0 0 
ERH_HUMAN 0 2 6 7 
NOC3L_HUMAN 3 8 1 6 
UCHL3_HUMAN 0 0 8 9 
VMP1_HUMAN 15 8 0 0 
VATE1_HUMAN 15 8 0 0 
GNPI1_HUMAN 0 0 13 11 
HDAC1_HUMAN 7 1 2 4 
HDAC2_HUMAN 4 0 4 3 
PMM2_HUMAN 8 5 7 7 
MGST3_HUMAN 5 2 0 0 
A1CF_HUMAN 0 0 9 16 
CENPV_HUMAN 11 11 0 0 
EMC4_HUMAN 10 3 0 0 
MAAI_HUMAN 0 0 12 11 
MEP50_HUMAN 0 0 12 10 
MK01_HUMAN 0 0 21 14 
NDUV2_HUMAN 4 9 0 0 
OSBL8_HUMAN 7 9 0 0 
RAD21_HUMAN 8 8 0 0 
SAC1_HUMAN 11 5 0 0 
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SAE2_HUMAN 0 0 9 7 
TMED5_HUMAN 9 11 0 0 
TCOF_HUMAN 1 1 4 6 
GAMT_HUMAN 0 0 9 7 
MARH5_HUMAN 11 4 0 0 
MUTA_HUMAN 0 0 3 0 
MARC1_HUMAN 6 8 0 0 
PFD5_HUMAN 0 0 10 12 
PNO1_HUMAN 10 8 0 0 
UBP10_HUMAN 0 0 9 7 
NDUA6_HUMAN 3 3 0 0 
EBP_HUMAN 13 12 0 0 
TYB10_HUMAN 0 0 13 12 
gnl|unk|ENST00000233143_3 0 0 13 12 
ASPC1_HUMAN 0 0 9 7 
IPO9_HUMAN 1 1 7 10 
LC7L3_HUMAN 4 6 9 4 
MCU_HUMAN 5 2 0 0 
MTAP_HUMAN 0 0 11 15 
NU107_HUMAN 10 3 0 0 
PLOD3_HUMAN 0 0 3 8 
RBM15_HUMAN 6 3 5 2 
RM45_HUMAN 9 4 1 0 
SC61B_HUMAN 10 9 0 0 
gnl|unk|ENST00000223641_2 10 9 0 0 
TMEM2_HUMAN 8 7 0 0 
TMOD3_HUMAN 7 8 0 0 
ABCE1_HUMAN 3 1 5 5 
RRP1B_HUMAN 4 7 0 1 
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PEPD_HUMAN 0 0 10 10 
SUCA_HUMAN 0 1 4 13 
PIMT_HUMAN 0 0 8 7 
TBRG4_HUMAN 0 0 10 6 
HNRL1_HUMAN 0 0 14 7 
NU5M_HUMAN 10 11 0 0 
NOP16_HUMAN 9 6 6 2 
BCCIP_HUMAN 4 2 7 6 
DDX24_HUMAN 6 4 7 3 
HNRH3_HUMAN 1 1 0 5 
MAL2_HUMAN 15 10 0 0 
RT05_HUMAN 0 1 5 5 
GOSR2_HUMAN 10 4 0 0 
EHD1_HUMAN 5 2 3 3 
TI17B_HUMAN 11 11 0 0 
GNA11_HUMAN 10 10 0 2 
GNAQ_HUMAN 1 0 0 0 
ACPH_HUMAN 0 0 6 10 
ESYT2_HUMAN 11 7 0 0 
GORS2_HUMAN 0 2 11 9 
PLST_HUMAN 0 0 6 8 
PYGL_HUMAN 0 0 9 6 
RAB18_HUMAN 12 12 0 0 
SARDH_HUMAN 0 0 9 10 
SCMC1_HUMAN 12 5 0 0 
STRAP_HUMAN 0 0 9 13 
TDIF2_HUMAN 10 6 0 2 
THIK_HUMAN 3 3 7 6 





8 7 0 0 
gnl|unk|ENST00000555061_8 8 7 0 0 
gnl|unk|ENST00000555404_9 8 7 0 0 
gnl|unk|ENST00000555593_8 8 7 0 0 
TMX2_HUMAN 4 5 0 0 
UTRO_HUMAN 1 1 7 11 
IVD_HUMAN 4 0 4 8 
MYO1D_HUMAN 10 11 0 0 
NDUBB_HUMAN 8 9 0 0 
CP27A_HUMAN 11 5 0 0 
ZYX_HUMAN 7 4 5 6 
ADPGK_HUMAN 10 3 0 0 
SRS10_HUMAN 2 0 8 6 
PERQ2_HUMAN 6 2 9 7 
PHS_HUMAN 1 1 4 2 
COA3_HUMAN 6 4 0 0 
ZN326_HUMAN 1 2 7 6 
ACTZ_HUMAN 0 0 6 7 
ACTY_HUMAN 0 0 3 0 
AKAP1_HUMAN 12 4 0 0 
DDRGK_HUMAN 13 7 0 0 
EXOSX_HUMAN 0 0 7 2 
MRP2_HUMAN 12 6 0 0 
NUDT5_HUMAN 0 0 12 9 
PSMD4_HUMAN 0 0 14 4 
S38A3_HUMAN 13 8 0 0 
SRRT_HUMAN 0 0 3 11 
TF3C1_HUMAN 0 2 7 9 
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TSR1_HUMAN 12 8 0 0 
ADK_HUMAN 0 0 12 11 
CND3_HUMAN 11 9 0 0 
CSN3_HUMAN 1 0 9 3 
MRRP1_HUMAN 3 6 5 1 
SRP68_HUMAN 2 3 6 6 
THTR_HUMAN 0 0 9 9 
PIGU_HUMAN 13 9 0 0 
ERG28_HUMAN 3 2 0 0 
MAT2B_HUMAN 0 0 6 6 
SPS2L_HUMAN 5 7 0 0 
GMFB_HUMAN 0 0 11 11 
MIC27_HUMAN 2 4 0 0 
GMDS_HUMAN 0 0 12 7 
MACF1_HUMAN 0 0 1 2 
LTOR1_HUMAN 4 3 3 1 
TPX2_HUMAN 5 5 0 0 
ASAH1_HUMAN 12 6 0 2 
BT3L4_HUMAN 0 0 12 12 
FERM2_HUMAN 0 0 4 10 
KPRA_HUMAN 0 0 12 11 
RM37_HUMAN 0 6 6 5 
RRP12_HUMAN 5 3 10 0 
THRB_HUMAN 3 3 0 0 
AUP1_HUMAN 6 5 0 0 
OCAD1_HUMAN 4 4 0 0 
DDX46_HUMAN 1 0 4 5 
LAMP2_HUMAN 12 6 0 0 
CPSF6_HUMAN 6 3 6 4 
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STMN1_HUMAN 0 0 9 6 
VATL_HUMAN 9 6 0 0 
GPC6_HUMAN 11 8 0 0 
ICAM1_HUMAN 9 9 0 0 
MAOM_HUMAN 0 0 7 9 
SEH1_HUMAN 9 10 0 0 
SMCA1_HUMAN 7 2 0 0 
RMND1_HUMAN 4 4 0 0 
SCPDL_HUMAN 10 10 0 0 
PRKRA_HUMAN 0 0 8 7 
TIA1_HUMAN 0 0 24 19 
CREL1_HUMAN 8 10 0 0 
CSTF1_HUMAN 0 0 8 13 
PCM1_HUMAN 3 5 0 0 
PFD3_HUMAN 0 0 11 11 
PVR_HUMAN 9 7 0 0 
LTOR3_HUMAN 6 4 3 6 
MPC2_HUMAN 1 0 0 0 
DYL1_HUMAN 13 14 24 20 
gnl|unk|ENST00000242577_8 13 14 24 20 
gnl|unk|ENST00000392508_8 13 14 24 20 
gnl|unk|ENST00000392509_8 13 14 24 20 
gnl|unk|ENST00000548342_9 13 14 24 20 
gnl|unk|ENST00000549989_9 13 14 24 20 
RU1C_HUMAN 7 6 6 4 
ZFPL1_HUMAN 6 5 0 0 
SMRD2_HUMAN 3 2 0 0 
SMRD1_HUMAN 1 1 0 0 
APEX1_HUMAN 11 6 0 0 
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DUS9_HUMAN 0 3 6 7 
ERLN1_HUMAN 18 19 0 0 
HG2A_HUMAN 10 10 0 0 
IF2B2_HUMAN 0 0 15 30 
PININ_HUMAN 8 9 0 0 
RIF1_HUMAN 10 7 0 0 
RMD3_HUMAN 1 10 0 0 
UBE2K_HUMAN 0 0 13 2 
gnl|unk|ENST00000510719_9 0 0 13 2 
COASY_HUMAN 4 5 3 4 
PAK2_HUMAN 0 0 5 6 
S10A1_HUMAN 0 0 3 7 
MCM4_HUMAN 0 0 10 9 
SRC_HUMAN 6 4 0 0 
NAKD2_HUMAN 0 0 10 10 
RER1_HUMAN 9 5 0 0 
TTC38_HUMAN 0 0 10 10 
AP2M1_HUMAN 5 5 6 6 
CB047_HUMAN 8 5 0 0 
HMGN3_HUMAN 4 13 0 0 
PREP_HUMAN 0 0 12 10 
RM15_HUMAN 0 0 5 12 
RS28_HUMAN 0 3 6 10 
gnl|unk|ENST00000441378_1 0 3 6 10 
gnl|unk|ENST00000442562_1 0 3 6 10 
gnl|unk|ENST00000473748_1 0 3 6 10 
gnl|unk|ENST00000600659_1 0 3 6 10 
S38A2_HUMAN 16 6 0 0 
MOV10_HUMAN 0 0 4 3 
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TMCO1_HUMAN 7 4 0 0 
HBA_HUMAN 6 7 0 0 
RL29_HUMAN 4 5 4 5 
TOM7_HUMAN 4 3 0 0 
gnl|unk|ENST00000358435_4 4 3 0 0 
TM41B_HUMAN 10 5 0 0 
RM47_HUMAN 0 0 8 12 
TCTP_HUMAN 0 0 9 9 
RAB6A_HUMAN 11 14 0 0 
gnl|unk|ENST00000536566_1
2 
0 0 0 0 
CPNS1_HUMAN 0 0 10 4 
CPT2_HUMAN 8 7 0 0 
EEA1_HUMAN 0 0 3 6 
ITA2_HUMAN 13 4 0 0 
MSH6_HUMAN 3 7 0 0 
PDIP3_HUMAN 5 6 0 0 
PTCD3_HUMAN 0 0 5 5 
SMCA4_HUMAN 5 5 0 0 
VAMP3_HUMAN 11 7 0 0 
gnl|unk|ENST00000054666_6 11 7 0 0 
ZW10_HUMAN 10 8 0 0 
ELOB_HUMAN 0 0 12 9 
NDUA7_HUMAN 6 6 0 0 
RNZ2_HUMAN 0 0 10 7 
AK1BA_HUMAN 0 0 8 8 
CHRD1_HUMAN 0 0 9 6 
MDR1_HUMAN 6 3 0 0 
CP20A_HUMAN 4 6 0 0 
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PCY1A_HUMAN 6 5 0 0 
VKGC_HUMAN 7 7 0 0 
HKDC1_HUMAN 6 6 0 0 
SPB6_HUMAN 0 0 6 3 
RAE1L_HUMAN 7 4 0 0 
CLU_HUMAN 0 0 3 4 
3BHS7_HUMAN 7 4 0 0 
AP1G1_HUMAN 0 1 7 8 
ARMT1_HUMAN 0 0 6 8 
F210B_HUMAN 10 9 0 0 
HERP1_HUMAN 10 10 0 0 
HSBP1_HUMAN 0 0 11 10 
gnl|unk|ENST00000433866_6 0 0 11 10 
gnl|unk|ENST00000570259_5 0 0 11 10 
NDUS4_HUMAN 10 5 0 0 
PLLP_HUMAN 7 7 0 0 
SCRB1_HUMAN 9 9 0 0 
TMEM9_HUMAN 13 6 0 0 
CD99_HUMAN 11 6 0 0 
AIMP2_HUMAN 1 1 10 4 
CY24A_HUMAN 2 3 0 0 
GALM_HUMAN 0 0 7 7 
BLVRB_HUMAN 0 0 8 9 
QCR8_HUMAN 5 4 0 0 
gnl|unk|ENST00000378667_5 5 4 0 0 
RM41_HUMAN 0 0 9 8 
BST2_HUMAN 7 6 0 0 
gnl|unk|ENST00000533098_5 7 6 0 0 
ARAP1_HUMAN 6 5 5 5 
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COX7R_HUMAN 12 9 0 0 
OSTC_HUMAN 10 9 0 0 
ADDA_HUMAN 4 4 2 1 
CPT1A_HUMAN 12 8 0 0 
CSN6_HUMAN 0 0 6 7 
EFTS_HUMAN 5 6 4 4 
PECR_HUMAN 0 0 10 8 
RT31_HUMAN 0 0 10 10 
FKBP3_HUMAN 0 0 8 8 
CAN1_HUMAN 0 0 7 10 
CADH2_HUMAN 2 1 0 0 
KPYR_HUMAN 0 0 18 18 
DREB_HUMAN 6 4 4 1 
STX5_HUMAN 6 8 0 0 
QSOX2_HUMAN 6 5 0 0 
SUCB1_HUMAN 2 0 2 5 
TMED1_HUMAN 6 4 0 0 
GPDA_HUMAN 0 0 7 7 
MFF_HUMAN 6 4 0 0 
CPNE3_HUMAN 0 0 4 8 
NFS1_HUMAN 0 0 10 10 
TXD17_HUMAN 0 0 6 7 
IMP3_HUMAN 0 1 7 4 
DNMT1_HUMAN 7 3 0 0 
RUXG_HUMAN 7 8 0 0 
gnl|unk|ENST00000272348_6 7 8 0 0 
ATAD1_HUMAN 2 0 0 0 
SPG7_HUMAN 7 3 0 0 
RPOM_HUMAN 5 1 3 1 
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DAG1_HUMAN 7 3 0 0 
PELP1_HUMAN 6 6 4 2 
HIG1A_HUMAN 9 9 0 0 
gnl|unk|ENST00000418900_4 9 9 0 0 
gnl|unk|ENST00000625589_4 9 9 0 0 
GAR1_HUMAN 2 4 5 6 
MLXPL_HUMAN 6 4 4 6 
MPRD_HUMAN 4 8 0 0 
NDUS7_HUMAN 10 7 0 0 
AN32E_HUMAN 0 0 5 4 
RM17_HUMAN 0 0 10 7 
IF2B3_HUMAN 0 0 17 29 
K1C10_HUMAN 16 1 0 0 
RM01_HUMAN 0 0 3 6 
TGM2_HUMAN 6 10 0 0 
EFGM_HUMAN 0 0 5 9 
PDXK_HUMAN 0 0 7 6 
SRP09_HUMAN 0 1 8 8 
gnl|unk|ENST00000304786_8 0 1 8 8 
gnl|unk|ENST00000445874_6 0 1 8 8 
A1AG1_HUMAN 0 0 9 7 
DUS3_HUMAN 0 0 5 10 
DYLT1_HUMAN 10 9 0 0 
gnl|unk|ENST00000367085_4 10 9 0 0 
OGFR_HUMAN 0 0 9 7 
QKI_HUMAN 0 0 5 8 
RCN2_HUMAN 2 5 6 5 
RFC3_HUMAN 9 6 0 0 
RHOB_HUMAN 5 6 0 0 
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RNPS1_HUMAN 11 3 2 3 
TMA16_HUMAN 13 6 0 0 
IF2B_HUMAN 4 5 0 0 
PACN3_HUMAN 3 2 0 1 
DCAKD_HUMAN 3 2 0 0 
NDUA2_HUMAN 1 1 0 0 
F134C_HUMAN 5 1 0 0 
SC5A6_HUMAN 3 1 0 0 
PDCD5_HUMAN 0 0 1 3 
gnl|unk|ENST00000221784_4 0 0 1 3 
gnl|unk|ENST00000586035_6 0 0 1 3 
LRP1_HUMAN 6 1 0 0 
ROMO1_HUMAN 7 6 0 0 
gnl|unk|ENST00000374078_3 7 6 0 0 
gnl|unk|ENST00000397416_1 7 6 0 0 
PYR1_HUMAN 1 2 2 1 
IFM3_HUMAN 0 2 4 6 
ATP6_HUMAN 7 8 0 0 
CNIH4_HUMAN 12 6 0 0 
gnl|unk|ENST00000468318_8 12 6 0 0 
GRWD1_HUMAN 3 1 0 0 
ACOC_HUMAN 0 0 5 9 
CNN3_HUMAN 0 0 8 1 
IDI1_HUMAN 0 0 6 10 
LAMC1_HUMAN 6 3 3 1 
ODR4_HUMAN 9 3 0 0 
UB2G2_HUMAN 5 8 0 0 
UMPS_HUMAN 0 0 7 9 
ZCCHV_HUMAN 8 5 0 0 
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NCBP1_HUMAN 0 0 5 5 
EIF3K_HUMAN 0 0 7 8 
LYAR_HUMAN 4 3 0 1 
UCHL5_HUMAN 0 0 6 5 
TACO1_HUMAN 0 0 6 6 
VA0D1_HUMAN 3 1 0 0 
PAPS1_HUMAN 0 0 5 7 
MFN2_HUMAN 4 3 0 0 
EWS_HUMAN 3 2 4 5 
MFAP1_HUMAN 1 3 5 5 
MRE11_HUMAN 1 1 2 3 
PRP4_HUMAN 6 7 4 0 
REEP6_HUMAN 4 5 0 3 
GSHB_HUMAN 0 0 6 2 
BYST_HUMAN 6 6 1 2 
SUMO1_HUMAN 0 0 3 3 
RPAC1_HUMAN 1 1 1 1 
TF3C5_HUMAN 6 4 6 2 
NDUA3_HUMAN 4 4 0 0 
gnl|unk|ENST00000391763_4 4 4 0 0 
gnl|unk|ENST00000419113_4 4 4 0 0 
UT14A_HUMAN 3 2 0 4 
UT14C_HUMAN 0 0 0 0 
CCHL_HUMAN 9 7 0 0 
CP2W1_HUMAN 8 8 0 0 
ECE1_HUMAN 5 5 0 0 
GNA1_HUMAN 0 0 8 9 
HS2ST_HUMAN 1 3 0 0 
NDUB7_HUMAN 4 4 0 0 
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TNPO1_HUMAN 0 0 23 29 
ATP5I_HUMAN 0 10 0 0 
gnl|unk|ENST00000304312_4 0 10 0 0 
MPPB_HUMAN 0 0 4 6 
SSDH_HUMAN 0 0 6 8 
FN3K_HUMAN 1 0 7 7 
SNRPA_HUMAN 0 0 7 7 
NT5D2_HUMAN 1 3 3 4 
TOM34_HUMAN 2 3 4 4 
EXOS5_HUMAN 0 0 10 6 
SRC8_HUMAN 0 0 7 6 
ARSB_HUMAN 0 0 8 6 
FADS1_HUMAN 4 6 0 0 
HAT1_HUMAN 0 0 10 7 
MA1B1_HUMAN 8 5 0 0 
MTPN_HUMAN 0 0 0 5 
RM16_HUMAN 0 5 0 3 
SBP1_HUMAN 0 0 9 7 
TSN6_HUMAN 5 4 0 0 
WDR18_HUMAN 2 0 6 6 
SK2L2_HUMAN 2 1 4 2 
LONP2_HUMAN 3 3 0 0 
ALG5_HUMAN 8 1 0 0 
DEFM_HUMAN 4 4 0 0 
CPSF2_HUMAN 0 0 6 4 
SH3G1_HUMAN 0 0 7 5 
VISL1_HUMAN 2 1 5 2 
RBM25_HUMAN 0 0 6 6 
LSM4_HUMAN 0 0 4 5 
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GGH_HUMAN 0 0 2 4 
IR3IP_HUMAN 6 6 0 0 
gnl|unk|ENST00000256433_3 6 6 0 0 
gnl|unk|ENST00000588705_3 6 6 0 0 
ILK_HUMAN 3 0 0 0 
TIM13_HUMAN 3 0 0 1 
gnl|unk|ENST00000215570_5 3 0 0 1 
HEM3_HUMAN 0 0 9 6 
RO60_HUMAN 0 0 5 4 
gnl|unk|ENST00000487233_4 1 4 5 2 
gnl|unk|ENST00000412502_4 0 0 0 0 
EXOS3_HUMAN 4 4 5 3 
LYSC_HUMAN 6 2 5 4 
gnl|unk|ENST00000352511_9
3 
1 2 2 2 
BCAT1_HUMAN 0 0 8 7 
P121C_HUMAN 4 1 0 0 
P121A_HUMAN 0 0 0 0 
ACADM_HUMAN 0 0 3 8 
CBX1_HUMAN 0 0 7 8 
CSN2_HUMAN 0 0 5 4 
DHSO_HUMAN 0 0 4 6 
GLRX5_HUMAN 0 0 6 9 
I2BP2_HUMAN 0 0 11 3 
ORNT1_HUMAN 3 5 0 0 
PCAT1_HUMAN 10 6 0 0 
UD2B7_HUMAN 5 5 0 0 
VRK1_HUMAN 9 5 0 0 
CBR1_HUMAN 0 0 7 2 
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AMPB_HUMAN 0 0 7 6 
TIAR_HUMAN 0 0 23 15 
SRSF5_HUMAN 0 0 8 6 
CARM1_HUMAN 0 0 8 7 
FA98A_HUMAN 2 1 3 2 
PSPC1_HUMAN 1 0 5 8 
SUN1_HUMAN 8 0 0 0 
CNPY3_HUMAN 0 0 4 9 
PCP_HUMAN 0 0 4 7 
PPID_HUMAN 0 0 6 7 
PYRG1_HUMAN 0 0 10 6 
RM49_HUMAN 1 1 6 8 
SMC3_HUMAN 9 3 0 0 
TAM41_HUMAN 9 7 0 0 
UBXN4_HUMAN 9 7 0 0 
XPC_HUMAN 6 7 0 0 
NDC1_HUMAN 1 2 0 0 
MCM7_HUMAN 0 0 8 6 
RT34_HUMAN 0 0 7 9 
DCTP1_HUMAN 0 0 0 2 
SPCS3_HUMAN 1 1 0 0 
TM189_HUMAN 7 0 0 0 
ANXA7_HUMAN 0 0 5 1 
PUM3_HUMAN 0 1 5 6 
RENR_HUMAN 6 0 0 0 
TIF1A_HUMAN 0 0 6 6 
VAS1_HUMAN 4 4 0 0 
ATP8_HUMAN 3 0 0 0 
MMS19_HUMAN 0 0 6 5 
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VAMP8_HUMAN 5 4 0 0 
gnl|unk|ENST00000263864_8 5 4 0 0 
CNOT1_HUMAN 0 0 2 2 
SNF5_HUMAN 4 4 0 0 
CXB1_HUMAN 6 9 0 0 
NIP7_HUMAN 6 4 0 0 
NDUC2_HUMAN 3 4 0 0 
gnl|unk|ENST00000525085_5 3 4 0 0 
ABCF2_HUMAN 6 1 1 2 
LICH_HUMAN 3 2 4 2 
RFA2_HUMAN 5 3 1 0 
RFC5_HUMAN 8 2 0 0 
RPF2_HUMAN 1 4 1 0 
SORT_HUMAN 7 4 0 0 
SDF2L_HUMAN 0 2 5 8 
CRK_HUMAN 0 0 8 6 
DBLOH_HUMAN 0 0 0 4 
DRG2_HUMAN 0 0 7 8 
GILT_HUMAN 0 0 8 8 
PCCB_HUMAN 0 0 6 6 
RM53_HUMAN 0 0 8 6 
ATPD_HUMAN 5 6 0 0 
ICAL_HUMAN 0 0 8 4 
ISOC1_HUMAN 0 0 2 9 
LEG1_HUMAN 0 0 4 4 
LMF2_HUMAN 8 3 0 0 
NUP54_HUMAN 3 4 0 0 
RHG01_HUMAN 0 0 8 6 
K2013_HUMAN 5 2 0 0 
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DTD1_HUMAN 0 0 5 4 
SERB_HUMAN 0 0 6 8 
BACH_HUMAN 0 0 2 3 
UXS1_HUMAN 4 2 0 0 
SCRIB_HUMAN 6 1 0 0 
SYLM_HUMAN 0 0 4 6 
S27A2_HUMAN 7 6 0 0 
HINT2_HUMAN 0 0 6 7 
CS052_HUMAN 3 6 0 0 
DCUP_HUMAN 0 0 3 0 
EIF1_HUMAN 0 0 9 6 
GMPPA_HUMAN 0 0 6 8 
LSM3_HUMAN 0 0 7 8 
RM21_HUMAN 0 0 6 6 
SYEM_HUMAN 0 0 6 4 
TRM1_HUMAN 0 0 8 7 
GCSH_HUMAN 0 0 6 8 
gnl|unk|ENST00000564386_9 0 0 6 8 
NAF1_HUMAN 0 0 6 7 
REEP5_HUMAN 5 6 0 0 
NDUB1_HUMAN 3 5 0 0 
gnl|unk|ENST00000553514_8 3 5 0 0 
gnl|unk|ENST00000555441_6 3 5 0 0 
TM256_HUMAN 6 3 0 0 
MTA2_HUMAN 0 2 0 0 
PTN11_HUMAN 0 0 2 2 
CDK1_HUMAN 3 0 0 0 
DCTN1_HUMAN 0 0 2 5 
NGDN_HUMAN 4 4 3 2 
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NEUL_HUMAN 0 0 1 1 
ZGPAT_HUMAN 1 1 0 0 
MIC13_HUMAN 0 5 0 0 
UTP4_HUMAN 0 0 7 6 
DIM1_HUMAN 1 0 0 0 
CASC4_HUMAN 8 6 0 0 
ELOV1_HUMAN 8 6 0 0 
YKT6_HUMAN 3 0 4 3 
SDC1_HUMAN 0 2 6 5 
5NTC_HUMAN 0 0 7 7 
CE051_HUMAN 0 0 2 6 
EI2BG_HUMAN 0 0 5 9 
ENOPH_HUMAN 0 0 6 6 
GPX4_HUMAN 0 0 1 1 
NIF3L_HUMAN 0 0 1 1 
PSD10_HUMAN 0 0 9 6 
SRSF6_HUMAN 0 0 2 6 
gnl|unk|ENST00000605204_2
9 
0 0 0 0 
ARSE_HUMAN 6 7 0 0 
MAN1_HUMAN 8 6 0 0 
PSB7_HUMAN 0 0 6 7 
RBP56_HUMAN 9 8 14 12 
SRP54_HUMAN 0 6 3 2 
KDM1A_HUMAN 3 4 0 0 
ERF1_HUMAN 0 0 9 5 
NUP43_HUMAN 7 6 0 0 
ACACA_HUMAN 0 0 3 1 
RT09_HUMAN 0 0 8 2 
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PHIP_HUMAN 7 4 0 0 
FAH2B_HUMAN 0 0 7 6 
FKB1A_HUMAN 0 0 6 5 
GMPR2_HUMAN 0 0 8 4 
MBOA7_HUMAN 6 8 0 0 
PPIG_HUMAN 7 7 0 0 
PRP31_HUMAN 0 0 6 7 
SF3B6_HUMAN 0 0 8 4 
SYTC_HUMAN 0 0 7 5 
TOM1_HUMAN 0 0 8 6 
TM127_HUMAN 5 5 0 0 
PPT1_HUMAN 0 0 5 7 
FUCO_HUMAN 0 0 5 7 
PTPA_HUMAN 0 0 6 6 
PSMD8_HUMAN 2 2 2 1 
APLP2_HUMAN 2 3 0 0 
PYRD_HUMAN 0 2 0 0 
IDH3A_HUMAN 0 0 6 5 
PSMF1_HUMAN 2 1 3 2 
HPRT_HUMAN 0 0 4 6 
GSTT1_HUMAN 0 0 1 2 
PP14B_HUMAN 0 0 0 5 
PSIP1_HUMAN 5 4 0 0 
TGON2_HUMAN 3 5 3 1 
DDX56_HUMAN 0 1 6 6 
CUL2_HUMAN 0 0 0 1 
COA1_HUMAN 2 1 0 0 
KAPCA_HUMAN 2 1 3 0 
MASU1_HUMAN 2 0 4 6 
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MIC26_HUMAN 6 7 0 0 
P4K2A_HUMAN 7 6 0 0 
RBM8A_HUMAN 1 4 5 4 
gnl|unk|ENST00000484825_9 1 4 5 4 
gnl|unk|ENST00000465744_1
4 
4 4 1 1 
gnl|unk|ENST00000471855_4 4 4 1 1 
gnl|unk|ENST00000502784_1
1 
1 4 3 0 
PHOCN_HUMAN 0 1 7 1 
ICT1_HUMAN 0 0 4 3 
gnl|unk|ENST00000580800_9 0 0 4 3 
IWS1_HUMAN 0 0 11 3 
MPI_HUMAN 0 0 6 8 
RM19_HUMAN 0 0 6 5 
SHPK_HUMAN 0 0 6 5 
STK4_HUMAN 0 0 2 5 
UAP1_HUMAN 0 0 5 5 
WDR43_HUMAN 0 0 6 4 
TIDC1_HUMAN 6 4 0 0 
gnl|unk|ENST00000463927_5 0 0 0 0 
gnl|unk|ENST00000486418_5 0 0 0 0 
gnl|unk|ENST00000492164_5 0 0 0 0 
CADH1_HUMAN 5 4 0 0 
DDX27_HUMAN 5 3 3 2 
GALK1_HUMAN 0 0 3 8 
MRP1_HUMAN 8 3 0 0 
RBM14_HUMAN 3 7 0 0 
PTPM1_HUMAN 2 4 0 0 
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HXK2_HUMAN 0 0 2 8 
NDUF4_HUMAN 8 3 0 0 
AATF_HUMAN 1 0 1 3 
ESF1_HUMAN 4 1 3 0 
JAGN1_HUMAN 4 5 0 0 
MAK16_HUMAN 7 4 0 0 
T126A_HUMAN 11 2 0 0 
WDR5_HUMAN 0 3 2 2 
RT07_HUMAN 0 0 2 4 
TOLIP_HUMAN 4 3 3 1 
MP2K2_HUMAN 0 0 8 3 
OCLN_HUMAN 7 2 0 0 
ACO13_HUMAN 0 0 3 4 
TMX3_HUMAN 4 7 0 0 
RM11_HUMAN 0 2 2 3 
ACAD9_HUMAN 5 2 0 0 
P3H1_HUMAN 0 0 3 2 
SR140_HUMAN 0 0 6 6 
SC11C_HUMAN 1 1 0 0 
gnl|unk|ENST00000299714_4 1 1 0 0 
CLCN7_HUMAN 3 0 0 0 
S19A1_HUMAN 6 5 0 0 
HMGB2_HUMAN 5 2 0 0 
ABHD6_HUMAN 4 4 0 0 
KAD1_HUMAN 0 0 4 2 
FAHD1_HUMAN 0 0 5 7 
CPSF5_HUMAN 0 0 3 4 
RET4_HUMAN 0 0 4 5 
SNX5_HUMAN 4 3 4 2 
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APOA2_HUMAN 6 3 0 0 
gnl|unk|ENST00000367990_7 6 3 0 0 
gnl|unk|ENST00000463273_1
0 
6 3 0 0 
gnl|unk|ENST00000463812_5 6 3 0 0 
gnl|unk|ENST00000469730_5 6 3 0 0 
gnl|unk|ENST00000470459_5 6 3 0 0 
gnl|unk|ENST00000481413_1
2 
6 3 0 0 
gnl|unk|ENST00000481511_8 6 3 0 0 
ELOV5_HUMAN 6 5 0 0 
G45IP_HUMAN 5 4 0 0 
REEP4_HUMAN 6 4 0 0 
SFXN2_HUMAN 7 6 0 0 
TF3C3_HUMAN 6 5 2 0 
VATF_HUMAN 6 4 0 0 
VWA8_HUMAN 1 3 6 2 
CATIN_HUMAN 0 1 5 5 
RT17_HUMAN 0 1 6 6 
ADNP_HUMAN 2 3 2 2 
BRCC3_HUMAN 0 0 2 2 
GID8_HUMAN 0 0 7 6 
SDHF2_HUMAN 0 0 6 6 
DSC2_HUMAN 1 4 0 0 
DSC3_HUMAN 0 0 0 0 
ARF6_HUMAN 2 5 0 0 
NLTP_HUMAN 0 0 0 5 
ATX10_HUMAN 0 0 3 7 
GOGB1_HUMAN 3 2 0 0 
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DNJA3_HUMAN 5 0 0 1 
ADA10_HUMAN 2 1 0 0 
SYVM_HUMAN 0 0 5 3 
TM41A_HUMAN 4 0 0 0 
MYADM_HUMAN 4 2 0 0 
AG10A_HUMAN 7 3 0 0 
AG10B_HUMAN 7 3 0 0 
APOH_HUMAN 6 4 0 0 
MAP2_HUMAN 0 0 4 8 
NECT2_HUMAN 7 2 0 0 
DHRS4_HUMAN 0 0 2 6 
ARFG1_HUMAN 4 1 1 3 
NEUR1_HUMAN 0 0 4 7 
ZCCHL_HUMAN 4 2 0 0 
SYNE3_HUMAN 3 1 0 0 
SPT6H_HUMAN 0 0 2 3 
S23A2_HUMAN 2 2 0 0 
TSNAX_HUMAN 0 0 4 1 
DERL1_HUMAN 0 4 0 0 
KYNU_HUMAN 0 0 0 1 
HDGR2_HUMAN 0 0 3 2 
DNJC7_HUMAN 0 0 3 2 
RT14_HUMAN 0 0 5 5 
PWP1_HUMAN 0 0 1 1 
ARPC4_HUMAN 0 0 1 1 
UB2V1_HUMAN 0 0 3 2 
ATM_HUMAN 6 5 0 0 
APC1_HUMAN 3 3 1 0 
KIF4A_HUMAN 4 2 0 0 
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MARE2_HUMAN 5 2 0 0 
MPU1_HUMAN 6 6 0 0 
RAP2B_HUMAN 6 6 0 0 
RN149_HUMAN 6 5 0 0 
TM135_HUMAN 3 3 0 0 
UBIA1_HUMAN 5 5 0 0 
YIF1B_HUMAN 6 6 0 0 
gnl|unk|ENST00000514511_3 3 0 4 5 
gnl|unk|ENST00000557933_3
7 
5 3 0 0 
RTN3_HUMAN 0 2 0 0 
FAD1_HUMAN 0 0 6 6 
HTRA2_HUMAN 0 0 5 4 
IPYR2_HUMAN 0 0 3 3 
NOL9_HUMAN 0 0 6 6 
PFD2_HUMAN 0 0 6 6 
PRPS3_HUMAN 0 0 4 4 
SCOC_HUMAN 0 0 4 4 
gnl|unk|ENST00000512749_5 0 0 4 4 
TRM1L_HUMAN 0 0 6 6 
XPO7_HUMAN 0 0 6 6 
CG050_HUMAN 3 4 0 0 
IF4H_HUMAN 0 0 3 8 
PSME4_HUMAN 0 0 2 6 
3MG_HUMAN 5 6 0 0 
ENAH_HUMAN 0 0 3 1 
COX11_HUMAN 4 4 0 0 
B4GA1_HUMAN 4 1 0 0 
F169A_HUMAN 6 3 0 0 
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AP3B1_HUMAN 0 0 3 6 
DPOD1_HUMAN 0 0 4 4 
ARMC1_HUMAN 0 0 4 6 
DDX50_HUMAN 2 0 5 5 
DHB7_HUMAN 6 5 0 0 
GEPH_HUMAN 0 0 5 5 
S100P_HUMAN 0 0 3 8 
SC24C_HUMAN 4 6 0 0 
CLPX_HUMAN 1 2 2 1 
DOPD_HUMAN 0 0 5 2 
DHX30_HUMAN 3 0 0 0 
CD63_HUMAN 4 2 0 0 
STEA3_HUMAN 1 0 0 0 
TIM14_HUMAN 1 0 0 0 
FCGRN_HUMAN 6 2 0 0 
SRPK1_HUMAN 0 0 3 3 
SLK_HUMAN 0 0 3 1 
MCAT_HUMAN 2 1 0 0 
SSFA2_HUMAN 5 4 0 0 
PPAC_HUMAN 0 0 0 1 
EIF3J_HUMAN 0 0 3 3 
IF4G2_HUMAN 1 0 1 2 
SPRY7_HUMAN 0 1 0 0 
IMA3_HUMAN 0 0 5 2 
RIR2_HUMAN 0 0 3 4 
CYTC_HUMAN 0 0 4 5 
MAP11_HUMAN 0 0 2 0 
RN126_HUMAN 1 1 0 0 
ANO6_HUMAN 6 5 0 0 
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ATF2_HUMAN 7 4 0 0 
MGAT2_HUMAN 1 5 0 0 
PLK1_HUMAN 5 0 0 0 
PTTG_HUMAN 2 3 1 3 
RING1_HUMAN 6 5 0 0 
RING2_HUMAN 6 5 0 0 
SCAM1_HUMAN 6 5 0 0 
C2AIL_HUMAN 0 2 4 5 
CCD12_HUMAN 0 0 6 4 
COA7_HUMAN 0 0 5 6 
CUL4A_HUMAN 0 0 6 5 
NIT2_HUMAN 0 0 5 6 
PCTL_HUMAN 0 0 5 6 
PPIF_HUMAN 0 0 6 5 
RBM10_HUMAN 0 0 5 6 
SUOX_HUMAN 0 0 5 4 
TIGAR_HUMAN 0 0 5 5 
TRUA_HUMAN 0 0 4 4 
WASL_HUMAN 3 2 0 2 
XPOT_HUMAN 0 0 4 4 
YLPM1_HUMAN 0 0 6 3 
SEP14_HUMAN 0 0 0 0 
SEPT7_HUMAN 0 0 1 1 
gnl|unk|ENST00000338231_1
1 
0 0 0 0 
gnl|unk|ENST00000428414_1
6 
0 0 0 0 
BCAM_HUMAN 3 5 0 0 
UBR4_HUMAN 1 0 5 1 
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MD1L1_HUMAN 4 6 0 0 
MBOA5_HUMAN 3 2 0 0 
GBF1_HUMAN 0 0 4 4 
BCS1_HUMAN 3 2 0 0 
EPT1_HUMAN 6 4 0 0 
MTND_HUMAN 0 0 0 3 
PEX14_HUMAN 5 2 0 0 
RIR1_HUMAN 0 0 0 3 
UFSP2_HUMAN 0 3 0 0 
PISD_HUMAN 3 2 0 0 
DNLI1_HUMAN 0 0 4 4 
PPCE_HUMAN 0 0 3 4 
DDB2_HUMAN 1 0 0 0 
NDUB3_HUMAN 2 0 0 0 
GLYC_HUMAN 0 0 4 5 
TFG_HUMAN 0 0 1 4 
PLXB2_HUMAN 5 1 0 0 
PSB2_HUMAN 0 0 2 0 
XPO5_HUMAN 1 0 4 0 
MDN1_HUMAN 0 0 2 1 
FMNL2_HUMAN 1 0 0 0 
PRC2A_HUMAN 5 0 0 0 
LRC8D_HUMAN 0 1 0 0 
DRG1_HUMAN 1 1 0 1 
LRC8E_HUMAN 5 0 0 0 
NDRG1_HUMAN 6 1 0 0 
CF089_HUMAN 6 4 0 0 
CHD7_HUMAN 6 2 0 0 
DIDO1_HUMAN 6 3 0 0 
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ESAM_HUMAN 4 3 0 0 
FRAS1_HUMAN 5 3 0 0 
MK03_HUMAN 2 4 7 5 
RLP24_HUMAN 6 4 0 0 
SELT_HUMAN 3 4 0 0 
gnl|unk|ENST00000466234_3 3 4 0 0 
SLTM_HUMAN 6 4 0 0 
TF3C4_HUMAN 5 4 0 0 
TI17A_HUMAN 6 2 0 0 
gnl|unk|ENST00000478378_1
6 
6 2 0 0 
TM209_HUMAN 6 3 0 0 
TM2D2_HUMAN 6 4 0 0 
UBP30_HUMAN 6 2 0 0 
gnl|unk|ENST00000480219_5 4 2 0 0 
NU2M_HUMAN 1 2 0 0 
gnl|unk|ENST00000361453_7 1 2 0 0 
gnl|unk|ENST00000457540_8 1 2 0 0 
ASF1A_HUMAN 0 0 6 4 
ATG5_HUMAN 0 0 2 1 
CSN5_HUMAN 0 0 6 2 
DPH2_HUMAN 0 0 4 6 
GCDH_HUMAN 0 0 4 3 
GELS_HUMAN 0 0 4 6 
GGA2_HUMAN 0 0 4 6 
MISSL_HUMAN 0 0 4 6 
PAPOB_HUMAN 0 0 4 5 
PGP_HUMAN 0 0 5 5 
PRC2C_HUMAN 0 0 2 1 
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RM10_HUMAN 0 0 3 7 
RPC5_HUMAN 0 0 6 4 
SF3A2_HUMAN 0 0 3 0 
SYHC_HUMAN 0 0 3 6 
TRI33_HUMAN 0 0 2 2 
DC1L1_HUMAN 1 0 0 0 
DC1L2_HUMAN 1 0 0 0 
CLPT1_HUMAN 1 6 0 0 
CRKL_HUMAN 0 0 0 3 
TI23B_HUMAN 3 6 0 0 
TIM23_HUMAN 3 6 0 0 
LRC47_HUMAN 0 0 4 3 
GLYR1_HUMAN 3 2 0 0 
THOP1_HUMAN 0 0 3 4 
TNPO2_HUMAN 0 0 19 24 
DJC13_HUMAN 5 0 0 0 
ARPC3_HUMAN 0 0 4 4 
gnl|unk|ENST00000426440_5 0 0 4 4 
gnl|unk|ENST00000547365_3 0 0 4 4 
CLCC1_HUMAN 6 1 0 0 
HEXA_HUMAN 0 0 4 4 
PLCA_HUMAN 4 5 0 0 
MRS2_HUMAN 5 4 0 0 
LSM7_HUMAN 0 0 1 5 
DDX6_HUMAN 4 1 1 0 
SNG2_HUMAN 4 3 0 0 
CND1_HUMAN 1 1 0 0 
BAZ2A_HUMAN 1 2 0 0 
TRAM1_HUMAN 1 3 0 0 
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SPF27_HUMAN 3 3 1 0 
NBAS_HUMAN 0 2 0 0 
S39A4_HUMAN 0 2 0 0 
HACD2_HUMAN 1 3 0 0 
RU2A_HUMAN 0 1 1 3 
CS025_HUMAN 6 2 0 0 
gnl|unk|ENST00000578324_2
1 
0 0 2 2 
gnl|unk|ENST00000582050_8 0 0 2 2 
gnl|unk|ENST00000582746_1
4 
0 0 2 2 
YLAT2_HUMAN 6 2 0 0 
DPM3_HUMAN 3 3 0 0 
gnl|unk|ENST00000368400_3 3 3 0 0 
gnl|unk|ENST00000377524_2 1 0 0 0 
ABI1_HUMAN 6 2 0 0 
CD151_HUMAN 3 0 0 0 
CHSTD_HUMAN 7 1 0 0 
COIA1_HUMAN 5 0 0 2 
DNLI3_HUMAN 4 1 0 0 
ITM2C_HUMAN 6 3 0 0 
MTCH1_HUMAN 2 2 0 0 
NUP50_HUMAN 1 0 3 5 
PPIH_HUMAN 4 1 0 0 
PWP2_HUMAN 2 0 5 2 
gnl|unk|ENST00000433009_1
0 
4 3 0 0 
GL8D1_HUMAN 3 4 0 0 
SAHH2_HUMAN 2 2 0 0 
DDX20_HUMAN 0 0 3 3 
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EDF1_HUMAN 0 0 5 4 
HDAC6_HUMAN 0 0 5 2 
HDHD3_HUMAN 0 0 5 4 
HELLS_HUMAN 0 0 2 5 
RL22L_HUMAN 0 0 1 1 
RWDD1_HUMAN 0 0 3 4 
gnl|unk|ENST00000518117_1
1 
0 0 3 4 
gnl|unk|ENST00000332180_7
0 
0 0 4 4 
gnl|unk|ENST00000550053_7
1 
0 0 4 4 
gnl|unk|ENST00000620430_7
1 
0 0 4 4 
AGRIN_HUMAN 3 4 0 0 
TOIP2_HUMAN 2 1 0 0 
NKD1_HUMAN 2 4 0 0 
TAGL2_HUMAN 0 0 4 1 
ACS2B_HUMAN 0 0 3 3 
UBP14_HUMAN 0 0 3 1 
ALG11_HUMAN 4 3 0 0 
BRI3B_HUMAN 6 2 0 0 
DLRB1_HUMAN 1 3 0 2 
gnl|unk|ENST00000357156_3 1 3 0 2 
H1BP3_HUMAN 0 0 3 5 
ITB5_HUMAN 4 0 0 0 
LSR_HUMAN 1 5 0 0 
PRR11_HUMAN 5 2 0 0 
RUS1_HUMAN 4 4 0 0 
SRBD1_HUMAN 5 2 0 0 
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CSN4_HUMAN 0 0 5 2 
CHP1_HUMAN 4 2 0 0 
CISD1_HUMAN 3 3 0 0 
gnl|unk|ENST00000489785_8 3 3 0 0 
SYFB_HUMAN 0 0 1 4 
RBBP9_HUMAN 0 0 4 1 
BEND3_HUMAN 3 4 0 0 
BZW1_HUMAN 0 1 0 0 
SPF45_HUMAN 3 3 0 0 
FA8A1_HUMAN 5 1 0 0 
ZNT7_HUMAN 3 3 0 0 
PCNP_HUMAN 0 0 3 4 
ADRM1_HUMAN 0 0 0 1 
PTPRK_HUMAN 2 1 0 0 
SEC62_HUMAN 1 3 0 0 
gnl|unk|ENST00000460513_4 1 3 0 0 
gnl|unk|ENST00000487736_9 1 3 0 0 
DRS7B_HUMAN 3 4 0 0 
SMYD5_HUMAN 0 0 4 0 
COPG2_HUMAN 0 0 6 9 
MY18A_HUMAN 3 1 0 0 
AR6P1_HUMAN 2 0 0 0 
ACATN_HUMAN 6 2 0 0 
AT2C1_HUMAN 2 4 0 0 
CND2_HUMAN 6 2 0 0 
GCP2_HUMAN 1 0 0 0 
JAK1_HUMAN 4 2 0 0 
LAP4A_HUMAN 6 2 0 0 




MP2K3_HUMAN 4 1 0 0 
RPB9_HUMAN 5 3 0 0 
SLU7_HUMAN 4 4 0 0 
TIM16_HUMAN 4 4 0 0 
TIM8B_HUMAN 4 4 0 0 
UBXN1_HUMAN 1 0 4 3 
VPS45_HUMAN 3 4 0 0 
WDR55_HUMAN 3 0 0 0 
gnl|unk|ENST00000347364_6 1 2 0 0 
gnl|unk|ENST00000399054_1
1 
1 2 0 0 
gnl|unk|ENST00000609375_1
1 
1 2 0 0 
gnl|unk|ENST00000354895_3 4 4 0 0 
gnl|unk|ENST00000493646_6 4 1 0 0 
PRPF3_HUMAN 1 2 1 0 
gnl|unk|ENST00000493553_7 1 2 1 0 
RUXF_HUMAN 1 1 0 2 
CTDS1_HUMAN 4 4 0 0 
CUL1_HUMAN 0 0 2 1 
MP2K4_HUMAN 0 0 2 4 
NDUF5_HUMAN 0 0 4 4 
PAIP1_HUMAN 0 0 0 3 
PTMS_HUMAN 0 0 3 1 
RRP44_HUMAN 0 0 4 4 
GHC1_HUMAN 1 5 0 0 
NUP53_HUMAN 0 6 0 0 
MCM5_HUMAN 0 2 1 2 
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ACADS_HUMAN 0 0 1 4 
CNNM3_HUMAN 4 2 0 0 
MCMBP_HUMAN 0 0 2 3 
NRBP_HUMAN 0 0 3 0 
SDF2_HUMAN 4 2 0 0 
gnl|unk|ENST00000591903_1
1 
4 2 0 0 
SYMPK_HUMAN 0 0 3 4 
SYSM_HUMAN 0 0 0 3 
TRRAP_HUMAN 4 1 0 0 
CHD1_HUMAN 2 3 0 0 
DIAP1_HUMAN 0 0 1 2 
ABHDA_HUMAN 0 0 0 1 
RPAB1_HUMAN 0 3 0 1 
TAF4_HUMAN 0 0 0 2 
NXF1_HUMAN 1 3 0 0 
COR1B_HUMAN 0 0 1 1 
DGLB_HUMAN 1 1 0 0 
ABD12_HUMAN 1 1 0 0 
EIF3D_HUMAN 0 0 1 1 
FTO_HUMAN 0 0 3 0 
IMPA3_HUMAN 0 2 0 0 
RT30_HUMAN 0 1 1 0 
CBPD_HUMAN 2 1 0 0 
SP9_HUMAN 0 0 4 0 
RSU1_HUMAN 0 1 0 0 
S12A2_HUMAN 1 4 0 0 
E41L5_HUMAN 0 2 0 0 
LIMS1_HUMAN 0 2 0 0 
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TCRG1_HUMAN 0 0 2 2 
EPHB4_HUMAN 6 1 0 0 
RRAS2_HUMAN 0 1 0 0 
COX15_HUMAN 4 3 0 0 
DEGS1_HUMAN 5 1 0 0 
EMC3_HUMAN 3 4 0 0 
KIF23_HUMAN 4 0 0 0 
LACTB_HUMAN 2 0 0 0 
NC2B_HUMAN 4 3 0 0 
NOC2L_HUMAN 1 0 0 1 
P4HA2_HUMAN 2 0 0 0 
RBX1_HUMAN 4 2 1 0 
gnl|unk|ENST00000476110_6 4 2 1 0 
RNF5_HUMAN 3 3 0 0 
SAS10_HUMAN 3 0 0 0 
SCFD2_HUMAN 6 1 0 0 
TAF8_HUMAN 2 3 0 0 
TBG1_HUMAN 5 0 0 0 
TBG2_HUMAN 5 0 0 0 
TTYH3_HUMAN 2 0 0 0 
TXD15_HUMAN 2 0 0 0 
ZCHC3_HUMAN 2 1 0 0 
gnl|unk|ENST00000599243_8 5 0 0 0 
AGRG1_HUMAN 0 1 0 0 
ERGI1_HUMAN 0 1 0 0 
gnl|unk|ENST00000521392_1
0 
0 1 0 0 
gnl|unk|ENST00000523650_6 0 1 0 0 
GTR8_HUMAN 1 2 0 0 
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RS30_HUMAN 0 1 0 1 
gnl|unk|ENST00000279259_5 0 1 0 1 
STX16_HUMAN 0 2 0 0 
gnl|unk|ENST00000493301_7 0 2 0 0 
TM115_HUMAN 1 4 0 0 
AIP_HUMAN 0 0 2 5 
CMBL_HUMAN 0 0 1 0 
ES8L2_HUMAN 0 0 4 3 
NELFB_HUMAN 0 0 3 4 
RPB4_HUMAN 0 0 4 3 
SYNM_HUMAN 0 0 1 4 
WDR3_HUMAN 0 0 2 3 
XPP1_HUMAN 0 0 2 4 
HN1L_HUMAN 0 0 0 4 
gnl|unk|ENST00000568376_3 0 0 0 0 
ABCB6_HUMAN 0 4 0 0 
MDC1_HUMAN 2 0 0 0 
ULA1_HUMAN 0 0 3 1 
ADDG_HUMAN 0 4 0 0 
AQR_HUMAN 0 0 1 5 
CDV3_HUMAN 0 0 1 3 
GOLP3_HUMAN 2 4 0 0 
PKP4_HUMAN 3 1 0 0 
SPS1_HUMAN 0 0 3 2 
TAP1_HUMAN 3 0 0 0 
VATH_HUMAN 0 1 0 4 
ZFR_HUMAN 0 0 5 0 
CD032_HUMAN 2 2 0 0 
NR3L1_HUMAN 3 2 0 0 
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GEMI5_HUMAN 0 0 1 1 
DMD_HUMAN 2 0 0 0 
LIS1_HUMAN 0 0 3 1 
PRIO_HUMAN 5 1 0 0 
PX11B_HUMAN 1 2 0 0 
PPME1_HUMAN 0 0 0 1 
SUGP2_HUMAN 0 0 0 1 
SYVN1_HUMAN 1 0 0 0 
NUBP2_HUMAN 0 0 0 2 
RM38_HUMAN 0 0 0 1 
ILEU_HUMAN 0 0 3 2 
NDUB8_HUMAN 1 2 0 0 
CDC27_HUMAN 2 1 0 0 
EXOS7_HUMAN 0 0 2 3 
DDAH1_HUMAN 0 0 1 2 
GPAA1_HUMAN 2 3 0 0 
INF2_HUMAN 0 0 2 2 
ARC1A_HUMAN 0 0 5 3 
ELP1_HUMAN 0 0 1 2 
CETN2_HUMAN 0 3 0 0 
EMC8_HUMAN 2 3 0 0 
gnl|unk|ENST00000435200_9 2 3 0 0 
gnl|unk|ENST00000595980_6 2 3 0 0 
ENY2_HUMAN 4 2 0 0 
gnl|unk|ENST00000518584_5 4 2 0 0 
MSH3_HUMAN 1 0 0 0 
NOL7_HUMAN 1 5 0 0 
SNUT1_HUMAN 1 0 2 2 
STX7_HUMAN 4 1 0 0 
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WBP11_HUMAN 1 1 2 0 
YIPF5_HUMAN 3 2 0 0 
ERBB2_HUMAN 0 1 0 0 
FIP1_HUMAN 3 2 0 0 
IDH3B_HUMAN 0 2 0 0 
MGST2_HUMAN 1 2 0 0 
gnl|unk|ENST00000506797_5 1 2 0 0 
gnl|unk|ENST00000515067_3 1 2 0 0 
SFXN4_HUMAN 3 2 0 0 
SYDM_HUMAN 0 0 0 1 
CEBPZ_HUMAN 0 0 0 3 
CNOT3_HUMAN 0 0 1 1 
F192A_HUMAN 0 0 1 2 
FCL_HUMAN 0 0 0 3 
GTPB3_HUMAN 0 0 3 3 
IDH3G_HUMAN 0 0 2 1 
IF1AY_HUMAN 0 0 5 1 
KGUA_HUMAN 0 0 1 1 
MCTS1_HUMAN 0 0 1 0 
NTM1A_HUMAN 0 0 3 2 
PDPR_HUMAN 0 0 1 5 
PPIL1_HUMAN 0 0 1 2 
gnl|unk|ENST00000483552_4 0 0 1 2 
RBM4_HUMAN 0 0 5 1 
RBPMS_HUMAN 0 0 2 4 
RPAC2_HUMAN 0 0 4 0 
SMAP_HUMAN 0 0 4 1 
SPB8_HUMAN 0 0 1 3 
TGT_HUMAN 0 0 4 2 
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gnl|unk|ENST00000445547_4 0 0 3 1 
DNJA2_HUMAN 5 0 0 0 
DJC10_HUMAN 2 0 0 0 
PEX3_HUMAN 1 3 0 0 
KIME_HUMAN 0 0 1 4 
TEX10_HUMAN 0 0 3 2 
TSN14_HUMAN 3 0 0 0 
UBQL2_HUMAN 1 0 2 2 
VP26A_HUMAN 0 0 1 4 
PLCE_HUMAN 1 4 0 0 
ARPC5_HUMAN 0 0 0 4 
CTBP1_HUMAN 0 0 1 3 
NSF1C_HUMAN 0 0 1 2 
NUCKS_HUMAN 0 0 1 2 
ABCD1_HUMAN 1 1 0 0 
TIM8A_HUMAN 0 0 1 1 
NFXL1_HUMAN 1 1 0 0 
AURKB_HUMAN 2 0 0 0 
GGT2_HUMAN 0 1 0 0 
GGT3_HUMAN 0 1 0 0 
NT5D1_HUMAN 0 0 2 1 
MGME1_HUMAN 0 0 1 1 
F120A_HUMAN 0 0 1 2 
TMM70_HUMAN 0 2 0 0 
RAD50_HUMAN 1 0 0 0 
TFCP2_HUMAN 0 1 0 0 
SC16A_HUMAN 0 0 0 2 
DDX23_HUMAN 0 0 2 0 
CDIPT_HUMAN 1 1 0 0 
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EXOS6_HUMAN 1 0 1 2 
GDAP1_HUMAN 1 0 0 0 
HM20A_HUMAN 4 1 0 0 
K1C23_HUMAN 3 0 0 0 
KTAP2_HUMAN 2 2 0 0 
gnl|unk|ENST00000463527_6 2 2 0 0 
LAT4_HUMAN 3 0 0 0 
NIPBL_HUMAN 1 2 0 0 
S20A1_HUMAN 3 0 0 0 
S35F6_HUMAN 2 3 0 0 
SGPP1_HUMAN 3 1 0 0 
SMC6_HUMAN 4 1 0 0 
T2FA_HUMAN 4 1 0 0 
VTNC_HUMAN 2 3 0 0 
COR2A_HUMAN 0 2 0 0 
gnl|unk|ENST00000370153_1
18 
1 1 0 0 
gnl|unk|ENST00000465289_1
11 
1 1 0 0 
ADX_HUMAN 0 0 3 2 
AFAD_HUMAN 0 0 0 1 
CPSM_HUMAN 0 0 1 4 
D2HDH_HUMAN 0 0 2 3 
EHBP1_HUMAN 0 0 1 2 
F1142_HUMAN 0 0 5 0 
FETUA_HUMAN 0 0 0 3 
FL2D_HUMAN 0 0 2 2 
HEAT3_HUMAN 0 0 1 2 
KIF2C_HUMAN 0 0 1 4 
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MT2_HUMAN 0 0 2 3 
gnl|unk|ENST00000245185_6 0 0 2 3 
gnl|unk|ENST00000561491_4 0 0 2 3 
NQO2_HUMAN 0 0 2 0 
PGTA_HUMAN 0 0 1 0 
PRUNE_HUMAN 0 0 3 2 
QTRD1_HUMAN 0 0 2 3 
RDH13_HUMAN 0 0 1 4 
TWF2_HUMAN 0 0 1 2 
UFM1_HUMAN 0 0 0 2 
gnl|unk|ENST00000239878_5 0 0 0 2 
MIPEP_HUMAN 0 0 0 2 
NICA_HUMAN 0 2 0 0 
VPP2_HUMAN 2 1 0 0 
SPS2_HUMAN 0 0 1 2 
MA2B1_HUMAN 0 0 2 1 
EI2BD_HUMAN 0 0 3 1 
KNOP1_HUMAN 0 3 0 0 
EHMT2_HUMAN 1 2 1 0 
SMCE1_HUMAN 0 2 0 0 
IL6RB_HUMAN 2 0 0 0 
RM43_HUMAN 0 0 1 0 
F136A_HUMAN 1 0 1 0 
S35E1_HUMAN 1 1 0 0 
RN213_HUMAN 0 0 1 0 
SARNP_HUMAN 0 0 0 1 
XYLB_HUMAN 0 0 0 2 
DDX54_HUMAN 1 1 0 0 
SPTC2_HUMAN 1 0 0 0 
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TM165_HUMAN 1 1 0 0 
GSTA3_HUMAN 0 0 0 2 
ANKH1_HUMAN 0 0 1 0 
STX4_HUMAN 0 1 0 0 
GHITM_HUMAN 0 2 0 0 
STRN3_HUMAN 0 0 0 1 
RPE_HUMAN 0 0 0 2 
GALT1_HUMAN 1 0 0 0 
NLRX1_HUMAN 2 1 0 0 
SF3B5_HUMAN 0 0 0 1 
gnl|unk|ENST00000367569_6 0 0 0 1 
B2MG_HUMAN 0 2 0 0 
PROX1_HUMAN 1 1 0 0 
XPP3_HUMAN 0 0 2 2 
CDCA3_HUMAN 1 3 0 0 
CNIH1_HUMAN 3 1 0 0 
CSMT1_HUMAN 3 1 0 0 
DDX52_HUMAN 3 0 1 0 
FXR1_HUMAN 3 0 0 0 
HEMH_HUMAN 2 1 0 0 
HNRLL_HUMAN 2 0 0 0 
LITAF_HUMAN 4 0 0 0 
MA1A2_HUMAN 1 0 0 0 
MLF2_HUMAN 2 2 0 0 
NFIP1_HUMAN 2 2 0 0 
gnl|unk|ENST00000509436_2 2 2 0 0 
NID1_HUMAN 3 1 0 0 
PALM_HUMAN 4 0 0 0 
PLPP6_HUMAN 2 2 0 0 
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RM54_HUMAN 2 0 1 1 
SAMC_HUMAN 4 0 0 0 
SURF1_HUMAN 2 2 0 0 
T10B_HUMAN 2 0 0 0 
gnl|unk|ENST00000530751_2 2 0 0 0 
TCF20_HUMAN 2 0 0 0 
TR112_HUMAN 1 1 0 0 
UQCC2_HUMAN 2 2 0 0 
gnl|unk|ENST00000374231_3 2 2 0 0 
VATD_HUMAN 1 0 0 0 
ZO1_HUMAN 1 0 0 0 
CLUS_HUMAN 0 2 1 1 
gnl|unk|ENST00000622242_5 0 1 1 1 
OSTB_HUMAN 1 3 0 0 
CBPE_HUMAN 0 0 0 1 
DIP2B_HUMAN 0 0 2 2 
DUT_HUMAN 0 0 2 0 
EIF2A_HUMAN 0 0 2 2 
GPX2_HUMAN 0 0 0 4 
GYS1_HUMAN 0 0 2 0 
HEXI1_HUMAN 0 0 1 2 
KPCA_HUMAN 0 0 3 0 
MISP_HUMAN 0 0 0 2 
MRT4_HUMAN 0 0 0 2 
NOL11_HUMAN 0 0 2 1 
OGFD1_HUMAN 0 0 3 0 
P3H3_HUMAN 0 0 1 3 
RFC4_HUMAN 0 0 0 1 
SZRD1_HUMAN 0 0 1 2 
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UBC9_HUMAN 0 0 1 0 
UFD1_HUMAN 0 0 2 1 
gnl|unk|ENST00000495554_4
6 
0 0 0 1 
gnl|unk|ENST00000612404_5 0 0 0 2 
VASP_HUMAN 0 0 1 0 
PDCD6_HUMAN 0 0 0 2 
EPHA2_HUMAN 3 0 0 0 
PURA2_HUMAN 0 0 1 2 
RM23_HUMAN 0 1 0 2 
SVIL_HUMAN 3 0 0 0 
CAF1A_HUMAN 2 0 0 0 
RAB23_HUMAN 2 0 0 0 
UBAC2_HUMAN 0 2 0 0 
PKP3_HUMAN 0 1 0 0 
HD_HUMAN 0 0 1 1 
ATLA2_HUMAN 1 1 0 0 
BLMH_HUMAN 0 0 1 0 
MIA2_HUMAN 0 2 0 0 
HPBP1_HUMAN 0 0 1 0 
RBM12_HUMAN 0 0 0 1 
OSTF1_HUMAN 0 0 2 0 
ZN638_HUMAN 0 2 0 0 
CDC20_HUMAN 2 0 0 0 
RHG18_HUMAN 0 0 0 2 
UDB10_HUMAN 2 1 0 0 
MPRIP_HUMAN 0 1 0 0 
SYCC_HUMAN 0 0 1 0 
TBCD_HUMAN 0 0 0 1 
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S12A7_HUMAN 1 0 0 0 
PB1_HUMAN 0 2 0 0 
PHF5A_HUMAN 0 0 1 0 
DDX41_HUMAN 1 0 0 0 
LGMN_HUMAN 0 0 1 1 
NPC1_HUMAN 0 1 0 0 
ACOX3_HUMAN 3 0 0 0 
COBL_HUMAN 1 0 0 0 
CR3L2_HUMAN 1 2 0 0 
CWC22_HUMAN 2 0 0 0 
FA83D_HUMAN 2 1 0 0 
KIF22_HUMAN 1 0 0 0 
MBD1_HUMAN 2 1 0 0 
MTA1_HUMAN 1 2 0 0 
NSUN5_HUMAN 1 1 0 0 
NUP37_HUMAN 2 1 0 0 
OSBL9_HUMAN 1 0 0 0 
PINX1_HUMAN 1 2 0 0 
RBBP5_HUMAN 1 2 0 0 
RHOF_HUMAN 1 1 0 0 
RINT1_HUMAN 1 0 0 0 
S26A6_HUMAN 1 2 0 0 
SATT_HUMAN 2 0 0 0 
TBP_HUMAN 2 1 0 0 
TMTC3_HUMAN 2 0 0 0 
APOC3_HUMAN 0 2 0 0 
gnl|unk|ENST00000470144_2 0 2 0 0 
COIL_HUMAN 0 2 0 0 
CTNA2_HUMAN 0 3 0 0 
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CWC27_HUMAN 0 1 1 1 
FA83H_HUMAN 1 1 0 0 
MICB_HUMAN 0 3 0 0 
ODB2_HUMAN 0 2 0 0 
PEMT_HUMAN 0 1 0 0 
SC24D_HUMAN 0 1 1 0 
SCAF8_HUMAN 0 1 2 0 
TAP26_HUMAN 1 2 0 0 
UBQL4_HUMAN 0 1 0 0 
AASS_HUMAN 0 0 0 2 
API5_HUMAN 0 0 1 2 
CAH13_HUMAN 0 0 2 1 
CIP4_HUMAN 0 0 2 1 
COG8_HUMAN 0 0 2 1 
CS043_HUMAN 0 0 1 2 
DFFA_HUMAN 0 0 1 2 
GSCR2_HUMAN 0 0 1 0 
HNMT_HUMAN 0 0 0 2 
HYES_HUMAN 0 0 1 2 
IPO11_HUMAN 0 0 1 1 
JMJD6_HUMAN 0 0 1 2 
LSM1_HUMAN 0 0 0 1 
MCES_HUMAN 0 0 1 1 
NIPA_HUMAN 0 0 1 0 
PAXB1_HUMAN 0 0 0 3 
PLPP_HUMAN 0 0 1 2 
RT25_HUMAN 0 0 0 3 
gnl|unk|ENST00000444840_5 0 0 0 3 
gnl|unk|ENST00000447299_8 0 0 0 3 
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RUSD2_HUMAN 0 0 1 0 
S10AB_HUMAN 0 0 3 0 
SMC4_HUMAN 0 0 1 2 
TAGL_HUMAN 0 0 0 2 
TX1B3_HUMAN 0 0 1 1 
ZC3H4_HUMAN 1 0 1 0 
TM177_HUMAN 0 1 0 0 
RT26_HUMAN 0 0 0 2 
SF3B4_HUMAN 0 0 1 0 
DYL2_HUMAN 11 11 0 0 
UBP15_HUMAN 0 0 0 1 
INT3_HUMAN 1 0 0 0 
ROCK2_HUMAN 0 0 1 0 
PKCB1_HUMAN 0 1 0 0 
ORC2_HUMAN 1 0 0 0 
PACN2_HUMAN 0 0 1 0 
NFU1_HUMAN 0 0 0 1 
TAF5_HUMAN 1 0 0 0 
CPLX2_HUMAN 0 0 0 1 
LARP1_HUMAN 1 0 0 0 
LRRF1_HUMAN 0 0 0 1 
B4GT1_HUMAN 1 1 0 0 
CLN6_HUMAN 2 0 0 0 
FER_HUMAN 1 1 0 0 
FRIH_HUMAN 1 0 0 0 
MPZL1_HUMAN 1 1 0 0 
NIPA1_HUMAN 1 1 0 0 
OSBL2_HUMAN 1 1 0 0 
PLCB_HUMAN 2 0 0 0 
237 
 
PON3_HUMAN 1 1 0 0 
RAB6C_HUMAN 1 1 0 0 
REEP3_HUMAN 2 0 0 0 
SFR19_HUMAN 1 1 0 0 
SKT_HUMAN 1 0 0 0 
SUZ12_HUMAN 1 0 0 0 
TAP2_HUMAN 1 1 0 0 
TP53B_HUMAN 1 0 0 0 
UTP20_HUMAN 2 0 0 0 
EXOC4_HUMAN 0 1 0 0 
BAK_HUMAN 0 1 0 0 
CASP_HUMAN 0 2 0 0 
CHCH1_HUMAN 0 2 0 0 
CHD1L_HUMAN 0 1 0 0 
ERG24_HUMAN 0 2 0 0 
FKBP8_HUMAN 0 2 0 0 
GOGA5_HUMAN 0 1 0 0 
HIG2A_HUMAN 0 1 0 0 
HMDH_HUMAN 0 1 0 0 
HSF1_HUMAN 0 1 0 0 
MLX_HUMAN 0 1 0 0 
NTH_HUMAN 0 2 0 0 
PRAF1_HUMAN 0 1 0 0 
SFT2C_HUMAN 0 1 0 0 
STX12_HUMAN 1 1 0 0 
TM109_HUMAN 0 2 0 0 
TX264_HUMAN 0 2 0 0 
RT35_HUMAN 1 0 0 0 
MTFP1_HUMAN 1 0 0 0 
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AKA12_HUMAN 0 0 0 1 
AMRA1_HUMAN 0 0 1 0 
ATG4B_HUMAN 0 0 1 0 
gnl|unk|ENST00000400772_3 0 0 1 0 
gnl|unk|ENST00000415107_1 0 0 1 0 
gnl|unk|ENST00000468018_5 0 0 1 0 
gnl|unk|ENST00000479554_2 0 0 1 0 
gnl|unk|ENST00000482507_3 0 0 1 0 
gnl|unk|ENST00000494465_4 0 0 1 0 
gnl|unk|ENST00000625810_5 0 0 1 0 
CHCH2_HUMAN 0 0 0 2 
CHCH9_HUMAN 0 0 0 2 
COA6_HUMAN 0 0 0 1 
CRYL1_HUMAN 0 0 0 1 
CSTF2_HUMAN 0 0 2 0 
DAXX_HUMAN 0 0 0 1 
DDX10_HUMAN 0 0 2 0 
DEOC_HUMAN 0 0 1 1 
DYR_HUMAN 0 0 0 1 
EXOS2_HUMAN 0 0 0 1 
EXOS9_HUMAN 0 0 1 1 
FBX22_HUMAN 0 0 1 1 
FNTB_HUMAN 0 0 2 0 
GET4_HUMAN 0 0 1 1 
GSH0_HUMAN 0 0 1 1 
GSH1_HUMAN 0 0 0 1 
HEBP1_HUMAN 1 0 1 0 
I2BP1_HUMAN 0 0 1 1 
NHP2_HUMAN 0 0 2 0 
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OXSR1_HUMAN 0 0 1 0 
PFD6_HUMAN 0 0 1 0 
PHP14_HUMAN 0 0 1 0 
PPM1F_HUMAN 0 0 0 1 
PYRG2_HUMAN 0 0 1 1 
RBM28_HUMAN 0 0 0 1 
RT63_HUMAN 0 0 0 1 
RYDEN_HUMAN 0 0 2 0 
gnl|unk|ENST00000590378_6 0 0 2 0 
SAP3_HUMAN 0 0 1 0 
SHLB1_HUMAN 0 0 0 2 
SNX1_HUMAN 0 0 0 2 
SSA27_HUMAN 0 0 1 0 
TRMB_HUMAN 0 0 1 1 
U3IP2_HUMAN 0 0 1 1 
WDR61_HUMAN 0 0 1 1 
gnl|unk|ENST00000428512_3 0 0 0 2 
gnl|unk|ENST00000492223_1 0 0 2 0 
VRK3_HUMAN 1 0 0 0 
K1C13_HUMAN 163 128 0 0 
K1C9_HUMAN 1 0 0 0 
B2CL1_HUMAN 1 0 0 0 
DNJA4_HUMAN 1 0 0 0 
GPC5C_HUMAN 1 0 0 0 
HINT3_HUMAN 1 0 0 0 
INT1_HUMAN 1 0 0 0 
ITM2B_HUMAN 1 0 0 0 
JAG1_HUMAN 1 0 0 0 
LPP_HUMAN 1 0 0 0 
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NOP10_HUMAN 1 0 0 0 
gnl|unk|ENST00000328848_6 1 0 0 0 
P2RX4_HUMAN 1 0 0 0 
RHDF2_HUMAN 1 0 0 0 
RSF1_HUMAN 1 0 0 0 
SELS_HUMAN 1 0 0 0 
SP3_HUMAN 1 0 0 0 
STF1_HUMAN 1 0 0 0 
TM45B_HUMAN 1 0 0 0 
TM55B_HUMAN 1 0 0 0 
UBXN6_HUMAN 1 0 0 0 
ZNRF1_HUMAN 1 0 0 0 
EPN4_HUMAN 1 0 0 0 
KDIS_HUMAN 1 0 0 0 
CLAP2_HUMAN 0 1 0 0 
CTL1_HUMAN 0 1 0 0 
gnl|unk|ENST00000607692_1
1 
0 1 0 0 
DECR2_HUMAN 0 1 0 0 
ERAL1_HUMAN 0 1 0 0 
MEN1_HUMAN 0 1 0 0 
MPRA_HUMAN 0 1 0 0 
NEUA_HUMAN 0 1 0 0 
P66A_HUMAN 0 1 0 0 
PEX13_HUMAN 0 1 0 0 
PTSS2_HUMAN 0 1 0 0 
RBM26_HUMAN 0 1 0 0 
RHG17_HUMAN 0 1 0 0 
S27A4_HUMAN 0 1 0 0 
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S4A7_HUMAN 0 1 0 0 
SERC1_HUMAN 0 1 0 0 
SMI20_HUMAN 0 1 0 0 
gnl|unk|ENST00000506197_3 0 1 0 0 
TERF2_HUMAN 0 1 0 0 
TFDP1_HUMAN 0 1 0 0 
TMUB1_HUMAN 0 1 0 0 
TRPV2_HUMAN 0 1 0 0 
TYW1B_HUMAN 0 1 0 0 
ZN593_HUMAN 0 1 0 0 
ZN687_HUMAN 0 1 0 0 
ZN740_HUMAN 0 1 0 0 
gnl|unk|ENST00000552429_8 0 1 0 0 
CPSF1_HUMAN 1 0 0 0 
ARL3_HUMAN 0 0 0 1 
AROS_HUMAN 0 0 0 1 
gnl|unk|ENST00000420879_1 0 0 0 1 
BPNT1_HUMAN 0 0 0 1 
BZW2_HUMAN 0 0 0 1 
CCD97_HUMAN 0 0 1 0 
CI114_HUMAN 0 0 0 1 
CIAO1_HUMAN 0 0 1 0 
gnl|unk|ENST00000272402_3
1 
0 0 1 0 
CLPP_HUMAN 0 0 0 1 
COX17_HUMAN 0 0 0 1 
DLG1_HUMAN 0 0 0 1 
DPY30_HUMAN 0 0 1 0 
gnl|unk|ENST00000295066_9 0 0 1 0 
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gnl|unk|ENST00000342166_6 0 0 1 0 
GAK_HUMAN 0 0 1 0 
GCP60_HUMAN 0 0 0 1 
GLO2_HUMAN 0 0 0 1 
HAP28_HUMAN 0 0 0 1 
HDHD2_HUMAN 0 0 0 1 
JIP4_HUMAN 0 0 1 0 
KAP1_HUMAN 0 0 0 1 
KAT3_HUMAN 0 0 1 0 
KCC2D_HUMAN 0 0 1 0 
KPRB_HUMAN 0 0 1 0 
MT1E_HUMAN 0 0 0 1 
NELFD_HUMAN 0 0 0 1 
PARN_HUMAN 0 0 0 1 
PDCD4_HUMAN 0 0 0 1 
PDE12_HUMAN 0 0 1 0 
PP1R7_HUMAN 0 0 0 1 
RM28_HUMAN 0 0 0 1 
RT21_HUMAN 0 0 0 1 
gnl|unk|ENST00000581066_7 0 0 0 1 
gnl|unk|ENST00000614145_7 0 0 0 1 
SSF1_HUMAN 0 0 0 1 
SURF6_HUMAN 0 0 1 0 
SYAM_HUMAN 0 0 1 0 
SYF2_HUMAN 0 0 0 1 
SYRM_HUMAN 0 0 0 1 
TIPRL_HUMAN 0 0 0 1 
TTC27_HUMAN 0 0 0 1 
TWF1_HUMAN 0 0 1 0 
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UBA3_HUMAN 0 0 1 0 
UBA5_HUMAN 0 0 1 0 
gnl|unk|ENST00000494112_1
4 
0 0 1 0 
UBP2L_HUMAN 0 0 0 1 
UBP4_HUMAN 0 0 0 1 
UFC1_HUMAN 0 0 1 0 
gnl|unk|ENST00000527153_6 0 0 1 0 
ENTP5_HUMAN 0 0 0 1 










SC61G_HUMAN 95.00% 16 
ELAV1_HUMAN 100.00% 5 
DPB1_HUMAN 100.00% 65 
ERF1_HUMAN 100.00% 16 
HS71A_HUMAN,HS71B_HUMAN 100.00% 449 
GNAI3_HUMAN 100.00% 245 
PRS4_HUMAN 100.00% 8 
CKLF6_HUMAN 98.90% 8 
HNRPC_HUMAN 100.00% 46 
POL_HV1C4 100.00% 3535 
POL_HV1B9 100.00% 3037 
POL_HV1AN 100.00% 715 
WDR26_HUMAN 99.90% 2 
RB22A_HUMAN 100.00% 22 
RAB1B_HUMAN 100.00% 150 
RL8_HUMAN 100.00% 140 
POL_HV1A2 100.00% 4156 
CPNS1_HUMAN 100.00% 8 
SUCA_HUMAN 100.00% 3 
THTM_HUMAN 99.10% 3 
DDRGK_HUMAN 95.00% 1 
GBB4_HUMAN 100.00% 114 
OLA1_HUMAN 99.90% 11 
G6PI_HUMAN 100.00% 266 
PRS8_HUMAN 100.00% 14 
ABHEB_HUMAN 100.00% 2 
VTA1_HUMAN 100.00% 41 
POL_HV19N 99.60% 794 
CCNB2_HUMAN 98.10% 2 
POL_HV196 100.00% 1459 
POL_HV193 100.00% 1188 
POL_HV192 100.00% 685 
EIF3H_HUMAN 100.00% 8 
VP26A_HUMAN 100.00% 8 
DDAH2_HUMAN 100.00% 4 
P5CR1_HUMAN 100.00% 28 
ELMO1_HUMAN 100.00% 21 
KCAB2_HUMAN 100.00% 41 
EFHD2_HUMAN 100.00% 3 
SYYC_HUMAN 100.00% 96 
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TCPD_HUMAN 100.00% 236 
QCR1_HUMAN 100.00% 95 
UMPS_HUMAN 100.00% 10 
4F2_HUMAN 100.00% 525 
RS2_HUMAN 100.00% 220 
SMC2_HUMAN 99.90% 1 
SNAA_HUMAN 100.00% 157 
MANF_HUMAN 95.00% 5 
CYBP_HUMAN 100.00% 121 
IGSF8_HUMAN 100.00% 3 
PSA6_HUMAN 100.00% 21 
LETM1_HUMAN 100.00% 21 
CBR1_HUMAN 100.00% 49 
ARPC4_HUMAN 100.00% 41 
STK4_HUMAN 99.90% 1 
RL36A_HUMAN 100.00% 16 
DHCR7_HUMAN 100.00% 12 
ABRAL_HUMAN 99.10% 23 
DIP2B_HUMAN 100.00% 23 
EIF3B_HUMAN 100.00% 24 
SFXN1_HUMAN 100.00% 22 
ASNS_HUMAN 100.00% 62 
COMD3_HUMAN 95.00% 2 
PFKAP_HUMAN 100.00% 169 
HCD2_HUMAN 100.00% 183 
TB10B_HUMAN 95.00% 9 
PSD12_HUMAN 100.00% 13 
YBOX3_HUMAN 100.00% 69 
NDUAA_HUMAN 100.00% 1 
ARHG6_HUMAN 95.00% 3 
PHB2_HUMAN 100.00% 237 
IMB1_HUMAN 100.00% 141 
PE2R4_HUMAN 95.00% 4 
TEBP_HUMAN 100.00% 31 
TMED9_HUMAN 100.00% 11 
PPAC_HUMAN 95.00% 3 
SSBP_HUMAN 100.00% 25 
MTFP1_HUMAN 99.80% 3 
TIM14_HUMAN 100.00% 5 
SYIM_HUMAN 100.00% 2 
CPZIP_HUMAN 100.00% 28 
CD37_HUMAN 100.00% 4 
TXTP_HUMAN 100.00% 21 
246 
 
AIMP2_HUMAN 95.00% 14 
PURA_HUMAN 95.00% 8 
SMD1_HUMAN 100.00% 19 
H2AV_HUMAN,H2AZ_HUMAN 99.80% 34 
NAA50_HUMAN 99.90% 2 
RL13A_HUMAN 100.00% 104 
RAP2B_HUMAN 100.00% 17 
IMA5_HUMAN 97.40% 5 
MYO1F_HUMAN 100.00% 18 
NIBAN_HUMAN 100.00% 64 
MMAB_HUMAN 95.00% 1 
PLS1_HUMAN 100.00% 22 
PGM1_HUMAN 100.00% 10 
SPCS1_HUMAN 95.00% 3 
RS13_HUMAN 100.00% 173 
PDCD4_HUMAN 100.00% 9 
SYFA_HUMAN 100.00% 15 
SC61B_HUMAN 95.00% 9 
ANTR2_HUMAN 95.00% 2 
PPIB_HUMAN 100.00% 122 
ACTZ_HUMAN 100.00% 8 
HNRPU_HUMAN 100.00% 11 
SATT_HUMAN 100.00% 144 
ANO6_HUMAN 100.00% 6 
ITIH2_HUMAN 100.00% 11 
ANXA6_HUMAN 100.00% 635 
TXNL1_HUMAN 99.90% 5 
HBS1L_HUMAN 95.00% 7 
SYQ_HUMAN 100.00% 51 
PPP5_HUMAN 100.00% 10 
AKAP5_HUMAN 99.90% 7 
MCM5_HUMAN 100.00% 13 
TMCO1_HUMAN 95.00% 4 
RL3_HUMAN 100.00% 257 
GCN1_HUMAN 100.00% 15 
ODP2_HUMAN 100.00% 13 
RALA_HUMAN 100.00% 71 
STXB2_HUMAN 100.00% 169 
JAK1_HUMAN 100.00% 11 
PRS6A_HUMAN 100.00% 11 
RHG04_HUMAN 100.00% 13 
DEN2D_HUMAN 95.00% 5 
XPO5_HUMAN 97.10% 1 
247 
 
G6PD_HUMAN 100.00% 21 
CGL_HUMAN 100.00% 64 
CPIN1_HUMAN 95.00% 1 
VAV_HUMAN 100.00% 2 
ENOA_HUMAN 100.00% 1748 
DYH6_HUMAN 99.70% 2 
GBG2_HUMAN 100.00% 13 
ARPC5_HUMAN 100.00% 34 
41_HUMAN 100.00% 52 
CO3_HUMAN 100.00% 17 
EIF3C_HUMAN,EIFCL_HUMAN 100.00% 23 
EZRI_HUMAN 100.00% 1035 
IF4H_HUMAN 100.00% 21 
CN166_HUMAN 99.90% 14 
RL36_HUMAN 100.00% 71 
SYK_HUMAN 100.00% 15 
HMHA1_HUMAN 100.00% 3 
SND1_HUMAN 100.00% 81 
WASP_HUMAN 100.00% 61 
PSD13_HUMAN 100.00% 46 
GALM_HUMAN 95.00% 1 
SYLC_HUMAN 100.00% 9 
PIMT_HUMAN 100.00% 75 
RL23A_HUMAN 100.00% 40 
MOT1_HUMAN 100.00% 106 
PP1G_HUMAN 100.00% 59 
PLXA1_HUMAN 100.00% 4 
SCAM2_HUMAN 95.00% 8 
NUP37_HUMAN 95.00% 1 
ACBP_HUMAN 100.00% 2 
CPNE3_HUMAN 100.00% 20 
RL7A_HUMAN 100.00% 240 
AN32E_HUMAN 100.00% 6 
PSA1_HUMAN 100.00% 42 
GBB2_HUMAN 100.00% 261 
C1TC_HUMAN 100.00% 223 
SYNC_HUMAN 100.00% 90 
ITA3_HUMAN 100.00% 2 
RAB5B_HUMAN 100.00% 50 
PNPH_HUMAN 100.00% 66 
MYO1G_HUMAN 100.00% 956 
SC22B_HUMAN 100.00% 6 
DNJA1_HUMAN 100.00% 22 
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CAPG_HUMAN 100.00% 36 
MRP1_HUMAN 100.00% 91 
VATA_HUMAN 100.00% 13 
TBB4B_HUMAN 100.00% 1449 
SPCS2_HUMAN 95.00% 3 
GIT1_HUMAN 99.20% 6 
COR1A_HUMAN 100.00% 443 
UBC12_HUMAN 95.00% 2 
ATPD_HUMAN 100.00% 29 
RL28_HUMAN 100.00% 60 
RLA0_HUMAN 100.00% 160 
ARHG1_HUMAN 100.00% 21 
CCD47_HUMAN 95.00% 2 
RS24_HUMAN 100.00% 62 
ARF3_HUMAN 100.00% 256 
ACTN1_HUMAN 100.00% 171 
DD19A_HUMAN 100.00% 7 
NDRG3_HUMAN 97.90% 10 
ANXA7_HUMAN 100.00% 118 
BAG2_HUMAN 100.00% 22 
S38A5_HUMAN 100.00% 15 
IF16_HUMAN 100.00% 5 
TCP4_HUMAN 100.00% 4 
UTRO_HUMAN 100.00% 16 
RUXF_HUMAN 100.00% 6 
DEST_HUMAN 95.00% 2 
TTL12_HUMAN 95.00% 7 
LDHB_HUMAN 100.00% 186 
S10AA_HUMAN 100.00% 67 
SAR1B_HUMAN 99.90% 9 
PRS6B_HUMAN 100.00% 10 
THIO_HUMAN 100.00% 47 
ITB2_HUMAN 100.00% 276 
SUCB2_HUMAN 100.00% 12 
LIMA1_HUMAN 97.90% 10 
TP4A1_HUMAN 100.00% 13 
PICAL_HUMAN 100.00% 6 
DDX3X_HUMAN 100.00% 58 
SSRA_HUMAN 100.00% 38 
ACTBL_HUMAN 100.00% 298 
FLVC1_HUMAN 100.00% 6 
EXOC8_HUMAN 95.00% 4 
STA5B_HUMAN 95.00% 6 
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HBB_HUMAN 100.00% 85 
DLG1_HUMAN 100.00% 8 
LRC57_HUMAN 98.90% 1 
DYH7_HUMAN 98.90% 1 
DHSO_HUMAN 99.90% 5 
UBP5_HUMAN 100.00% 6 





GSTK1_HUMAN 100.00% 33 
GTR1_HUMAN 100.00% 75 
UGGG1_HUMAN 100.00% 8 
IST1_HUMAN 99.50% 1 
RSMN_HUMAN 99.80% 4 
VINC_HUMAN 100.00% 177 
TAOK3_HUMAN 100.00% 15 
IDHP_HUMAN 100.00% 162 
RELL1_HUMAN 95.00% 7 
TERA_HUMAN 100.00% 284 
HPRT_HUMAN 100.00% 95 
ITA4_HUMAN 100.00% 227 
BAF_HUMAN 100.00% 36 
SEC63_HUMAN 100.00% 2 
IF2B3_HUMAN 100.00% 153 
THOC4_HUMAN 95.00% 1 
H2A2C_HUMAN 100.00% 228 
RL31_HUMAN 100.00% 32 
PSMD9_HUMAN 95.00% 1 
TCPQ_HUMAN 100.00% 424 
NSF_HUMAN 100.00% 20 
VPS28_HUMAN 100.00% 55 
CNO10_HUMAN 95.00% 4 
NEB2_HUMAN 100.00% 8 
PRAF3_HUMAN 100.00% 2 
OPA1_HUMAN 100.00% 34 
RS26_HUMAN 100.00% 143 
POL_HV1OY 100.00% 4642 
TCPG_HUMAN 100.00% 371 
PP1B_HUMAN 100.00% 58 
ARHG2_HUMAN 99.90% 1 
DAZP1_HUMAN 95.00% 1 
FMNL1_HUMAN 100.00% 114 
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LTV1_HUMAN 99.10% 5 
BLMH_HUMAN 100.00% 34 
LRCH4_HUMAN 100.00% 2 
1C03_HUMAN 100.00% 312 
ARC1B_HUMAN 100.00% 92 
RUXGL_HUMAN,RUXG_HUMAN 95.00% 8 
PAK2_HUMAN 100.00% 58 
TNIP2_HUMAN 100.00% 16 
AT1B3_HUMAN 100.00% 134 
VIME_HUMAN 100.00% 669 
HM13_HUMAN 99.90% 7 
AIP_HUMAN 100.00% 14 
LCK_HUMAN 100.00% 138 
IPO5_HUMAN 100.00% 31 
COX6C_HUMAN 100.00% 2 
CISD1_HUMAN 100.00% 87 
IMDH2_HUMAN 100.00% 94 
PPIH_HUMAN 100.00% 8 
HINT3_HUMAN 95.00% 9 
RANG_HUMAN 100.00% 70 
CAZA2_HUMAN 100.00% 50 
1433E_HUMAN 100.00% 334 
RL23_HUMAN 100.00% 98 
DDX5_HUMAN 100.00% 137 
CD3D_HUMAN 100.00% 18 
NDUA7_HUMAN 99.90% 4 
HDAC1_HUMAN 95.00% 3 
NP1L4_HUMAN 99.50% 52 
SHIP1_HUMAN 100.00% 2 
ZAP70_HUMAN 100.00% 52 
HNRPQ_HUMAN 100.00% 137 
RAB21_HUMAN 100.00% 28 
ENPL_HUMAN 100.00% 581 
RS18_HUMAN 100.00% 94 
SYIC_HUMAN 100.00% 102 
RS11_HUMAN 100.00% 63 
ERAP1_HUMAN 100.00% 22 
UBXN1_HUMAN 100.00% 4 
TFAM_HUMAN 100.00% 52 
NEUR3_HUMAN 95.00% 1 
CKAP5_HUMAN 100.00% 9 
HNRDL_HUMAN 99.90% 22 
CALU_HUMAN 95.00% 8 
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OTUB1_HUMAN 100.00% 7 
CSK2B_HUMAN 100.00% 10 
COMT_HUMAN 100.00% 4 
TPIS_HUMAN 100.00% 339 
DNJC5_HUMAN 100.00% 5 
SYWC_HUMAN 100.00% 95 
ITAL_HUMAN 100.00% 331 
PLEK_HUMAN 100.00% 44 
TNPO1_HUMAN 100.00% 7 
XPO1_HUMAN 100.00% 15 
UB2L6_HUMAN 100.00% 3 
NDUB8_HUMAN 95.00% 2 
ATD3A_HUMAN 100.00% 58 
ERBIN_HUMAN 95.00% 5 
PSME2_HUMAN 100.00% 24 
RHOC_HUMAN 100.00% 250 
CD5_HUMAN 100.00% 311 
HNRPK_HUMAN 100.00% 91 
FEN1_HUMAN 100.00% 9 
AT5F1_HUMAN 100.00% 55 
SEPT6_HUMAN 100.00% 67 
EXOC3_HUMAN 99.90% 2 
SYG_HUMAN 100.00% 114 
VPS29_HUMAN 100.00% 13 
IF2G_HUMAN 100.00% 26 
RL15_HUMAN 100.00% 106 
CCD51_HUMAN 95.00% 3 
SASH3_HUMAN 100.00% 27 
RS27_HUMAN 100.00% 35 
ADAS_HUMAN 100.00% 16 
NDUV1_HUMAN 100.00% 4 
S43A3_HUMAN 99.80% 2 
KIRR2_HUMAN 95.00% 5 
RAB8A_HUMAN 100.00% 226 
TOP2A_HUMAN 96.10% 2 
IF2P_HUMAN 100.00% 13 
RB27A_HUMAN 100.00% 86 
SEPT2_HUMAN 100.00% 67 
TBA1C_HUMAN 100.00% 917 
EFGM_HUMAN 98.90% 1 
PDIA3_HUMAN 100.00% 253 
ADT2_HUMAN 100.00% 220 
SGT1_HUMAN 100.00% 6 
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IQGA1_HUMAN 100.00% 627 
RAGP1_HUMAN 100.00% 5 
FLII_HUMAN 100.00% 3 
STX11_HUMAN 100.00% 79 
DPP3_HUMAN 95.00% 12 
PSMF1_HUMAN 95.00% 10 
GELS_HUMAN 100.00% 11 
CSK_HUMAN 100.00% 110 
PSB6_HUMAN 100.00% 13 
PGK1_HUMAN 100.00% 806 
RS21_HUMAN 100.00% 43 
PSB4_HUMAN 100.00% 19 
PI4KA_HUMAN 100.00% 3 
NDUA8_HUMAN 95.00% 2 
RASK_HUMAN 99.90% 86 
GRPE1_HUMAN 100.00% 12 
TIAR_HUMAN 100.00% 6 
E41L5_HUMAN 100.00% 8 
RS19_HUMAN 100.00% 97 
S38A1_HUMAN 100.00% 21 
PA1B3_HUMAN 100.00% 44 
DNJB1_HUMAN 98.60% 1 
UB2D2_HUMAN,UB2D3_HUMAN 100.00% 16 
TIM50_HUMAN 95.00% 5 
GHITM_HUMAN 95.00% 2 
FPPS_HUMAN 100.00% 8 
APMAP_HUMAN 100.00% 4 
GSTO1_HUMAN 100.00% 47 
SAHH_HUMAN 100.00% 116 
E2AK2_HUMAN 100.00% 2 
ECI2_HUMAN 100.00% 6 
RBBP4_HUMAN 95.00% 2 
CD47_HUMAN 100.00% 68 
F10A1_HUMAN 100.00% 104 
SAMN1_HUMAN 95.00% 1 
TMEDA_HUMAN 100.00% 40 
PSME3_HUMAN 95.00% 2 
PHB_HUMAN 100.00% 204 
GFPT1_HUMAN 100.00% 19 
CHSP1_HUMAN 100.00% 24 
ALBU_HUMAN 100.00% 56 
NDUA2_HUMAN 95.00% 1 
CD6_HUMAN 100.00% 288 
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COPD_HUMAN 99.80% 1 
HNRPL_HUMAN 100.00% 32 
ARRB2_HUMAN 98.70% 2 
2AAA_HUMAN 100.00% 32 
SEPT7_HUMAN 100.00% 91 
RS30_HUMAN 95.00% 12 
BIN1_HUMAN 95.00% 1 
RFTN1_HUMAN 100.00% 111 
C1TM_HUMAN 100.00% 3 
RN149_HUMAN 95.00% 5 
NIPS2_HUMAN 94.90% 1 
ECHD1_HUMAN 100.00% 2 
PUR2_HUMAN 100.00% 148 
FBP1L_HUMAN 99.90% 4 
AT2B4_HUMAN 100.00% 54 
H12_HUMAN 99.90% 80 
ATP5H_HUMAN 100.00% 38 
LCAP_HUMAN 100.00% 319 
LMAN1_HUMAN 100.00% 39 
LONM_HUMAN 100.00% 158 
RS27A_HUMAN 100.00% 81 
PGAM1_HUMAN 100.00% 169 
CD59_HUMAN 95.00% 25 
DCTP1_HUMAN 100.00% 8 
GAG_HV1MN 100.00% 5802 
ADT3_HUMAN 99.90% 158 
GDIB_HUMAN 100.00% 242 
MPC2_HUMAN 95.00% 1 
HEM6_HUMAN 100.00% 62 
B2CL1_HUMAN 100.00% 3 
SERPH_HUMAN 100.00% 56 
HNRPF_HUMAN 100.00% 82 
SRP09_HUMAN 95.00% 3 
DPP4_HUMAN 100.00% 10 
CHCH2_HUMAN 100.00% 21 
SEPT1_HUMAN 100.00% 20 
ELOV5_HUMAN 95.00% 10 
COPB2_HUMAN 100.00% 23 
PSMD5_HUMAN 100.00% 4 
KS6A1_HUMAN 99.70% 2 
IF2B_HUMAN 100.00% 3 
BDH_HUMAN 100.00% 30 
SP16H_HUMAN 100.00% 9 
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EF2_HUMAN 100.00% 613 
GRB2_HUMAN 100.00% 17 
WASF2_HUMAN 95.00% 1 
ROA1_HUMAN 100.00% 89 
ATP5L_HUMAN 100.00% 38 
ML12A_HUMAN,ML12B_HUMAN 100.00% 213 
CALX_HUMAN 100.00% 187 
PHAG1_HUMAN 100.00% 8 
NPM_HUMAN 100.00% 94 
VDAC1_HUMAN 100.00% 203 
CTDS1_HUMAN 95.50% 1 
RAN_HUMAN 100.00% 153 
BASI_HUMAN 100.00% 200 
EIF3K_HUMAN 100.00% 10 
SMAD3_HUMAN 99.40% 1 
PKN1_HUMAN 100.00% 2 
SYMC_HUMAN 100.00% 35 
SH3K1_HUMAN 100.00% 32 
NDUS7_HUMAN 95.00% 1 
PSDE_HUMAN 100.00% 7 
VPS4B_HUMAN 100.00% 43 
SYTC_HUMAN 100.00% 47 
KAD3_HUMAN 100.00% 11 
LAT1_HUMAN 100.00% 51 
FA5_HUMAN 100.00% 55 
ODO1_HUMAN 100.00% 14 
BIN2_HUMAN 100.00% 6 
UGPA_HUMAN 100.00% 226 
MPCP_HUMAN 100.00% 41 
RL5_HUMAN 100.00% 212 
CD48_HUMAN 100.00% 151 
GSLG1_HUMAN 97.40% 1 
HMGB2_HUMAN 99.90% 5 
PSB1_HUMAN 100.00% 13 
TFR1_HUMAN 100.00% 246 
SPTN1_HUMAN 100.00% 347 
MIC19_HUMAN 100.00% 33 
RS5_HUMAN 100.00% 73 
ECHM_HUMAN 97.80% 8 
RPN2_HUMAN 100.00% 37 
ANX11_HUMAN 100.00% 33 
HNRH1_HUMAN 100.00% 29 
IF4G1_HUMAN 100.00% 52 
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CARL2_HUMAN 97.50% 7 
GBP1_HUMAN 100.00% 27 
PSB10_HUMAN 95.00% 9 
RS14_HUMAN 100.00% 42 
EIF3E_HUMAN 100.00% 6 
TOM22_HUMAN 100.00% 22 
TICN2_HUMAN 100.00% 100 
NDUS1_HUMAN 100.00% 3 
ASSY_HUMAN 100.00% 28 
OCAD2_HUMAN 100.00% 1 
MLEC_HUMAN 99.90% 1 
MACD1_HUMAN 100.00% 13 
SYDM_HUMAN 95.00% 10 
SAR1A_HUMAN 99.90% 12 
BUB3_HUMAN 100.00% 4 
VP26B_HUMAN 95.00% 1 
KCY_HUMAN 95.00% 7 
gnl|unk|TRINITY_DN8_c0_g1_i1_4 98.80% 77 
HG2A_HUMAN 100.00% 52 
PSA3_HUMAN 100.00% 12 
CD3G_HUMAN 95.00% 6 
2B14_HUMAN 100.00% 559 
RAB7A_HUMAN 100.00% 192 
GLYM_HUMAN 100.00% 330 
SQRD_HUMAN 100.00% 10 
SERB_HUMAN 100.00% 4 
PAIRB_HUMAN 100.00% 9 
SFPQ_HUMAN 100.00% 23 
PRPS1_HUMAN 100.00% 28 
N2DL2_HUMAN 100.00% 23 
LY75_HUMAN 100.00% 5 
DLDH_HUMAN 100.00% 171 
KINH_HUMAN 100.00% 21 
UPAR_HUMAN 100.00% 46 
TMOD3_HUMAN 100.00% 22 
QCR6_HUMAN 95.00% 16 
CSDE1_HUMAN 100.00% 6 
ICAM1_HUMAN 100.00% 149 
PRDX2_HUMAN 100.00% 67 
PABP1_HUMAN 100.00% 352 
POL_HV1ND 99.60% 1984 
RS4X_HUMAN 100.00% 299 
DC1I2_HUMAN 95.00% 7 
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CAZA1_HUMAN 100.00% 149 
ACAP1_HUMAN 100.00% 36 
DOCK8_HUMAN 100.00% 37 
SC5A6_HUMAN 100.00% 6 
K2C1_HUMAN 100.00% 25 
HSPB1_HUMAN 100.00% 14 
RAP2C_HUMAN 100.00% 16 
RL6_HUMAN 100.00% 223 
TBCA_HUMAN 100.00% 8 
UB2V2_HUMAN 98.10% 4 
PSB2_HUMAN 100.00% 20 
CNOT1_HUMAN 100.00% 30 
U5S1_HUMAN 95.00% 9 
DUT_HUMAN 100.00% 25 
HDDC2_HUMAN 99.80% 1 
SH21A_HUMAN 100.00% 6 
CSK22_HUMAN 99.20% 1 
FXR1_HUMAN 100.00% 18 
ALDOC_HUMAN 100.00% 187 
ESYT1_HUMAN 100.00% 17 
STT3B_HUMAN 95.00% 3 
TPP2_HUMAN 100.00% 8 
ENV_HV1MN 100.00% 534 
EIF3F_HUMAN 100.00% 33 
STX3_HUMAN 100.00% 21 
LIMS1_HUMAN 95.00% 4 
NDUS2_HUMAN 96.50% 1 
RPIA_HUMAN 100.00% 3 
DPA1_HUMAN 100.00% 48 
NHRF1_HUMAN 100.00% 408 
PYRG1_HUMAN 100.00% 20 
FLNB_HUMAN 100.00% 596 
NNTM_HUMAN 100.00% 11 
TNR6_HUMAN 100.00% 127 
TCPB_HUMAN 100.00% 302 
ZYX_HUMAN 100.00% 9 
STIP1_HUMAN 100.00% 162 
SCRIB_HUMAN 100.00% 60 
PSA4_HUMAN 100.00% 35 
RADI_HUMAN 100.00% 642 
SRSF7_HUMAN 100.00% 8 
PELO_HUMAN 95.00% 2 
TPD52_HUMAN 100.00% 6 
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ECH1_HUMAN 100.00% 136 
TMX1_HUMAN 95.00% 6 
IF4A1_HUMAN 100.00% 313 
NUDC_HUMAN 100.00% 67 
PLSL_HUMAN 100.00% 852 
IFM2_HUMAN 100.00% 81 
DHE3_HUMAN 100.00% 105 
ACO13_HUMAN 95.00% 1 
THY1_HUMAN 100.00% 172 
AIFM1_HUMAN 100.00% 53 
CXCR4_HUMAN 95.00% 10 
PGRC2_HUMAN 95.00% 1 
ENV_HV196 100.00% 64 
RSSA_HUMAN 100.00% 274 
FA49B_HUMAN 100.00% 41 
USP9X_HUMAN 100.00% 7 
TOM70_HUMAN 100.00% 29 
STAT3_HUMAN 100.00% 11 
YBOX1_HUMAN 100.00% 265 
CYB5B_HUMAN 95.00% 8 
ATPG_HUMAN 100.00% 78 
ARF6_HUMAN 100.00% 88 
ACTN4_HUMAN 100.00% 542 
TRXR1_HUMAN 100.00% 15 
CLH1_HUMAN 100.00% 934 
MK03_HUMAN 99.80% 13 
COX2_HUMAN 100.00% 40 
EPN4_HUMAN 100.00% 4 
MAP11_HUMAN 95.00% 2 
EHD4_HUMAN 100.00% 104 
SRSF1_HUMAN 100.00% 9 
TAGL2_HUMAN 100.00% 180 
TES_HUMAN 100.00% 73 
BT3L4_HUMAN 99.40% 1 
EIF3I_HUMAN 100.00% 28 
ACPM_HUMAN 100.00% 2 
PPIL1_HUMAN 100.00% 55 
COPG1_HUMAN 100.00% 23 
HACD3_HUMAN 95.00% 2 
GANAB_HUMAN 100.00% 141 
GLRX3_HUMAN 100.00% 2 
RL35A_HUMAN 100.00% 28 
PAR12_HUMAN 95.00% 1 
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DQA1_HUMAN 100.00% 41 
BACH_HUMAN 100.00% 54 
SSRD_HUMAN 95.00% 9 
gnl|unk|TRINITY_DN1102_c0_g1_i1_2 100.00% 63 
DDX21_HUMAN 100.00% 5 
1B44_HUMAN 100.00% 452 
LIS1_HUMAN 100.00% 25 
SETLP_HUMAN,SET_HUMAN 100.00% 14 
SRSF3_HUMAN 100.00% 24 
NUDT5_HUMAN 100.00% 2 
RCD1_HUMAN 100.00% 25 
TSP1_HUMAN 100.00% 18 
RHG17_HUMAN 100.00% 20 
ANXA4_HUMAN 100.00% 34 
ERO1A_HUMAN 100.00% 18 
PA1B2_HUMAN 100.00% 8 
TCPZ_HUMAN 100.00% 197 
MAP4_HUMAN 99.20% 1 
AP1B1_HUMAN 100.00% 39 
MCM3_HUMAN 100.00% 15 
IF5A1_HUMAN 100.00% 143 
S4A7_HUMAN 100.00% 77 
AGK_HUMAN 100.00% 10 
M2OM_HUMAN 100.00% 77 
PP16B_HUMAN 100.00% 12 
UN13D_HUMAN 100.00% 26 
TMM43_HUMAN 95.00% 3 
LC7L3_HUMAN 95.00% 2 
AATM_HUMAN 100.00% 121 
KAP2_HUMAN 100.00% 70 
MDHM_HUMAN 100.00% 514 
NIT2_HUMAN 95.00% 2 
RAP1B_HUMAN 100.00% 399 
PNPT1_HUMAN 100.00% 2 
ARPC3_HUMAN 100.00% 34 
K1C10_HUMAN 99.90% 6 
ITB1_HUMAN 100.00% 122 
CC50A_HUMAN 100.00% 24 
HCDH_HUMAN 100.00% 45 
RGAP1_HUMAN 100.00% 26 
EIF3A_HUMAN 100.00% 62 
PBDC1_HUMAN 94.60% 3 
TBB5_HUMAN 100.00% 1573 
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RL34_HUMAN 99.20% 20 
GPR15_HUMAN 97.30% 3 
DREB_HUMAN 100.00% 77 
TB10A_HUMAN 100.00% 5 
ICOSL_HUMAN 99.90% 2 
PSD11_HUMAN 100.00% 45 
BCAT2_HUMAN 100.00% 6 
CAB39_HUMAN 100.00% 24 
MARK3_HUMAN 99.80% 5 
SIT1_HUMAN 100.00% 41 
CYFP2_HUMAN 100.00% 13 
MPPA_HUMAN 100.00% 10 
CLIC1_HUMAN 100.00% 493 
BYST_HUMAN 95.00% 1 
PEBP1_HUMAN 100.00% 53 
SDF2L_HUMAN 95.00% 4 
CPNE1_HUMAN 100.00% 58 
ODO2_HUMAN 100.00% 26 
ERP29_HUMAN 100.00% 23 
PDC10_HUMAN 100.00% 45 
H2AY_HUMAN 95.00% 3 
ARK72_HUMAN 95.00% 5 
TAP2_HUMAN 100.00% 5 
VTNC_HUMAN 95.00% 94 
AP2B1_HUMAN 100.00% 43 
FSCN1_HUMAN 100.00% 80 
VAMP2_HUMAN,VAMP3_HUMAN 95.00% 6 
DQA2_HUMAN 98.20% 118 
HNRL2_HUMAN 100.00% 2 
ATPO_HUMAN 100.00% 79 
NF1_HUMAN 95.00% 2 
ATPB_HUMAN 100.00% 528 
ERF3A_HUMAN 100.00% 31 
SYDC_HUMAN 100.00% 202 
SH3G1_HUMAN 100.00% 15 
NDRG1_HUMAN 100.00% 21 
ANXA5_HUMAN 100.00% 14 
TMED2_HUMAN 100.00% 1 
NAMPT_HUMAN 100.00% 5 
KPYM_HUMAN 100.00% 1199 
DNMT1_HUMAN 99.90% 1 
FLOT1_HUMAN 100.00% 13 
SNP23_HUMAN 100.00% 32 
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SYRC_HUMAN 100.00% 33 
TBA4A_HUMAN 100.00% 1076 
EMC1_HUMAN 99.90% 1 
GLYC_HUMAN 100.00% 38 
ACPH_HUMAN 100.00% 31 
SCOT1_HUMAN 100.00% 15 





RL26L_HUMAN,RL26_HUMAN 100.00% 22 
ACSL3_HUMAN 98.50% 20 
CHM2B_HUMAN 98.70% 5 
SPAG1_HUMAN 95.00% 2 
LASP1_HUMAN 100.00% 89 
PSMG2_HUMAN 95.00% 6 
EF1G_HUMAN 100.00% 230 
LGUL_HUMAN 100.00% 6 
STML2_HUMAN 100.00% 43 
ARRD1_HUMAN 95.00% 4 
DKC1_HUMAN 100.00% 4 
ETFA_HUMAN 100.00% 80 
RL35_HUMAN 100.00% 91 
MB12B_HUMAN 95.00% 1 
MARCS_HUMAN 100.00% 43 
TRAP1_HUMAN 100.00% 115 
RL18_HUMAN 100.00% 176 
ILF2_HUMAN 95.00% 4 
ROCK1_HUMAN 100.00% 4 
FDFT_HUMAN 98.30% 3 
H14_HUMAN 100.00% 85 
MPPB_HUMAN 100.00% 8 
ABCE1_HUMAN 100.00% 53 
HABP2_HUMAN 100.00% 13 
UB2L3_HUMAN 100.00% 20 
TIPRL_HUMAN 100.00% 4 
TPM3_HUMAN 100.00% 291 
FHL1_HUMAN 95.00% 9 
PDIA6_HUMAN 100.00% 145 
HS90B_HUMAN 100.00% 1331 
NPTN_HUMAN 100.00% 6 
SODM_HUMAN 100.00% 47 
IF2B1_HUMAN 100.00% 82 
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RAB5A_HUMAN 99.60% 43 
MPZL1_HUMAN 95.00% 21 
ACOT9_HUMAN 98.80% 1 
FUMH_HUMAN 100.00% 16 
CLCA_HUMAN 100.00% 10 
AFAD_HUMAN 100.00% 4 
APT_HUMAN 100.00% 41 
RD23B_HUMAN 100.00% 48 
TBB4A_HUMAN 100.00% 1229 
SNX18_HUMAN 95.00% 7 
RAB10_HUMAN 100.00% 106 
FBRL_HUMAN 100.00% 7 
XRCC6_HUMAN 100.00% 46 
RTN3_HUMAN 95.00% 5 
FABP5_HUMAN 100.00% 98 
RL27_HUMAN 100.00% 143 
LRC47_HUMAN 100.00% 6 
IDH3G_HUMAN 100.00% 3 
RASN_HUMAN 100.00% 122 
1A32_HUMAN,1A74_HUMAN 100.00% 354 
VDAC3_HUMAN 100.00% 46 
C1QBP_HUMAN 100.00% 201 
ARP5L_HUMAN 100.00% 7 
BROX_HUMAN 100.00% 38 




EMC2_HUMAN 95.00% 4 
LDHA_HUMAN 100.00% 377 
AT1B1_HUMAN 95.00% 4 
LAT3_HUMAN 95.00% 2 
NAA10_HUMAN 100.00% 7 
RM14_HUMAN 95.00% 4 
CH60_HUMAN 100.00% 717 
JAM1_HUMAN 100.00% 57 
XRP2_HUMAN 100.00% 19 
CD2AP_HUMAN 100.00% 15 
OSTC_HUMAN 95.00% 1 
GMFG_HUMAN 100.00% 38 
DHB4_HUMAN 100.00% 3 
COTL1_HUMAN 100.00% 118 
RHOG_HUMAN 100.00% 149 
H2A1C_HUMAN 100.00% 203 
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VPS35_HUMAN 100.00% 42 
RL21_HUMAN 100.00% 83 
NDUA5_HUMAN 95.00% 1 
IDH3A_HUMAN 100.00% 42 
GNA13_HUMAN 100.00% 94 
EXOC7_HUMAN 95.00% 3 
SPEE_HUMAN 100.00% 16 
HBA_HUMAN 100.00% 177 
PTPRC_HUMAN 100.00% 1034 
ETFB_HUMAN 100.00% 66 
E41L2_HUMAN 100.00% 641 
RL19_HUMAN 100.00% 37 
SAM50_HUMAN 100.00% 8 
CDC42_HUMAN 100.00% 270 
DIAP1_HUMAN 100.00% 18 
H15_HUMAN 100.00% 20 
1A24_HUMAN 100.00% 502 
ARP2_HUMAN 100.00% 59 
AHNK_HUMAN 100.00% 589 
LIN7C_HUMAN 100.00% 24 
AT1A3_HUMAN 100.00% 374 
LKHA4_HUMAN 99.90% 3 
PPCE_HUMAN 95.00% 1 
SERC3_HUMAN 95.00% 3 
F136A_HUMAN 95.00% 1 
EF1B_HUMAN 100.00% 43 
WIPF1_HUMAN 97.50% 9 
PDLI7_HUMAN 95.00% 1 
EI2BA_HUMAN 100.00% 6 
TRI25_HUMAN 100.00% 33 
AT11C_HUMAN 100.00% 26 
UBE2N_HUMAN 100.00% 30 
KPRB_HUMAN 100.00% 9 
CDK1_HUMAN 100.00% 41 
ARBK1_HUMAN 100.00% 2 
CAPR1_HUMAN 100.00% 8 
IF4B_HUMAN 100.00% 5 
RUVB2_HUMAN 100.00% 64 
RL30_HUMAN 100.00% 193 
SYEP_HUMAN 100.00% 65 
GRP75_HUMAN 100.00% 225 
RL13_HUMAN 100.00% 113 
AIMP1_HUMAN 100.00% 24 
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AT2B1_HUMAN 99.90% 16 
PP1A_HUMAN 100.00% 75 
APOC3_HUMAN 95.00% 31 
GDIR2_HUMAN 100.00% 220 
SYHC_HUMAN 100.00% 2 
ICAM3_HUMAN 100.00% 230 
AATC_HUMAN 100.00% 26 
PLEC_HUMAN 100.00% 26 
F162A_HUMAN 99.90% 1 
SEPT9_HUMAN 100.00% 57 
KRT83_HUMAN 100.00% 7 
PRKDC_HUMAN 99.90% 1 
MDHC_HUMAN 100.00% 161 
CNDP2_HUMAN 100.00% 62 
PDIA1_HUMAN 100.00% 178 
NLTP_HUMAN 100.00% 43 
SAHH2_HUMAN 100.00% 28 
CD70_HUMAN 100.00% 31 
SYVC_HUMAN 100.00% 44 
ATX10_HUMAN 95.00% 5 
ABCF1_HUMAN 100.00% 26 
PI42A_HUMAN 100.00% 14 
PAR1_HUMAN 95.00% 11 
SUV3_HUMAN 99.90% 3 
ETHE1_HUMAN 100.00% 59 
PSMD2_HUMAN 100.00% 35 
CD3Z_HUMAN 100.00% 1 
RM19_HUMAN 99.80% 4 
QCR7_HUMAN 100.00% 3 
ACSL4_HUMAN 100.00% 32 
DYN2_HUMAN 100.00% 12 
RAB8B_HUMAN 100.00% 237 
RS8_HUMAN 100.00% 239 
RENT1_HUMAN 100.00% 28 
RL22_HUMAN 100.00% 53 
IDH3B_HUMAN 100.00% 9 
OST48_HUMAN 100.00% 56 
CPT1A_HUMAN 100.00% 7 
E41L3_HUMAN 100.00% 59 
AT2A3_HUMAN 99.80% 17 
RS17_HUMAN 100.00% 117 
LRRF1_HUMAN 95.00% 1 
PIPNB_HUMAN 100.00% 9 
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BTF3_HUMAN 100.00% 11 
NB5R3_HUMAN 100.00% 56 
PUR6_HUMAN 100.00% 96 
PP2BA_HUMAN 100.00% 10 
TWF2_HUMAN 100.00% 52 
RS15A_HUMAN 100.00% 80 
SH3L3_HUMAN 95.00% 18 
ARP3_HUMAN 100.00% 114 
MACF1_HUMAN 99.90% 2 
TRBC1_HUMAN,TRBC2_HUMAN 100.00% 25 
NPS3A_HUMAN 95.00% 4 
RINI_HUMAN 100.00% 13 
PGAM5_HUMAN 100.00% 8 
FLNA_HUMAN 100.00% 867 
PRP19_HUMAN 100.00% 1 
AP2M1_HUMAN 100.00% 43 
gnl|unk|TRINITY_DN8_c0_g2_i1_11 100.00% 43 
RL10A_HUMAN 100.00% 104 
ACOT1_HUMAN 100.00% 3 
RAB2A_HUMAN 100.00% 14 
PSME1_HUMAN 100.00% 24 
CECR5_HUMAN 99.80% 6 
SRP68_HUMAN 99.90% 1 
AKAP2_HUMAN 100.00% 33 
COPB_HUMAN 100.00% 30 
ESTD_HUMAN 100.00% 9 
MTA2_HUMAN 95.00% 1 
USO1_HUMAN 95.00% 3 
DYHC1_HUMAN 100.00% 85 
URP2_HUMAN 100.00% 340 
IF4A3_HUMAN 100.00% 47 
EM55_HUMAN 100.00% 16 
RL14_HUMAN 100.00% 111 
CUL1_HUMAN 99.70% 1 
ES1_HUMAN 100.00% 7 
TBG1_HUMAN 100.00% 4 
LSR_HUMAN 95.00% 4 
PRDX5_HUMAN 100.00% 41 
THIC_HUMAN 100.00% 106 
NIPS1_HUMAN 100.00% 28 
3HIDH_HUMAN 100.00% 6 
PABP4_HUMAN 100.00% 134 
TBA1B_HUMAN 99.90% 1231 
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AMPL_HUMAN 100.00% 92 
EFR3A_HUMAN 100.00% 8 
ANM5_HUMAN 100.00% 6 
SPTB2_HUMAN 100.00% 357 
HS105_HUMAN 100.00% 156 
HNRPD_HUMAN 100.00% 24 
ADDA_HUMAN 95.00% 5 
1B18_HUMAN 99.20% 647 
RL9_HUMAN 100.00% 160 
YKT6_HUMAN 100.00% 10 
PSMD3_HUMAN 100.00% 30 
RAC1_HUMAN 100.00% 137 
RS9_HUMAN 100.00% 149 
IPYR_HUMAN 100.00% 169 
UBA1_HUMAN 100.00% 134 
RS20_HUMAN 100.00% 94 
FUBP2_HUMAN 100.00% 2 
MTPN_HUMAN 95.00% 4 
DECR_HUMAN 100.00% 13 
MOGS_HUMAN 100.00% 6 
STX6_HUMAN 95.00% 2 
GPX4_HUMAN 100.00% 22 
1A11_HUMAN 100.00% 591 
GLPC_HUMAN 100.00% 19 
RL27A_HUMAN 100.00% 70 
SODC_HUMAN 100.00% 105 
DX39B_HUMAN 100.00% 26 
AHSA1_HUMAN 100.00% 47 
DBNL_HUMAN 100.00% 10 
ACTC_HUMAN 100.00% 2040 
GLYG_HUMAN 95.00% 1 
TNR8_HUMAN 100.00% 19 
PARK7_HUMAN 100.00% 124 
TCPE_HUMAN 100.00% 238 
DQB1_HUMAN 100.00% 47 
QCR2_HUMAN 100.00% 37 
RS3_HUMAN 100.00% 237 
DOPD_HUMAN 100.00% 7 
MBNL1_HUMAN 100.00% 16 
G3P_HUMAN 100.00% 1100 
CD99_HUMAN 100.00% 11 
PSA7_HUMAN 100.00% 28 
RBM8A_HUMAN 95.00% 2 
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A2MG_HUMAN 100.00% 48 
PSMD7_HUMAN 100.00% 28 
GGT2_HUMAN 100.00% 7 
RS12_HUMAN 100.00% 104 
NDUF4_HUMAN 95.00% 2 
MYL6_HUMAN 100.00% 177 
ADA_HUMAN 100.00% 35 
PUR1_HUMAN 95.00% 4 
PDCL3_HUMAN 95.00% 6 
MIF_HUMAN 100.00% 132 
DNJA2_HUMAN 100.00% 11 
PRDX6_HUMAN 100.00% 267 
RU17_HUMAN 99.20% 1 
RHG30_HUMAN 100.00% 11 
CORO7_HUMAN 100.00% 7 
SYSC_HUMAN 100.00% 68 
DHX9_HUMAN 100.00% 39 
DDB1_HUMAN 95.00% 1 
CD38_HUMAN 100.00% 249 
ROA2_HUMAN 100.00% 84 
SMD2_HUMAN 100.00% 6 
3BP1_HUMAN 99.90% 1 
T200A_HUMAN 100.00% 8 
STAT1_HUMAN 100.00% 3 
CATA_HUMAN 95.00% 1 
IF2A_HUMAN 100.00% 41 




FUBP3_HUMAN 95.00% 1 
MCA3_HUMAN 100.00% 15 
PDCD5_HUMAN 100.00% 23 
SYFB_HUMAN 100.00% 32 
CD166_HUMAN 100.00% 97 
U2AF2_HUMAN 95.00% 2 
STX7_HUMAN 95.00% 3 
RAB43_HUMAN 96.40% 30 
TPM4_HUMAN 100.00% 278 
VPS4A_HUMAN 100.00% 19 
S39AA_HUMAN 95.00% 4 
PPP6_HUMAN 100.00% 14 
NDUBA_HUMAN 99.90% 1 
KAD2_HUMAN 100.00% 175 
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TIM16_HUMAN 95.00% 9 
RASL3_HUMAN 100.00% 72 
SF3B1_HUMAN 99.90% 2 
RL4_HUMAN 100.00% 416 
LAMP1_HUMAN 99.90% 5 
SMC4_HUMAN 95.00% 2 
CHM4A_HUMAN 95.00% 1 
RPN1_HUMAN 100.00% 148 
RAB6A_HUMAN 100.00% 40 
MP2K1_HUMAN 100.00% 44 
ALDOA_HUMAN 100.00% 663 
ENOB_HUMAN 99.70% 497 
NONO_HUMAN 100.00% 7 
F120A_HUMAN 100.00% 6 
VP37C_HUMAN 95.00% 1 
TS101_HUMAN 100.00% 101 
NDUV2_HUMAN 100.00% 6 
RAB35_HUMAN 100.00% 131 
ATPK_HUMAN 100.00% 38 
GLU2B_HUMAN 100.00% 37 
NDUAC_HUMAN 95.00% 1 
CLIC4_HUMAN 100.00% 186 
ADHX_HUMAN 100.00% 8 
AAAT_HUMAN 100.00% 323 
SORCN_HUMAN 100.00% 33 
RS3A_HUMAN 100.00% 293 
IDI1_HUMAN 95.00% 6 
PRS7_HUMAN 100.00% 11 
PSA2_HUMAN 95.00% 3 
OAT_HUMAN 100.00% 30 
RS25_HUMAN 100.00% 74 
SMD3_HUMAN 100.00% 14 
PCBP2_HUMAN 100.00% 131 
NTF2_HUMAN 100.00% 22 
RAB5C_HUMAN 100.00% 119 
FKBP4_HUMAN 100.00% 50 
MYH10_HUMAN 100.00% 572 
SERA_HUMAN 100.00% 181 
PACN2_HUMAN 100.00% 90 
SSDH_HUMAN 100.00% 5 
RB33A_HUMAN 97.90% 1 
PLS3_HUMAN 100.00% 10 
PFKAL_HUMAN 100.00% 64 
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MTM1_HUMAN 100.00% 5 
RL32_HUMAN 100.00% 68 
SPCS3_HUMAN 98.30% 4 
FA98A_HUMAN 95.00% 1 
PRDX1_HUMAN 100.00% 436 
CTR1_HUMAN 100.00% 46 
PDCD6_HUMAN 100.00% 19 
CAP1_HUMAN 100.00% 170 
RLA1_HUMAN 100.00% 58 
HUWE1_HUMAN 100.00% 35 
ARF4_HUMAN 100.00% 172 
MK01_HUMAN 100.00% 19 
TPSN_HUMAN 100.00% 4 
H4_HUMAN 100.00% 249 
TMEM2_HUMAN 99.90% 1 
CNPY2_HUMAN 100.00% 14 
FLOT2_HUMAN 100.00% 65 
MCM7_HUMAN 98.20% 12 
MIA2_HUMAN 99.80% 3 
NEF_HV1MN 100.00% 4 
UB2V1_HUMAN 99.90% 6 
IMA1_HUMAN 100.00% 32 
S10AB_HUMAN 100.00% 21 
GOGA7_HUMAN 99.90% 4 
GBB1_HUMAN 100.00% 278 
PRDX3_HUMAN 100.00% 4 
CBPN_HUMAN 95.00% 8 
CHM4B_HUMAN 100.00% 23 
RRAS2_HUMAN 100.00% 51 
CSK21_HUMAN 100.00% 36 
SC23B_HUMAN 100.00% 4 
NICA_HUMAN 100.00% 3 
S10A6_HUMAN 99.90% 6 
GBG4_HUMAN 95.00% 3 
DDX6_HUMAN 100.00% 94 
PSA_HUMAN 100.00% 63 
RAC2_HUMAN 100.00% 234 
HSP7C_HUMAN 100.00% 1027 
IKBB_HUMAN 95.00% 4 
AMPB_HUMAN 100.00% 5 
NDKA_HUMAN 100.00% 300 
PEX14_HUMAN 95.00% 1 
RL38_HUMAN 100.00% 48 
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DDX17_HUMAN 100.00% 93 
AL9A1_HUMAN 100.00% 10 
TXND5_HUMAN 95.00% 4 
CUTA_HUMAN 95.00% 2 
IF6_HUMAN 100.00% 15 
FNBP1_HUMAN 100.00% 141 
PTH2_HUMAN 95.00% 7 
TCPA_HUMAN 100.00% 346 
NDUB5_HUMAN 95.00% 2 
RTN4_HUMAN 100.00% 14 
KAP0_HUMAN 95.00% 6 
DHB12_HUMAN 100.00% 4 
RS10L_HUMAN,RS10_HUMAN 100.00% 18 
DPM3_HUMAN 95.00% 10 
TM9S2_HUMAN 95.00% 5 
RHG15_HUMAN 100.00% 20 
EF1D_HUMAN 100.00% 101 
ITA5_HUMAN 100.00% 4 
ECHA_HUMAN 100.00% 21 
IFM1_HUMAN 99.80% 77 
EBP_HUMAN 99.90% 3 
ABHDA_HUMAN 100.00% 3 
VP37B_HUMAN 95.00% 6 
PFKAM_HUMAN 100.00% 16 
DRA_HUMAN 100.00% 515 
SDHA_HUMAN 100.00% 18 
ANXA2_HUMAN 100.00% 722 
COF1_HUMAN 100.00% 430 
EIF1_HUMAN 95.00% 4 
RLA2_HUMAN 100.00% 143 
ZCHC3_HUMAN 100.00% 8 
ACADV_HUMAN 100.00% 47 
PTBP1_HUMAN 100.00% 43 
HPBP1_HUMAN 100.00% 2 
ERP44_HUMAN 98.00% 1 
MIC60_HUMAN 100.00% 90 
MY18A_HUMAN 100.00% 41 
TMM33_HUMAN 95.00% 2 
PCH2_HUMAN 95.00% 1 
CH10_HUMAN 100.00% 152 
LEUK_HUMAN 100.00% 79 
NFKB1_HUMAN 100.00% 2 
MYO1C_HUMAN 95.00% 4 
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MRP_HUMAN 99.90% 42 
STOM_HUMAN 100.00% 104 
RL18A_HUMAN 100.00% 135 
TLDC1_HUMAN 95.00% 3 
TP4A3_HUMAN 95.00% 3 
SNTB1_HUMAN 99.80% 1 
IL16_HUMAN 100.00% 204 
EIF2A_HUMAN 100.00% 12 
1433F_HUMAN 100.00% 79 
EFTU_HUMAN 100.00% 345 
PLRG1_HUMAN 95.00% 2 
RL24_HUMAN 100.00% 87 
CD3E_HUMAN 100.00% 23 
HNRPR_HUMAN 100.00% 77 
MOES_HUMAN 100.00% 1723 
STK10_HUMAN 100.00% 31 
NDKB_HUMAN 100.00% 267 
DOCK2_HUMAN 100.00% 47 
LRC59_HUMAN 100.00% 7 
TBB6_HUMAN 99.90% 422 
PFD2_HUMAN 100.00% 22 
RL10_HUMAN 100.00% 180 
CO4A_HUMAN,CO4B_HUMAN 100.00% 19 
PYR1_HUMAN 100.00% 45 
GTR3_HUMAN 100.00% 42 
ACAD9_HUMAN 100.00% 16 
B2MG_HUMAN 100.00% 77 
CD81_HUMAN 100.00% 405 
HSDL2_HUMAN 99.90% 6 
GNAS1_HUMAN 100.00% 93 
XPO2_HUMAN 100.00% 22 
ACACA_HUMAN 100.00% 16 
RAP1A_HUMAN 100.00% 329 
ATD3B_HUMAN 99.90% 32 
ACON_HUMAN 100.00% 35 
ACDSB_HUMAN 100.00% 5 
TKT_HUMAN 100.00% 72 
ARPC2_HUMAN 100.00% 77 
PTCA_HUMAN 100.00% 58 
ALDR_HUMAN 100.00% 30 
KIF23_HUMAN 100.00% 25 
FUS_HUMAN 99.90% 9 
AP2A1_HUMAN 100.00% 41 
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EXOC4_HUMAN 100.00% 10 
ACLY_HUMAN 100.00% 207 
IF4E_HUMAN 99.90% 4 
EVL_HUMAN 100.00% 24 
MYH9_HUMAN 100.00% 2360 
GRP78_HUMAN 100.00% 418 
SDHB_HUMAN 100.00% 9 
LPXN_HUMAN 100.00% 10 
RCC2_HUMAN 100.00% 12 
PSD10_HUMAN 95.00% 2 




MARK2_HUMAN 100.00% 21 
RAB14_HUMAN 100.00% 64 
ZDHC5_HUMAN 100.00% 21 
MTX1_HUMAN 95.00% 1 
PUR8_HUMAN 100.00% 60 
BIEA_HUMAN 100.00% 32 
ECHB_HUMAN 100.00% 9 
ATG3_HUMAN 100.00% 7 
PARP1_HUMAN 100.00% 38 
CDC37_HUMAN 100.00% 74 
PDIA4_HUMAN 100.00% 79 
PDC6I_HUMAN 100.00% 357 
IQGA2_HUMAN 100.00% 104 
XPP1_HUMAN 100.00% 11 
GLPK_HUMAN 100.00% 3 
DOC10_HUMAN 100.00% 11 
ZCCHV_HUMAN 100.00% 60 
TAP1_HUMAN 95.00% 4 
IPO7_HUMAN 100.00% 22 
RTCB_HUMAN 100.00% 19 
SNTB2_HUMAN 100.00% 7 
1433G_HUMAN 100.00% 169 
PA2G4_HUMAN 100.00% 172 
NACAM_HUMAN 100.00% 64 
GLRX1_HUMAN 95.00% 1 
LFA3_HUMAN 100.00% 14 
ATPA_HUMAN 100.00% 408 
COASY_HUMAN 95.00% 2 
NDUA9_HUMAN 95.00% 2 
COX41_HUMAN 100.00% 36 
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SDCB1_HUMAN 100.00% 50 
YTHD2_HUMAN 95.00% 2 
GRP2_HUMAN 95.00% 2 
TXD17_HUMAN 100.00% 29 
S38A2_HUMAN 100.00% 14 
PFD3_HUMAN 99.90% 3 
AK1A1_HUMAN 100.00% 63 
CSRP1_HUMAN 100.00% 50 
PUR9_HUMAN 100.00% 391 
RN213_HUMAN 100.00% 11 
PTPRA_HUMAN 100.00% 1 
DNJC7_HUMAN 100.00% 3 
KDIS_HUMAN 100.00% 6 
CD82_HUMAN 95.00% 3 
THIL_HUMAN 100.00% 29 
G3BP1_HUMAN 100.00% 22 
PRP8_HUMAN 99.30% 1 
AN32A_HUMAN 100.00% 11 
VILI_HUMAN 95.00% 2 
TRUA_HUMAN 95.70% 2 
RBM3_HUMAN 95.00% 1 
L1CAM_HUMAN 100.00% 515 
MFGM_HUMAN 100.00% 52 
LPPRC_HUMAN 100.00% 129 
DDX1_HUMAN 100.00% 4 
HNRPM_HUMAN 100.00% 47 
CAPZB_HUMAN 100.00% 103 
EXOC5_HUMAN 95.00% 4 
STMN1_HUMAN 100.00% 29 
ODPA_HUMAN 100.00% 10 
TLN1_HUMAN 100.00% 465 
MB12A_HUMAN 95.00% 5 
MAOM_HUMAN 100.00% 62 
RL17_HUMAN 100.00% 200 
CDV3_HUMAN 100.00% 19 
KCNN4_HUMAN 100.00% 5 
RS29_HUMAN 95.00% 3 
CN37_HUMAN 100.00% 62 
LMAN2_HUMAN 95.00% 3 
PPIA_HUMAN 100.00% 1309 
FAS_HUMAN 100.00% 709 
AT1A1_HUMAN 100.00% 596 
HS90A_HUMAN 100.00% 962 
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BAP31_HUMAN 100.00% 29 
COX5A_HUMAN 100.00% 20 
CNN2_HUMAN 100.00% 159 
RB11B_HUMAN 100.00% 96 
NAA15_HUMAN 100.00% 24 
LG3BP_HUMAN 99.90% 1 
COR1C_HUMAN 100.00% 114 
PSMD6_HUMAN 100.00% 17 
PSB8_HUMAN 100.00% 9 
VPS25_HUMAN 100.00% 3 
6PGD_HUMAN 100.00% 113 
RL11_HUMAN 100.00% 62 
PRS10_HUMAN 100.00% 10 
S29A1_HUMAN 100.00% 82 
RS23_HUMAN 100.00% 29 
XRCC5_HUMAN 100.00% 14 
CY1_HUMAN 100.00% 10 
SCO1_HUMAN 95.00% 1 
ILK_HUMAN 100.00% 29 
CAN1_HUMAN 100.00% 8 
RACK1_HUMAN 100.00% 215 
VDAC2_HUMAN 100.00% 121 






NDUS8_HUMAN 95.00% 3 
PLCG1_HUMAN 97.50% 1 
SR140_HUMAN 95.00% 2 
CAND1_HUMAN 100.00% 53 
SYPL1_HUMAN 95.00% 14 
CIB1_HUMAN 100.00% 3 
SDC4_HUMAN 100.00% 19 
LMNB1_HUMAN 99.50% 6 
THIM_HUMAN 100.00% 58 
LEG1_HUMAN 100.00% 28 
TCPH_HUMAN 100.00% 188 
MTCH2_HUMAN 100.00% 37 
CLDN1_HUMAN 99.90% 2 
PTMA_HUMAN 95.00% 7 
RS6_HUMAN 100.00% 155 
RT29_HUMAN 97.10% 1 
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1433B_HUMAN 100.00% 112 
CALM_HUMAN 100.00% 9 
RHOF_HUMAN 100.00% 99 
NP1L1_HUMAN 100.00% 132 
STXB3_HUMAN 100.00% 105 
ODPB_HUMAN 100.00% 12 
TOM40_HUMAN 100.00% 18 
PROF1_HUMAN 100.00% 678 
TXD12_HUMAN 100.00% 5 
DJB11_HUMAN 100.00% 6 
VASP_HUMAN 100.00% 113 
HYOU1_HUMAN 100.00% 19 
ATX2L_HUMAN 100.00% 4 
AP2S1_HUMAN 99.90% 2 
PUR4_HUMAN 100.00% 26 
CALR_HUMAN 100.00% 160 
CNBP_HUMAN 99.90% 1 
SH3L1_HUMAN 100.00% 19 
PEDF_HUMAN 100.00% 3 
MLF2_HUMAN 100.00% 14 
IPYR2_HUMAN 99.90% 22 
TIM44_HUMAN 95.00% 3 
P5CS_HUMAN 99.60% 4 
COX5B_HUMAN 100.00% 9 
DP13A_HUMAN 95.00% 2 
UN45A_HUMAN 95.00% 2 
DBLOH_HUMAN 99.80% 6 
HCLS1_HUMAN 100.00% 38 
RFC2_HUMAN 95.00% 1 
APOE_HUMAN 100.00% 42 
RUVB1_HUMAN 100.00% 108 
WDR1_HUMAN 100.00% 181 
SQSTM_HUMAN 95.00% 1 
RL12_HUMAN 100.00% 158 
1B14_HUMAN 99.90% 555 
CLTR1_HUMAN 100.00% 6 
ROA3_HUMAN 100.00% 21 
UBA5_HUMAN 100.00% 7 
TCTP_HUMAN 100.00% 47 
NEK7_HUMAN 95.00% 1 
CASL_HUMAN 95.00% 4 
GDIR1_HUMAN 100.00% 138 
EF1A1_HUMAN 100.00% 1274 
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PCNA_HUMAN 100.00% 33 
UBP14_HUMAN 100.00% 12 
PSMD4_HUMAN 95.00% 2 
PP2AA_HUMAN,PP2AB_HUMAN 100.00% 6 
U2AF1_HUMAN,U2AF5_HUMAN 95.00% 3 
EIF3M_HUMAN 100.00% 25 
EDC4_HUMAN 100.00% 8 
NADE_HUMAN 95.00% 2 
GNAI2_HUMAN 100.00% 469 
NCKPL_HUMAN 100.00% 3 
PLCG2_HUMAN 99.00% 1 
MTDC_HUMAN 95.00% 8 
HSP74_HUMAN 100.00% 40 
ACTG_HUMAN 100.00% 2528 
1433Z_HUMAN 100.00% 273 
GCP2_HUMAN 95.00% 1 
CYTB_HUMAN 97.60% 3 
RAB1A_HUMAN 99.90% 131 
RL7_HUMAN 100.00% 269 
TALDO_HUMAN 100.00% 35 
TBCB_HUMAN 100.00% 10 
RS15_HUMAN 100.00% 62 
CYC_HUMAN 100.00% 40 
PSMD1_HUMAN 100.00% 13 
PSB3_HUMAN 100.00% 13 
SNX6_HUMAN 95.00% 2 
SELB_HUMAN 95.00% 1 
DNPH1_HUMAN 99.90% 2 
ARL8A_HUMAN,ARL8B_HUMAN 95.00% 3 
HINT1_HUMAN 99.90% 1 
RS7_HUMAN 100.00% 93 
sp|Q9C0C9|UBE2O_HUMAN 100.00% 8 
GLOD4_HUMAN 100.00% 20 
FKB1A_HUMAN 100.00% 24 
MPP6_HUMAN 100.00% 38 
EIF3D_HUMAN 100.00% 17 
SPIT2_HUMAN 97.50% 1 
ACADM_HUMAN 95.00% 4 
AT2A2_HUMAN 100.00% 39 
RS16_HUMAN 100.00% 244 
MOV10_HUMAN 100.00% 129 
PI51A_HUMAN 100.00% 3 
EIF3G_HUMAN 99.90% 12 
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STX4_HUMAN 100.00% 47 
PIPNA_HUMAN 100.00% 12 
OGA_HUMAN 95.00% 1 
AP2A2_HUMAN 100.00% 43 
NDUS3_HUMAN 100.00% 13 
LYPA1_HUMAN 100.00% 28 
ARI2_HUMAN 95.00% 1 
BAHC1_HUMAN 95.00% 12 
STK26_HUMAN 100.00% 38 
ACTA_HUMAN 100.00% 1855 
1433T_HUMAN 100.00% 92 
ZCCHL_HUMAN 95.00% 2 
MARE1_HUMAN 100.00% 13 
MPRD_HUMAN 100.00% 10 
POL_HV1Z2 100.00% 2594 
POL_HV1YF 100.00% 1056 
POL_HV1YB 99.80% 1100 
POL_HV1Y2 100.00% 5181 
CD44_HUMAN 100.00% 160 
RM12_HUMAN 100.00% 20 
SRP14_HUMAN 100.00% 12 
TM41A_HUMAN 95.00% 5 
POL_HV1V9 100.00% 801 
DPYL2_HUMAN 100.00% 86 
RHOA_HUMAN 100.00% 285 
PEF1_HUMAN 99.80% 2 
CX7A2_HUMAN 100.00% 16 
CD97_HUMAN 100.00% 34 
RAE1L_HUMAN 95.00% 7 
PCKGM_HUMAN 100.00% 9 
FYN_HUMAN 100.00% 106 
PSA5_HUMAN 100.00% 41 
COPA_HUMAN 100.00% 121 
SUMO4_HUMAN 95.00% 19 
SRSF8_HUMAN 98.60% 11 
POL_HV1RH 100.00% 2837 
IF4A2_HUMAN 100.00% 165 
SC24C_HUMAN 100.00% 3 
POL_HV1N5 100.00% 3562 
TADBP_HUMAN 99.90% 4 
POL_HV1MP 100.00% 1326 
SYAC_HUMAN 100.00% 132 
POL_HV1MN 100.00% 4667 
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POL_HV1MA 98.90% 1356 
NUCB2_HUMAN 100.00% 10 
POL_HV1M2 100.00% 898 
NUCL_HUMAN 100.00% 23 
S10A4_HUMAN 100.00% 74 
VAMP8_HUMAN 100.00% 2 
PRDX4_HUMAN 100.00% 39 
POL_HV1JR 100.00% 4692 
Table 4a. All proteins identified for the HIV-1(MN)/H9 CL.4 virus. 





POL_HV1J3 99.90% 2295 
SC61G_HUMAN 95.00% 25 
DPB1_HUMAN 100.00% 216 
ERF1_HUMAN 100.00% 4 
HS71A_HUMAN,HS71B_HUMAN 100.00% 412 
GNAI3_HUMAN 100.00% 304 
S39AE_HUMAN 100.00% 9 
PRS4_HUMAN 99.80% 5 
CKLF6_HUMAN 95.00% 15 
PLS1_HUMAN 99.90% 7 
SNP29_HUMAN 95.00% 4 
RM04_HUMAN 99.90% 2 
HNRPC_HUMAN 100.00% 19 
POL_HV1C4 100.00% 2361 
PTN6_HUMAN 100.00% 12 
RAB1B_HUMAN 100.00% 179 
RL8_HUMAN 100.00% 58 
CPNS1_HUMAN 100.00% 4 
SUCA_HUMAN 100.00% 23 
DNPEP_HUMAN 95.00% 7 
DDRGK_HUMAN 95.00% 4 
OLA1_HUMAN 100.00% 11 
ECI1_HUMAN 95.00% 2 
ATP5I_HUMAN 100.00% 23 
PRAF2_HUMAN 95.00% 1 
ABHD6_HUMAN 95.00% 3 
G6PI_HUMAN 100.00% 305 
SNAG_HUMAN 100.00% 13 
PRS8_HUMAN 100.00% 4 
SSBP_HUMAN 100.00% 50 
KPCD2_HUMAN 99.80% 8 
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VTA1_HUMAN 100.00% 11 
MYH11_HUMAN 99.80% 191 
POL_HV193 100.00% 662 
POL_HV192 99.90% 447 
QCR7_HUMAN 100.00% 22 
C42S1_HUMAN 95.00% 17 
ACTY_HUMAN,ACTZ_HUMAN 100.00% 13 
TRAT1_HUMAN 95.00% 2 
SEP15_HUMAN 95.00% 4 
NDUS4_HUMAN 99.90% 2 
P5CR1_HUMAN 99.80% 14 
VATL_HUMAN 95.00% 8 
ELMO1_HUMAN 95.00% 7 
TIM14_HUMAN 95.00% 3 
GSTM2_HUMAN 99.90% 2 
ACTB_HUMAN 100.00% 5221 
KCAB2_HUMAN 100.00% 2 
ATPO_HUMAN 100.00% 140 
SYYC_HUMAN 100.00% 38 
TCPD_HUMAN 100.00% 138 
QCR1_HUMAN 100.00% 307 
4F2_HUMAN 100.00% 441 
RS2_HUMAN 100.00% 235 
SRPRB_HUMAN 100.00% 35 
TM109_HUMAN 95.00% 22 
M4K1_HUMAN 95.00% 1 
SNAA_HUMAN 100.00% 37 
MANF_HUMAN 100.00% 110 
CYBP_HUMAN 100.00% 19 
NTAL_HUMAN 100.00% 57 
PSA6_HUMAN 100.00% 26 
LETM1_HUMAN 100.00% 41 
ARPC4_HUMAN 100.00% 100 
STK4_HUMAN 97.80% 5 
RL36A_HUMAN,RL36L_HUMAN 100.00% 27 
GGT1_HUMAN 100.00% 79 
DHCR7_HUMAN 100.00% 56 
IGKC_HUMAN 100.00% 107 
ABRAL_HUMAN 100.00% 16 
DIP2B_HUMAN 100.00% 67 
TALDO_HUMAN 95.00% 3 
TNAP3_HUMAN 100.00% 99 
SFXN1_HUMAN 100.00% 53 
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RL31_HUMAN 100.00% 18 
DGUOK_HUMAN 95.00% 1 
GCDH_HUMAN 100.00% 7 
PFKAP_HUMAN 100.00% 77 
HCD2_HUMAN 100.00% 210 
TB10B_HUMAN 95.00% 6 
PSD12_HUMAN 95.00% 8 
SC11C_HUMAN 100.00% 1 
NDUAA_HUMAN 100.00% 23 
PHB2_HUMAN 100.00% 271 
CLIC2_HUMAN 100.00% 94 
TMED9_HUMAN 100.00% 39 
PPAC_HUMAN 100.00% 20 
MTFP1_HUMAN 100.00% 9 
CCR7_HUMAN 100.00% 25 
TXTP_HUMAN 100.00% 60 
PTBP1_HUMAN 100.00% 4 
SRSF3_HUMAN 100.00% 37 
SMD1_HUMAN 100.00% 15 




RL13A_HUMAN 100.00% 83 
RAP2B_HUMAN 99.90% 34 
TEBP_HUMAN 100.00% 22 
ITB7_HUMAN 100.00% 37 
BZW1_HUMAN 100.00% 2 
PGM1_HUMAN 100.00% 4 
ABHDA_HUMAN 100.00% 2 
SPCS1_HUMAN 95.00% 12 
RS13_HUMAN 100.00% 170 
PDCD4_HUMAN 99.80% 3 
SYFA_HUMAN 100.00% 4 
SC61B_HUMAN 95.00% 12 
BCAT1_HUMAN 100.00% 44 
HNRPU_HUMAN 100.00% 20 
SATT_HUMAN 100.00% 138 
ANO6_HUMAN 100.00% 4 
ITIH2_HUMAN 100.00% 33 
ANXA6_HUMAN 100.00% 751 
TXNL1_HUMAN 95.00% 2 
P5CR2_HUMAN 94.60% 5 
PPP5_HUMAN 95.00% 3 
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PO210_HUMAN 95.00% 1 
1C01_HUMAN 100.00% 627 
RL3_HUMAN 100.00% 154 
GCN1_HUMAN 100.00% 2 
ODP2_HUMAN 100.00% 114 
RALA_HUMAN 100.00% 87 
JAK1_HUMAN 100.00% 24 
RIPL2_HUMAN 99.80% 1 
SNX2_HUMAN 100.00% 2 
PRS6A_HUMAN 97.10% 1 
ITB1_HUMAN 100.00% 4 
RHG04_HUMAN 95.00% 1 
PUR4_HUMAN 100.00% 3 
G6PD_HUMAN 95.00% 1 
SAC1_HUMAN 95.00% 4 
CPIN1_HUMAN 95.00% 1 
VAV_HUMAN 95.00% 1 
ENOA_HUMAN 100.00% 1309 
GBG2_HUMAN 100.00% 21 
ARPC5_HUMAN 100.00% 62 




IL3RA_HUMAN 95.00% 8 
HLAF_HUMAN 100.00% 25 
41_HUMAN 100.00% 123 
IF4E2_HUMAN 95.00% 2 
EIF3C_HUMAN,EIFCL_HUMAN 100.00% 4 
EZRI_HUMAN 100.00% 1117 
RD23A_HUMAN 100.00% 3 
CN166_HUMAN 99.80% 20 
RL36_HUMAN 100.00% 41 
SYK_HUMAN 100.00% 13 
MTMRC_HUMAN 95.00% 3 
CNNM3_HUMAN 100.00% 11 
LYRIC_HUMAN 97.50% 2 
SND1_HUMAN 100.00% 40 
WASP_HUMAN 100.00% 8 
PSD13_HUMAN 100.00% 16 
SYLC_HUMAN 100.00% 16 
PIMT_HUMAN 100.00% 8 
RL23A_HUMAN 100.00% 11 
MOT1_HUMAN 100.00% 110 
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PP1G_HUMAN 99.30% 125 
PLXA1_HUMAN 100.00% 6 
SCAM2_HUMAN 97.00% 12 
TOR1A_HUMAN 95.00% 2 
CPNE3_HUMAN 100.00% 47 
RL7A_HUMAN 100.00% 188 
DPM1_HUMAN 100.00% 19 
CCL22_HUMAN 100.00% 32 
PSA1_HUMAN 100.00% 35 
GBB2_HUMAN 100.00% 282 
RL22L_HUMAN 96.30% 11 
LIN7A_HUMAN 100.00% 37 
IDHC_HUMAN 96.40% 5 
SEC62_HUMAN 100.00% 14 
RAB5B_HUMAN 100.00% 48 
PNPH_HUMAN 100.00% 97 
MYO1G_HUMAN 100.00% 1109 
SC22B_HUMAN 100.00% 25 
DLDH_HUMAN 100.00% 156 
SSDH_HUMAN 95.00% 1 
CAPG_HUMAN 100.00% 52 
MRP1_HUMAN 100.00% 70 
NIBAN_HUMAN 100.00% 7 
VATA_HUMAN 100.00% 19 
TBB4B_HUMAN 100.00% 978 
TNFL9_HUMAN 100.00% 32 
SPCS2_HUMAN 100.00% 15 
COR1A_HUMAN 100.00% 380 




ATPD_HUMAN 100.00% 38 
RL28_HUMAN 100.00% 55 
RLA0_HUMAN 100.00% 116 
BCAT2_HUMAN 100.00% 77 
RS24_HUMAN 100.00% 54 
ARF1_HUMAN,ARF3_HUMAN 100.00% 259 
ACTN1_HUMAN 99.80% 146 
NDRG3_HUMAN 100.00% 20 
ANXA7_HUMAN 100.00% 83 
BAG2_HUMAN 100.00% 7 
TMED4_HUMAN 100.00% 22 
S38A5_HUMAN 100.00% 33 
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EPN1_HUMAN 100.00% 13 
SDF2_HUMAN 95.00% 5 
RUXF_HUMAN 95.00% 1 
DEST_HUMAN 100.00% 67 
APOA1_HUMAN 95.00% 2 
TTL12_HUMAN 95.00% 2 
LDHB_HUMAN 100.00% 290 
TNIP1_HUMAN 100.00% 5 
THEM6_HUMAN 100.00% 6 
DHRS7_HUMAN 100.00% 20 
MCCA_HUMAN 100.00% 4 
LRC8C_HUMAN 99.90% 1 
PRS6B_HUMAN 99.80% 1 
THIO_HUMAN 100.00% 84 
ITB2_HUMAN 100.00% 77 
SUCB2_HUMAN 100.00% 43 
KAT3_HUMAN 100.00% 9 
LIMA1_HUMAN 100.00% 27 
SYIM_HUMAN 100.00% 1 
BID_HUMAN 95.00% 5 
VASP_HUMAN 100.00% 75 
SSRA_HUMAN 100.00% 71 
EFTS_HUMAN 100.00% 10 
ACTBL_HUMAN 100.00% 530 
1B41_HUMAN 100.00% 1065 
FLVC1_HUMAN 100.00% 11 
QOR_HUMAN 100.00% 5 
LPCT4_HUMAN 100.00% 11 
LTOR3_HUMAN 95.00% 1 
STA5B_HUMAN 95.00% 2 
HBB_HUMAN 100.00% 29 
DLG1_HUMAN 95.00% 10 
LRC57_HUMAN 100.00% 3 
TBK1_HUMAN 95.00% 1 
GSTK1_HUMAN 100.00% 29 
HIBCH_HUMAN 100.00% 6 
GTR1_HUMAN 100.00% 84 
CY24B_HUMAN 97.90% 6 
UGGG1_HUMAN 100.00% 60 
IST1_HUMAN 100.00% 30 
TAOK3_HUMAN 100.00% 2 
IDI1_HUMAN 100.00% 3 
RM45_HUMAN 95.00% 2 
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HPRT_HUMAN 100.00% 48 
ITA4_HUMAN 100.00% 152 
BAF_HUMAN 100.00% 37 
IF2B3_HUMAN 97.00% 8 
IL18R_HUMAN 100.00% 38 
IL27B_HUMAN 100.00% 39 
SLK_HUMAN 100.00% 19 
H2A2A_HUMAN,H2A2C_HUMAN 100.00% 174 
TCPQ_HUMAN 100.00% 237 
NSF_HUMAN 99.90% 4 
VPS28_HUMAN 100.00% 8 
CCD50_HUMAN 98.30% 2 
CNO10_HUMAN 95.00% 1 
NEB2_HUMAN 99.90% 3 
PRAF3_HUMAN 100.00% 29 
OPA1_HUMAN 100.00% 58 
FRIL_HUMAN 99.90% 13 
PP1B_HUMAN 100.00% 161 
SC6A6_HUMAN 95.00% 2 
TOIP1_HUMAN 95.00% 5 
ATAD1_HUMAN 98.20% 3 
BLMH_HUMAN 99.90% 3 
LRCH4_HUMAN 100.00% 2 
ARC1B_HUMAN 100.00% 253 
RUXG_HUMAN 95.00% 3 
PAK2_HUMAN 100.00% 4 
UCRI_HUMAN 100.00% 22 
AT1B3_HUMAN 100.00% 196 
VIME_HUMAN 100.00% 427 
HM13_HUMAN 100.00% 13 
ERG7_HUMAN 100.00% 18 
RUVB1_HUMAN 100.00% 91 
RT34_HUMAN 100.00% 11 
EHD4_HUMAN 100.00% 149 
IPO5_HUMAN 100.00% 37 
COX6C_HUMAN 100.00% 28 
CISD1_HUMAN 100.00% 27 
IMDH2_HUMAN 100.00% 118 
TP4A2_HUMAN 100.00% 23 
RANG_HUMAN 100.00% 17 
1433E_HUMAN 100.00% 261 
CIP4_HUMAN 95.00% 1 
RL23_HUMAN 100.00% 64 
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DDX5_HUMAN 100.00% 64 
NDUA7_HUMAN 100.00% 34 
HDAC1_HUMAN 95.00% 1 
NP1L4_HUMAN 97.30% 27 
SHIP1_HUMAN 100.00% 11 
HNRPQ_HUMAN 100.00% 52 
GNA15_HUMAN 100.00% 27 
MILK1_HUMAN 99.80% 1 
ZNT1_HUMAN 95.70% 1 
RAB21_HUMAN 100.00% 62 
ENPL_HUMAN 100.00% 971 
RS18_HUMAN 100.00% 78 
SYIC_HUMAN 100.00% 35 
LTMD1_HUMAN 100.00% 18 
ERAP1_HUMAN 100.00% 56 
CP51A_HUMAN 100.00% 5 
TFAM_HUMAN 100.00% 13 
TAGL2_HUMAN 100.00% 190 
CKAP5_HUMAN 97.60% 3 
CALU_HUMAN 100.00% 14 
OTUB1_HUMAN 100.00% 26 
CSK2B_HUMAN 95.00% 1 
COMT_HUMAN 100.00% 93 
TPIS_HUMAN 100.00% 359 
DNJC5_HUMAN 100.00% 38 
RTCB_HUMAN 100.00% 28 
CD80_HUMAN 100.00% 137 
PKHF2_HUMAN 99.90% 11 
SYWC_HUMAN 100.00% 24 
APOE_HUMAN 100.00% 29 
ITAL_HUMAN 100.00% 66 
CD63_HUMAN 95.00% 5 
PLEK_HUMAN 100.00% 64 
XPO1_HUMAN 100.00% 8 
FGR_HUMAN 100.00% 31 
ATD3A_HUMAN 100.00% 72 
ERBIN_HUMAN 99.90% 16 
RT26_HUMAN 95.00% 1 
E41L2_HUMAN 100.00% 3 
PSME2_HUMAN 100.00% 46 
BASP1_HUMAN 100.00% 164 
HNRPK_HUMAN 100.00% 33 
FEN1_HUMAN 95.00% 1 
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QCR8_HUMAN 100.00% 8 
AT5F1_HUMAN 100.00% 123 
SEPT6_HUMAN 100.00% 65 
PLP2_HUMAN 95.00% 13 
SYG_HUMAN 100.00% 18 
FKBP2_HUMAN 100.00% 50 
RRAS2_HUMAN 100.00% 77 
IF2G_HUMAN 99.80% 7 
CCD51_HUMAN 95.00% 1 
RS27L_HUMAN,RS27_HUMAN 95.00% 5 
CNIH4_HUMAN 95.00% 2 
ADAS_HUMAN 100.00% 81 
NDUV1_HUMAN 100.00% 30 
PTSS1_HUMAN 95.00% 4 
ICT1_HUMAN 95.00% 2 
TRFL_HUMAN 99.90% 13 
S43A3_HUMAN 100.00% 129 
SYDM_HUMAN 100.00% 14 
FMNL1_HUMAN 100.00% 55 
CLPP_HUMAN 100.00% 2 
TOP2A_HUMAN 100.00% 3 
BAX_HUMAN 100.00% 8 
RB27A_HUMAN 100.00% 124 
SEPT2_HUMAN 100.00% 58 
TBA1C_HUMAN 100.00% 646 
EFGM_HUMAN 99.80% 5 
PDIA3_HUMAN 100.00% 833 
ADT2_HUMAN 100.00% 286 
SGT1_HUMAN 95.00% 1 
IQGA1_HUMAN 100.00% 356 
SYEP_HUMAN 100.00% 36 
NSDHL_HUMAN 100.00% 9 
STX11_HUMAN 100.00% 81 
MIC26_HUMAN 98.40% 4 
DPP3_HUMAN 95.00% 4 
GELS_HUMAN 100.00% 32 
CSK_HUMAN 100.00% 67 
PSB6_HUMAN 100.00% 12 
DAF_HUMAN 100.00% 15 
PGK1_HUMAN 100.00% 610 
RS21_HUMAN 100.00% 12 
PSB4_HUMAN 100.00% 14 
UFM1_HUMAN 100.00% 5 
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RL15_HUMAN 100.00% 122 
PI4KA_HUMAN 100.00% 11 
P4HA1_HUMAN 100.00% 31 
NDUA8_HUMAN 100.00% 29 
HYAS1_HUMAN 95.00% 3 
K22E_HUMAN 100.00% 14 
RASK_HUMAN 100.00% 201 
GRPE1_HUMAN 100.00% 27 
RAB7L_HUMAN 100.00% 2 
RS19_HUMAN 100.00% 24 
EF1A1_HUMAN 100.00% 803 
DQB1_HUMAN 100.00% 235 
S38A1_HUMAN 95.00% 3 
AGFG1_HUMAN 95.00% 3 
UB2D2_HUMAN,UB2D3_HUMAN 95.00% 16 
TIM50_HUMAN 100.00% 3 
GHITM_HUMAN 95.00% 5 
NDUS6_HUMAN 97.80% 2 
FPPS_HUMAN 100.00% 68 
APMAP_HUMAN 100.00% 50 
GSTO1_HUMAN 100.00% 35 
P3H1_HUMAN 95.00% 1 
PLCC_HUMAN 95.00% 2 
THIK_HUMAN 100.00% 16 
ATD3B_HUMAN 99.90% 38 
SAHH_HUMAN 100.00% 92 
S61A1_HUMAN 100.00% 47 
CD47_HUMAN 100.00% 51 
F10A1_HUMAN 100.00% 43 
RM15_HUMAN 95.00% 2 
HMOX2_HUMAN 95.00% 4 
SAMN1_HUMAN 100.00% 6 
RT27_HUMAN 100.00% 12 
TMEDA_HUMAN 100.00% 99 
PHB_HUMAN 100.00% 204 
TOP1_HUMAN 99.80% 3 
GFPT1_HUMAN 100.00% 10 
ALBU_HUMAN 100.00% 179 
NDUA2_HUMAN 100.00% 2 
S12A6_HUMAN 100.00% 40 
HNRPL_HUMAN 100.00% 17 
2AAA_HUMAN 100.00% 39 
SEPT7_HUMAN 100.00% 63 
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TKFC_HUMAN 100.00% 14 
RFTN1_HUMAN 100.00% 227 
CTL2_HUMAN 100.00% 30 
RN149_HUMAN 97.30% 2 
NIPS2_HUMAN 100.00% 3 
PUR2_HUMAN 100.00% 54 
AT2B4_HUMAN 100.00% 100 
MRRP3_HUMAN 95.00% 1 
H12_HUMAN 97.20% 8 
ATP5H_HUMAN 100.00% 125 
LMAN1_HUMAN 100.00% 58 
GYS1_HUMAN 95.00% 4 
LONM_HUMAN 100.00% 80 
OCAD1_HUMAN 95.00% 3 
RS27A_HUMAN 100.00% 98 
PGAM1_HUMAN 100.00% 182 
DCTP1_HUMAN 100.00% 3 
GAG_HV1MN 100.00% 4231 
ADT3_HUMAN 100.00% 225 
EIF3K_HUMAN 95.00% 1 
1B47_HUMAN 100.00% 974 
RT21_HUMAN 95.00% 2 
SEC63_HUMAN 100.00% 7 
RS28_HUMAN 100.00% 30 
ERLN2_HUMAN 100.00% 10 
PEX14_HUMAN 96.80% 10 
MPC2_HUMAN 100.00% 8 
HEM6_HUMAN 100.00% 147 
MIC27_HUMAN 95.00% 2 
SERPH_HUMAN 100.00% 100 
SRP09_HUMAN 100.00% 39 
GCSAM_HUMAN 100.00% 49 
SEPT1_HUMAN 100.00% 9 
LEG3_HUMAN 100.00% 13 
ELOV5_HUMAN 95.00% 14 
COPB2_HUMAN 100.00% 25 
BDH_HUMAN 100.00% 75 
EF2_HUMAN 100.00% 537 
GRB2_HUMAN 100.00% 19 
WASF2_HUMAN 100.00% 6 
ROA1_HUMAN 100.00% 24 
ATP5L_HUMAN 100.00% 86 
1433Z_HUMAN 100.00% 236 
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ML12A_HUMAN,ML12B_HUMAN 100.00% 169 
PPR18_HUMAN 100.00% 32 
NAA15_HUMAN 100.00% 3 
PSMG1_HUMAN 95.00% 4 
NPM_HUMAN 100.00% 92 
VDAC1_HUMAN 100.00% 419 
GDS1_HUMAN 100.00% 3 
RAN_HUMAN 100.00% 92 
BASI_HUMAN 100.00% 346 
DNJB2_HUMAN 95.00% 1 
MZB1_HUMAN 100.00% 123 
PKN1_HUMAN 95.00% 1 
SYMC_HUMAN 100.00% 14 
SH3K1_HUMAN 100.00% 24 
NDUS7_HUMAN 100.00% 13 
PSDE_HUMAN 100.00% 4 
VPS4B_HUMAN 100.00% 14 
SYTC_HUMAN 100.00% 9 
LAT1_HUMAN 100.00% 36 
FBLL1_HUMAN 98.00% 10 
FA5_HUMAN 100.00% 24 
UGPA_HUMAN 95.00% 3 
CAB39_HUMAN 100.00% 48 
MPCP_HUMAN 100.00% 155 
RL5_HUMAN 100.00% 129 
TCPG_HUMAN 100.00% 179 
PSB1_HUMAN 100.00% 14 
TFR1_HUMAN 100.00% 417 
SPTN1_HUMAN 100.00% 876 
BRI3B_HUMAN 95.00% 4 
LAMP2_HUMAN 100.00% 37 
MIC19_HUMAN 100.00% 27 
RS5_HUMAN 100.00% 36 
ECHM_HUMAN 100.00% 42 
SAHH2_HUMAN 100.00% 39 
ARF5_HUMAN 99.80% 159 
RRAS_HUMAN 98.10% 22 
RPN2_HUMAN 100.00% 182 
ANX11_HUMAN 100.00% 34 
HNRH1_HUMAN 100.00% 11 
CISD2_HUMAN 100.00% 24 
STT3A_HUMAN 100.00% 28 
IF4G1_HUMAN 100.00% 4 
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GBP1_HUMAN 95.00% 12 
STXB2_HUMAN 100.00% 67 
PSB10_HUMAN 95.00% 10 
RS14_HUMAN 100.00% 8 
TOM22_HUMAN 100.00% 31 
GPI8_HUMAN 95.00% 6 
NDUS1_HUMAN 100.00% 80 
MESD_HUMAN 99.80% 6 
WDFY1_HUMAN 99.80% 3 
PDLI1_HUMAN 100.00% 7 
NDUB8_HUMAN 100.00% 16 
C42S2_HUMAN 100.00% 15 
OCAD2_HUMAN 95.00% 1 
MACD1_HUMAN 100.00% 3 
1C12_HUMAN 100.00% 757 
USMG5_HUMAN 100.00% 14 
GLIP1_HUMAN 100.00% 2 
RT22_HUMAN 100.00% 10 
TIM9_HUMAN 100.00% 2 
KCY_HUMAN 100.00% 11 
HG2A_HUMAN 100.00% 339 
NECT1_HUMAN 100.00% 11 
PSA3_HUMAN 97.40% 18 
SRSF6_HUMAN 98.70% 1 
AT5EL_HUMAN,ATP5E_HUMAN 95.00% 2 
RAB7A_HUMAN 100.00% 161 
RL10_HUMAN 100.00% 169 
GLYM_HUMAN 100.00% 348 
CATC_HUMAN 100.00% 10 
PRS7_HUMAN 99.90% 9 
PRPS1_HUMAN 100.00% 21 
CPT2_HUMAN 100.00% 7 
LY75_HUMAN 100.00% 84 
KINH_HUMAN 97.10% 1 
CSDE1_HUMAN 95.00% 1 
AN32B_HUMAN 96.10% 5 
ICAM1_HUMAN 100.00% 527 
PRDX2_HUMAN 100.00% 57 
MOB1A_HUMAN,MOB1B_HUMAN 100.00% 4 
PABP1_HUMAN 100.00% 79 
RS4X_HUMAN 100.00% 303 
CAZA1_HUMAN 100.00% 172 
DOCK8_HUMAN 100.00% 31 
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SC5A6_HUMAN 100.00% 16 
ENV_HV1Z8 99.10% 28 
KAD4_HUMAN 100.00% 5 
OFUT1_HUMAN 100.00% 5 
KPCB_HUMAN 100.00% 39 
HSPB1_HUMAN 100.00% 5 
RT14_HUMAN 95.00% 3 
RL6_HUMAN 100.00% 151 
TBCA_HUMAN 100.00% 14 
OSTC_HUMAN 99.80% 24 
CD37_HUMAN 100.00% 149 
PSB2_HUMAN 100.00% 31 
EF1A2_HUMAN 100.00% 292 
NOP56_HUMAN 95.00% 1 
DUT_HUMAN 100.00% 10 
ALDOC_HUMAN 100.00% 222 
TRPV2_HUMAN 100.00% 37 
ESYT1_HUMAN 100.00% 26 
PROSC_HUMAN 100.00% 2 
STT3B_HUMAN 100.00% 32 
GBG5_HUMAN 100.00% 29 
RM24_HUMAN 95.00% 1 
IF4G2_HUMAN 95.00% 1 
CDS2_HUMAN 95.00% 7 




EIF3F_HUMAN 100.00% 7 
CEPT1_HUMAN 95.00% 6 
ANXA2_HUMAN 100.00% 217 
NDUS2_HUMAN 100.00% 45 
RPIA_HUMAN 99.90% 5 
ADRO_HUMAN 100.00% 6 
NHRF1_HUMAN 100.00% 346 
MOT4_HUMAN 100.00% 65 
TNR5_HUMAN 100.00% 66 
FLNB_HUMAN 100.00% 8 
NNTM_HUMAN 100.00% 22 
TCPB_HUMAN 100.00% 196 
GP183_HUMAN 100.00% 8 
VCAM1_HUMAN 100.00% 5 
E41LB_HUMAN 95.00% 1 
ENV_HV1B9 99.80% 33 
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IMB1_HUMAN 100.00% 43 
SCRIB_HUMAN 100.00% 42 
RT06_HUMAN 95.00% 4 
ITAV_HUMAN 95.00% 3 
PSA4_HUMAN 100.00% 18 
SUMO3_HUMAN 95.00% 12 
RADI_HUMAN 100.00% 955 
SRSF7_HUMAN 100.00% 29 
RM47_HUMAN 95.00% 6 
DAD1_HUMAN 100.00% 12 
ECH1_HUMAN 100.00% 165 
TMX1_HUMAN 100.00% 61 
IF4A1_HUMAN 100.00% 157 
NUDC_HUMAN 100.00% 2 
PLSL_HUMAN 100.00% 1376 
HS74L_HUMAN 99.50% 6 
DHE3_HUMAN 100.00% 216 
ACO13_HUMAN 99.90% 13 
OSBP2_HUMAN 94.90% 1 
THY1_HUMAN 100.00% 18 
AIFM1_HUMAN 100.00% 93 
DDX3X_HUMAN 100.00% 30 
CXCR4_HUMAN 95.00% 8 
PGRC2_HUMAN 99.90% 1 
AR6P1_HUMAN 95.00% 6 
MRP4_HUMAN 100.00% 24 
RSSA_HUMAN 100.00% 95 
FA49B_HUMAN 100.00% 50 
USP9X_HUMAN 99.80% 6 




YBOX1_HUMAN 100.00% 12 
ERG24_HUMAN 95.00% 1 
ICOS_HUMAN 99.80% 23 
ATPG_HUMAN 100.00% 164 
ARF6_HUMAN 100.00% 184 
ACTN4_HUMAN 100.00% 590 
MRRP1_HUMAN 100.00% 4 
CLH1_HUMAN 100.00% 790 
TMED7_HUMAN 100.00% 4 
DSRAD_HUMAN 95.00% 1 
COX2_HUMAN 100.00% 66 
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PPOX_HUMAN 95.00% 1 
TYK2_HUMAN 100.00% 22 
RM03_HUMAN 95.00% 3 
SRSF1_HUMAN 100.00% 16 
ARPC3_HUMAN 100.00% 69 
TMC8_HUMAN 100.00% 2 
PKHO2_HUMAN 100.00% 7 
ACPM_HUMAN 100.00% 66 
C1TC_HUMAN 100.00% 104 
RS26_HUMAN 100.00% 78 
SRC_HUMAN 100.00% 77 
RM39_HUMAN 95.00% 2 
ETFB_HUMAN 100.00% 99 
HACD3_HUMAN 100.00% 6 
MYDGF_HUMAN 100.00% 22 
GANAB_HUMAN 100.00% 571 
RL35A_HUMAN 100.00% 45 
SEP11_HUMAN 99.80% 52 
MLEC_HUMAN 100.00% 65 
DQA1_HUMAN 95.00% 70 
SSRD_HUMAN 100.00% 74 
INSR_HUMAN 100.00% 52 
SYVN1_HUMAN 95.00% 5 
RCD1_HUMAN 100.00% 6 
TSP1_HUMAN 95.00% 1 
DRA_HUMAN 100.00% 820 
ANXA4_HUMAN 100.00% 65 
ERO1A_HUMAN 100.00% 182 
S12A2_HUMAN 100.00% 37 
PA1B2_HUMAN 100.00% 15 
TCPZ_HUMAN 100.00% 102 
PLRKT_HUMAN 99.90% 1 
CERS2_HUMAN 95.00% 2 
AP1B1_HUMAN 100.00% 50 
L2HDH_HUMAN 95.00% 5 
FAF1_HUMAN 95.00% 2 
S4A7_HUMAN 100.00% 104 
AGK_HUMAN 100.00% 43 
M2OM_HUMAN 100.00% 148 
PP16B_HUMAN 100.00% 63 
GTR14_HUMAN 100.00% 31 
SRPRA_HUMAN 100.00% 7 
AATM_HUMAN 100.00% 167 
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CCNY_HUMAN 97.40% 9 
RALB_HUMAN 99.90% 60 
MDHM_HUMAN 100.00% 609 
NIT2_HUMAN 100.00% 10 
SIPA1_HUMAN 100.00% 6 
RAP1B_HUMAN 100.00% 390 
PNPT1_HUMAN 100.00% 11 
ZDH20_HUMAN 95.00% 2 
RM48_HUMAN 95.00% 2 
SYVM_HUMAN 95.00% 2 
K1C10_HUMAN 100.00% 17 
H2B1M_HUMAN 100.00% 62 
DERL1_HUMAN 95.00% 2 
CC50A_HUMAN 100.00% 23 
HCDH_HUMAN 100.00% 29 
AP2A2_HUMAN 100.00% 52 
RGAP1_HUMAN 100.00% 70 




ASAH1_HUMAN 95.00% 1 
KAD3_HUMAN 99.90% 9 
TBB5_HUMAN 100.00% 1090 
RL34_HUMAN 100.00% 13 
PBIP1_HUMAN 95.00% 1 
ASCC3_HUMAN 99.70% 1 
DREB_HUMAN 100.00% 36 
TB10A_HUMAN 100.00% 11 
MARK3_HUMAN 97.70% 9 
PYRG1_HUMAN 100.00% 21 
MUC18_HUMAN 100.00% 32 
SIT1_HUMAN 100.00% 37 
MTX2_HUMAN 95.00% 4 
TMCO1_HUMAN 100.00% 19 
CYFP2_HUMAN 100.00% 44 
PLOD3_HUMAN 100.00% 5 
MPPA_HUMAN 100.00% 17 
ARL2_HUMAN 100.00% 4 
CLIC1_HUMAN 100.00% 806 
PEBP1_HUMAN 100.00% 31 
SDF2L_HUMAN 100.00% 18 
CPNE1_HUMAN 100.00% 104 
TRAF3_HUMAN 100.00% 4 
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ODO2_HUMAN 100.00% 72 
ERP29_HUMAN 100.00% 59 
SLAF6_HUMAN 100.00% 24 
PDC10_HUMAN 100.00% 44 
H2AY_HUMAN 97.80% 1 
ARK72_HUMAN 100.00% 13 
ACOT8_HUMAN 100.00% 7 
HMCS1_HUMAN 100.00% 4 
TAP2_HUMAN 100.00% 9 
GRHPR_HUMAN 100.00% 56 
VTNC_HUMAN 95.00% 87 
AP2B1_HUMAN 100.00% 59 
FSCN1_HUMAN 100.00% 406 
DQA2_HUMAN 100.00% 227 
ATPB_HUMAN 100.00% 990 
ERF3A_HUMAN 100.00% 12 
SYDC_HUMAN 100.00% 128 
ANXA5_HUMAN 100.00% 11 
TMED2_HUMAN 97.50% 8 
KPYM_HUMAN 100.00% 1210 
FLOT1_HUMAN 100.00% 258 
1A31_HUMAN 100.00% 1112 
SNP23_HUMAN 100.00% 93 
SYRC_HUMAN 100.00% 15 
TBA4A_HUMAN 100.00% 736 
AL5AP_HUMAN 95.00% 9 
CALX_HUMAN 100.00% 369 
EMC1_HUMAN 100.00% 31 
ACPH_HUMAN 96.70% 1 
SCOT1_HUMAN 100.00% 53 
EHD1_HUMAN 100.00% 912 
HS105_HUMAN 100.00% 83 
LACB2_HUMAN 100.00% 5 
RL26L_HUMAN 100.00% 6 
ACSL3_HUMAN 100.00% 65 
LASP1_HUMAN 100.00% 10 
EF1G_HUMAN 100.00% 116 
LGUL_HUMAN 100.00% 13 
STML2_HUMAN 100.00% 77 




UCHL3_HUMAN 95.00% 14 
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DKC1_HUMAN 100.00% 4 
CUL3_HUMAN 95.00% 4 
ST17B_HUMAN 95.00% 2 
LTOR1_HUMAN 100.00% 13 
NCLN_HUMAN 100.00% 41 
ETFA_HUMAN 100.00% 200 
RL35_HUMAN 100.00% 45 
NDUB9_HUMAN 100.00% 6 
MARCS_HUMAN 100.00% 129 
TRAP1_HUMAN 100.00% 209 
RL18_HUMAN 100.00% 234 
RL7_HUMAN 100.00% 245 
RB22A_HUMAN 100.00% 16 
FDFT_HUMAN 100.00% 11 
MPPB_HUMAN 100.00% 25 
1A23_HUMAN 98.60% 836 
ST38L_HUMAN 97.80% 5 
CD22_HUMAN 100.00% 29 
ABCE1_HUMAN 100.00% 3 
ITPA_HUMAN 99.90% 5 
HABP2_HUMAN 98.30% 8 
UB2L3_HUMAN 100.00% 24 
TPM3_HUMAN 100.00% 237 
AL1B1_HUMAN 100.00% 70 
PDIA6_HUMAN 100.00% 369 
HS90B_HUMAN 100.00% 653 
OXA1L_HUMAN 99.80% 1 
NPTN_HUMAN 100.00% 7 
SODM_HUMAN 100.00% 32 
PPIB_HUMAN 100.00% 349 
MPZL1_HUMAN 100.00% 19 
MICA1_HUMAN 95.00% 10 
FUMH_HUMAN 100.00% 96 
BST2_HUMAN 95.00% 20 
PSMD7_HUMAN 100.00% 15 
APT_HUMAN 100.00% 40 
RD23B_HUMAN 100.00% 41 
TBB4A_HUMAN 100.00% 817 
RAB10_HUMAN 100.00% 143 
XRCC6_HUMAN 100.00% 7 
RTN3_HUMAN 97.50% 6 
FABP5_HUMAN 100.00% 70 
RL27_HUMAN 100.00% 123 
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IDH3G_HUMAN 100.00% 18 
RASN_HUMAN 100.00% 207 
TFG_HUMAN 100.00% 5 
VDAC3_HUMAN 100.00% 175 
TMED3_HUMAN 100.00% 16 
FLOT2_HUMAN 100.00% 214 
C1QBP_HUMAN 100.00% 202 
ARP5L_HUMAN 100.00% 41 
SLAF1_HUMAN 100.00% 93 
BROX_HUMAN 100.00% 21 
RUXE_HUMAN 95.00% 18 
EMC2_HUMAN 100.00% 10 
LDHA_HUMAN 100.00% 423 
PKHF1_HUMAN 99.20% 3 
AT1B1_HUMAN 100.00% 32 
SAR1A_HUMAN 99.50% 9 
RHG01_HUMAN 95.00% 4 
ERGI3_HUMAN 95.00% 1 
SUCB1_HUMAN 100.00% 36 
CH60_HUMAN 100.00% 1290 
PPIF_HUMAN 100.00% 20 
XRP2_HUMAN 100.00% 37 
GMFG_HUMAN 100.00% 26 
DHB4_HUMAN 100.00% 125 
NDUC2_HUMAN 95.00% 1 
RHOG_HUMAN 100.00% 240 
HSDL2_HUMAN 98.40% 4 
RL21_HUMAN 100.00% 89 
NDUA5_HUMAN 100.00% 14 
IDH3A_HUMAN 100.00% 94 
GNA13_HUMAN 100.00% 111 
EVI2B_HUMAN 95.00% 1 
SPEE_HUMAN 100.00% 4 
HBA_HUMAN 100.00% 122 
PTPRC_HUMAN 100.00% 838 
COPG1_HUMAN 100.00% 16 
ERMP1_HUMAN 95.00% 5 
6PGL_HUMAN 95.00% 1 
RL19_HUMAN 100.00% 25 
CHID1_HUMAN 100.00% 29 
SAM50_HUMAN 100.00% 48 
POTEF_HUMAN 100.00% 1014 
CDC42_HUMAN 100.00% 249 
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DNJC3_HUMAN 100.00% 9 
RL27A_HUMAN 100.00% 42 
DIAP1_HUMAN 100.00% 18 
ARP2_HUMAN 100.00% 143 
PLCH1_HUMAN 95.00% 2 
PSD11_HUMAN 100.00% 11 
EF1B_HUMAN 100.00% 24 
THIOM_HUMAN 95.00% 1 
VATB1_HUMAN 95.00% 1 
CD59_HUMAN 100.00% 45 
K2C1_HUMAN 100.00% 94 
AT11C_HUMAN 100.00% 34 
KPRB_HUMAN 100.00% 4 
EXOC1_HUMAN 100.00% 3 
RUVB2_HUMAN 100.00% 56 
RL30_HUMAN 100.00% 184 
NDUB4_HUMAN 100.00% 3 
RL14_HUMAN 100.00% 142 
GRP75_HUMAN 100.00% 564 
RL13_HUMAN 100.00% 66 
AIMP1_HUMAN 100.00% 15 
DEFI6_HUMAN 100.00% 5 
AT2B1_HUMAN 100.00% 103 
RS25_HUMAN 100.00% 59 
PP1A_HUMAN 100.00% 167 
APOC3_HUMAN 95.00% 10 
PLST_HUMAN 100.00% 245 
GDIR2_HUMAN 100.00% 155 
ICAM3_HUMAN 100.00% 247 
AATC_HUMAN 100.00% 43 
PLEC_HUMAN 99.90% 3 
F162A_HUMAN 100.00% 17 
PP2AA_HUMAN,PP2AB_HUMAN 99.90% 1 
SEPT9_HUMAN 100.00% 58 
PRKDC_HUMAN 100.00% 4 
MDHC_HUMAN 100.00% 108 
CNDP2_HUMAN 100.00% 7 
PDIA1_HUMAN 100.00% 492 
FKB11_HUMAN 100.00% 17 
CD70_HUMAN 100.00% 479 
SYVC_HUMAN 100.00% 24 
RM21_HUMAN 95.00% 5 
ABCF1_HUMAN 95.00% 6 
298 
 
PI42A_HUMAN 100.00% 24 
TRAF1_HUMAN 100.00% 32 
MIRO2_HUMAN 95.00% 7 
AFG32_HUMAN 100.00% 21 
PSMD2_HUMAN 100.00% 18 
REEP5_HUMAN 95.00% 10 
RM19_HUMAN 100.00% 10 
DYN2_HUMAN 100.00% 4 
GDIB_HUMAN 100.00% 127 
RAB8B_HUMAN 100.00% 262 
RS8_HUMAN 100.00% 230 
RENT1_HUMAN 100.00% 12 
RL22_HUMAN 100.00% 19 
NDUA6_HUMAN 100.00% 40 
IDH3B_HUMAN 100.00% 24 
1B07_HUMAN 100.00% 887 
EMC7_HUMAN 100.00% 9 
BRK1_HUMAN 95.00% 1 
AT2A3_HUMAN 99.80% 42 
RS17_HUMAN 100.00% 22 
PIPNB_HUMAN 100.00% 5 
NB5R3_HUMAN 100.00% 150 
TWF2_HUMAN 100.00% 34 
RS15A_HUMAN 100.00% 60 
MLF2_HUMAN 100.00% 6 
SH3L3_HUMAN 95.00% 12 
ARP3_HUMAN 100.00% 320 
MACF1_HUMAN 99.90% 2 
NPS3A_HUMAN 100.00% 15 
PGAM5_HUMAN 100.00% 16 
FLNA_HUMAN 100.00% 691 
AP2M1_HUMAN 100.00% 76 
GTR5_HUMAN 95.00% 17 
RL10A_HUMAN 100.00% 21 
RT25_HUMAN 100.00% 11 
RAB2A_HUMAN 100.00% 37 
PSME1_HUMAN 100.00% 41 
CECR5_HUMAN 100.00% 26 
AKAP2_HUMAN 100.00% 20 
COPB_HUMAN 100.00% 42 
SPRY4_HUMAN 100.00% 8 
2B17_HUMAN 100.00% 862 
DYHC1_HUMAN 100.00% 4 
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URP2_HUMAN 100.00% 197 
IF4A3_HUMAN 100.00% 14 
RGS19_HUMAN 100.00% 15 
RS11_HUMAN 100.00% 85 
TBRG4_HUMAN 100.00% 12 
AIMP2_HUMAN 95.00% 18 
ES1_HUMAN 100.00% 43 
DNJA1_HUMAN 100.00% 35 
PRDX5_HUMAN 100.00% 92 
THIC_HUMAN 100.00% 41 
NIPS1_HUMAN 100.00% 183 
1A02_HUMAN 100.00% 1332 
SNG2_HUMAN 99.60% 1 
HINT2_HUMAN 100.00% 21 
CLPB_HUMAN 100.00% 12 
3HIDH_HUMAN 95.00% 4 
PABP4_HUMAN 100.00% 34 
ADT1_HUMAN 99.90% 127 
EFR3A_HUMAN 100.00% 13 
ADPGK_HUMAN 95.00% 5 
SPTB2_HUMAN 100.00% 1052 
IPYR_HUMAN 100.00% 76 
MIC25_HUMAN 95.00% 1 
HNRPD_HUMAN 100.00% 9 
CD226_HUMAN 100.00% 41 
PREB_HUMAN 100.00% 6 
CLPT1_HUMAN 95.00% 1 
RT17_HUMAN 95.00% 1 
RUS1_HUMAN 100.00% 4 
RL9_HUMAN 100.00% 112 
PRPF3_HUMAN 95.00% 1 
YKT6_HUMAN 100.00% 4 
PSMD3_HUMAN 100.00% 2 
ISOC2_HUMAN 100.00% 11 
TMM68_HUMAN 100.00% 9 
PSB5_HUMAN 94.70% 1 
RAC1_HUMAN 100.00% 171 
ACSL4_HUMAN 100.00% 187 
RS9_HUMAN 100.00% 165 
UBA1_HUMAN 100.00% 115 
RS20_HUMAN 100.00% 52 
NENF_HUMAN 95.00% 1 
ENOG_HUMAN 100.00% 275 
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DECR_HUMAN 100.00% 44 
MOGS_HUMAN 100.00% 50 
1B51_HUMAN,1B78_HUMAN 100.00% 1099 
EIF3I_HUMAN 95.00% 3 
SLIRP_HUMAN 100.00% 16 
NDUS5_HUMAN 100.00% 10 
SC5A3_HUMAN 100.00% 10 
SODC_HUMAN 100.00% 19 
DX39B_HUMAN 100.00% 13 
AHSA1_HUMAN 100.00% 17 
DBNL_HUMAN 100.00% 34 
ACTC_HUMAN 100.00% 1811 
TNR8_HUMAN 100.00% 18 
PARK7_HUMAN 100.00% 91 
ADA10_HUMAN 100.00% 17 
TCPE_HUMAN 100.00% 110 
RM14_HUMAN 95.00% 1 
QCR2_HUMAN 100.00% 129 
RS3_HUMAN 100.00% 159 
DOPD_HUMAN 100.00% 61 
G3P_HUMAN 100.00% 952 
ACD11_HUMAN 95.00% 1 
SRC8_HUMAN 99.80% 3 
RT09_HUMAN 100.00% 9 
CD99_HUMAN 100.00% 18 
FAK2_HUMAN 100.00% 1 
PSA7_HUMAN 100.00% 35 
DHSO_HUMAN 100.00% 34 
A2MG_HUMAN 100.00% 21 
TMX4_HUMAN 95.00% 4 
KAPCA_HUMAN 100.00% 3 
RS12_HUMAN 100.00% 62 
QSOX2_HUMAN 95.00% 2 
TCTP_HUMAN 100.00% 23 
NDUF4_HUMAN 95.00% 12 
MYL6_HUMAN 100.00% 180 
ADA_HUMAN 100.00% 17 
PLXB2_HUMAN 100.00% 40 
PUR1_HUMAN 99.90% 3 
LYN_HUMAN 99.30% 27 
MIF_HUMAN 100.00% 120 
DNJA2_HUMAN 100.00% 11 
PRDX6_HUMAN 100.00% 117 
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CORO7_HUMAN 100.00% 29 
SYSC_HUMAN 100.00% 13 
LFA3_HUMAN 100.00% 28 
F234A_HUMAN 95.00% 6 
CD79B_HUMAN 95.00% 2 
DHX9_HUMAN 100.00% 4 
DDB1_HUMAN 97.60% 3 
UBE2N_HUMAN 100.00% 50 
PFD6_HUMAN 95.00% 1 
SGMR1_HUMAN 95.00% 4 
ROA2_HUMAN 100.00% 3 
TERA_HUMAN 100.00% 95 
KTHY_HUMAN 100.00% 1 
RAP2C_HUMAN 100.00% 33 
T200A_HUMAN 100.00% 12 
PLMN_HUMAN 100.00% 32 
CATA_HUMAN 100.00% 75 
IF2A_HUMAN 100.00% 15 
CD19_HUMAN 97.20% 1 
PCBP1_HUMAN 100.00% 97 
RL37A_HUMAN 95.00% 6 
CTL1_HUMAN 95.00% 3 
SSRG_HUMAN 95.00% 27 
MCA3_HUMAN 100.00% 13 
PDCD5_HUMAN 100.00% 8 
SYFB_HUMAN 100.00% 6 
LCAP_HUMAN 100.00% 22 
OXYR_HUMAN 95.00% 1 
ITIH3_HUMAN 99.80% 5 
TPM4_HUMAN 100.00% 286 
S39AA_HUMAN 99.90% 11 
PPP6_HUMAN 95.00% 4 
NDUBA_HUMAN 100.00% 20 
KAD2_HUMAN 100.00% 59 
PEA15_HUMAN 95.00% 3 
TIM16_HUMAN 95.00% 1 
RASL3_HUMAN 100.00% 545 
SF3B1_HUMAN 100.00% 16 
RT12_HUMAN 99.80% 1 
PLCL2_HUMAN 100.00% 3 
RL4_HUMAN 100.00% 317 
EMB_HUMAN 97.60% 7 
HMGB1_HUMAN 100.00% 35 
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GNAQ_HUMAN 99.90% 1 
LAMP1_HUMAN 99.80% 16 
TACO1_HUMAN 99.80% 2 
RPN1_HUMAN 100.00% 491 
RAB6A_HUMAN 100.00% 36 
MP2K1_HUMAN 95.00% 1 
SE1L1_HUMAN 95.00% 8 
ALDOA_HUMAN 100.00% 611 
ENOB_HUMAN 98.60% 356 
CMC1_HUMAN 100.00% 52 
SHKB1_HUMAN 99.90% 6 
LEG1_HUMAN 100.00% 160 
CO1A2_HUMAN 98.80% 1 
NONO_HUMAN 95.00% 5 
ENTP1_HUMAN 100.00% 196 
EIF3D_HUMAN 100.00% 4 
IF5_HUMAN 99.80% 1 
ILVBL_HUMAN 99.80% 1 
TS101_HUMAN 100.00% 40 
NDUV2_HUMAN 100.00% 27 
VATH_HUMAN 95.00% 5 
RAB35_HUMAN 100.00% 167 
SPCS3_HUMAN 100.00% 15 
ATPK_HUMAN 100.00% 55 
GLU2B_HUMAN 100.00% 119 
NDUAC_HUMAN 100.00% 35 
VAT1_HUMAN 95.00% 2 
SCAM3_HUMAN 95.00% 1 
CLIC4_HUMAN 100.00% 149 
ADHX_HUMAN 95.00% 2 
AAAT_HUMAN 100.00% 266 
SORCN_HUMAN 100.00% 22 
RS3A_HUMAN 100.00% 225 
IDHP_HUMAN 100.00% 358 
TREX1_HUMAN 95.00% 8 
SUMO1_HUMAN 95.00% 6 
SMD3_HUMAN 95.00% 9 
CLM8_HUMAN 100.00% 3 
NACAM_HUMAN 100.00% 14 
NTF2_HUMAN 100.00% 13 
RBP2_HUMAN 99.90% 1 
RAB5C_HUMAN 100.00% 53 
SERA_HUMAN 100.00% 31 
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PACN2_HUMAN 100.00% 102 
ESTD_HUMAN 100.00% 2 
PCBP2_HUMAN 100.00% 79 
PLS3_HUMAN 99.90% 3 
PFKAL_HUMAN 100.00% 90 
VAMP5_HUMAN 97.70% 9 
STAT1_HUMAN 100.00% 12 
PRDX1_HUMAN 100.00% 212 
CTR1_HUMAN 100.00% 19 
PDCD6_HUMAN 95.00% 8 
PIGT_HUMAN 100.00% 4 
RL29_HUMAN 100.00% 21 
CAP1_HUMAN 100.00% 80 
RLA1_HUMAN 100.00% 39 
COTL1_HUMAN 100.00% 44 
HUWE1_HUMAN 100.00% 8 
ARF4_HUMAN 100.00% 149 
IF5A1_HUMAN,IF5AL_HUMAN 100.00% 67 
MMAB_HUMAN 95.00% 3 
TMED5_HUMAN 100.00% 3 
GATM_HUMAN 100.00% 11 
TPSN_HUMAN 100.00% 76 
H4_HUMAN 100.00% 215 
DTNA_HUMAN 94.70% 4 
CNPY2_HUMAN 100.00% 43 
RM01_HUMAN 95.00% 3 
1C03_HUMAN 100.00% 723 
CTGE5_HUMAN,MIA2_HUMAN 95.00% 15 
TMC6_HUMAN 100.00% 15 
UB2V1_HUMAN 100.00% 14 
S10AB_HUMAN 98.30% 1 





MCCB_HUMAN 100.00% 15 
CD86_HUMAN 99.80% 14 
GOGA7_HUMAN 100.00% 27 
GBB1_HUMAN 100.00% 354 
MSMO1_HUMAN 96.10% 2 
PRDX3_HUMAN 100.00% 154 
CHM4B_HUMAN 100.00% 56 
CSK21_HUMAN,CSK23_HUMAN 100.00% 28 
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PTCD3_HUMAN 100.00% 11 
GLRX1_HUMAN 97.40% 1 
NICA_HUMAN 100.00% 64 
DDX6_HUMAN 100.00% 11 
PSA_HUMAN 99.80% 2 
RAC2_HUMAN 100.00% 252 
HSP7C_HUMAN 100.00% 1004 
EH1L1_HUMAN 96.50% 3 
CYB5B_HUMAN 100.00% 40 
PAGE5_HUMAN 95.00% 11 
TM205_HUMAN 100.00% 24 
GLGB_HUMAN 100.00% 55 
NDKA_HUMAN 100.00% 179 
RL38_HUMAN 100.00% 19 
DDX17_HUMAN 100.00% 50 
AL9A1_HUMAN 100.00% 3 
CAPZB_HUMAN 100.00% 155 
TXND5_HUMAN 100.00% 221 
NDUB1_HUMAN 100.00% 13 
PDXK_HUMAN 95.00% 2 
IF6_HUMAN 100.00% 9 
FNBP1_HUMAN 100.00% 39 
TNR4_HUMAN 95.00% 8 
PTH2_HUMAN 95.00% 14 
TCPA_HUMAN 100.00% 201 
NDUB5_HUMAN 100.00% 9 
QPCTL_HUMAN 95.00% 7 
RTN4_HUMAN 100.00% 32 
SUMF2_HUMAN 100.00% 4 
KAP0_HUMAN 100.00% 8 
DHB12_HUMAN 100.00% 101 
KPCD_HUMAN 100.00% 27 
DPM3_HUMAN 95.00% 12 
TM9S2_HUMAN 95.00% 1 
RHG15_HUMAN 97.60% 2 
RM46_HUMAN 95.00% 3 
LSP1_HUMAN 100.00% 269 
EF1D_HUMAN 100.00% 56 
ITA5_HUMAN 99.90% 2 
PX11B_HUMAN 100.00% 10 
EBP_HUMAN 100.00% 4 
FCRLA_HUMAN 99.90% 1 
MPU1_HUMAN 100.00% 4 
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FA98A_HUMAN 95.00% 1 
PGRC1_HUMAN 100.00% 16 
RL32_HUMAN 100.00% 56 
ATLA3_HUMAN 100.00% 9 
VP37B_HUMAN 95.00% 2 
PFKAM_HUMAN 98.90% 23 
TM214_HUMAN 95.00% 4 
SDHA_HUMAN 100.00% 82 
COPT1_HUMAN 95.00% 11 
IVD_HUMAN 100.00% 3 




FADS2_HUMAN 100.00% 27 
IGHG1_HUMAN 100.00% 141 
RLA2_HUMAN 100.00% 101 
WDR11_HUMAN 95.00% 1 
ECHA_HUMAN 100.00% 97 
ZCHC3_HUMAN 100.00% 7 
ACADV_HUMAN 100.00% 48 
TYB4_HUMAN 100.00% 19 
MAGT1_HUMAN 99.90% 13 
ERP44_HUMAN 100.00% 61 
CNPY3_HUMAN 99.90% 2 
SURF4_HUMAN 100.00% 15 
MIC60_HUMAN 100.00% 120 
TMM33_HUMAN 100.00% 23 
DRB4_HUMAN 100.00% 208 
CH10_HUMAN 100.00% 223 
LEUK_HUMAN 100.00% 109 
COX8A_HUMAN 95.00% 1 
MYO1C_HUMAN 100.00% 361 
MRP_HUMAN 99.90% 54 
RM38_HUMAN 100.00% 4 
STOM_HUMAN 100.00% 41 
ACBP_HUMAN 99.90% 3 
RL18A_HUMAN 100.00% 141 
TLDC1_HUMAN 95.00% 6 
TP4A3_HUMAN 100.00% 13 
IL16_HUMAN 100.00% 39 
OST48_HUMAN 100.00% 174 
1433F_HUMAN 100.00% 70 
EFTU_HUMAN 100.00% 487 
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DHB7_HUMAN 95.00% 1 
GNPI1_HUMAN 100.00% 2 
FA10_HUMAN 95.00% 2 




HNRPR_HUMAN 100.00% 22 
MOES_HUMAN 100.00% 2077 
STK10_HUMAN 100.00% 49 
NDKB_HUMAN 100.00% 138 
DOCK2_HUMAN 100.00% 20 
LRC59_HUMAN 95.00% 7 
STIP1_HUMAN 100.00% 76 
TBB6_HUMAN 99.90% 283 
PFD2_HUMAN 100.00% 8 
ERAP2_HUMAN 100.00% 2 
NDUAD_HUMAN 100.00% 33 
PYR1_HUMAN 100.00% 81 
ACAD9_HUMAN 100.00% 9 
B2MG_HUMAN 100.00% 149 
CD81_HUMAN 100.00% 158 
CD48_HUMAN 100.00% 531 
GNAS1_HUMAN 100.00% 262 
K1C9_HUMAN 100.00% 11 
XPO2_HUMAN 100.00% 15 
RAP1A_HUMAN 100.00% 411 
PDIP2_HUMAN 95.00% 1 
ACON_HUMAN 100.00% 118 
ACDSB_HUMAN 100.00% 7 
TKT_HUMAN 100.00% 67 
ARPC2_HUMAN 100.00% 202 
PTCA_HUMAN 100.00% 27 
TMM43_HUMAN 100.00% 32 
KIF23_HUMAN 100.00% 93 
AP2A1_HUMAN 100.00% 79 
EXOC4_HUMAN 95.00% 1 
ACLY_HUMAN 100.00% 69 
ACS2L_HUMAN 100.00% 7 
EVL_HUMAN 100.00% 45 
MYH9_HUMAN 100.00% 2243 
GRP78_HUMAN 100.00% 1104 
SDHB_HUMAN 100.00% 76 
LPXN_HUMAN 100.00% 2 
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CISY_HUMAN 100.00% 198 
GT251_HUMAN 95.00% 3 
MARK2_HUMAN 100.00% 22 
SC11A_HUMAN 100.00% 17 
RAB14_HUMAN 100.00% 70 
ZDHC5_HUMAN 100.00% 35 
MTX1_HUMAN 100.00% 20 
KDIS_HUMAN 100.00% 8 
PUR8_HUMAN 100.00% 20 
CD20_HUMAN 100.00% 507 
ECHB_HUMAN 100.00% 58 
THRB_HUMAN 95.00% 4 
PARP1_HUMAN 100.00% 4 
CDC37_HUMAN 100.00% 20 
FMNL3_HUMAN 100.00% 22 
ODO1_HUMAN 100.00% 40 
PDIA4_HUMAN 100.00% 328 
PDC6I_HUMAN 100.00% 161 
CASP1_HUMAN 100.00% 21 
DPA1_HUMAN 100.00% 50 
SMD2_HUMAN 100.00% 2 
RT36_HUMAN 95.00% 17 
MYO1D_HUMAN 100.00% 18 
ZCCHV_HUMAN 100.00% 20 
PGES2_HUMAN 100.00% 12 
SNTB2_HUMAN 97.70% 7 
AMPL_HUMAN 100.00% 49 
1433G_HUMAN 100.00% 104 
SPP24_HUMAN 95.00% 3 
PA2G4_HUMAN 100.00% 38 
CLCA_HUMAN 100.00% 4 
MARE1_HUMAN 100.00% 39 
ATPA_HUMAN 100.00% 659 
NDUA9_HUMAN 100.00% 38 
COX41_HUMAN 100.00% 80 
SDCB1_HUMAN 100.00% 162 
PPIL1_HUMAN 100.00% 19 
TMED1_HUMAN 95.00% 8 
TXD17_HUMAN 100.00% 17 
S38A2_HUMAN 95.00% 1 
PFD3_HUMAN 95.00% 1 
AK1A1_HUMAN 100.00% 45 
HAX1_HUMAN 95.00% 4 
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CSRP1_HUMAN 100.00% 21 
PUR9_HUMAN 100.00% 271 
FAH2A_HUMAN,FAH2B_HUMAN 95.00% 3 
OXLA_HUMAN 100.00% 4 
DHRS4_HUMAN 100.00% 20 
ACOT1_HUMAN 100.00% 6 
CD82_HUMAN 100.00% 46 
THIL_HUMAN 100.00% 114 
ERGI1_HUMAN 100.00% 9 
ESAM_HUMAN 100.00% 4 
AN32A_HUMAN 100.00% 3 
HVCN1_HUMAN 97.40% 16 
BOLA2_HUMAN 100.00% 3 
RT28_HUMAN 96.50% 11 
LPPRC_HUMAN 100.00% 370 
DDX1_HUMAN 99.90% 4 
CL17A_HUMAN 100.00% 26 
HNRPM_HUMAN 100.00% 7 
EXOC5_HUMAN 100.00% 7 
PTPRA_HUMAN 100.00% 26 
ODPA_HUMAN 100.00% 124 
TLN1_HUMAN 100.00% 215 
FKBP4_HUMAN 100.00% 6 
MB12A_HUMAN 95.00% 5 
MAOM_HUMAN 100.00% 68 
RL17_HUMAN 100.00% 97 
IFM1_HUMAN 100.00% 50 
FETUA_HUMAN 95.00% 6 
KCNN4_HUMAN 100.00% 2 
RS29_HUMAN 100.00% 9 
GIMA5_HUMAN 100.00% 26 
PANX1_HUMAN 95.00% 1 




CN37_HUMAN 100.00% 22 
LMAN2_HUMAN 100.00% 79 
PPIA_HUMAN 100.00% 720 
GSTP1_HUMAN 100.00% 345 
FAS_HUMAN 100.00% 263 
AT1A1_HUMAN 100.00% 935 
PDIA5_HUMAN 100.00% 5 
HS90A_HUMAN 100.00% 773 
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BAP31_HUMAN 100.00% 77 
COX5A_HUMAN 100.00% 51 
NDUB3_HUMAN 100.00% 4 
CNN2_HUMAN 100.00% 178 
RBG1L_HUMAN 100.00% 14 
RB11B_HUMAN 100.00% 100 
MVP_HUMAN 98.90% 1 
CQ062_HUMAN 100.00% 3 
S1PR4_HUMAN 100.00% 6 
COR1C_HUMAN 100.00% 125 
PSMD6_HUMAN 95.00% 1 
6PGD_HUMAN 100.00% 64 
RL11_HUMAN 100.00% 41 
PRS10_HUMAN 100.00% 12 
S29A1_HUMAN 100.00% 102 
RS23_HUMAN 100.00% 28 
CY1_HUMAN 100.00% 77 
AP180_HUMAN 97.10% 5 
NAV1_HUMAN 99.90% 1 
PRC1_HUMAN 100.00% 3 
SCO1_HUMAN 100.00% 6 
ILK_HUMAN 100.00% 9 
CAN1_HUMAN 100.00% 6 
VDAC2_HUMAN 100.00% 250 
NCPR_HUMAN 100.00% 38 
SELPL_HUMAN 95.00% 1 
PRAX_HUMAN 95.80% 3 
GPX7_HUMAN 100.00% 5 
NDUS8_HUMAN 100.00% 18 
CAND1_HUMAN 100.00% 24 
SYPL1_HUMAN 95.00% 10 
STIM1_HUMAN 100.00% 11 
CIB1_HUMAN 100.00% 53 





TCPH_HUMAN 100.00% 64 
MTCH2_HUMAN 100.00% 60 
CLDN1_HUMAN 100.00% 18 
UBC12_HUMAN 95.00% 1 
LSM2_HUMAN 95.00% 3 
RS6_HUMAN 100.00% 125 
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JAK3_HUMAN 100.00% 4 
RT29_HUMAN 100.00% 8 
1433B_HUMAN 100.00% 88 
CALM_HUMAN 100.00% 22 
RHOF_HUMAN 100.00% 137 
GLPC_HUMAN 95.00% 4 
TSN14_HUMAN 95.00% 4 
TECR_HUMAN 100.00% 8 
NDUA4_HUMAN 95.00% 7 
NP1L1_HUMAN 100.00% 112 
SCRB1_HUMAN 100.00% 100 
TNIK_HUMAN 100.00% 12 
STXB3_HUMAN 100.00% 87 
ODPB_HUMAN 100.00% 144 
RS15_HUMAN 100.00% 115 
TOM40_HUMAN 100.00% 61 
PROF1_HUMAN 100.00% 462 
TXD12_HUMAN 100.00% 32 
DJB11_HUMAN 100.00% 49 
HYOU1_HUMAN 100.00% 430 
AP2S1_HUMAN 100.00% 3 
KDSR_HUMAN 100.00% 4 






HINT1_HUMAN 99.90% 1 
SYNC_HUMAN 100.00% 13 
RCN2_HUMAN 99.80% 4 
SH3L1_HUMAN 100.00% 32 
NOMO1_HUMAN,NOMO3_HUMAN 100.00% 21 
IPYR2_HUMAN 100.00% 38 
GPR15_HUMAN 100.00% 21 
TIM44_HUMAN 100.00% 11 
MPI_HUMAN 95.00% 1 
P5CS_HUMAN 100.00% 17 
PEX16_HUMAN 99.90% 1 
COX5B_HUMAN 100.00% 38 
GSHR_HUMAN 100.00% 2 
ATP6_HUMAN 95.00% 7 
CD2_HUMAN 95.00% 4 
SYQ_HUMAN 100.00% 19 
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NU1M_HUMAN 95.00% 8 
HCLS1_HUMAN 100.00% 39 
SERC_HUMAN 100.00% 56 
WDR1_HUMAN 100.00% 282 
RL12_HUMAN 100.00% 29 
RDH11_HUMAN 100.00% 18 
SUSD3_HUMAN 95.00% 18 
ROA3_HUMAN 100.00% 27 
CX6B1_HUMAN 100.00% 18 
NUCB1_HUMAN 100.00% 7 
TRUA_HUMAN 95.00% 1 
GDIR1_HUMAN 100.00% 84 
TPP1_HUMAN 95.00% 1 
UBP14_HUMAN 100.00% 5 
CS052_HUMAN 95.00% 2 
U2AF1_HUMAN,U2AF5_HUMAN 100.00% 4 
CKAP4_HUMAN 100.00% 14 
PLCE_HUMAN 100.00% 11 
EIF3M_HUMAN 100.00% 8 
CAZA2_HUMAN 100.00% 52 
ACOD_HUMAN 95.00% 3 
DECR2_HUMAN 100.00% 2 
FCER2_HUMAN 100.00% 79 
S52A2_HUMAN 95.00% 4 
GNAI2_HUMAN 100.00% 605 
NCKPL_HUMAN 100.00% 8 
PLCG2_HUMAN 100.00% 64 
MTDC_HUMAN 100.00% 13 
HSP74_HUMAN 100.00% 22 
PUR6_HUMAN 100.00% 70 
ACTG_HUMAN 100.00% 4972 
CYTB_HUMAN 100.00% 8 
RAB1A_HUMAN 100.00% 191 
LIRB1_HUMAN 100.00% 11 
TBCB_HUMAN 95.00% 4 
CYC_HUMAN 100.00% 28 
PSMD1_HUMAN 100.00% 3 
MGST1_HUMAN 95.00% 10 
DJC11_HUMAN 95.00% 9 
PSB3_HUMAN 100.00% 6 
ARL8B_HUMAN 100.00% 14 
RAB8A_HUMAN 100.00% 337 
RS7_HUMAN 100.00% 49 
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FKB1A_HUMAN 100.00% 37 
MPP6_HUMAN 100.00% 74 
CP054_HUMAN 100.00% 38 
ACADM_HUMAN 100.00% 19 
AT2A2_HUMAN 100.00% 112 
RS16_HUMAN 100.00% 130 
MOV10_HUMAN 100.00% 61 
PI51A_HUMAN 95.00% 4 
EIF3G_HUMAN 95.00% 4 
STX4_HUMAN 100.00% 38 
PIPNA_HUMAN 96.80% 2 
NDUS3_HUMAN 100.00% 89 
LYPA1_HUMAN 100.00% 36 
BAHC1_HUMAN 95.00% 14 
MYADM_HUMAN 95.00% 9 
STK26_HUMAN 100.00% 35 
1433T_HUMAN 100.00% 81 
ZCCHL_HUMAN 99.70% 1 
TNR6_HUMAN 100.00% 115 
MPRD_HUMAN 100.00% 17 
POL_HV1Z2 100.00% 1504 
POL_HV1YF 100.00% 683 
FETA_HUMAN 100.00% 13 
POL_HV1Y2 100.00% 3133 
CD44_HUMAN 100.00% 348 
RM12_HUMAN 100.00% 29 
IQGA2_HUMAN 100.00% 188 
SRP14_HUMAN 100.00% 34 
LACTB_HUMAN 99.90% 1 
TM41A_HUMAN 100.00% 11 
DPYL2_HUMAN 98.30% 9 
RHOA_HUMAN 100.00% 279 
PEF1_HUMAN 100.00% 10 
CX7A2_HUMAN 100.00% 47 
CD97_HUMAN 100.00% 129 
TM9S4_HUMAN 100.00% 13 
SCPDL_HUMAN 100.00% 14 
RAE1L_HUMAN 99.80% 1 
PCKGM_HUMAN 100.00% 41 
FYN_HUMAN 100.00% 55 
PSA5_HUMAN 100.00% 35 
COPA_HUMAN 100.00% 138 
RHG17_HUMAN 100.00% 14 
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PD1L1_HUMAN 100.00% 9 
POL_HV1RH 100.00% 1646 
GRSF1_HUMAN 95.00% 6 
NLTP_HUMAN 100.00% 66 
IF4A2_HUMAN 99.90% 83 
RS10_HUMAN 100.00% 3 
DAAM1_HUMAN 100.00% 3 
POL_HV1OY 100.00% 2653 
TNAP2_HUMAN 95.00% 2 
TADBP_HUMAN 95.00% 5 
POL_HV1MP 100.00% 836 
SYAC_HUMAN 100.00% 18 
POL_HV1MN 100.00% 2925 
NUCB2_HUMAN 100.00% 3 
NUCL_HUMAN 100.00% 53 
RACK1_HUMAN 100.00% 100 
S10A4_HUMAN 99.90% 5 
VAMP8_HUMAN 95.00% 7 
GNA1_HUMAN 95.00% 6 
FA65B_HUMAN 100.00% 5 
PRDX4_HUMAN 100.00% 84 
POL_HV1JR 100.00% 2894 
Table 4b. All proteins identified for the HIV-1(MN)CL.4/CEMx174(T1). 









GRK6_HUMAN 100.00% 15 
POL_HV1J3 100.00% 4591 
HS71A_HUMAN,HS71B_HUMAN 100.00% 216 
GNAI3_HUMAN 100.00% 256 
POL_HV1ET 100.00% 1513 
POL_HV1EL 100.00% 4744 
CD53_HUMAN 99.80% 31 
PRS4_HUMAN 95.00% 13 
1B18_HUMAN 100.00% 669 
POL_HV1B9 100.00% 5932 
RAB1B_HUMAN 100.00% 245 
RL8_HUMAN 100.00% 25 
POL_HV1A2 100.00% 6876 
CPNS1_HUMAN 99.80% 2 
VATE1_HUMAN 100.00% 4 
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OLA1_HUMAN 100.00% 20 
ATP5I_HUMAN 95.00% 4 
G6PI_HUMAN 100.00% 97 
VAPA_HUMAN 100.00% 40 
ATP5L_HUMAN 100.00% 41 
PRS8_HUMAN 100.00% 3 
VTA1_HUMAN 100.00% 86 
POL_HV19N 100.00% 1615 
POL_HV197 100.00% 2127 
POL_HV196 100.00% 2675 
POL_HV193 100.00% 2147 
POL_HV192 100.00% 1306 
ANTR1_HUMAN 100.00% 4 
CD109_HUMAN 100.00% 3 
ACYP1_HUMAN 99.90% 2 
ITIH1_HUMAN 99.80% 5 
SEP15_HUMAN 95.00% 1 
CXAR_HUMAN 100.00% 19 
PA1B3_HUMAN 100.00% 11 
VATL_HUMAN 95.00% 6 
ACTB_HUMAN 100.00% 2308 
IL2RG_HUMAN 100.00% 25 
SYYC_HUMAN 100.00% 43 
TCPD_HUMAN 100.00% 109 
QCR1_HUMAN 100.00% 27 
4F2_HUMAN 100.00% 769 
RS2_HUMAN 100.00% 127 
TM109_HUMAN 95.00% 3 
SNAA_HUMAN 100.00% 23 
MANF_HUMAN 100.00% 4 
CD38_HUMAN 100.00% 605 
CYBP_HUMAN 100.00% 35 
IGSF8_HUMAN 100.00% 205 
AP1B1_HUMAN 100.00% 41 
LETM1_HUMAN 100.00% 7 
ARPC4_HUMAN 100.00% 84 
PSN1_HUMAN 99.80% 14 
DHCR7_HUMAN 100.00% 13 
ABRAL_HUMAN 100.00% 2 
DIP2B_HUMAN 100.00% 56 
SFXN1_HUMAN 100.00% 33 
ASNS_HUMAN 100.00% 12 
IF2G_HUMAN 100.00% 5 
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STMN1_HUMAN 100.00% 21 
ABI2_HUMAN 100.00% 2 
PFKAP_HUMAN 100.00% 44 
HCD2_HUMAN 100.00% 57 
PSD12_HUMAN 95.00% 4 
PAIP1_HUMAN 95.00% 1 
PHB2_HUMAN 100.00% 106 
VP26A_HUMAN 100.00% 15 
CBPN_HUMAN 95.00% 2 
TMED9_HUMAN 100.00% 15 
RLA1_HUMAN 95.00% 7 
TIM14_HUMAN 95.00% 1 
TXTP_HUMAN 100.00% 28 
1C07_HUMAN 100.00% 512 
HMGA1_HUMAN 100.00% 12 
SRSF3_HUMAN 100.00% 15 
PURA_HUMAN 100.00% 23 
SMD1_HUMAN 100.00% 11 
H2AV_HUMAN,H2AZ_HUMAN 100.00% 107 
RL13A_HUMAN 100.00% 40 
OTUB1_HUMAN 100.00% 7 
RAP2B_HUMAN 100.00% 38 
MMAB_HUMAN 95.00% 1 
PLS1_HUMAN 95.00% 17 
PGM1_HUMAN 99.80% 6 
GCSAM_HUMAN 100.00% 4 
RS13_HUMAN 100.00% 35 
MSI2H_HUMAN 100.00% 43 
LDLR_HUMAN 100.00% 66 
HNRPU_HUMAN 100.00% 11 
SATT_HUMAN 100.00% 20 
ANO6_HUMAN 100.00% 26 
ITIH2_HUMAN 100.00% 60 
ANXA6_HUMAN 100.00% 461 
SYQ_HUMAN 95.00% 1 
PTN1_HUMAN 99.90% 1 
RL3_HUMAN 100.00% 90 
ODP2_HUMAN 100.00% 17 
RALA_HUMAN 100.00% 47 
JAK1_HUMAN 99.70% 1 
gnl|unk|TRINITY_DN764_c26_g3_i1_5 99.80% 40 
SNX2_HUMAN 100.00% 7 
ITB1_HUMAN 100.00% 354 
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G6PD_HUMAN 100.00% 10 
SAC1_HUMAN 100.00% 10 
BT3L4_HUMAN 99.90% 4 
ENOA_HUMAN 100.00% 993 
CHMP3_HUMAN 100.00% 17 
CO4A5_HUMAN 98.00% 2 
1B08_HUMAN 100.00% 756 
CO3_HUMAN 100.00% 110 
EIF3C_HUMAN,EIFCL_HUMAN 100.00% 3 
EZRI_HUMAN 100.00% 1071 
IF4H_HUMAN 95.00% 4 
CN166_HUMAN 95.00% 1 
RL36_HUMAN 100.00% 15 
SYK_HUMAN 99.90% 1 
ILF3_HUMAN 100.00% 5 
MKRN1_HUMAN 98.00% 1 
WASP_HUMAN 100.00% 134 
PSD13_HUMAN 99.50% 3 
SYLC_HUMAN 100.00% 6 
PIMT_HUMAN 100.00% 17 
RL23A_HUMAN 100.00% 8 
MOT1_HUMAN 100.00% 108 
PLXA1_HUMAN 100.00% 3 
SCAM2_HUMAN 99.80% 18 
KCAB2_HUMAN 95.00% 2 
VP26B_HUMAN 100.00% 26 
CPNE3_HUMAN 100.00% 29 
RL7A_HUMAN 100.00% 89 
IGSF3_HUMAN 100.00% 37 
LTOR1_HUMAN 100.00% 18 
PSA1_HUMAN 100.00% 10 
PURB_HUMAN 100.00% 4 
GBB2_HUMAN 100.00% 276 
RAB5B_HUMAN 100.00% 59 
ACTZ_HUMAN 100.00% 19 
PNPH_HUMAN 100.00% 16 
MYO1G_HUMAN 100.00% 159 
SC22B_HUMAN 100.00% 22 
CLCB_HUMAN 100.00% 53 
MRP1_HUMAN 100.00% 7 
VATA_HUMAN 100.00% 12 
TBB4B_HUMAN 100.00% 1258 
CD320_HUMAN 95.00% 6 
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PRAF2_HUMAN 95.00% 3 
DHPR_HUMAN 95.50% 1 
COR1A_HUMAN 100.00% 218 
RTN4_HUMAN 100.00% 11 
RL28_HUMAN 100.00% 6 
RLA0_HUMAN 100.00% 46 
TSP4_HUMAN 99.90% 13 
ARHG1_HUMAN 100.00% 104 
ACTN1_HUMAN 100.00% 67 
NDRG3_HUMAN 99.80% 3 
ANXA7_HUMAN 100.00% 39 
BUB3_HUMAN 99.80% 1 
TMED4_HUMAN 100.00% 2 
ARC1A_HUMAN 100.00% 31 
RUXF_HUMAN 100.00% 4 
ERI3_HUMAN 97.00% 5 
DEST_HUMAN 98.50% 1 
LDHB_HUMAN 100.00% 264 
RHEB_HUMAN 100.00% 3 
THIO_HUMAN 100.00% 29 
EHD3_HUMAN 98.40% 91 
ITB2_HUMAN 100.00% 78 
SUCB2_HUMAN 95.00% 1 
PICAL_HUMAN 100.00% 3 
SSRA_HUMAN 100.00% 20 
HYES_HUMAN 100.00% 19 
1B41_HUMAN 99.90% 685 
LBR_HUMAN 99.30% 1 
VPS36_HUMAN 100.00% 4 
ANXA1_HUMAN 100.00% 237 
HBB_HUMAN 100.00% 96 
LRC57_HUMAN 100.00% 23 
TWF2_HUMAN 100.00% 23 
UBP5_HUMAN 100.00% 3 
GSTK1_HUMAN 100.00% 6 
UGGG1_HUMAN 100.00% 7 
PORIM_HUMAN 95.00% 1 
IST1_HUMAN 100.00% 96 
MCP_HUMAN 95.00% 16 
PKHG1_HUMAN 100.00% 2 
VINC_HUMAN 100.00% 1 
TAOK3_HUMAN 100.00% 7 
IDI1_HUMAN 95.00% 3 
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RELL1_HUMAN 95.00% 2 
HPRT_HUMAN 100.00% 5 
ITA4_HUMAN 100.00% 527 
H2B1J_HUMAN 100.00% 215 
BAF_HUMAN 100.00% 14 
IF2B3_HUMAN 100.00% 19 
SLK_HUMAN 100.00% 9 
HBEGF_HUMAN 100.00% 12 
H2A2A_HUMAN,H2A2C_HUMAN 100.00% 295 
STAM1_HUMAN 100.00% 7 
RL31_HUMAN,gnl|unk|TRINITY_DN2162_c0_g2_i1_5 95.00% 6 
TCPQ_HUMAN 100.00% 280 
VPS28_HUMAN 100.00% 201 
CNO10_HUMAN 100.00% 4 
GIT2_HUMAN 95.00% 6 
PRAF3_HUMAN 99.80% 1 
RS26_HUMAN 100.00% 40 
TCPG_HUMAN 100.00% 202 
PP1B_HUMAN 100.00% 17 
NCKP1_HUMAN 99.90% 1 
KIRR1_HUMAN 100.00% 39 
TM55B_HUMAN 95.00% 2 
FMNL1_HUMAN 100.00% 16 
BLMH_HUMAN 100.00% 6 
ARC1B_HUMAN 100.00% 84 
PAK2_HUMAN 100.00% 93 
AT1B3_HUMAN 100.00% 201 
VIME_HUMAN 100.00% 12 
ERG7_HUMAN 100.00% 3 
LCK_HUMAN 100.00% 461 
IPO5_HUMAN 100.00% 9 
COX6C_HUMAN 100.00% 14 
IMDH2_HUMAN 100.00% 30 
AT2B1_HUMAN 99.90% 25 
SND1_HUMAN 100.00% 2 
PPIH_HUMAN 100.00% 18 
TP4A2_HUMAN 100.00% 74 
RANG_HUMAN 100.00% 26 
1433E_HUMAN 100.00% 220 
CIP4_HUMAN 100.00% 10 
LAT_HUMAN 95.00% 6 
gnl|unk|TRINITY_DN3129_c0_g1_i1_18 95.00% 4 
RL23_HUMAN 100.00% 7 
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DDX5_HUMAN 99.80% 22 
SHIP1_HUMAN 100.00% 27 
ZAP70_HUMAN 100.00% 11 
HNRPQ_HUMAN 100.00% 78 
RAB21_HUMAN 100.00% 20 
ENPL_HUMAN 100.00% 293 
RS18_HUMAN 100.00% 51 
SYIC_HUMAN 100.00% 21 
SH3G1_HUMAN 100.00% 9 
CALU_HUMAN 99.90% 2 
CSK2B_HUMAN 100.00% 24 
COMT_HUMAN 100.00% 8 
TPIS_HUMAN 100.00% 199 
DNJC5_HUMAN 100.00% 27 
SYWC_HUMAN 100.00% 19 
ITAL_HUMAN 100.00% 42 
CD63_HUMAN 95.00% 16 
TNPO1_HUMAN 97.00% 1 
XPO1_HUMAN 100.00% 2 
ATD3A_HUMAN 100.00% 3 
SERC5_HUMAN 95.00% 2 
RHOC_HUMAN 100.00% 721 
DNJC7_HUMAN 95.00% 1 
CD5_HUMAN 100.00% 251 
BGLR_HUMAN 95.00% 2 
AT5F1_HUMAN 100.00% 46 
SEPT6_HUMAN 100.00% 38 
PLP2_HUMAN 100.00% 57 
APOH_HUMAN 99.00% 4 
SYG_HUMAN 100.00% 26 
RRAS2_HUMAN 100.00% 22 
VPS29_HUMAN 100.00% 29 
RL15_HUMAN 100.00% 49 
RS27L_HUMAN,RS27_HUMAN 100.00% 13 
S43A3_HUMAN 100.00% 15 
KIRR2_HUMAN 95.00% 1 
RAB8A_HUMAN 100.00% 293 
CLPP_HUMAN 100.00% 5 
CD151_HUMAN 99.00% 18 
PSA6_HUMAN 100.00% 11 
PDIA3_HUMAN 100.00% 354 
ADT2_HUMAN 100.00% 197 
IQGA1_HUMAN 100.00% 173 
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GDIA_HUMAN 100.00% 93 
HSP77_HUMAN 96.00% 149 
SYEP_HUMAN 100.00% 59 
RHOG_HUMAN 100.00% 169 
STX11_HUMAN 95.00% 1 
DPP3_HUMAN 95.00% 8 
ELOC_HUMAN 99.40% 1 
PSMF1_HUMAN 95.00% 4 
GELS_HUMAN 100.00% 57 
CSK_HUMAN 100.00% 22 
TB10B_HUMAN 95.00% 1 
GSHB_HUMAN 99.20% 1 
DAF_HUMAN 100.00% 84 
PGK1_HUMAN 100.00% 642 
PSB4_HUMAN 100.00% 2 
PI4KA_HUMAN 100.00% 3 
GAG_HV2KR 100.00% 14 
K22E_HUMAN 100.00% 45 
RASK_HUMAN 100.00% 114 
TIAR_HUMAN 99.80% 1 
E41L5_HUMAN 100.00% 17 
RS19_HUMAN 100.00% 9 
PTN11_HUMAN 95.00% 2 
S38A1_HUMAN 100.00% 14 
UB2D2_HUMAN,UB2D3_HUMAN 100.00% 16 
FPPS_HUMAN 100.00% 37 
APMAP_HUMAN 100.00% 4 
GSTO1_HUMAN 100.00% 30 
SAHH_HUMAN 100.00% 34 
ELAV1_HUMAN 95.00% 3 
RBBP4_HUMAN 100.00% 2 
CD47_HUMAN 100.00% 91 
F10A1_HUMAN 100.00% 229 
APCD1_HUMAN 100.00% 3 
ATX2_HUMAN 99.90% 7 
TMEDA_HUMAN 100.00% 89 
PHB_HUMAN 100.00% 109 
TOP1_HUMAN 100.00% 3 
GFPT1_HUMAN 100.00% 21 
CHSP1_HUMAN 96.30% 1 
ALBU_HUMAN 100.00% 180 
CD6_HUMAN 95.00% 7 
HNRPL_HUMAN 99.90% 4 
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2AAA_HUMAN 100.00% 60 
IF2B2_HUMAN 100.00% 43 
SEPT7_HUMAN 100.00% 32 
GAG_HV1Y2 100.00% 6847 
RS30_HUMAN 95.00% 1 
RFTN1_HUMAN 100.00% 6 
CTL2_HUMAN 100.00% 33 
GAG_HV1W2 100.00% 6157 
RN149_HUMAN 95.00% 5 
MCTS1_HUMAN 95.00% 8 
PUR2_HUMAN 95.00% 2 
FBP1L_HUMAN 100.00% 57 
AT2B4_HUMAN 100.00% 32 
H12_HUMAN 100.00% 283 
ATP5H_HUMAN 100.00% 54 
LCAP_HUMAN 100.00% 66 
LMAN1_HUMAN 100.00% 15 
LONM_HUMAN 100.00% 26 
CYFP1_HUMAN 99.90% 42 
RS27A_HUMAN 100.00% 209 
PGAM1_HUMAN 100.00% 157 
ARPC5_HUMAN 100.00% 26 
GAG_HV1MN 100.00% 6225 
ADT3_HUMAN 99.90% 144 
NSMA2_HUMAN 100.00% 39 
ABR_HUMAN 100.00% 18 
MPC2_HUMAN 95.00% 4 
PO210_HUMAN 100.00% 3 
SERPH_HUMAN 100.00% 26 
HNRPF_HUMAN 100.00% 11 
SRP09_HUMAN 100.00% 21 
UBE2K_HUMAN 95.00% 3 
gnl|unk|TRINITY_DN2950_c0_g1_i1_2 100.00% 14 
COPB2_HUMAN 96.60% 1 
DNPH1_HUMAN 99.90% 6 
KS6A1_HUMAN 95.00% 4 
CO6A1_HUMAN 100.00% 8 
BDH_HUMAN 100.00% 6 
EF2_HUMAN 100.00% 315 
GRB2_HUMAN 100.00% 29 
WASF2_HUMAN 100.00% 6 
ROA1_HUMAN 100.00% 55 
GAG_HV1C4 100.00% 5198 
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ML12A_HUMAN,ML12B_HUMAN 100.00% 40 
NPM_HUMAN 100.00% 48 
VDAC1_HUMAN 100.00% 221 
GDS1_HUMAN 100.00% 17 
RAN_HUMAN 100.00% 105 
BASI_HUMAN 100.00% 231 
MZB1_HUMAN 100.00% 33 
PKN1_HUMAN 100.00% 103 
SYMC_HUMAN 100.00% 11 
VPS4B_HUMAN 100.00% 97 
HSP72_HUMAN 94.50% 493 
SYTC_HUMAN 100.00% 18 
LAT1_HUMAN 100.00% 202 
FA5_HUMAN 100.00% 54 
ODO1_HUMAN 99.90% 7 
UGPA_HUMAN 100.00% 49 
CAB39_HUMAN 100.00% 62 
MPCP_HUMAN 100.00% 89 
RL5_HUMAN 100.00% 70 
S61A1_HUMAN,S61A2_HUMAN 95.00% 12 
GSLG1_HUMAN 100.00% 21 
HMGB2_HUMAN 99.90% 16 
PSB1_HUMAN 99.90% 7 
LSM1_HUMAN 95.00% 1 
TFR1_HUMAN 100.00% 274 
SPTN1_HUMAN 100.00% 11 
LAMP2_HUMAN 100.00% 35 
RS5_HUMAN 100.00% 21 
M4K4_HUMAN 100.00% 16 
RRAS_HUMAN 100.00% 17 
RPN2_HUMAN 100.00% 44 
ANX11_HUMAN 100.00% 89 
GNA11_HUMAN 100.00% 40 
CD1C_HUMAN 100.00% 45 
HNRPK_HUMAN 100.00% 81 
STXB2_HUMAN 100.00% 2 
BDH2_HUMAN 97.70% 5 
DHSO_HUMAN 100.00% 29 
TOM22_HUMAN 98.10% 17 




MERL_HUMAN 100.00% 11 
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HNRPC_HUMAN 100.00% 9 
MACD1_HUMAN 100.00% 5 
SAR1A_HUMAN 99.90% 10 
ACTBL_HUMAN 100.00% 282 
DPYL2_HUMAN 100.00% 13 
OCAD2_HUMAN 100.00% 8 
PSA3_HUMAN 95.00% 6 
HGS_HUMAN 100.00% 5 
SEPT2_HUMAN 100.00% 28 
RAB7A_HUMAN 100.00% 172 
WIPF1_HUMAN 100.00% 21 
GLYM_HUMAN 100.00% 207 
SFPQ_HUMAN 100.00% 9 
PRPS1_HUMAN 100.00% 28 
PCBP3_HUMAN 98.50% 97 
POL_HV1H2 100.00% 8018 
N2DL2_HUMAN 100.00% 18 
DLDH_HUMAN 100.00% 29 
ICAM1_HUMAN 100.00% 57 
PRDX2_HUMAN 100.00% 79 
MOB1A_HUMAN,MOB1B_HUMAN 100.00% 23 
PABP1_HUMAN 100.00% 488 
POL_HV1ND 100.00% 3698 
RS4X_HUMAN 100.00% 117 
CAZA1_HUMAN 100.00% 101 
POL_HV1OY 100.00% 7793 
ACAP1_HUMAN 100.00% 21 
CD1B_HUMAN 100.00% 219 
RL38_HUMAN 95.00% 7 
CA2D2_HUMAN 99.50% 2 
SF3B3_HUMAN 95.00% 1 
RL6_HUMAN 100.00% 103 
TBCA_HUMAN 100.00% 16 
UB2V2_HUMAN 97.50% 17 
OSTC_HUMAN 95.00% 2 
PSB2_HUMAN 100.00% 8 
CNOT1_HUMAN 100.00% 72 
U5S1_HUMAN 100.00% 16 
NOP56_HUMAN 95.00% 7 
DUT_HUMAN 98.00% 9 
RB11B_HUMAN 100.00% 125 
SH21A_HUMAN 100.00% 4 
ENV_HV1S1 100.00% 435 
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CSK22_HUMAN 99.00% 11 
ALDOC_HUMAN 100.00% 18 
P2RY8_HUMAN 99.90% 3 
ESYT1_HUMAN 100.00% 5 
STT3B_HUMAN 99.90% 1 
ARRD1_HUMAN 100.00% 6 
GBG5_HUMAN 100.00% 42 
GMFG_HUMAN 100.00% 17 
ENV_HV1MA 100.00% 176 
ENV_HV1LW 99.60% 398 
EIF3F_HUMAN 100.00% 7 
LASP1_HUMAN 100.00% 28 
ANXA2_HUMAN 99.90% 2 
ENV_HV1JR 100.00% 325 
ROR2_HUMAN 100.00% 12 
NHRF1_HUMAN 100.00% 338 
LAIR1_HUMAN 95.00% 3 
NNTM_HUMAN 100.00% 24 
TCPB_HUMAN 100.00% 162 
DCTP1_HUMAN 95.00% 1 
STIP1_HUMAN 100.00% 17 
IMB1_HUMAN 100.00% 57 
SCRIB_HUMAN 100.00% 17 
CUL3_HUMAN 100.00% 4 
PSA4_HUMAN 100.00% 8 
RADI_HUMAN 100.00% 811 
SRSF7_HUMAN 100.00% 20 
AGFG1_HUMAN 99.40% 2 
DAD1_HUMAN 95.00% 6 
ITA6_HUMAN 100.00% 105 
ECH1_HUMAN 100.00% 53 
TMX1_HUMAN 100.00% 30 
IF4A1_HUMAN 100.00% 148 
NUDC_HUMAN 100.00% 2 
PLSL_HUMAN 100.00% 610 
DHE3_HUMAN 100.00% 52 
AIFM1_HUMAN 95.00% 1 
CXCR4_HUMAN 100.00% 15 
ENV_HV196 100.00% 89 
RSSA_HUMAN 100.00% 81 
FA49B_HUMAN 100.00% 35 
YBOX1_HUMAN 100.00% 164 
ATPG_HUMAN 100.00% 64 
325 
 
ARF6_HUMAN 100.00% 113 
ACTN4_HUMAN 100.00% 109 
CLH1_HUMAN 100.00% 4231 
TMED7_HUMAN 100.00% 2 
DSRAD_HUMAN 95.00% 2 
COX2_HUMAN 100.00% 15 
EPN4_HUMAN 95.00% 11 
CCR5_HUMAN 100.00% 4 
EHD4_HUMAN 100.00% 100 
SRSF1_HUMAN 100.00% 19 
ARPC3_HUMAN 100.00% 61 
TMC8_HUMAN 95.00% 1 
EIF3I_HUMAN 100.00% 3 
ACPM_HUMAN 97.40% 1 
C1TC_HUMAN 100.00% 94 
COPG1_HUMAN 99.90% 1 
MYDGF_HUMAN 95.00% 6 
GANAB_HUMAN 100.00% 196 
RL35A_HUMAN 99.20% 3 
BACH_HUMAN 100.00% 14 
SSRD_HUMAN 100.00% 17 
CD1E_HUMAN 99.40% 34 




RCD1_HUMAN 100.00% 37 
TSP1_HUMAN 100.00% 34 
RHG17_HUMAN 100.00% 18 
gnl|unk|TRINITY_DN557_c0_g2_i1_7 95.10% 39 
H1X_HUMAN 94.60% 1 
ERO1A_HUMAN 100.00% 21 
S12A2_HUMAN 95.00% 3 
AIMP2_HUMAN 95.00% 4 
TCPZ_HUMAN 100.00% 97 
TEST_HUMAN 100.00% 14 
MCM3_HUMAN 100.00% 3 
RUVB1_HUMAN 100.00% 16 
S4A7_HUMAN 100.00% 27 
M2OM_HUMAN 100.00% 40 
VAX2_HUMAN 98.30% 1 
GTR14_HUMAN 95.40% 25 
AATM_HUMAN 100.00% 48 
A2MG_HUMAN 100.00% 270 
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MDHM_HUMAN 100.00% 169 
RAP1B_HUMAN 100.00% 291 
NIF3L_HUMAN 95.00% 1 
K1C10_HUMAN 100.00% 48 
CC50A_HUMAN 100.00% 17 
HCDH_HUMAN 100.00% 54 
AP2A2_HUMAN 99.00% 19 
EMB_HUMAN 95.00% 2 
EFNB2_HUMAN 95.00% 7 
EIF3A_HUMAN 100.00% 7 
PRS6A_HUMAN 95.00% 2 
TBB5_HUMAN 100.00% 1380 
RL34_HUMAN 99.30% 14 
GILT_HUMAN 95.00% 2 
DCK_HUMAN 96.20% 1 
TB10A_HUMAN 100.00% 25 
BCAT2_HUMAN 100.00% 5 
YBOX2_HUMAN 98.60% 41 
PYRG1_HUMAN 100.00% 10 
MUC18_HUMAN 100.00% 50 
SIT1_HUMAN 100.00% 54 
CYFP2_HUMAN 100.00% 76 
CLIC1_HUMAN 100.00% 267 
PEBP1_HUMAN 100.00% 12 
CJ088_HUMAN 100.00% 9 
NED4L_HUMAN 95.00% 1 
ODO2_HUMAN 100.00% 11 
ERP29_HUMAN 100.00% 14 
PDC10_HUMAN 100.00% 43 
H2AY_HUMAN 100.00% 31 
ARK72_HUMAN 100.00% 18 
DOC11_HUMAN 100.00% 8 
ILK_HUMAN 98.10% 13 
VTNC_HUMAN 95.00% 74 
CUX1_HUMAN 100.00% 3 
AP2B1_HUMAN 99.90% 29 
VAMP2_HUMAN,VAMP3_HUMAN 95.00% 12 
RL22_HUMAN,gnl|unk|TRINITY_DN567_c1_g1_i1_6 100.00% 30 
ATPO_HUMAN 100.00% 81 
LST8_HUMAN 95.00% 1 
ATPB_HUMAN 100.00% 558 
ERF3A_HUMAN 100.00% 17 
SYDC_HUMAN 100.00% 41 
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EF1A1_HUMAN 100.00% 1128 
ANXA5_HUMAN 100.00% 61 
KPYM_HUMAN 100.00% 566 
FLOT1_HUMAN 100.00% 172 
SNP23_HUMAN 100.00% 32 
SYRC_HUMAN 95.00% 8 
TBA4A_HUMAN 100.00% 882 
CALX_HUMAN 100.00% 146 
GLYC_HUMAN 96.80% 32 
IMPA1_HUMAN 99.90% 3 
CSN1_HUMAN 99.50% 1 
ACPH_HUMAN 95.00% 2 
SCOT1_HUMAN 97.00% 3 
MYH10_HUMAN 100.00% 132 
EHD1_HUMAN 100.00% 169 
ITM2C_HUMAN 100.00% 14 
RL26L_HUMAN,RL26_HUMAN 100.00% 19 
ACSL3_HUMAN 99.80% 9 
CHM2B_HUMAN 99.10% 1 
RAB4B_HUMAN 96.50% 51 
EF1G_HUMAN 100.00% 70 
LGUL_HUMAN 100.00% 13 
H2A1B_HUMAN,H2A1C_HUMAN,H2A3_HUMAN 100.00% 272 
CDK6_HUMAN 100.00% 45 
ETFA_HUMAN 100.00% 5 
RL35_HUMAN 100.00% 24 
VIPR2_HUMAN 100.00% 12 
MB12B_HUMAN 100.00% 112 
RL18_HUMAN 100.00% 95 
ILF2_HUMAN 100.00% 13 
RPN1_HUMAN 100.00% 129 
H31_HUMAN 100.00% 77 
RB22A_HUMAN 100.00% 52 
FDFT_HUMAN 100.00% 26 
H14_HUMAN 100.00% 295 
HABP2_HUMAN 95.00% 1 
UB2L3_HUMAN 100.00% 25 
TIPRL_HUMAN 95.00% 3 
TPM3_HUMAN 100.00% 22 
PDIA6_HUMAN 100.00% 79 
EPHB6_HUMAN 100.00% 97 
HS90B_HUMAN 100.00% 566 
RAB5A_HUMAN 100.00% 68 
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MPZL1_HUMAN 100.00% 60 
GAPR1_HUMAN 100.00% 30 
CLCA_HUMAN 100.00% 71 
TIF1B_HUMAN 100.00% 7 
RYDEN_HUMAN 99.90% 3 
APT_HUMAN 100.00% 106 
RD23B_HUMAN 100.00% 1 
TTC7A_HUMAN 95.00% 1 
TBB4A_HUMAN 100.00% 1029 
SNX18_HUMAN 95.00% 1 
RAB10_HUMAN 100.00% 200 
XRCC6_HUMAN 100.00% 8 
RTN3_HUMAN 95.00% 2 
FABP5_HUMAN 100.00% 31 
RL27_HUMAN 100.00% 34 
IDH3G_HUMAN 100.00% 5 
RASN_HUMAN 100.00% 111 
PPIL3_HUMAN 95.00% 4 
VDAC3_HUMAN 100.00% 79 
FLOT2_HUMAN 100.00% 112 
C1QBP_HUMAN 100.00% 29 
ARP5L_HUMAN 100.00% 20 
BROX_HUMAN 100.00% 95 
RUXE_HUMAN 95.00% 13 
LDHA_HUMAN 100.00% 266 
LAT3_HUMAN 95.00% 2 
TMIG2_HUMAN 100.00% 17 
CH60_HUMAN 100.00% 496 
ACSL4_HUMAN 100.00% 16 
XRP2_HUMAN 100.00% 22 
CD2AP_HUMAN 100.00% 50 
NRN1_HUMAN 95.00% 1 
ENV_HV1Y2 100.00% 284 
ABHEB_HUMAN 99.90% 4 
DHB4_HUMAN 100.00% 23 
RL21_HUMAN 100.00% 32 
CD9_HUMAN 100.00% 71 
IDH3A_HUMAN 100.00% 43 
GNA13_HUMAN 100.00% 153 
HBA_HUMAN 100.00% 152 
PTPRC_HUMAN 100.00% 605 
ETFB_HUMAN 100.00% 21 
PROF2_HUMAN 95.00% 6 
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6PGL_HUMAN 100.00% 16 
RL19_HUMAN 100.00% 2 
SAM50_HUMAN 100.00% 1 
CDC42_HUMAN 100.00% 331 
H15_HUMAN 100.00% 191 
1A24_HUMAN 100.00% 771 
ARP2_HUMAN 100.00% 70 
LIN7C_HUMAN 95.00% 1 
AT1A3_HUMAN 100.00% 433 
PZP_HUMAN 100.00% 158 
LKHA4_HUMAN 95.00% 2 
SERC3_HUMAN 100.00% 45 
CD59_HUMAN 100.00% 108 
K2C1_HUMAN 100.00% 103 
AT11C_HUMAN 95.00% 4 
UBE2N_HUMAN 100.00% 73 
KPRB_HUMAN 100.00% 7 
DYN3_HUMAN 99.90% 26 
FSHR_HUMAN 98.30% 1 
RUVB2_HUMAN 100.00% 29 
RL30_HUMAN 96.30% 39 
GRP75_HUMAN 100.00% 143 
RL13_HUMAN 100.00% 66 
CALM_HUMAN 100.00% 4 
RS25_HUMAN 100.00% 45 
PP1A_HUMAN 100.00% 22 
APOC3_HUMAN 98.90% 8 
GDIR2_HUMAN 100.00% 210 
ICAM3_HUMAN 100.00% 25 
AATC_HUMAN 100.00% 3 
SEPT9_HUMAN 100.00% 25 
MDHC_HUMAN 100.00% 71 
PDIA1_HUMAN 100.00% 47 
SAHH2_HUMAN 100.00% 12 
SYVC_HUMAN 100.00% 2 
ATX2L_HUMAN 100.00% 21 
FBLN1_HUMAN 95.00% 1 
ATX10_HUMAN 95.00% 1 
ABCF1_HUMAN 95.00% 1 
PI42A_HUMAN 100.00% 13 
HMCS1_HUMAN 99.00% 4 
PSMD2_HUMAN 100.00% 9 




CNOT3_HUMAN 100.00% 1 
GDIB_HUMAN 100.00% 479 
RAB8B_HUMAN 100.00% 308 
RS8_HUMAN 100.00% 86 
RENT1_HUMAN 100.00% 97 
SRGP2_HUMAN 100.00% 7 
IDH3B_HUMAN 100.00% 3 
AT2A3_HUMAN 100.00% 132 
RS17_HUMAN 100.00% 20 
PIPNB_HUMAN 100.00% 24 
NB5R3_HUMAN 100.00% 65 
PP2BA_HUMAN 99.70% 4 
RS15A_HUMAN 100.00% 44 
SH3L3_HUMAN 95.00% 10 
CD8A_HUMAN 100.00% 56 
ARP3_HUMAN 100.00% 160 
CYTB_HUMAN 100.00% 5 
TRBC1_HUMAN,TRBC2_HUMAN 100.00% 4 
RFA3_HUMAN 95.00% 5 
FLNA_HUMAN 100.00% 2 
AP2M1_HUMAN 100.00% 4 
RL10A_HUMAN 100.00% 53 
RAB2A_HUMAN 100.00% 46 
RABP1_HUMAN 100.00% 65 
GLU2B_HUMAN 100.00% 58 
CD4_HUMAN 100.00% 110 
COPB_HUMAN 100.00% 9 
2B17_HUMAN 95.00% 9 
DYHC1_HUMAN 100.00% 3 
URP2_HUMAN 100.00% 329 
IF4A3_HUMAN 99.40% 11 
RGS19_HUMAN 100.00% 3 
RS11_HUMAN 100.00% 47 
RAF1_HUMAN 95.00% 5 
RL14_HUMAN 100.00% 65 
GPC1_HUMAN 100.00% 123 
H10_HUMAN 100.00% 7 
DNJA1_HUMAN 100.00% 62 
PRDX5_HUMAN 100.00% 58 
THIC_HUMAN 100.00% 28 
NIPS1_HUMAN 100.00% 22 
ZCHC3_HUMAN 95.00% 5 
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VANG1_HUMAN 95.00% 2 
PABP4_HUMAN 100.00% 207 
DPB1_HUMAN 95.00% 1 
EFR3A_HUMAN 100.00% 11 
SPTB2_HUMAN 100.00% 15 
IPYR_HUMAN 100.00% 49 
HS105_HUMAN 100.00% 5 
HNRPD_HUMAN 100.00% 35 
ELOB_HUMAN 99.80% 1 
SF3B6_HUMAN 95.00% 1 
RL9_HUMAN 100.00% 39 
YKT6_HUMAN 100.00% 22 
PSMD3_HUMAN 100.00% 9 
PSB5_HUMAN 95.00% 1 
RS9_HUMAN 100.00% 96 
UBA1_HUMAN 100.00% 157 
GNA15_HUMAN 100.00% 31 
RS20_HUMAN 100.00% 25 
VAPB_HUMAN 98.30% 4 
ENOG_HUMAN 100.00% 251 
FUBP2_HUMAN 100.00% 2 
RSMB_HUMAN 100.00% 9 
NASP_HUMAN 100.00% 10 
R4RL2_HUMAN 99.90% 1 
HN1_HUMAN 95.00% 1 
DECR_HUMAN 97.60% 1 
MOGS_HUMAN 100.00% 4 
CPPED_HUMAN 100.00% 5 
RL27A_HUMAN 100.00% 24 
SC5A3_HUMAN 100.00% 3 
SODC_HUMAN 100.00% 12 
DX39B_HUMAN 100.00% 9 
AHSA1_HUMAN 99.80% 10 
DBNL_HUMAN 100.00% 20 
ACTC_HUMAN 100.00% 762 
PLCL1_HUMAN 100.00% 9 
RUXGL_HUMAN 95.00% 5 
PARK7_HUMAN 100.00% 54 
ADA10_HUMAN 100.00% 52 
TCPE_HUMAN 100.00% 71 
CAPZB_HUMAN 100.00% 71 
QCR2_HUMAN 100.00% 31 
PPIB_HUMAN 100.00% 117 
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RS3_HUMAN 100.00% 100 
DOPD_HUMAN 100.00% 27 
G3P_HUMAN 100.00% 1064 
CD99_HUMAN 100.00% 12 
PSA7_HUMAN 100.00% 12 
ZNRF1_HUMAN 95.00% 1 
RS12_HUMAN 100.00% 8 
TCTP_HUMAN 100.00% 32 
EIF3E_HUMAN 100.00% 2 
MYL6_HUMAN 100.00% 89 
ADA_HUMAN 100.00% 433 
ARF1_HUMAN 100.00% 305 
SORT_HUMAN 95.00% 2 
MIF_HUMAN 100.00% 157 
DNJA2_HUMAN 100.00% 22 
PRDX6_HUMAN 100.00% 100 
SYSC_HUMAN 100.00% 20 
LFA3_HUMAN 100.00% 14 
F234A_HUMAN 100.00% 15 
DHX9_HUMAN 100.00% 15 
DDB1_HUMAN 95.00% 2 
ROA2_HUMAN 100.00% 32 
TERA_HUMAN 100.00% 71 
KTHY_HUMAN 100.00% 9 
3BP1_HUMAN 98.70% 4 
APOB_HUMAN 99.90% 4 
IF2A_HUMAN 100.00% 8 
PCBP1_HUMAN 100.00% 195 
BZW2_HUMAN 95.00% 2 
CTL1_HUMAN 100.00% 10 
MCA3_HUMAN 100.00% 2 
SYFB_HUMAN 100.00% 5 
ITIH3_HUMAN 100.00% 54 
VPS4A_HUMAN 100.00% 18 
PP2AA_HUMAN 100.00% 20 
S39AA_HUMAN 95.00% 7 
PTK7_HUMAN 100.00% 58 
KAD2_HUMAN 100.00% 16 
RASL3_HUMAN 100.00% 45 
ROAA_HUMAN 100.00% 24 
SF3B1_HUMAN 100.00% 7 
RL4_HUMAN 100.00% 136 
CECR5_HUMAN 95.00% 1 
333 
 
AMPL_HUMAN 99.90% 3 
HMGB1_HUMAN 100.00% 23 
ATPD_HUMAN 100.00% 19 
LAMP1_HUMAN 100.00% 27 
NLGNY_HUMAN 100.00% 28 
RAB6A_HUMAN 100.00% 86 
STABP_HUMAN 100.00% 16 
ALDOA_HUMAN 100.00% 304 
ENOB_HUMAN 100.00% 251 
PACN1_HUMAN 100.00% 13 
RAC1_HUMAN 100.00% 361 
TOLIP_HUMAN 95.00% 2 
RU2B_HUMAN 96.90% 1 
NONO_HUMAN 97.10% 5 
F120A_HUMAN 100.00% 9 
gnl|unk|TRINITY_DN1340_c0_g1_i1_4 95.00% 9 
TMM8A_HUMAN 99.80% 1 
T106B_HUMAN 100.00% 6 
PA1B2_HUMAN 100.00% 10 
TS101_HUMAN 100.00% 345 
CTR3_HUMAN 100.00% 35 
RAB35_HUMAN 100.00% 303 
ATPK_HUMAN 100.00% 11 
VAT1_HUMAN 100.00% 78 
SCAM3_HUMAN 100.00% 5 
CLIC4_HUMAN 100.00% 37 
ABCE1_HUMAN 99.10% 1 
CD28_HUMAN 100.00% 34 
AAAT_HUMAN 100.00% 107 
SORCN_HUMAN 100.00% 21 
RS3A_HUMAN 100.00% 128 
IDHP_HUMAN 100.00% 84 
PRS7_HUMAN 100.00% 13 
SMD3_HUMAN 100.00% 22 
PCBP2_HUMAN 100.00% 175 
NTF2_HUMAN 100.00% 39 
RAB5C_HUMAN 100.00% 108 
SERA_HUMAN 100.00% 124 
PACN2_HUMAN 100.00% 313 
ESTD_HUMAN 100.00% 20 
STAT1_HUMAN 99.90% 1 
PRDX1_HUMAN 100.00% 169 
LC7L2_HUMAN 95.00% 4 
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CTR1_HUMAN 100.00% 29 
PDCD6_HUMAN 100.00% 20 
RL29_HUMAN 100.00% 15 
CAP1_HUMAN 100.00% 23 
SRP14_HUMAN 100.00% 38 
KC1G1_HUMAN 99.70% 3 
ITIH4_HUMAN 100.00% 4 
ARF4_HUMAN 100.00% 172 
IF5AL_HUMAN 100.00% 28 
MK01_HUMAN 100.00% 4 
PTPRK_HUMAN 100.00% 10 
H4_HUMAN 100.00% 554 
KPCA_HUMAN 100.00% 191 
MIA2_HUMAN 95.00% 1 
TMC6_HUMAN 100.00% 10 
UB2V1_HUMAN 99.10% 17 
GOGA7_HUMAN 100.00% 19 
GBB1_HUMAN 100.00% 353 
PRDX3_HUMAN 100.00% 59 
CHM4B_HUMAN 100.00% 102 
CSK21_HUMAN 100.00% 85 
CHMP5_HUMAN 100.00% 13 
NICA_HUMAN 100.00% 42 
S10A6_HUMAN 95.00% 1 
DDX6_HUMAN 100.00% 67 
CO9_HUMAN 100.00% 7 
RAC2_HUMAN 100.00% 370 
CYB5B_HUMAN 95.00% 10 
GLGB_HUMAN 100.00% 6 
NDKA_HUMAN 100.00% 91 
DDX17_HUMAN 100.00% 34 
STK24_HUMAN 99.70% 12 
TXND5_HUMAN 100.00% 19 
FNBP1_HUMAN 100.00% 204 
TCPA_HUMAN 100.00% 143 
MARCS_HUMAN 100.00% 39 
KAP0_HUMAN 95.00% 4 
DHB12_HUMAN 100.00% 30 
DPM3_HUMAN 95.00% 4 
SUMO2_HUMAN 95.00% 11 
EF1D_HUMAN 100.00% 12 
ITA5_HUMAN 100.00% 12 
IFM1_HUMAN 100.00% 37 
335 
 
PACN3_HUMAN 95.00% 1 
OSBP1_HUMAN 100.00% 2 
MPU1_HUMAN 100.00% 6 
CD3D_HUMAN 100.00% 12 
ABHDA_HUMAN 100.00% 2 
VP37B_HUMAN 100.00% 17 
DRA_HUMAN 100.00% 29 
SDHA_HUMAN 100.00% 16 
NLTP_HUMAN 99.80% 5 
COF1_HUMAN 100.00% 466 
RLA2_HUMAN 100.00% 43 
ARF5_HUMAN 100.00% 186 
ECHA_HUMAN 99.80% 1 
FAM3C_HUMAN 95.00% 5 
ACADV_HUMAN 99.80% 1 
TYB4_HUMAN 99.90% 2 
SURF4_HUMAN 100.00% 4 
MIC60_HUMAN 100.00% 17 
TMM33_HUMAN 95.00% 11 
PDPK2_HUMAN 95.00% 2 
CH10_HUMAN 100.00% 90 
LEUK_HUMAN 100.00% 105 
MYO1C_HUMAN 100.00% 12 
MRP_HUMAN 100.00% 61 
IGF1R_HUMAN 100.00% 14 
RL18A_HUMAN 100.00% 31 
gnl|unk|TRINITY_DN565_c0_g3_i1_5 100.00% 51 
gnl|unk|TRINITY_DN201_c0_g2_i1_4 99.90% 627 
OST48_HUMAN 100.00% 50 
1433F_HUMAN 100.00% 45 
EFTU_HUMAN 100.00% 161 
TMED2_HUMAN 100.00% 6 
SEM7A_HUMAN 100.00% 521 
FA10_HUMAN 100.00% 54 
RL24_HUMAN 100.00% 31 
CD3E_HUMAN 100.00% 18 
HNRPR_HUMAN 100.00% 60 
MOES_HUMAN 100.00% 1638 
STK10_HUMAN 100.00% 23 
NDKB_HUMAN 100.00% 91 
PTPRF_HUMAN 100.00% 30 
DOCK2_HUMAN 100.00% 13 
LRC59_HUMAN 100.00% 10 
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TBB6_HUMAN 99.80% 418 
PFD2_HUMAN 99.90% 1 
RL10_HUMAN 100.00% 79 
CO4A_HUMAN,CO4B_HUMAN 100.00% 12 
NDUAD_HUMAN 95.00% 3 
PYR1_HUMAN 100.00% 13 
B2MG_HUMAN 100.00% 149 
CD81_HUMAN 100.00% 203 
GNAS1_HUMAN 100.00% 214 
K1C9_HUMAN 100.00% 8 
RSU1_HUMAN 98.80% 1 
CHM2A_HUMAN 99.90% 14 
1433B_HUMAN 100.00% 54 
RAP1A_HUMAN 100.00% 232 
ACON_HUMAN 100.00% 30 
MARK2_HUMAN 100.00% 10 
TKT_HUMAN 100.00% 67 
ARPC2_HUMAN 100.00% 94 
PTCA_HUMAN 100.00% 23 
TMM43_HUMAN 95.00% 1 
gnl|unk|TRINITY_DN4399_c0_g1_i1_3 95.00% 2 
ALDR_HUMAN 100.00% 16 
KIF23_HUMAN 95.00% 1 
FUS_HUMAN 95.00% 1 
AP2A1_HUMAN 100.00% 20 
DDX3Y_HUMAN 97.50% 14 
ACLY_HUMAN 100.00% 38 
EVL_HUMAN 100.00% 12 
MYH9_HUMAN 100.00% 557 
GRP78_HUMAN 100.00% 376 
SDHB_HUMAN 100.00% 6 
RCC2_HUMAN 100.00% 6 
CISY_HUMAN 100.00% 36 
RS28_HUMAN 100.00% 5 
SC11A_HUMAN 95.00% 7 
RAB14_HUMAN 100.00% 96 
TRAT1_HUMAN 95.00% 4 
PTPRA_HUMAN 99.80% 4 
SLIT1_HUMAN 100.00% 14 
TBA8_HUMAN 95.10% 548 
PUR8_HUMAN 100.00% 25 
ECHB_HUMAN 97.00% 1 
gnl|unk|TRINITY_DN655_c0_g1_i1_5 95.00% 4 
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THRB_HUMAN 100.00% 50 
PARP1_HUMAN 97.00% 1 
CDC37_HUMAN 100.00% 24 
PDIA4_HUMAN 100.00% 140 
PDC6I_HUMAN 100.00% 600 
PAK4_HUMAN 100.00% 17 
STRAP_HUMAN 100.00% 6 
SMD2_HUMAN 100.00% 8 
CHM1B_HUMAN 98.20% 17 
ZCCHV_HUMAN 100.00% 132 
RTCB_HUMAN 100.00% 11 
C2D1A_HUMAN 100.00% 2 
1433G_HUMAN 100.00% 92 
GTR1_HUMAN 100.00% 55 
SPP24_HUMAN 95.00% 2 
PA2G4_HUMAN 100.00% 53 
FRIH_HUMAN 98.40% 3 
NACAM_HUMAN 100.00% 32 
MARE1_HUMAN 95.00% 11 
ATPA_HUMAN 100.00% 454 
SDCB1_HUMAN 100.00% 313 
PPIL1_HUMAN 100.00% 54 
HEXA_HUMAN 100.00% 7 
S38A2_HUMAN 99.90% 9 
SH3G3_HUMAN 100.00% 5 
PUR9_HUMAN 100.00% 86 
NLGN2_HUMAN 98.70% 13 
SCAM1_HUMAN 95.00% 3 
CD82_HUMAN 100.00% 12 
THIL_HUMAN 100.00% 12 
PRP8_HUMAN 100.00% 12 
AN32A_HUMAN 100.00% 13 
BOLA2_HUMAN 95.00% 5 
FINC_HUMAN 100.00% 3 
DYN2_HUMAN 100.00% 22 
MFGM_HUMAN 100.00% 387 
LPPRC_HUMAN 100.00% 36 
DDX1_HUMAN 100.00% 2 
CD7_HUMAN 100.00% 31 
HNRPM_HUMAN 95.00% 5 
RU17_HUMAN 95.00% 4 
ODPA_HUMAN 100.00% 28 
TLN1_HUMAN 100.00% 78 
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FKBP4_HUMAN 100.00% 31 
MB12A_HUMAN 99.80% 25 
RL17_HUMAN 100.00% 64 
FETUA_HUMAN 99.90% 2 
H13_HUMAN 99.10% 263 
CN37_HUMAN 100.00% 421 
LMAN2_HUMAN 100.00% 53 
FUMH_HUMAN 98.10% 2 
TGON2_HUMAN 95.00% 1 
PPIA_HUMAN 100.00% 1660 
FAS_HUMAN 100.00% 123 
AT1A1_HUMAN 100.00% 739 
HS90A_HUMAN 100.00% 652 
BAP31_HUMAN 100.00% 18 
CNN2_HUMAN 100.00% 21 
SRC_HUMAN 100.00% 4 
HINT1_HUMAN 100.00% 6 
COR1C_HUMAN 100.00% 27 
PSMD6_HUMAN 100.00% 4 
VPS25_HUMAN 100.00% 14 
6PGD_HUMAN 100.00% 54 
RL11_HUMAN 100.00% 49 
TOM70_HUMAN 99.40% 1 
DREB_HUMAN 100.00% 12 
PP1G_HUMAN 99.80% 10 
RS23_HUMAN 100.00% 33 
XRCC5_HUMAN 100.00% 14 
NOTC3_HUMAN 100.00% 39 
CCND3_HUMAN 95.00% 3 
CAN1_HUMAN 100.00% 7 
HEXB_HUMAN 100.00% 19 
VDAC2_HUMAN 100.00% 102 
SELPL_HUMAN 95.00% 1 
EIF3L_HUMAN 100.00% 5 
PRAX_HUMAN 96.70% 1 
CLH2_HUMAN 99.80% 789 
NDUS8_HUMAN 95.00% 1 
MBLC2_HUMAN 100.00% 16 
HP1B3_HUMAN 100.00% 1 
SR140_HUMAN 97.40% 1 
CAND1_HUMAN 100.00% 22 
CIB1_HUMAN 100.00% 11 
LMNB1_HUMAN 100.00% 13 
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THIM_HUMAN 100.00% 7 
HSP7C_HUMAN 100.00% 1380 
USMG5_HUMAN 95.00% 1 
TCPH_HUMAN 100.00% 69 
MTCH2_HUMAN 100.00% 25 
CLDN1_HUMAN 95.00% 3 
UBC12_HUMAN 95.00% 8 
PTMA_HUMAN 95.00% 6 
RS6_HUMAN 100.00% 36 
ABI1_HUMAN 99.80% 1 
RHOF_HUMAN 100.00% 19 
HNRH2_HUMAN 100.00% 6 
TSN14_HUMAN 100.00% 12 
TECR_HUMAN 95.00% 3 
NP1L1_HUMAN 100.00% 40 
CD1D_HUMAN 100.00% 29 
PTBP1_HUMAN 100.00% 21 
STXB3_HUMAN 100.00% 49 
ODPB_HUMAN 100.00% 56 
RS15_HUMAN 98.50% 8 
TOM40_HUMAN 100.00% 16 
PROF1_HUMAN 100.00% 397 
TXD12_HUMAN 100.00% 2 
DJB11_HUMAN 96.70% 2 
HYOU1_HUMAN 100.00% 94 
CALR_HUMAN 100.00% 150 
VPS35_HUMAN 100.00% 202 
SYNC_HUMAN 100.00% 23 
RCN2_HUMAN 100.00% 8 
NOMO3_HUMAN 99.00% 1 
PEDF_HUMAN 100.00% 62 
IPYR2_HUMAN 95.00% 5 
SO3A1_HUMAN 95.00% 3 
S29A1_HUMAN 100.00% 178 
SYPL1_HUMAN 95.00% 17 
CD2_HUMAN 95.00% 1 
PTN23_HUMAN 99.90% 2 
P4K2A_HUMAN 99.90% 3 
HCLS1_HUMAN 95.00% 3 
APOE_HUMAN 100.00% 40 
SERC_HUMAN 100.00% 22 
CATD_HUMAN 99.90% 4 
WDR1_HUMAN 100.00% 185 
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RL12_HUMAN 100.00% 11 
CR2_HUMAN 100.00% 40 
ROA3_HUMAN 100.00% 18 
RS24_HUMAN 100.00% 13 
LUM_HUMAN 100.00% 18 
GDIR1_HUMAN 100.00% 103 
ICAM2_HUMAN 100.00% 67 
TPP1_HUMAN 95.00% 2 
PCNA_HUMAN 100.00% 37 
UBP14_HUMAN 100.00% 12 
CHLE_HUMAN 97.00% 5 
CKAP4_HUMAN 100.00% 6 
EIF3M_HUMAN 95.00% 3 
CAZA2_HUMAN 100.00% 40 
GNAI2_HUMAN 100.00% 469 
TTYH3_HUMAN 100.00% 24 
NCKPL_HUMAN 100.00% 30 
HSP74_HUMAN 100.00% 17 
PUR6_HUMAN 100.00% 90 
ACTG_HUMAN 100.00% 2270 
SNAG_HUMAN 100.00% 29 
1433Z_HUMAN 100.00% 326 
1A68_HUMAN 100.00% 733 
THBG_HUMAN 95.00% 14 
KCY_HUMAN 95.00% 2 
RAB1A_HUMAN 100.00% 242 
RL7_HUMAN 100.00% 80 
TALDO_HUMAN 95.00% 6 
TBCB_HUMAN 95.00% 4 
CYC_HUMAN 99.90% 1 
ADHX_HUMAN 100.00% 4 
ARL8B_HUMAN 100.00% 18 
RS7_HUMAN 100.00% 40 
GLOD4_HUMAN 95.00% 7 
FKB1A_HUMAN 100.00% 16 
ESYT2_HUMAN 100.00% 20 
ACADM_HUMAN 100.00% 6 
AT2A2_HUMAN 100.00% 54 
RS16_HUMAN 100.00% 91 
MOV10_HUMAN 100.00% 402 
STX4_HUMAN 100.00% 21 
PIPNA_HUMAN 95.00% 5 
RASA2_HUMAN 100.00% 28 
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NDUS3_HUMAN 95.00% 2 
LYPA1_HUMAN 100.00% 2 
BAHC1_HUMAN 98.40% 2 
STK26_HUMAN 100.00% 17 
1433T_HUMAN 100.00% 81 
H2B1K_HUMAN,H2BFS_HUMAN 100.00% 266 
ZCCHL_HUMAN 95.00% 7 
MPRD_HUMAN 100.00% 43 
POL_HV1Z2 100.00% 4176 
POL_HV1YF 100.00% 1796 
FETA_HUMAN 100.00% 21 
CD44_HUMAN 100.00% 76 
RM12_HUMAN 95.00% 1 
1C14_HUMAN 99.90% 390 
TM41A_HUMAN 95.00% 2 
POL_HV1V9 100.00% 1617 
RHOA_HUMAN 100.00% 798 
PEF1_HUMAN 100.00% 34 
POL_HV1U4 100.00% 1911 
CD97_HUMAN 100.00% 21 
TM9S4_HUMAN 95.00% 4 
S38A5_HUMAN 99.90% 1 
PSA5_HUMAN 100.00% 11 
COPA_HUMAN 100.00% 14 
SRSF8_HUMAN 95.00% 12 
POL_HV1S2 100.00% 1619 
POL_HV1RH 100.00% 4887 
GSTP1_HUMAN 100.00% 210 
SAP_HUMAN 100.00% 35 
IF4A2_HUMAN 99.90% 98 
TAGL2_HUMAN 100.00% 85 
K2C79_HUMAN 96.10% 9 
POL_HV1MV 99.90% 398 
POL_HV1N5 100.00% 5527 
TADBP_HUMAN 95.00% 3 
POL_HV1MP 99.90% 2224 
SYAC_HUMAN 100.00% 63 
POL_HV1MN 100.00% 6829 
POL_HV1MA 100.00% 2780 
NUCB2_HUMAN 100.00% 30 
POL_HV1LW 100.00% 7666 
POL_HV1M2 100.00% 2061 
NUCL_HUMAN 100.00% 11 
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RACK1_HUMAN 100.00% 90 
BAIP2_HUMAN 100.00% 72 
PRDX4_HUMAN 99.40% 28 
POL_HV1JR 100.00% 7922 




















Neuropeptides are small signaling molecules in the CNS of many species, and 
play important roles in the regulation of behavior and many other physiological 
processes(Burbach, 2011; Nathoo, Moeller, Westlund, & Hart, 2001; L. S. Nelson, 
Rosoff, & Li, 1998; Zhang, Buchberger, Muthuvel, & Li, 2015). In the past two decades, 
many novel neuropeptides have been discovered by untargeted approaches(Hori et al., 
2001; Kojima et al., 1999; Meunier et al., 1995; Sakurai, Amemiya, Ishii, Matsuzaki, 
Chemelli, Tanaka, Williams, Richardson, et al., 1998; Tatemoto et al., 1998). Some of 
these novel neuropeptides and their receptors, in particular nociceptin and orexin A and 
B, have since gone on to clinical trials as drugs or drug targets(Coleman & Renger, 
2010; Lambert, 2008), which have recently produced the drug suvorexant(Patel, Aspesi, 
& Evoy, 2015). Thus, the discovery of novel neuropeptides may allow novel approaches 
to pharmacologic intervention in psychiatric disorders. However, in the past decade, no 
novel neuropeptides have been discovered, and new approaches to novel neuropeptide 
discovery may be needed. 
A recently developed technique for studying translational regulation, ribosomal 
profiling, has uncovered that there may be many short, unannotated open reading 
frames (sORFs) in mammalian genomes(Brar & Weissman, 2015; Ingolia, 2014; Ingolia 
et al., 2014; Kondo et al., 2010; Slavoff, Heo, Budnik, Hanakahi, & Saghatelian, 2014). 
The translated products of these sORFs are very short peptides (<100 amino acids), and 
have been named micropeptides. Several of these have been found to be functional in 
human tissue systems such as skeletal muscle and the cardiovascular system(Anderson 
et al., 2015; C. Lee et al., 2015; Magny et al., 2013). In particular, the Toddler peptide 
has been found to be a secreted ligand for a G-protein coupled receptor (GPCR)(Pauli et 
al., 2014). Since nearly all known neuropeptides are ligands for GPCRs(Burbach, 2011; 
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Zhang, Wang, Parks, & Civelli, 2011), these recent discoveries motivate the hypothesis 
that some of these sORF-encoded peptides could be undiscovered neuropeptides. 
In Chapters 2 and 3, I have developed and applied a novel method for profiling 
cell and tissue samples for micropeptides by mass spectrometry(Tharakan, Tao, Ubaida-
Mohien, Dinglasan, & Graham, 2015). This micropeptidomics method can be easily 
adapted to the CNS to perform neuropeptidomics(Romanova & Sweedler, 2015), which 
is an approach that entails extraction of all neuropeptides from brain cells or brain tissue 
samples and then sequencing all neuropeptides by mass spectrometry. The method I 
have developed can increase neuropeptide discovery rates by several fold over 
traditional mass spectrometry-based neuropeptidomics techniques(Tharakan et al., 
2015). Therefore, a combination of my neuropeptidomics method with ribosomal profiling 
of mouse brain allows novel sORF-encoded neuropeptide discovery in the mammalian 
CNS. 
In this Chapter, we apply the same micropeptidomics methods to the mouse 
brain, in an attempt to apply the methods to a more constrained system and gain 
biological insights. While biochemical detection of these micropeptides proves that the 
micropeptides are translated, but this does not necessarily mean that they are functional, 
as they may be translational byproducts. We hypothesized in this Chapter that 
micropeptides which are functional in the brain will be expressed in a regulated manner 
during adolescent development. Thus, in order to validate the micropeptide targets thus 
discovered, we quantified these micropeptides by mass spectrometry, by time and mass 
tag quantitative profiling. Thus, the goals of this Chapter are, first, the discovery of 
translated micropeptides in the mammalian brain; with the hypothesis that the 
mammalian brain will have functional micropeptides. We approach this hypothesis by 
discovering sORFs that have ribosomal content in mouse brain by ribosomal profiling 
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(RP) and by mass spectrometry-based neuropeptidomics, using RP-derived sequences 
as databases for MS analysis. Second, we validate the novel CNS micropeptides by 
examining their regulation in development, with the hypothesis that micropeptides which 
are functional in the mammalian brain will change their abundance over the course of 
development. We approach this hypothesis by performing a screen for regulated 
micropeptides over the course of adolescence. 
 
Methods 
Mouse brain peptide extraction. A protease inhibitor solution was prepared by dissolving 
1 Sigma Protease Inhibitor Tablet in 50 mL of Phosphate-buffered Saline, for a final 
concentration of AEBSF, 2 mM, Aprotinin, 0.3 μM, Bestatin, 130 μM, EDTA, 1 mM, E-64, 
14 μM, and Leupeptin, 1 μM. This buffer was then used to perfuse the animals according 
to standard protocols after deep anesthetization, with perfusion being accomplished at a 
rate of 4 mL per minute for 5 minutes, until liver was visibly cleared of blood. Whole 
brains were then dissected out by standard protocols, and brains were heat inactivated 
by the Denator laser-guided heat inactivation system according to published 
protocols(Svensson et al., 2009), in the procedure for fresh frozen tissue without tissue 
structure preservation. The brains were then flash-frozen on liquid nitrogen and stored at 
-80C. Brains were then immersed into cold .5% acetic acid (pH ~2) to thaw, with 7.5 
uL/mg tissue, minced, and triturated with a 21G needle, then transferred to a 5 mL Duall 
tissue grinder, to be homogenized with 20 strokes left and right. To shear DNA to reduce 
viscosity, samples were then treated with sonication with a 10 second burst at level 4, 
with a 20 second pause on ice, for 5 cycles. The homogenates were then cleared by 
centrifuging at 20,000xg at 4C for 20 minutes. The supernatant was then collected and 
loaded onto 30 kDa molecular weight cutoff filters, and centrifuged through them to 
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remove high molecular weight components, by centrifugation at 14,000xg for 10 
minutes, at room temperature so as not to disrupt the chemistry of the filter. Flowthrough 
of the filtration was then collected and desalted by solid-phase extraction. Briefly, C18 
SepPaks (Waters) were preconditioned with 10 mL of a buffer of 5% acetonitrile, 94.9% 
water, with .1% formic acid. The flowthrough sample was then loaded on these columns. 
Flowthrough of the filtration was then loaded onto the column. The sample was then 
desalted by washing with 20 mL of the preconditioning buffer, then eluted with a buffer of 
70% acetonitrile, 29.9% water, with .1% formic acid. This elution was then evaporated to 
dryness under vacuum. 
Database construction from ribosome profiling data. Ribosome profiling data was 
obtained from two published datasets, a cerebellum ribosome profiling dataset(Ishimura 
et al., 2014) and a frontal lobe ribosome profiling dataset(Hornstein et al., 2016). Briefly, 
in the former dataset, three cerebella were pooled for each library preparation, with brain 
tissues homogenized in a polysome buffer with DNase I, 100 ug/ml cycloheximide, and 2 
ug/ml harringtonine, blocking both ribosome elongation and ribosome initiation(Ingolia et 
al., 2011). Samples were treated with RNase I and pelleted into a 1M sucrose cushion, 
as previously described(Ingolia, Brar, Rouskin, McGeachy, & Weissman, 2012). Upon 
gel purification, 26-34 nucleotide length fragments were purified, and library preparation 
proceeded according to standard protocols. In the latter dataset, the frontal lobe of the 
mice was dissected by standard protocols, and the ribosome footprints were isolated 
and purified in the standard manner. However, the ligation step was then omitted and a 
small RNA library preparation kit was used to produce the final library (smRNA-Seq Kit 
for Illumina). Finally, a ribosome profiling dataset was generated from mouse brain using 
published protocols(Ingolia et al., 2012). From these sequencing data, proteome 
348 
 
databases were constructed using a novel method by Olexiouk (Olexiouk, Menschaert, 
et al, forthcoming). 
Mass spectrometry-based peptidomics analysis and TMT labelling, database searching 
and publication re-analysis. Datasets used for this study were the peptidomics study 
generated above, and the Sharma et al. mouse brain proteome(Sharma et al., 2015). In 
that study, brain regions were dissected from coronal sections from P60 mice. We used 
datasets only from the pre-frontal cortex experiments, and microglial and neuronal 
primary cell cultures. From this, the database searching was performed as in Chapter 3, 
with the ribosome profiling-based datasets concatenated as described and searched 
with the previously described settings. 
 
Results 
In these experiments, we performed peptidomics and proteogenomics analyses 
on the mouse brain in order to discover novel neuropeptides. In one experiment, we 
extracted neuropeptides from 6 mouse brains, one from each of three adolescent 
timepoints, at 4 weeks, 5 weeks and 6 weeks old, with two replicates per timepoint. The 
samples were labelled with TMT and for quantification. This experiment produced a 
dataset, at 1% FDR, of 368 proteins in 311 clusters, with the highest abundant protein 
being Immunoglobulin at 651 spectra followed by Ubiquitin at 617 spectra (Table 1). This 
is to be expected for a neuropeptides extraction, which extracts only soluble proteins. Of 
the 601 clustered proteins, 15 were known neuropeptides or their precursors (Table 2). 
We note that this workflow cannot differentiate between neuropeptides and their 
precursors, since a tryptic digest was done. The substantial number of neuropeptides 
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detected shows that the protocol is sensitive enough to observe neuropeptides, which 
are generally thought to be low abundance as signaling molecules. 
Sixteen spectra mapped to the transcript 2210013O21Rik, which is a transcript 
without an annotated function. The peptide sequence thus determined maps to exon 1 of 
the corresponding transcript, with a canonical start and stop codon, defining a short 
ORF. This sORF contains 5 tryptic cleavage sites, producing 6 tryptic peptides, or 5 if 
one proline-blocked tryptic site is ignored(Olsen, Ong, & Mann, 2004). Of these, 3 tryptic 
peptides were detected by mass spectrometry, with high probabilities for all peptides 
(Table 3). An example spectrum and mass table from the peptide is shown in Figure 1. 
We also examined the translation of the protein by ribosome profiling. All three mouse 
brain ribosome profiling datasets showed substantial coverage of this locus by ribosome 
profiling reads (Figure 2).  
To further examine the expression of this peptide, we also attempted to study its 
regulation over the course of adolescent development. We utilized the TMT labelling 
data to look for quantitative changes in the expression of the peptide over the course of 
adolescence, from 4 weeks development, 5 weeks development, and 6 weeks 
development. However, no substantial change was found in the abundance of the 
peptide over this timecourse (Figure 3). It is possible that, since whole brains were used 
in this experiment, there may be more region-specific changes which could not be found. 
Unlike embryonic development, the mouse brain undergoes only subtle changes during 
the course of adolescent development, although specific regions may change more 
substantially.  
To further examine this peptide and its function, we searched for the expression 
of the underlying transcript in the database BioGPS, which has microarray-based 
datasets detailing expression of all known transcripts. These results are summarized in 
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Figure 4. The transcript is found to have highest expression in mouse brain out of all 
tissues in mouse, in particular in dorsal root ganglia, hypothalamus, and amygdala. The 
latter two regions are involved in regulation of behavior, indicating that this peptide is 
likely to be a behavior regulating neuropeptide. 
In order to rule out contamination from the periphery in our sample, we re-
analyzed datasets from Sharma et al (see Methods), using proteomics data from 
cultured primary neurons and microglia. These datasets also contained the novel 
peptide, albeit at a lower intensity, likely because they were not targeted toward soluble 
peptide extractions. Thus, our bioinformatics framework allows us to find a novel 
micropeptide in published datasets, as well. Since these proteomics datasets were 
derived from cultured primary neurons and microglia, we can conclude that the peptide 
is produced locally, rather than crossing from the periphery as a secreted hormone. 
Finally, we further utilized this published dataset to attempt to find brain region-
specific micropeptides. We used published datasets from dissected pre-frontal cortex, a 
region known to undergo changes during adolescence. While these datasets were 
derived from P60 mice, which are adult mice, the targets thus derived may be interesting 
candidates for future work on adolescent development, since they are expressed in the 
pre-frontal cortex. Analyzing these datasets using the cerebellum-derived database 
generated a dataset of 7,309 proteins in 5,312 clusters. Of these, 61 were potential 
micropeptide hits. These were subjected to the screening by BLAST searches as 
described in Chapter 3. Twelve micropeptides were found to be translated from 5’ 
untranslated regions of known transcripts. Of these, 11 were found to map ambiguously 
to another isoform of a known gene, leaving one putative micropeptide. Twenty-six 
micropeptides were found to be translated from annotated long non-coding RNAs. Of 
these, homology screening rules out all but one. Thirteen micropeptides were found to 
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be alternately encoded from known exons. As we argued in Chapter 1, these cannot be 
unambiguously identified from mass spectrometry data. Ten micropeptides were found 
to be translated from transcripts expected to be degraded by nonsense-mediated decay; 
of these, one survived homology screening. 
 
Discussion 
In this chapter, we have developed a new proteogenomics framework utilizing 
ribosome profiling data, rather than RNAseq data, for generating databases for 
proteogenomics analyses. While no direct comparison between the two methods is 
within the scope of the work here, we suggest that this method appears to be more 
effective, since the search space is decreased by considering only ORFs which have 
substantial ribosomal content. As discussed in the introduction to this thesis, the 
ribosome profiling data should, in theory, match almost exactly to the proteomics data. 
However, it has been widely observed that ribosome profiling data and proteomics data 
mismatch to a large extent. Thus, allowing the two techniques to complement each other 
by orthogonally confirming results is a proteogenomics technique that allows the search 
space of the analysis to be decreased while nevertheless allowing dual confirmation of 
the novel protein identifications. Thus, in the case of searching the mouse brain for novel 
proteins, the ribosome profiling-based proteogenomics technique was successful, 
discovering indeed a new peptide. 
Short open reading frames (sORFs) are sequences of nucleotides in the human 
genome containing a start and an in-frame stop codon separated by less than 300 
nucleotides(Andrews & Rothnagel, 2014). The gene products of these sORFs are 
necessarily very short proteins of less than 100 amino acids. While there are many more 
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sORFs in most genomes than there are known genes [for example, the mouse genome 
has ~25,000 known genes, but ~47 million sORFs(Brown & Hancock, 2006; Crappe et 
al., 2013)], these very short genes have historically been understudied in all species, 
because of common bioinformatic, biochemical and genetic assumptions. First, since 
peptides generated from these sORFs would be very short, it was thought that they were 
unlikely to fold into stable structures which would allow them to be functional(Ingolia et 
al., 2014). Second, it is difficult to detect evolutionary conservation of these 
ORFs(Couso, 2015), and in classical random mutagenesis experiments, a shorter gene 
is less likely to be ‘hit’ than a longer one, leading to few phenotypes from these 
genes(Basrai et al., 1997). Finally, in a randomly-generated genome, there is a very high 
rate of occurrence of ORFs of <100 amino acids by random chance(Frith et al., 2006). 
All these lines of thinking led to the assumption that sORFs were non-functional, an 
assumption which has turned out to be wrong. 
The assumption has been disproven in the following ways. First, it has recently 
been recognized that intrinsically disordered proteins have many biological 
functions(Dyson & Wright, 2005; Wright & Dyson, 2015). Second, if homology detection 
is adjusted for the small length of these genes, a great deal of conservation can be 
found(Bazzini et al., 2014; Mackowiak et al., 2015). Finally and most importantly, next 
generation sequencing techniques such as RNA sequencing and ribosome profiling 
have shown that many of these sORFs are both transcribed and translated(Ingolia et al., 
2014; Ingolia et al., 2011). In particular, several significant novel genes, with likely roles 
in human disease, have been found recently. The peptide Myoregulin, which regulates 
the sarco/endoplasmic reticulum calcium ATPase (SERCA) pump in human skeletal 
muscle, was recently found by a bioinformatic screen(Anderson et al., 2015). This 
peptide is a fundamental discovery for the understanding of skeletal muscle physiology. 
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Similarly, the peptides MOTS-c (mitochondrial open reading frame of the 12S rRNA-c), 
discovered bioinformatically(C. Lee et al., 2015), and Toddler, discovered by ribosome 
profiling(Pauli et al., 2014), are involved in regulation of insulin metabolism in mouse and 
cardiovascular regulation in human, respectively(Yang, Maguire, & Davenport, 2015). 
Neuropeptides have long been recognized to be involved in regulation of 
behavior of human and other species(Burbach, 2011; Nathoo et al., 2001; L. S. Nelson 
et al., 1998; Zhang et al., 2015), and their involvement has been suggested in mental 
illness as well(Bissette et al., 1986; Caceda, Kinkead, & Nemeroff, 2007). In recent 
decades, the discovery, by various biochemical approaches, of novel neuropeptides has 
provided insights into the molecular regulation of behavior(Civelli et al., 2013; Hori et al., 
2001; Kojima et al., 1999; Meunier et al., 1995; Sakurai, Amemiya, Ishii, Matsuzaki, 
Chemelli, Tanaka, Williams, Richarson, et al., 1998; Tatemoto et al., 1998). For 
example, discovery of the orexin system, the peptides orexin A and orexin B and orexin 
receptor 1 and 2, has increased our understanding of sleep homeostasis, as well as pain 
and fear expression (de Lecea & Sutcliffe, 1999; Flores, Saravia, Maldonado, & 
Berrendero, 2015; Nunez, Rodrigo-Angulo, Andres, & Garzon, 2009). In this way, 
discovery of novel neuropeptides may provide insights into mental illness, for example, 
in the dysregulation of emotional expression. Furthermore, these discoveries have also 
yielded productive drug targets(Patel et al., 2015). Indeed, neuropeptides almost entirely 
signal through G-protein coupled receptors (GPCRs), which are the class of cell-surface 
molecules most commonly targeted by existing drugs(Civelli et al., 2013). Thus, 
discovery of novel neuropeptides is likely to produce new modes of pharmacological 
intervention in psychiatry. By discovering and validating novel sORF encoded peptides 
in the mammalian brain, novel neuronal signaling systems can be discovered; and by 
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studying these novel genes in the context of schizophrenia novel approaches for 
intervention in psychiatry can be produced. 
In this chapter, we have implemented a novel method for discovery of 
neuropeptides, which can easily be applied to any biological system. Here, we apply this 
system to the mouse brain. Here we combine novel neuropeptidomics techniques by 
mass spectrometry-based peptidomics with novel bioinformatics methods to discover 
micropeptides. Neuropeptidomics by mass spectrometry has been performed for many 
years, and standard techniques that have developed have been solubilization of brain 
extracts into acetic acid as a preservative against neuropeptide degradation. The novel 
neuropeptidomics methods we incorporate here are the heat-inactivation of brain 
samples by laser-guided heat delivery to the sample to a specific temperature for a 
specific time, immediately after dissection of the brain, in order to block neuropeptidases 
whose targets are unknown; simultaneously, we use microfiltration techniques, based on 
the highly successful FASP protocols, to purify the neuropeptides after heat-inactivation, 
preservation by acid, and extraction. We also combine these methods with novel 
techniques developed to discover micropeptides from mass spectrometry data. These 
techniques utilize ribosome profiling data with statistical methods to generate lists of all 
potentially translated ORFs in a transcriptome. By applying trypsin digestion to the 
neuropeptidomics extracts described above, we can use the databases thus generated 
to find micropeptides which act as neuropeptides, which is to say, secreted signaling 
molecules. As a proof of concept, in this chapter we describe a novel peptide translated 
from a short ORF, which is abundantly detected in our neuropeptidomics extracts. While 
we detect many cytosolic proteins which are not neuropeptides in our mass 
spectrometry data, and therefore cannot say with certainty that our novel peptide is a 
neuropeptide, the enrichment of such a peptide in the hypothalamus and amygdala 
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suggests that it may be involved in behavioral regulation, and a publication in peripheral 
T cells shows that activation by the peptide can occur by treatment in cell culture media, 
suggesting that it acts as a signaling peptide. Thus, we can show that our platform is 
indeed able to find novel micropeptides, and we have a strong suggestion that the 
peptide we discovered is a novel neuropeptide. We suggest, therefore, that our platform 
can find novel neuropeptides, and constitute a significant contribution to the field of 
neuropsychiatry. 
























sp|P62814|VATB2_MOUSEV-type proton ATPase subunit B, brain isoform OS=Mus 
musculus GN=Atp6v1b2 PE=1 SV=1 
100.00% 3 
G3UW55_MOUSE 100.00% 16 
E0CX65_MOUSE,Q2M4I8_MOUSE,Q6P6I8_MOUSE 100.00% 3 
A0A0A0MQA8_MOUSE,Q149W7_MOUSE,TKN1_MOUSE 100.00% 8 
D3YYN7_MOUSE,Q3UHK5_MOUSE,Q6ZQ49_MOUSE,sp|Q6PIE5|AT1A2_MOUSESodium
/potassium-transporting ATPase subunit alpha-2 OS=Mus musculus GN=Atp1a2 PE=1 SV=1 
98.20% 3 
D3YXH0_MOUSE,PCP4_MOUSE 100.00% 651 
sp|P56375|ACYP2_MOUSEAcylphosphatase-2 OS=Mus musculus GN=Acyp2 PE=1 SV=2 100.00% 18 
Q9Z1R9_MOUSE 100.00% 13 
D6REF3_MOUSE,Q5SS40_MOUSE,sp|P62259|1433E_MOUSE14-3-3 protein epsilon 
OS=Mus musculus GN=Ywhae PE=1 SV=1 
99.80% 4 
B2RTP7_MOUSE,K22E_MOUSE 100.00% 12 
QCR6_MOUSE 100.00% 33 
sp|Q3UNH4|GRIN1_MOUSEG protein-regulated inducer of neurite outgrowth 1 OS=Mus 
musculus GN=Gprin1 PE=1 SV=2 
100.00% 118 
F7BNZ5_MOUSE,Q8C0B4_MOUSE 100.00% 4 
B9EIV5_MOUSE,E9PZM8_MOUSE,F7BX42_MOUSE,Q3UH37_MOUSE,Q3UH69_MOUSE,
sp|Q99J85|NPTXR_MOUSENeuronal pentraxin receptor OS=Mus musculus GN=Nptxr 
PE=1 SV=1 
100.00% 5 
sp|Q60829|PPR1B_MOUSEProtein phosphatase 1 regulatory subunit 1B OS=Mus musculus 100.00% 4 
361 
 
GN=Ppp1r1b PE=1 SV=2 
sp|P63040|CPLX1_MOUSEComplexin-1 OS=Mus musculus GN=Cplx1 PE=1 SV=1 100.00% 22 
IF4B_MOUSE,Q3TDD8_MOUSE,Q3THB0_MOUSE,Q3TSY9_MOUSE 100.00% 6 
7B2_MOUSE,Q3TT51_MOUSE 100.00% 5 
452333,sp|Q91VW3|SH3L3_MOUSESH3 domain-binding glutamic acid-rich-like protein 3 
OS=Mus musculus GN=Sh3bgrl3 PE=1 SV=1 
100.00% 48 
Q564F6_MOUSE,sp|P56812|PDCD5_MOUSEProgrammed cell death protein 5 OS=Mus 
musculus GN=Pdcd5 PE=1 SV=3 
100.00% 36 
sp|P46414|CDN1B_MOUSECyclin-dependent kinase inhibitor 1B OS=Mus musculus 
GN=Cdkn1b PE=1 SV=2 
100.00% 26 
sp|Q32M26|CK087_MOUSEUncharacterized protein C11orf87 homolog OS=Mus musculus 
PE=2 SV=1 
100.00% 3 
sp|Q9WVA2|TIM8A_MOUSEMitochondrial import inner membrane translocase subunit Tim8 
A OS=Mus musculus GN=Timm8a1 PE=1 SV=1 
100.00% 4 
323714,328814,DTD1_MOUSE 100.00% 17 
MYL6_MOUSE,Q3TIG9_MOUSE,Q642K0_MOUSE 99.90% 2 
D3Z0Y2_MOUSE,Q53ZU7_MOUSE,Q6A0D0_MOUSE,Q6GT24_MOUSE,sp|O08709|PRDX
6_MOUSEPeroxiredoxin-6 OS=Mus musculus GN=Prdx6 PE=1 SV=3 
100.00% 2 
Q0VGU4_MOUSE 100.00% 54 
Q569X3_MOUSE,RU1C_MOUSE 100.00% 4 
sp|Q6W8Q3|PC4L1_MOUSEPurkinje cell protein 4-like protein 1 OS=Mus musculus 
GN=Pcp4l1 PE=1 SV=1 
100.00% 79 
Q3THA6_MOUSE,sp|Q8BL97|SRSF7_MOUSESerine/arginine-rich splicing factor 7 OS=Mus 
musculus GN=Srsf7 PE=1 SV=1 
99.80% 2 
sp|Q9CRB6|TPPP3_MOUSETubulin polymerization-promoting protein family member 3 
OS=Mus musculus GN=Tppp3 PE=1 SV=1 
100.00% 10 
sp|Q62048|PEA15_MOUSEAstrocytic phosphoprotein PEA-15 OS=Mus musculus 
GN=Pea15 PE=1 SV=1 
100.00% 18 
VATF_MOUSE 100.00% 5 
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CCKN_MOUSE 100.00% 9 
sp|Q8BTE0|SDHF4_MOUSESuccinate dehydrogenase assembly factor 4, mitochondrial 
OS=Mus musculus GN=Sdhaf4 PE=3 SV=2 
100.00% 18 
B9EKJ7_MOUSE,sp|P58871|TB182_MOUSE182 kDa tankyrase-1-binding protein OS=Mus 
musculus GN=Tnks1bp1 PE=1 SV=2 
100.00% 4 
A6ZI44_MOUSE,Q5FWB7_MOUSE,Q6NY00_MOUSE,sp|P05064|ALDOA_MOUSEFructose
-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2 
100.00% 5 
MAP6_MOUSE 100.00% 77 
A0A0A0MQ79_MOUSE,sp|Q3TLH4|PRC2C_MOUSEProtein PRRC2C OS=Mus musculus 
GN=Prrc2c PE=1 SV=3 
100.00% 4 




sp|O35143|ATIF1_MOUSEATPase inhibitor, mitochondrial OS=Mus musculus GN=Atpif1 
PE=1 SV=2 
100.00% 14 
ENOA_MOUSE,Q5FW97_MOUSE 100.00% 5 
Q14C38_MOUSE,sp|Q8CCT4|TCAL5_MOUSETranscription elongation factor A protein-like 
5 OS=Mus musculus GN=Tceal5 PE=1 SV=1 
100.00% 69 
COLI_MOUSE 100.00% 3 
MIA3_MOUSE 99.90% 5 
D0VYV7_MOUSE 100.00% 10 
Q5I0U7_MOUSE,TBCA_MOUSE 100.00% 20 
GUAD_MOUSE,Q3U0C4_MOUSE,Q548F2_MOUSE,Q69ZN0_MOUSE,Q6DFY1_MOUSE 99.70% 2 
TKNK_MOUSE 100.00% 6 
Q545V6_MOUSE,SMS_MOUSE 100.00% 9 
K22O_MOUSE 99.80% 16 
666324,E9Q827_MOUSE,sp|P56212|ARP19_MOUSEcAMP-regulated phosphoprotein 19 




sp|Q8BH93|MISSL_MOUSEMAPK-interacting and spindle-stabilizing protein-like OS=Mus 
musculus GN=Mapk1ip1l PE=2 SV=3 
100.00% 4 
CLCB_MOUSE 100.00% 7 
Q543N3_MOUSE,sp|Q61792|LASP1_MOUSELIM and SH3 domain protein 1 OS=Mus 
musculus GN=Lasp1 PE=1 SV=1 
100.00% 40 
Q9D881_MOUSE,sp|P19536|COX5B_MOUSECytochrome c oxidase subunit 5B, 









Calcium-regulated heat stable protein 1 OS=Mus musculus GN=Carhsp1 PE=1 SV=1 
100.00% 4 
Q3THQ5_MOUSE,sp|Q60864|STIP1_MOUSEStress-induced-phosphoprotein 1 OS=Mus 
musculus GN=Stip1 PE=1 SV=1 
100.00% 2 
IF4H_MOUSE,Q3TG58_MOUSE,Q564E5_MOUSE,Q80U88_MOUSE 100.00% 21 
sp|O88852|TSYL1_MOUSETestis-specific Y-encoded-like protein 1 OS=Mus musculus 
GN=Tspyl1 PE=2 SV=1 
100.00% 4 
sp|Q8BK30|NDUV3_MOUSENADH dehydrogenase [ubiquinone] flavoprotein 3, 
mitochondrial OS=Mus musculus GN=Ndufv3 PE=1 SV=1 
100.00% 35 
EPN1_MOUSE 100.00% 8 
AMD_MOUSE 100.00% 13 
A2AJH3_MOUSE,NMT2_MOUSE,Q3THR4_MOUSE 100.00% 3 
D3Z5R4_MOUSE,E9Q2D0_MOUSE,sp|P0C7L0|WIPF3_MOUSEWAS/WASL-interacting 
protein family member 3 OS=Mus musculus GN=Wipf3 PE=1 SV=1 
100.00% 57 
THIO_MOUSE 100.00% 42 
sp|Q91YQ3|CSDC2_MOUSECold shock domain-containing protein C2 OS=Mus musculus 
GN=Csdc2 PE=1 SV=2 
100.00% 8 
Q54AC6_MOUSE,sp|P56394|COX17_MOUSECytochrome c oxidase copper chaperone 100.00% 23 
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OS=Mus musculus GN=Cox17 PE=1 SV=2 
ICLN_MOUSE,Q923F1_MOUSE 100.00% 2 
sp|Q9DC07|LNEBL_MOUSELIM zinc-binding domain-containing Nebulette OS=Mus 
musculus GN=Nebl PE=1 SV=1 
100.00% 27 
HN1L_MOUSE,Q3TM10_MOUSE 100.00% 14 
A0A0G2JDN7_MOUSE,E9PZ43_MOUSE 100.00% 2 
sp|P38647|GRP75_MOUSEStress-70 protein, mitochondrial OS=Mus musculus GN=Hspa9 
PE=1 SV=3 
100.00% 3 
A0A0A0MQC7_MOUSE,A2A5Y6_MOUSE,TAU_MOUSE 100.00% 56 
sp|Q8R5H6|WASF1_MOUSEWiskott-Aldrich syndrome protein family member 1 OS=Mus 
musculus GN=Wasf1 PE=1 SV=2 
100.00% 5 
Q545B6_MOUSE,sp|P54227|STMN1_MOUSEStathmin OS=Mus musculus GN=Stmn1 
PE=1 SV=2 
100.00% 74 
sp|Q99M71|EPDR1_MOUSEMammalian ependymin-related protein 1 OS=Mus musculus 
GN=Epdr1 PE=1 SV=1 
100.00% 3 
MTPN_MOUSE 100.00% 7 
sp|P70349|HINT1_MOUSEHistidine triad nucleotide-binding protein 1 OS=Mus musculus 
GN=Hint1 PE=1 SV=3 
100.00% 11 
CEND_MOUSE 100.00% 114 
A8IK50_MOUSE,PCP2_MOUSE 100.00% 69 
A0A0G2JGX4_MOUSE,Q8VCE0_MOUSE,sp|Q6PIC6|AT1A3_MOUSESodium/potassium-
transporting ATPase subunit alpha-3 OS=Mus musculus GN=Atp1a3 PE=1 SV=1 
100.00% 5 
A2ARP8_MOUSE,sp|Q9QYR6|MAP1A_MOUSEMicrotubule-associated protein 1A OS=Mus 
musculus GN=Map1a PE=1 SV=2 
100.00% 28 
E9PX89_MOUSE,E9Q705_MOUSE,Q14A77_MOUSE,sp|Q8CEI1|BOLA3_MOUSEBolA-like 
protein 3 OS=Mus musculus GN=Bola3 PE=1 SV=1 
100.00% 5 
KCRB_MOUSE 100.00% 4 
UCRI_MOUSE 100.00% 25 
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ENSA_MOUSE 100.00% 246 
sp|A2A8L1|CHD5_MOUSE-DECOY 99.80% 3 
Q4FJU3_MOUSE,sp|Q9DCT8|CRIP2_MOUSECysteine-rich protein 2 OS=Mus musculus 
GN=Crip2 PE=1 SV=1 
100.00% 4 
sp|Q3U0V1|FUBP2_MOUSEFar upstream element-binding protein 2 OS=Mus musculus 
GN=Khsrp PE=1 SV=2 
100.00% 14 
SYN1_MOUSE 100.00% 45 
Q3ULN5_MOUSE,sp|P26883|FKB1A_MOUSEPeptidyl-prolyl cis-trans isomerase FKBP1A 
OS=Mus musculus GN=Fkbp1a PE=1 SV=2 
100.00% 14 
sp|Q9D8Z2|TRIA1_MOUSETP53-regulated inhibitor of apoptosis 1 OS=Mus musculus 
GN=Triap1 PE=1 SV=1 
100.00% 9 
TPIS_MOUSE 100.00% 33 
sp|Q9D1L0|CHCH2_MOUSECoiled-coil-helix-coiled-coil-helix domain-containing protein 2 
OS=Mus musculus GN=Chchd2 PE=2 SV=1 
81.90% 10 
Q9D6F8_MOUSE 56.30% 5 
Q059I1_MOUSE,RS28_MOUSE 100.00% 46 
Q3TY66_MOUSE,SCG1_MOUSE 100.00% 72 
WNK1_MOUSE 100.00% 4 
B1AX78_MOUSE,Q99JH2_MOUSE 100.00% 8 
NEU2_MOUSE,Q3UUQ5_MOUSE 100.00% 8 
H7BX95_MOUSE,sp|Q6PDM2|SRSF1_MOUSESerine/arginine-rich splicing factor 1 
OS=Mus musculus GN=Srsf1 PE=1 SV=3 
100.00% 17 
COA4_MOUSE 100.00% 14 
sp|Q78J03|MSRB2_MOUSEMethionine-R-sulfoxide reductase B2, mitochondrial OS=Mus 
musculus GN=Msrb2 PE=1 SV=1 
100.00% 8 
AAK1_MOUSE 100.00% 15 
Q3TJ52_MOUSE,Q3U041_MOUSE,Q3UQN3_MOUSE,Q6NVC3_MOUSE,sp|P54728|RD23





Q8C6L4_MOUSE,RTN3_MOUSE 100.00% 4 
sp|O08553|DPYL2_MOUSEDihydropyrimidinase-related protein 2 OS=Mus musculus 
GN=Dpysl2 PE=1 SV=2 
100.00% 12 
sp|Q9ERT9|PPR1A_MOUSEProtein phosphatase 1 regulatory subunit 1A OS=Mus 
musculus GN=Ppp1r1a PE=1 SV=1 
100.00% 56 
A2RTI3_MOUSE,LGMN_MOUSE,Q3UE99_MOUSE 100.00% 7 
sp|Q6QWF9|CK2N1_MOUSECalcium/calmodulin-dependent protein kinase II inhibitor 1 
OS=Mus musculus GN=Camk2n1 PE=1 SV=1 
100.00% 12 
ISCU_MOUSE 100.00% 7 
sp|Q99JX1|TAF11_MOUSETranscription initiation factor TFIID subunit 11 OS=Mus 
musculus GN=Taf11 PE=2 SV=1 
100.00% 5 
DOPD_MOUSE,Q3UNI8_MOUSE 100.00% 7 
C10_MOUSE 100.00% 3 
493543,HOP_MOUSE 100.00% 10 
K2C4_MOUSE 98.80% 7 
A0A0N4SUN8_MOUSE,A0A0N4SUQ1_MOUSE,A0A0N4SV32_MOUSE,A0A0N4SWH2_M
OUSE,Q3UEI6_MOUSE,Q3UJK2_MOUSE,Q3UMP4_MOUSE,Q3V274_MOUSE,sp|Q9CY5
8|PAIRB_MOUSEPlasminogen activator inhibitor 1 RNA-binding protein OS=Mus musculus 
GN=Serbp1 PE=1 SV=2 
100.00% 2 
NFH_MOUSE,Q80TQ3_MOUSE 100.00% 3 
sp|P60879|SNP25_MOUSESynaptosomal-associated protein 25 OS=Mus musculus 
GN=Snap25 PE=1 SV=1 
99.90% 2 
sp|Q60865|CAPR1_MOUSECaprin-1 OS=Mus musculus GN=Caprin1 PE=1 SV=2 100.00% 2 
539803,SYUA_MOUSE 100.00% 2 
sp|P20357|MTAP2_MOUSEMicrotubule-associated protein 2 OS=Mus musculus GN=Map2 
PE=1 SV=2 
100.00% 26 




E9QKI4_MOUSE,E9QKI5_MOUSE,sp|Q9D1F4|AKTS1_MOUSEProline-rich AKT1 substrate 
1 OS=Mus musculus GN=Akt1s1 PE=1 SV=1 
100.00% 3 
Q3TD71_MOUSE,Q3UY11_MOUSE,sp|Q8K021|SCAM1_MOUSESecretory carrier-
associated membrane protein 1 OS=Mus musculus GN=Scamp1 PE=1 SV=1 
100.00% 2 
sp|P52503|NDUS6_MOUSENADH dehydrogenase [ubiquinone] iron-sulfur protein 6, 
mitochondrial OS=Mus musculus GN=Ndufs6 PE=1 SV=2 
100.00% 84 
A0A0B4J1F2_MOUSE,A0A0B4J1M9_MOUSE,MAP4_MOUSE 100.00% 18 
sp|Q6IFX2|K1C42_MOUSEKeratin, type I cytoskeletal 42 OS=Mus musculus GN=Krt42 
PE=1 SV=1 
99.90% 28 
sp|Q8VED5|K2C79_MOUSEKeratin, type II cytoskeletal 79 OS=Mus musculus GN=Krt79 
PE=1 SV=2 
100.00% 20 
DYL2_MOUSE 100.00% 2 
PCNP_MOUSE,Q3UCC5_MOUSE 100.00% 35 
SCG2_MOUSE 100.00% 53 
Q8C1L7_MOUSE,RS21_MOUSE 100.00% 13 
134381 100.00% 9 





ribonucleoprotein U OS=Mus musculus GN=Hnrnpu PE=1 SV=1 
100.00% 2 
YAP1_MOUSE 100.00% 4 
A3KN68_MOUSE,sp|P80560|PTPR2_MOUSEReceptor-type tyrosine-protein phosphatase 
N2 OS=Mus musculus GN=Ptprn2 PE=1 SV=2 
100.00% 12 
685904,A0A0N4SUI7_MOUSE 100.00% 20 
sp|Q9CPU2|NDUB2_MOUSENADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 
2, mitochondrial OS=Mus musculus GN=Ndufb2 PE=1 SV=1 
100.00% 2 
Q3TG37_MOUSE,sp|P70441|NHRF1_MOUSENa(+)/H(+) exchange regulatory cofactor 100.00% 2 
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NHE-RF1 OS=Mus musculus GN=Slc9a3r1 PE=1 SV=3 
E0CZ08_MOUSE 95.80% 33 
PENK_MOUSE,Q3UXY8_MOUSE 100.00% 13 




splicing factor 3 OS=Mus musculus GN=Srsf3 PE=1 SV=1 
100.00% 3 
A0A087WNP6_MOUSE,CDV3_MOUSE 100.00% 72 
sp|Q3UGS4|F195B_MOUSEProtein FAM195B OS=Mus musculus GN=Fam195b PE=1 
SV=1 
100.00% 6 
sp|P13595|NCAM1_MOUSENeural cell adhesion molecule 1 OS=Mus musculus GN=Ncam1 
PE=1 SV=3 
6.70% 36 
B2RRX2_MOUSE,sp|P63328|PP2BA_MOUSESerine/threonine-protein phosphatase 2B 






Q7TT20_MOUSE,Q8CHE0_MOUSE 100.00% 92 
SCG3_MOUSE 100.00% 23 
A2BI30_MOUSE,F6ZGR6_MOUSE 100.00% 7 
sp|Q68ED7|CRTC1_MOUSECREB-regulated transcription coactivator 1 OS=Mus musculus 
GN=Crtc1 PE=1 SV=1 
100.00% 8 
V6BQR3_MOUSE 95.30% 10 
R7RU63_MOUSE,R7RVD4_MOUSE 100.00% 2 
33432 82.30% 334 
BIN1_MOUSE,Q6P1B9_MOUSE 100.00% 5 
Q3TCH2_MOUSE,sp|Q9R0P9|UCHL1_MOUSEUbiquitin carboxyl-terminal hydrolase 




Q3UI46_MOUSE,sp|P29595|NEDD8_MOUSENEDD8 OS=Mus musculus GN=Nedd8 PE=1 
SV=2 
100.00% 37 




OS=Mus musculus GN=Acyp1 PE=1 SV=2 
100.00% 10 
H2AX_MOUSE 100.00% 6 
sp|Q80Y61|BI2L2_MOUSEBrain-specific angiogenesis inhibitor 1-associated protein 2-like 
protein 2 OS=Mus musculus GN=Baiap2l2 PE=1 SV=1 
100.00% 2 
sp|Q8C3W1|CA198_MOUSEUncharacterized protein C1orf198 homolog OS=Mus musculus 
PE=1 SV=1 
100.00% 8 
Q3TH99_MOUSE,sp|Q9JM96|BORG4_MOUSECdc42 effector protein 4 OS=Mus musculus 
GN=Cdc42ep4 PE=1 SV=1 
100.00% 12 
tr|E0CX45|E0CX45_MOUSE-DECOY 100.00% 13 
sp|E9PUL5|PRRT2_MOUSEProline-rich transmembrane protein 2 OS=Mus musculus 
GN=Prrt2 PE=1 SV=1 
100.00% 19 
Q3TUB1_MOUSE,Q3U311_MOUSE,sp|Q03157|APLP1_MOUSEAmyloid-like protein 1 
OS=Mus musculus GN=Aplp1 PE=1 SV=1 
100.00% 4 
HEXB_MOUSE,Q3TXR9_MOUSE 100.00% 3 
J3QMK2_MOUSE 100.00% 2 
Q561N4_MOUSE 100.00% 5 
Q3TJA9_MOUSE,sp|Q99M87|DNJA3_MOUSEDnaJ homolog subfamily A member 3, 
mitochondrial OS=Mus musculus GN=Dnaja3 PE=1 SV=1 
100.00% 9 
sp|Q6PEV3|WIPF2_MOUSEWAS/WASL-interacting protein family member 2 OS=Mus 
musculus GN=Wipf2 PE=1 SV=1 
100.00% 4 
HN1_MOUSE 100.00% 38 
Q3ULN7_MOUSE,sp|Q9DCP9|DAZP2_MOUSEDAZ-associated protein 2 OS=Mus 
musculus GN=Dazap2 PE=1 SV=1 
100.00% 2 
B1AQ77_MOUSE,sp|Q61414|K1C15_MOUSEKeratin, type I cytoskeletal 15 OS=Mus 99.90% 21 
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musculus GN=Krt15 PE=1 SV=2 
G3UZA7_MOUSE,sp|Q9Z172|SUMO3_MOUSESmall ubiquitin-related modifier 3 OS=Mus 
musculus GN=Sumo3 PE=1 SV=1 
100.00% 53 
sp|Q9CRD0|OCAD1_MOUSEOCIA domain-containing protein 1 OS=Mus musculus 
GN=Ociad1 PE=1 SV=1 
100.00% 10 
sp|Q9JHU4|DYHC1_MOUSECytoplasmic dynein 1 heavy chain 1 OS=Mus musculus 
GN=Dync1h1 PE=1 SV=2 
99.50% 2 
Q3TCR9_MOUSE,Q8CBM0_MOUSE,ZYX_MOUSE 100.00% 17 
tr|A0A0G2JGW5|A0A0G2JGW5_MOUSE-DECOY 99.80% 5 
sp|Q8CI43|MYL6B_MOUSEMyosin light chain 6B OS=Mus musculus GN=Myl6b PE=1 SV=1 100.00% 4 
Q3TRX4_MOUSE,Q3UZP7_MOUSE,Q542N8_MOUSE 100.00% 26 
BSN_MOUSE 100.00% 9 









sp|Q80X50|UBP2L_MOUSEUbiquitin-associated protein 2-like OS=Mus musculus 
GN=Ubap2l PE=1 SV=1 
100.00% 17 
Q3U9A8_MOUSE,sp|Q9JJU8|SH3L1_MOUSESH3 domain-binding glutamic acid-rich-like 
protein OS=Mus musculus GN=Sh3bgrl PE=1 SV=1 
100.00% 14 
Q3UIL5_MOUSE 100.00% 9 
Q3TU64_MOUSE,Q3TUE2_MOUSE,Q3TX57_MOUSE,sp|Q01149|CO1A2_MOUSECollage
n alpha-2(I) chain OS=Mus musculus GN=Col1a2 PE=1 SV=2 
100.00% 20 
MT3_MOUSE,Q3USP9_MOUSE 100.00% 7 
B0QZN5_MOUSE,O35619_MOUSE,Q8CHR4_MOUSE,sp|P63044|VAMP2_MOUSEVesicle-





C16_MOUSEKeratin, type I cytoskeletal 16 OS=Mus musculus GN=Krt16 PE=1 SV=3 
100.00% 27 
B2RPU8_MOUSE,Q8CEW7_MOUSE 99.50% 10 
Q6ZWX2_MOUSE 100.00% 115 
D3Z1F7_MOUSE,sp|Q9DBN4|P33MX_MOUSEPutative monooxygenase p33MONOX 
OS=Mus musculus GN=P33monox PE=1 SV=1 
100.00% 11 
sp|Q9JMG7|HDGR3_MOUSEHepatoma-derived growth factor-related protein 3 OS=Mus 
musculus GN=Hdgfrp3 PE=1 SV=2 
100.00% 8 
Q3TGC5_MOUSE,Q5EBQ2_MOUSE,sp|P70296|PEBP1_MOUSEPhosphatidylethanolamine
-binding protein 1 OS=Mus musculus GN=Pebp1 PE=1 SV=3 
100.00% 92 
A2AMY5_MOUSE,sp|Q91VX2|UBAP2_MOUSEUbiquitin-associated protein 2 OS=Mus 
musculus GN=Ubap2 PE=1... 
100.00% 5 




PLD3_MOUSE 100.00% 3 
A0A0G2JEK2_MOUSE,Q6P3B4_MOUSE,sp|P63254|CRIP1_MOUSECysteine-rich protein 1 
OS=Mus musculus GN=Crip1 PE=1 SV=2 
100.00% 2 
665268 100.00% 46 
B7ZP22_MOUSE,ROA2_MOUSE 100.00% 6 
TBB3_MOUSE 99.10% 14 
sp|P56391|CX6B1_MOUSECytochrome c oxidase subunit 6B1 OS=Mus musculus 
GN=Cox6b1 PE=1 SV=2 
100.00% 69 
Q3U6L3_MOUSE,sp|Q9QUH0|GLRX1_MOUSEGlutaredoxin-1 OS=Mus musculus GN=Glrx 
PE=1 SV=3 
100.00% 6 
EF1B_MOUSE 100.00% 8 
F6XIX0_MOUSE 99.80% 7 
Q3TDY6_MOUSE,Q3U2Z6_MOUSE,Q8BNF3_MOUSE,TPP1_MOUSE 100.00% 4 
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K2C1_MOUSE 100.00% 22 
Q3U7H9_MOUSE,Q3UWS9_MOUSE 100.00% 13 
Q58E70_MOUSE 99.90% 2 




EID2_MOUSE 100.00% 8 
H7BWY8_MOUSE,TSR2_MOUSE,Z4YL87_MOUSE 100.00% 4 
MDHC_MOUSE 100.00% 6 
E9QAQ7_MOUSE,sp|A2BH40|ARI1A_MOUSEAT-rich interactive domain-containing protein 
1A OS=Mus musculus GN=Arid1a PE=1 SV=1 
100.00% 2 
Q6NZC5_MOUSE 100.00% 612 
sp|Q9QXV0|PCSK1_MOUSEProSAAS OS=Mus musculus GN=Pcsk1n PE=1 SV=2 100.00% 96 
sp|Q8K039|K1143_MOUSEUncharacterized protein KIAA1143 homolog OS=Mus musculus 
PE=1 SV=1 
100.00% 8 
B2RQX9_MOUSE,B2RXV9_MOUSE 100.00% 2 
A8IP69_MOUSE,sp|P61982|1433G_MOUSE14-3-3 protein gamma OS=Mus musculus 
GN=Ywhag PE=1 SV=2 
100.00% 6 
A6H6H4_MOUSE,sp|Q6ZWY8|TYB10_MOUSEThymosin beta-10 OS=Mus musculus 
GN=Tmsb10 PE=1 SV=3 
100.00% 58 
NEC2_MOUSE,Q3TT48_MOUSE,Q3TYM6_MOUSE,Q3UZV3_MOUSE,Q547J8_MOUSE 100.00% 3 
E9PY90_MOUSE,E9Q3S2_MOUSE,H3BJI6_MOUSE,H3BJS0_MOUSE,H3BK44_MOUSE,
H3BK48_MOUSE,H3BKH2_MOUSE,H3BKL6_MOUSE,H3BL19_MOUSE,Q3TZZ3_MOUSE,






Q8BH80_MOUSE,VAPB_MOUSE 100.00% 7 
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A3KGA5_MOUSE,CMC4_MOUSE 100.00% 5 
sp|Q9D8B3|CHM4B_MOUSECharged multivesicular body protein 4b OS=Mus musculus 
GN=Chmp4b PE=1 SV=2 
100.00% 5 
sp|Q6PGL7|FAM21_MOUSEWASH complex subunit FAM21 OS=Mus musculus GN=Fam21 
PE=1 SV=1 
100.00% 3 
407588,412206,IPKA_MOUSE 100.00% 9 
K2C5_MOUSE,Q32P04_MOUSE 100.00% 36 
NEUG_MOUSE 100.00% 279 
ENOG_MOUSE,Q3UJ20_MOUSE,Q545V3_MOUSE 100.00% 24 
LYAG_MOUSE 100.00% 17 
CH10_MOUSE,Q4KL76_MOUSE 100.00% 92 
DPP2_MOUSE 100.00% 3 
D3Z4A4_MOUSE 100.00% 2 
sp|Q99JI1|MSTN1_MOUSEMusculoskeletal embryonic nuclear protein 1 OS=Mus musculus 
GN=Mustn1 PE=1 SV=1 
100.00% 3 
D3Z2Z1_MOUSE,F8WIA1_MOUSE,sp|Q922J3|CLIP1_MOUSECAP-Gly domain-containing 
linker protein 1 OS=Mus musculus GN=Clip1 PE=1 SV=1 
100.00% 7 
CART_MOUSE 100.00% 7 
Q3URG1_MOUSE,TPPP_MOUSE 100.00% 18 
sp|Q99JP4|CDC26_MOUSEAnaphase-promoting complex subunit CDC26 OS=Mus 
musculus GN=Cdc26 PE=1 SV=1 
100.00% 15 
sp|P63101|1433Z_MOUSE14-3-3 protein zeta/delta OS=Mus musculus GN=Ywhaz PE=1 
SV=1 
100.00% 10 
SODC_MOUSE 100.00% 155 
J3QK04_MOUSE 8.50% 587 
CMGA_MOUSE 100.00% 6 
Q3TWF2_MOUSE,Q3U6V3_MOUSE,Q3U9G2_MOUSE,Q9DC41_MOUSE,sp|P20029|GRP




Q54A87_MOUSE,sp|Q9WTT4|VATG2_MOUSEV-type proton ATPase subunit G 2 OS=Mus 
musculus GN=Atp6v1g2 PE=1 SV=1 
100.00% 7 
DEMA_MOUSE 100.00% 19 
A0A0H2UH17_MOUSE,Q812D4_MOUSE,Q8BJ53_MOUSE 95.90% 8 
sp|Q61781|K1C14_MOUSEKeratin, type I cytoskeletal 14 OS=Mus musculus GN=Krt14 
PE=1 SV=2 
100.00% 35 
sp|P68510|1433F_MOUSE14-3-3 protein eta OS=Mus musculus GN=Ywhah PE=1 SV=2 99.80% 4 
sp|Q9Z1P6|NDUA7_MOUSENADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 7 OS=Mus musculus GN=Ndufa7 PE=1 SV=3 
100.00% 116 
sp|P97450|ATP5J_MOUSEATP synthase-coupling factor 6, mitochondrial OS=Mus 
musculus GN=Atp5j PE=1 SV=1 
100.00% 116 
TERA_MOUSE 100.00% 3 
sp|O09114|PTGDS_MOUSEProstaglandin-H2 D-isomerase OS=Mus musculus GN=Ptgds 
PE=1 SV=1 
100.00% 8 
PSB6_MOUSE 100.00% 34 
F7D425_MOUSE 100.00% 33 
C9K0Z8_MOUSE,HCN2_MOUSE 100.00% 2 
Q6A090_MOUSE,sp|Q9Z0H8|CLIP2_MOUSECAP-Gly domain-containing linker protein 2 
OS=Mus musculus GN=Clip2 PE=1 SV=2 
100.00% 4 
Q53YX2_MOUSE,THY1_MOUSE 100.00% 5 
sp|P61957|SUMO2_MOUSESmall ubiquitin-related modifier 2 OS=Mus musculus 
GN=Sumo2 PE=1 SV=1 
100.00% 69 
Q3U422_MOUSE,Q3U4K3_MOUSE,Q91WP8_MOUSE 100.00% 23 
A2AF33_MOUSE 100.00% 34 
B1AWD9_MOUSE 100.00% 11 
D3Z3A0_MOUSE,IPP2_MOUSE 100.00% 21 
E9Q0F0_MOUSE 100.00% 10 
HDGF_MOUSE 100.00% 9 
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AINX_MOUSE 100.00% 18 
RT31_MOUSE 100.00% 2 
NSG2_MOUSE,Q5SS02_MOUSE 100.00% 3 
A0A0N4SUV3_MOUSE,D3YTU0_MOUSE,Q9CXX2_MOUSE,sp|Q62442|VAMP1_MOUSEV
esicle-associated membrane protein 1 OS=Mus musculus GN=Vamp1 PE=1 SV=1 
100.00% 10 
Q3TYF2_MOUSE,Q543Y7_MOUSE,sp|Q61644|PACN1_MOUSEProtein kinase C and 
casein kinase substrate in neurons protein 1 OS=Mus musculus GN=Pacsin1 PE=1 SV=1 
100.00% 5 
A0A0A6YW88_MOUSE,sp|Q3UHL1|CAMKV_MOUSECaM kinase-like vesicle-associated 
protein OS=Mus musculus GN=Camkv PE=1 SV=2 
100.00% 8 
sp|Q9D8S9|BOLA1_MOUSEBolA-like protein 1 OS=Mus musculus GN=Bola1 PE=1 SV=1 100.00% 18 
CALM_MOUSE,Q3UKW2_MOUSE 100.00% 14 
RBP2_MOUSE 88.90% 16 
MIF_MOUSE,Q545F0_MOUSE 100.00% 29 
A0JLV3_MOUSE,B2RTK3_MOUSE,B2RVD5_MOUSE,Q8CBB6_MOUSE,Q921L4_MOUSE,
sp|P10853|H2B1F_MOUSEHistone H2B type 1-F/J/L OS=Mus musculus GN=Hist1h2bf 
PE=1 SV=2,sp|P10854|H2B1M_MOUSEHistone H2B type 1-M OS=Mus musculus 
GN=Hist1h2bm PE=1 SV=2,sp|Q64478|H2B1H_MOUSEHistone H2B type 1-H OS=Mus 
musculus GN=Hist1h2bh PE=1 SV=3,sp|Q64524|H2B2E_MOUSEHistone H2B type 2-E 
OS=Mus musculus GN=Hist2h2be PE=1 SV=3,sp|Q64525|H2B2B_MOUSEHistone H2B 
type 2-B OS=Mus musculus GN=Hist2h2bb PE=1 
SV=3,sp|Q6ZWY9|H2B1C_MOUSEHistone H2B type 1-C/E/G OS=Mus musculus 
GN=Hist1h2bc PE=1 SV=3,sp|Q8CGP0|H2B3B_MOUSEHistone H2B type 3-B OS=Mus 
musculus GN=Hist3h2bb PE=1 SV=3,sp|Q8CGP1|H2B1K_MOUSEHistone H2B type 1-K 
OS=Mus musculus GN=Hist1h2bk PE=1 SV=3,sp|Q8CGP2|H2B1P_MOUSEHistone H2B 
type 1-P OS=Mus musculus GN=Hist1h2bp PE=1 
SV=3,sp|Q9D2U9|H2B3A_MOUSEHistone H2B type 3-A OS=Mus musculus GN=Hist3h2ba 
PE=1 SV=3 
100.00% 5 
AMPH_MOUSE 100.00% 2 




protein theta OS=Mus musculus GN=Ywhaq PE=1 SV=1 
99.90% 7 
D3YYZ2_MOUSE 100.00% 395 
GLSK_MOUSE 100.00% 3 
VIP_MOUSE 100.00% 2 







CYC_MOUSE,G3UWG1_MOUSE,Q56A15_MOUSE 100.00% 139 
sp|Q91XV3|BASP1_MOUSEBrain acid soluble protein 1 OS=Mus musculus GN=Basp1 
PE=1 SV=3 
100.00% 192 
Q8R3X4_MOUSE,sp|O35857|TIM44_MOUSEMitochondrial import inner membrane 
translocase subunit TIM44 OS=Mus musculus GN=Timm44 PE=1 SV=2 
100.00% 5 
Q3U7Z6_MOUSE,Q5NCI4_MOUSE,Q6NWV5_MOUSE,sp|O70250|PGAM2_MOUSEPhosp
hoglycerate mutase 2 OS=Mus musculus GN=Pgam2 PE=1 
SV=3,sp|Q9DBJ1|PGAM1_MOUSEPhosphoglycerate mutase 1 OS=Mus musculus 
GN=Pgam1 PE=1 SV=3 
100.00% 6 
NFM_MOUSE 100.00% 19 
sp|P52760|UK114_MOUSERibonuclease UK114 OS=Mus musculus GN=Hrsp12 PE=1 
SV=3 
100.00% 50 
D3YZV2_MOUSE,E9QKI2_MOUSE 100.00% 4 
D3YZD8_MOUSE,D3Z442_MOUSE,sp|Q8R0P4|AAMDC_MOUSEMth938 domain-
containing protein OS=Mus musculus GN=Aamdc PE=1 SV=1 
100.00% 10 
Q9CVR0_MOUSE,sp|P68372|TBB4B_MOUSETubulin beta-4B chain OS=Mus musculus 
GN=Tubb4b PE=1 SV=1 
100.00% 19 





NEUM_MOUSE 100.00% 240 
E9Q7S0_MOUSE,F7BQW7_MOUSE,sp|Q8CHC4|SYNJ1_MOUSESynaptojanin-1 OS=Mus 
musculus GN=Synj1 PE=1 SV=3 
100.00% 16 
691526,Q8C0W0_MOUSE 100.00% 53 
B2RXL5_MOUSE,sp|Q78WH7|CK2N2_MOUSECalcium/calmodulin-dependent protein 
kinase II inhibitor 2 OS=Mus musculus GN=Camk2n2 PE=1 SV=1 
99.90% 8 
MRP_MOUSE 100.00% 33 
PGP_MOUSE 100.00% 4 
NPY_MOUSE 100.00% 32 
Q9D6T9_MOUSE,RT36_MOUSE 100.00% 36 
Q545F4_MOUSE,sp|P14602|HSPB1_MOUSEHeat shock protein beta-1 OS=Mus musculus 
GN=Hspb1 PE=1 SV=3 
100.00% 4 
sp|Q9CQ75|NDUA2_MOUSENADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 2 OS=Mus musculus GN=Ndufa2 PE=1 SV=3 
100.00% 3 
D3Z5K8_MOUSE,D3Z5K9_MOUSE 100.00% 2 
sp|Q59J78|MIMIT_MOUSEMimitin, mitochondrial OS=Mus musculus GN=Ndufaf2 PE=1 
SV=1 
100.00% 10 
Q497I3_MOUSE,sp|Q05816|FABP5_MOUSEFatty acid-binding protein, epidermal OS=Mus 
musculus GN=Fabp5 PE=1 SV=3 
100.00% 21 
EPN4_MOUSE,Q3TJF5_MOUSE,Q3UPG6_MOUSE,Q5SUH6_MOUSE,Q5SUH7_MOUSE 100.00% 3 
Q8C2K3_MOUSE 100.00% 605 
MCH_MOUSE,Q80ZR6_MOUSE 100.00% 8 
A0A0A6YY91_MOUSE 100.00% 42 
D3YYE1_MOUSE,D3Z7M9_MOUSE,F6UFG6_MOUSE,sp|O35381|AN32A_MOUSEAcidic 
leucine-rich nuclear phosphoprotein 32 family member A OS=Mus musculus GN=Anp32a 
PE=1 SV=1 
100.00% 7 
Q08EK4_MOUSE,Q08EK5_MOUSE,sp|Q6IFZ6|K2C1B_MOUSEKeratin, type II cytoskeletal 




TYB4_MOUSE 100.00% 113 
CATB_MOUSE,Q3TVS6_MOUSE 100.00% 34 
TRH_MOUSE 100.00% 16 
PCLO_MOUSE 100.00% 6 
Q3TIR0_MOUSE 5.80% 4 
sp|Q9R0H5|K2C71_MOUSEKeratin, type II cytoskeletal 71 OS=Mus musculus GN=Krt71 
PE=1 SV=1 
100.00% 12 
sp|Q9D727|CF226_MOUSEUncharacterized protein C6orf226 homolog OS=Mus musculus 
PE=1 SV=1 
100.00% 4 
Q5EBJ0_MOUSE,sp|P11404|FABPH_MOUSEFatty acid-binding protein, heart OS=Mus 
musculus GN=Fabp3 PE=1 SV=5 
100.00% 12 
COF1_MOUSE,F8WGL3_MOUSE,Q544Y7_MOUSE 100.00% 12 
COA6_MOUSE 100.00% 9 
sp|Q8C419|GP158_MOUSEProbable G-protein coupled receptor 158 OS=Mus musculus 
GN=Gpr158 PE=1 SV=2 
100.00% 2 
PRVA_MOUSE,Q545M7_MOUSE 100.00% 191 
A2AEC2_MOUSE 99.80% 61 
B2RSN3_MOUSE,sp|Q7TMM9|TBB2A_MOUSETubulin beta-2A chain OS=Mus musculus 
GN=Tubb2a PE=1 SV=1,sp|Q9CWF2|TBB2B_MOUSETubulin beta-2B chain OS=Mus 
musculus GN=Tubb2b PE=1 SV=1 
100.00% 14 
Q8CCS7_MOUSE 100.00% 3 
Q3TEK2_MOUSE,Q3TF16_MOUSE,Q3TH56_MOUSE,Q3TQ13_MOUSE,Q3TRH3_MOUS
E,Q3TZJ3_MOUSE,Q3U9L2_MOUSE,Q3UBA6_MOUSE,Q504P4_MOUSE,sp|P63017|HSP
7C_MOUSEHeat shock cognate 71 kDa protein OS=Mus musculus GN=Hspa8 PE=1 SV=1 
100.00% 7 
A2A513_MOUSE,sp|P02535|K1C10_MOUSEKeratin, type I cytoskeletal 10 OS=Mus 
musculus GN=Krt10 PE=1 SV=3 
100.00% 50 
A2AA85_MOUSE,sp|Q6NXN1|SZRD1_MOUSESUZ domain-containing protein 1 OS=Mus 




D3Z3F1_MOUSE,D3Z4V2_MOUSE,D3Z619_MOUSE,FIP1_MOUSE 100.00% 3 
F6VME3_MOUSE 100.00% 26 
ACBP_MOUSE,Q548W7_MOUSE 100.00% 336 
A2ATI6_MOUSE,A2ATI9_MOUSE,Q3TG07_MOUSE,Q3TIK1_MOUSE,Q3TX06_MOUSE,Q
3V458_MOUSE,sp|Q99JX3|GORS2_MOUSEGolgi reassembly-stacking protein 2 OS=Mus 
musculus GN=Gorasp2 PE=1 SV=3 
100.00% 3 
sp|Q9CPQ1|COX6C_MOUSECytochrome c oxidase subunit 6C OS=Mus musculus 
GN=Cox6c PE=1 SV=3 
100.00% 6 
E9QM38_MOUSE 100.00% 12 
PPIA_MOUSE,Q3UAJ1_MOUSE,Q5SVY2_MOUSE 100.00% 121 




Identified Protein Spectral Count 
ProSAAS 96 
Chromogranin B 72 
Secretogranin-2 53 
Pro-neuropeptide Y 32 
Secretogranin-3 23 
Proenkephalin-A 13 






Prothymosin alpha 3 
VIP peptides 2 



















TIC Start Stop 
(R)sTLPPGNTR(E) 100% 23.33 51.21688 9 3.677781 954.262 3751070 11 19 
(R)sTLPPGNTR(E) 100% 18.8 51.82865 5.16 3.853872 931.776 3011470 11 19 
(R)sTLPPGNTR(E) 100% 23.23 51.21688 9.04 2.823909 976.649 3960360 11 19 
(R)sTLPPGNTR(E) 100% 18.29 51.47157 8.08 2.39794 1,021.70 4191230 11 19 
(R)sTLPPGNTR(E) 100% 20.71 51.21688 5.87 1.958607 999.38 3601380 11 19 
(R)sTLPPGNTR(E) 97% 14.22 51.70115 1.77 1.568636 909.745 2100740 11 19 
(R)wDYPEGTPSGGSSTLPSAPPP
ASAGLk(S) 
100% 72.61 61.42182 60.14  3,080.42 5.16E+07 34 60 
(R)wDYPEGTPSGGSSTLPSAPPP
ASAGLk(S) 
100% 86.01 61.44331 80.14  3,102.32 9276140 34 60 
(R)wDYPEGTPSGGSSTLPSAPPP
ASAGLk(S) 
100% 33.45 61.41948 24.26  3,086.67 1.51E+07 34 60 
(R)wDYPEGTPSGGSSTLPSAPPP
ASAGLk(S) 
100% 34.41 61.44419 29.08  3,107.08 6640180 34 60 
(K)sHPPPPEk(-) 100% 25.47 53.67378 19.48 1.148742 485.259 1.95E+08 61 68 
(K)sHPPPPEk(-) 100% 21.42 53.67378 20.15 1 497.769 6.16E+07 61 68 
(K)sHPPPPEk(-) 100% 28.68 53.64467 12.56 1.677781 501.231 6046330 61 68 
(K)sHPPPPEk(-) 100% 20.83 53.70718 16.34 0.552842 613.344 519783 61 68 
(K)sHPPPPEk(-) 100% 26.46 53.67378 18.15 2.113509 486.507 2.23E+07 61 68 
(K)sHPPPPEk(-) 100% 18.64 53.70311 14.55 1.356547 637.989 387991 61 68 
(K)sHPPPPEk(-) 99% 16.48 53.6895 16.48 0.537602 674.166 346576 61 68 
(K)sHPPPPEk(-) 98% 24.19 53.64467 12.76  497.292 6.37E+07 61 68 
(K)sHPPPPEk(-) 98% 23.84 53.70539 21.05  567.396 893007 61 68 
(K)sHPPPPEk(-) 97% 21.7 53.64468 15.85  520.693 3597110 61 68 
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